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Pathogenesis
R2105 Gram-positive and Gram-negative bacteria induce
neutrophil oxygen burst augmented by platelets; role of
platelet-derived TXA2 in cellular host response
J. Miedzobrodzki, T. Panz, R. Jaworek, S. Chlopicki (Krakow, PL)
Objectives: The non-self particles and bacteria invading the bloodstream
(which circulate in the blood) trigger the inﬂammatory response e.g.
oxygen burst in neutrophils. This study was aimed to test the ability
of neutrophils to respond to variety of bacteria species and to latex
particles in absence and in presence of platelets. The second goal was
to investigate the role of platelet–derived TXA2 in the regulation of
neutrophil-response to latex. The following bacteria species were used
as stimulus generators: Gram+ bacteria such as Staphylococcus aureus
and Bacillus subtilis, Gram− bacteria as Escherichia coli and Klebsiella
pneumoniae.
Methods: The oxygen burst in neutrophils * platelets was investigated
with luminol chemiluminescence (CL). The role of TXA2 was studied
with the use of furegrelate, the TXA2 synthase inhibitor. All CL
experiments were performed with MicroLumat LB 96P Berthold
apparatus and WINGLOW programme.
Results: The Gram+ bacteria activate neutrophils. Neutrophils interact-
ing with platelets increase the intensity of oxygen burst when compared
with control neutrophils without platelets. There was no difference in
neutrophile stimulation between killed and live bacteria. In presence
of TXA2 inhibitor furegrelate, (bacteria induced and) latex-induced
oxygen burst of neutrophils, was completely blocked. The activation
of neutrophils with opsonised bacteria induces stronger oxygen burst
than stimulation with non-opsonised bacteria. The neutrophile activating
factor in Gram+ bacteria is connected with bacteria cell walls, and not
with their extracellular metabolites. In Gram− bacteria LPS inhibited
neutrophile response, the same effect was with polysaccharide capsule
of Klebsiella pneumoniae.
Conclusion: The stronger CL recorded in experiments with neutrophils
in the presence of platelets indicates the cooperation between these cells
during inﬂammation. TXA2 was the key mediator in platelet-dependent
ampliﬁcation of reactive oxygen species production by neutrophils.
R2106 Proﬁling the acute inﬂammatory response to heat-killed
menigococci and pneumococci in cerebrospinal ﬂuid
M. Wittwer, C. Bellac, S. Leib (Berne, CH)
Objectives: The two most common aetiological agents of bacterial
meningitis (BM) Streptococcus pneumoniae and Neisseria meningitidis
differ considerably with respect to mortality (approx. 30% vs. 10%) and
the incidence of neurological sequelae (approx. 40% vs. 10%). Here we
assessed the cytokine response to the two pathogens in the cerebrospinal
ﬂuid (CSF) after intracisternal challenge with heat killed bacteria in
infant rats with the aim to investigate the mechanisms for the observed
differences in clinical outcome.
Methods: Eleven days old Wistar rats were randomised for intracisternal
challenge with either 10 microL of saline containing heat killed
S. pneumoniae (serogroup 3; 5.00E+10 cfu/mL; n = 15) or heat killed
N. meningitidis (5.00E+10 cfu/mL; n = 15). Microsphere-based multiplex
assays (Lincoplex, Linco Research Inc., St Charles, MA, USA) was
used to assess the concentrations of IFN-gamma, TNF-alpha, IL-1alpha,
IL-1beta, IL-2, IL-4, IL-6, IL-10 and GM-CSF in CSF samples at 0 h,
3 h, 6 h, 9 h and 12 h after infection (n = 3 for each experimental group
and time).
Results: The inﬂammatory reaction to the two pathogens showed a
similar expression pattern over time for the assessed CSF parameters.
The presence of heat killed bacteria led to a pronounced increase
(~1000 fold) in the CSF concentration of the pro-inﬂammatory cytokines
IL-1beta, TNF-alpha and IL-6 over 12 h with peak levels at 3 h to 6 h after
challenge. Parallel to the pro-inﬂammatory cytokines the concentration
of the anti-inﬂammatory cytokine IL-10 was increased (~10 fold) starting
at 3 h after challenge.
Conclusion: Based on the assessed CSF parameters and time period,
we found no marked difference in the host reaction to the two heat
killed bacteria in the cerebrospinal ﬂuid. Thus, other mechanisms likely
including bacterial virulence factors may contribute to the observed
differences in clinical outcome of BM due to the two pathogens.
R2107 The effect of endocannabinoids on apoptosis in
“experimental sepsis model” on mice
D. Kilic, T.R. Aydos, Z. Keskil, O. Bozdogan, F. Andic, O. Korkut,
M. Edremitlioglu (Kirikkale, TR)
Purpose: To investigate the apoptotic changes in renal tissues of septic
mice and the effects of cannabinoid receptor antagonist (AM 630) and
agonists (anadamid and WIN55,212-2) on these changes.
Materials and Method: In this study, 56 healthy Swiss albino mice
weighing 25−35 g. The mice were randomly divided into 8 groups:
control, sham, sepsis, sepsis treated with anandamide or WIN 55,212-2 or
AM 630 and sepsis treated with ethanol or DMSO. Sepsis was induced by
cecal ligation and puncture (CLP) under ketamine/xylazine anaesthesia.
After 48 hours, the mice were treated intraperitoneally with anandamide
(5mg/kg) or its solvent ethanol, WIN 55,212-2 (5mg/kg), AM 630
(1mg/kg) or DMSO which is used as the solvent of both. Ten minutes
later, the abdomen was incised and periton culture specimen was taken
to conﬁrm the existence of sepsis. The kidneys were harvested and ﬁxed
in 10% neutral formolin solution. The apoptotic changes in glomerulus,
proximal and distal tubulus, and collecting ducts were determined using
TUNEL method.
Findings: Neither one of sepsis, anandamide, WIN 55,212-2, AM 630,
ethanol or DMSO caused any apoptotic effects on glomerulus. The
induced sepsis caused an increase of apoptosis on proximal and distal
tubulus. In these parts of kidney, while anandamide, WIN 55,212-2,
ethanol or DMSO did not make any changes, AM 630 caused a decline
in apoptosis. In the collecting ducts; groups of sepsis, anandamide,
WIN 55,212-2 and AM 630 did not show any differences than the sham
group.
Results: In consistency with other studies indicating the inducement of
apoptosis by endotoxin in some tissues; sepsis, induced by CLP in mice
renal proximal and distal tubulus, showed apoptotic effects in this study.
While anadamide and WIN55,212-2 did not cause any changes in this
effect, CB2 cannabinoid receptor antagonist AM 630 caused a decline
in apoptosis. In renal glomerulus, apoptotic changes did not increase.
R2108 The prevalence of Clostridium difﬁcile toxin as a cause
of acute or chronic diarrhoea in a high HIV prevalence
population in sub-Saharan Africa
M.B.J. Beadsworth, A.M. Perez, L. van Lieshout, A. Watson, C.A. Hart,
E. Zijlstra, N.J. Beeching (Liverpool, UK; Blantyre, MW; Leiden, NL)
Background: There have been relatively few studies on the prevalence
of Clostridium difﬁcile (CD) in developing countries, and even less on
the importance of CD in diarrhoea related to HIV in the tropics.
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Objective: To study the prevalence of CD toxin (CDT) in adults
hospitalised in Malawi with bowel disturbance related to HIV, compared
to controls.
Methods: All consenting adult patients with diarrhoea and controls were
recruited on every Tuesday and Wednesday for one year. Alongside
demographic data, HIV testing (and CD4 if HIV-1 positive) were
carried out. Clostridium Difﬁcile toxin A/B were tested using Techlab®
Elisa. HIV-1, Unigold® and Determine® Spot tests. CD4 Becton
Dickinson FACScount®. Conﬁrmation of toxins using Techlab® Elisa
and spectrometry is on-going.
Results: Over one year 398 were recruited, 84.4% of those were HIV
positive (n = 305). Approximately, 12% of those invited declined to enroll
over the year.
Acute diarrhoea was seen in 48.9%, chronic diarrhoea 32.5% and 19%
were controls. 96.4% of those with chronic diarrhoea were HIV-1
positive (p< 0.0001). Of the 137 so far tested for CDT in Malawi and
the UK, 23.4% (n = 32) are positive and 76.6% negative (n = 105). Of the
32 positive samples 34.4% are male and 62.5% are female. 80.6% had
diarrhoea, 19.4% were control patients. Of those with diarrhoea 72%
had non-bloody and 28% bloody.
Recent antibiotic use was described in 46.9%, denied in 46.9% and in
6.3% unknown. Complete analysis will be presented.
Conclusions: Thus far:
1. A quarter of recently hospitalised adults in Malawi have detectable
CD Toxin in faeces.
2. Over 80% of sequentially admitted adults are HIV positive, rising to
>95% of patients with chronic diarrhoea.
3. Preliminary analysis does not support a strong link between the
presence of CD toxin and diarrhoea or dysentery in this setting.
R2109 The role of Chlamydophila pneumoniae and human herpes
virus 6 in aetiopathogenesis of multiple sclerosis and the
relation of multiple sclerosis with apolipoprotein E genotypes
B. Kocazeybek, B. Karatoka, M. Aslan, S. Saribas, A. Altintas, S. Ergin,
V. Koksal, A. Dirican, S. Saib (Istanbul, TR)
MS (multiple sclerosis) is an disease of central nervous system (CNS)
which act on teenagers and adults. Some studies showed that several
infectious agents can play a role as the aetiological factor in MS
progression. ln the last three decades, investigators suggested that
microorganisms can be related with MS progression. The purpose of this
study was to investigate the relationship between MS and C. pneumoniae
with HHV-6, and also to determine the Apo E genotype distrubution in
MS patients and its relationship with C. pneumoniae and HHV-6.
39 MS patients, 42 healthy controls and 10 patients with other neurologic
diseases (OND) were included in this study. We detected C. pneumoniae
IgG, IgM and IgA with HHV-6 IgG and IgM in sera taken from
MS patients and healthy controls with microimmunﬂuorescence method
and we detected C. pneumoniae and HHV-6 DNA in cerebrospinal
ﬂuid (SCF) specimens taken from MS patients and OND patients with
Polymerase Chain Reaction (PCR). Apo E genotyping was applied on
whole blood samples (taken in EDTA tubes) of 36 MS patients and 30
healthy controls.
35 MS patients (89.7%), 32 healthy controls (76.2%) and 10
OND patients (100%) were previously infected with C. pneumoniae.
According to these results, there was no difference between these groups
when MS patients were compared, with control group. Furthermore,
C. pneumoniae or HHV-6 DNA was not detected in any of MS nor
OND patients’ CSF (cerebro spinal ﬂuid) samples. In 26, 8 and 2 of MS
patients, e3e3 (72.2%), e2e3 (22.2%) and e3e4 (%5.6) were detected,
respectively and Apo E genotype distrubution was found similiar with
the normal population when these results were compared with control
group. Furthermore, no relationship between Apo E e4 allele and MS
clinical ﬁndings were observed.
As a result of this study, we suggest that there is no triggering or
distrubing effect of C. pneumoniae or HHV-6 on MS which was thought
to be as multifactoriel ethiologic agents of MS progression according
to our ﬁndings. We suggest that Apo E genotype distrubutions in MS
patients is similar with normal population and there is no relation
between apo E alleles with disease duration and disability progression
in MS patients. We think that it is early to say something deﬁnite and
further studies were needed for relationship between Apo E genotype
with C. peumoniae and HHV-6.
R2110 The effect of variceal bleeding on T-cell subsets in patients
with cirrhosis
M. Lagadinou, E. Kaissi, M. Karakantza, H. Bassaris, C. Gogos
(Patras, GR)
Aim: Variceal bleeding may lead to infectious complications in patients
with liver failure. The aim of the present study was to investigate the
effect of variceal bleeding on T-cell supsets of patients with cirrhosis.
Patients and Methods: The study included 21 patients with biopsy
proven liver cirrhosis, that were admitted to the hospital. Six of them
were admitted to the Hospital due to variceal bleeding (group 2) while
the rest 15 were free of bleeding (group 1) and were admitted due to
another cause. T-cell subsets (Total T-cells [CD3], helper T-cells [CD4],
suppressor T-cells [CD8] and Natural Killer cells [CD56]) were measured
upon admission and day 3, by using ﬂow cytometry.
Results: The absolute number of T-cell subsets in group 1 vs group
2 were the following (mean ± SEM): Admission = CD3: 565±88
vs 507±197, CD56: 160±37 vs 95±14 (P< 0.05), CD4: 379±60
vs 311±143, CD8: 192±35 vs 172±56, Day 3 = CD3: 565±88 vs
259±62 (P< 0.05), CD56: 160±37 vs 60±13, CD4: 379±60 vs 178±36
(P< 0.05), CD8: 192±35 vs 111±62.
Conclusions: It seems that variceal bleeding may cause immunosup-
pression through a signiﬁcant decrease of Natural Killer cells, as well as
a decrease in total and helper T-cells. This may compromise immune
response and may be associated with the observed increased in the
frequency of infectious complications in cirrhotic patients, complicated
with variceal bleeding.
Bioﬁlm
R2111 Inﬂuence of organic and inorganic acids on bioﬁlm
formation by Salmonella spp.
I. Cirkovic, M. Svabic Vlahovic, S. Stepanovic (Belgrade, RS)
Bacterial bioﬁlms in food processing environments is of special
importance as it has the potential to act as the chronic source of microbial
contamination that may lead to food spoilage or transmission of diseases.
Bioﬁlms by pathogenic bacteria such as Salmonella spp. have been
reported. Numerous studies have shown that these bacteria are capable of
forming bioﬁlm under different environmental conditions. The objective
of the present study was to investigate the inﬂuence of organic and
inorganic acids on bioﬁlm formation by Salmonella spp.
The quantiﬁcation of bioﬁlm formation by 30 Salmonella spp. strains
was performed by the modiﬁed microtiter-plate test. After overnight
incubation in Trypcase-soy broth, which pH was adjusted by HCl and
acetic acid to 7; 6; 5 or 4, poured in 96-well ﬂat-bottomed plastic
microplates, bacterial bioﬁlms were ﬁxed with methanol and stained
with crystal violet. The bound dye was released with 33% glacial acetic
acid, and optical density was measured at 570 nm by using an automated
microtiter-plate reader. Upon the optical densities of bacterial bioﬁlms,
all strains were classiﬁed into the following categories: no bioﬁlm
producers, weak, moderate or strong bioﬁlm producers. Differences in
the quantity of produced bioﬁlm were examined by the Friedman test,
followed by the Wilcoxon signed ranks test. P values of <0.05 were
considered signiﬁcant.
The number of bioﬁlm producing strains were highest in broth at pH 7,
adjusted by HCl or acetic acid (26, 86.7%). In the media with HCl
14 (46.7%) strains produced bioﬁlm at pH 6, 7 (23.3%) strains at pH 5
and none at pH 4. In the media with acetic acid only 7 (23.3%) strains
produced bioﬁlm at pH 6, 1 (3.3%) strain at pH 5 and none at pH 4.
The quantity of bioﬁlm produced by tested strains was signiﬁcantly
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larger (p< 0.05) in medium at pH 7 than in other media. Organic acid
signiﬁcantly reduced (p< 0.05) bioﬁlm formation compare to inorganic
acid.
The obtained results showed that acid pH reduces the ability of
Salmonella spp. to produce bioﬁlm. The stronger inﬂuence of organic
compare to inorganic acid on bioﬁlm formation could have a great
implication in food industry.
Antimicrobial pharmacokinetics,
pharmacodynamics, general pharmacology
R2112 Pharmacokinetic study of ertapenem in the biliary tract
A. Skiada, D. Chardaloubas, D. Dimitroulis, A. Smyrnis, J. Anyfantis,
M. Grammatikou, E. Petrikkou, A. Papachristodoulou, G. Petrikkos
(Athens, GR)
Objectives: Ertapenem has been licensed for the treatment of
community acquired pneumonia, acute gynaecological infections and
intra-abdominal infections, including biliary tract infections. However,
pharmacokinetic data on biliary tract tissues are limited. The purpose
of this study was to measure the levels of ertapenem in the bile, the
gallbladder wall and the surrounding tissues of the biliary tract as well
as the kinetics of the drug.
Patients and Methods: Adult patients undergoing elective cholecystec-
tomy were included in the study, after giving informed consent. Patients
who had renal, hepatic or cardiac failure, as well as patients with an
active infection, were excluded. Two doses of ertapenem of 1gr were
administered via intravenous infusion of 30 minutes duration to all
patients, divided by a 24 h interval. Specimen of the bile, the wall of
the gall-bladder as well as of other tissues of the biliary tract were taken
intraoperatively. The specimen were obtained at various time intervals (0,
2, 4, 8, 12, 18 post administration of the second dose of the drug). Serum
levels of the drug were measured simultaneously. Agar well microbiology
diffusion method was used for determination of drug level.
Results: Twenty-six patients were initially enrolled in the study, but
eight were dropped out. Eighteen patients, 11 female and 7 male,
with an average age of 54 years (range 28 to 65) were evaluated.
After administration of ertapenem no serious adverse experiences were
observed. Serum samples were taken from 16 patients, bile samples from
18 and gallbladder tissue from 7. The concentrations of ertapenem in the
gallbladder tissues were noted to be lower as the time interval between
administration of the second dose of ertapenem and tissue sampling
increased. However, no such trend emerged regarding the concentrations
in bile and serum. The measured ertapenem concentrations in the bile
and the bile-to-plasma concentration ratio showed a broad variation. The
concentrations of ertapenem in serum ranged from 0.07 to 181mg/L,
with no clear correlation with the times of infusion of ertapenem. The
same was true for concentrations in the bile, which ranged from 0.31 to
389mg/L.
Conclusions: Concentrations of ertapenem in bile and serum vary
considerably from patient to patient. Since the sample was relatively
small, it would be interesting to extend it to include more patients in
order to better analyse the results.
R2113 Do high doses of quinolones decrease the emergence of
antibacterial resistance? A systematic review of data from
comparative clinical trials
M. Falagas, I. Bliziotis, P. Rafailidis (Athens, GR)
Background: The use of high doses of antimicrobial agents is considered
a therapeutic approach that may reduce the development of antimicrobial
resistance.
Methods: We performed a systematic review of the available data from
comparative clinical studies reporting on the emergence of resistance
when using different daily doses of quinolones.
Results: Relevant studies were identiﬁed from PubMed and the Cochrane
Central Register of Controlled Trials (until June 2006). Twelve studies
reported comparative data regarding the emergence of antimicrobial
resistance. Development of resistance occurred in patients of 5/12
studies included in the review, with no statistical difference between
the compared arms.
Conclusions: Although data from laboratory studies are indicative of a
beneﬁt from using high daily doses of quinolones in order to minimise
the emergence of antimicrobial resistance, the limited data from the
reviewed trials do not support this. Further comparative clinical studies
focusing on this issue are justiﬁed.
R2114 Adverse events and b-lactam trough plasma concentrations
during the treatment of endocarditis
P. Tattevin, O. Tribut, E. Polard, F. Gouaillier, M. Mercier,
C. Kervegant, J. Chapplain, C. Arvieux, C. Michelet (Rennes, FR)
Objectives: High doses of Beta-Lactam (BL) are recommended for the
treatment of infective endocarditis (IE). Guidelines have not signiﬁcantly
changed since 1960’s although IE is now frequently diagnosed in elderly
patients with comorbidities, which may affect BL pharmacokinetics. We
investigated the range of plasma BL concentrations achieved during the
treatment of IE and their association to potential adverse events (AE).
Methods: Prospective study of 30 consecutive patients with deﬁnite
IE (Duke criteria) treated with BL according to guidelines. Trough
BL plasma concentrations were determined by high performance liquid
chromatography at least twice during treatment. Potential AE were
deﬁned as events occurring after the initiation of BL and were
retrospectively extracted from medical chart and nurses reports by 2
investigators unaware of their BL concentrations.
Results: There were 21 men and 9 women. Mean age was 65.5 years
(SD 17.9). In 19 patients (63.3%), at least one AE was suspected
including sleep disorders (n = 11), confusion (n = 8), diarrhoea (n = 8),
vomiting (n = 6) and mood disorders (n = 7). Mean ± SD amoxicillin
concentrations were 33.6±22.7mg/L (31 measures) in patients without
AE and 92.7±80.1 (38 measures) in patients with AE (P< 0.001).
Through concentration Amoxicillin Cloxacillin Ceftriaxone
No. of measures 69 14 4
Mean (mg/L) 66.9 43.2 85.8
Standard deviation (SD) 68.4 37.4 36.6
Conclusions: The incidence of potential AE is high during the treatment
of IE with currently recommended doses of BL and is associated with
high trough BL plasma concentrations.
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R2115 Frequency of mutations in rpoB and katG gene of
rifampicine and isoniazid-resistant strains isolated from
primary and secondary tuberculosis infection in Iran
S. Zaker Bostanabad, L. Titov, A.R. Bahrmand, M. Taghikhani (Tehran,
IR; Minsk, BY)
Background: Multidrug-resistant M. tuberculosis is an emerging
problem of great importance to public health of Iran. The aim was to
determine resistance-associated mutation in 81 bp region of the rpo B
gene in Rif-r MBT strains. Resistance to izoniazid in M. tuberculosis is
associated with single nucleotide polymorphism resulting in amino acid
substitution in kat G gene.
Methods: 39 cultures of Rif-r Mycobacterium spp. were isolated from
160 sputum specimens collected in Iran, 34 Rif-r isolates (87%) were
identiﬁed as Mycobacterium tuberculosis. 28 IZN-R MBT were isolated
from patients with active pulmonary tuberculosis in Iran. 411 bp
fragments of rpo B gene and 209 bp fragments of kat G gene were
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PCR-autosequenced and analysed with computer programmes MEGA
and DNAMAN.
Results: For rpoB: It was detected 60 mutations and 13 microdeletions
in 29 RIF-r MBT (85%). No mutations were found in the core region of
the rpoB gene in 5 RIF-r MBT (15%). Of 60 found mutations 6 were
silent, 54 were missense. Most of detected deletions were identiﬁed in
codon 510. All silent mutations were localised in codon 507, missense
mutations produced 23 types of amino acid substitutions. Alterations in
these triplets displayed 50 and 35% tested isolates. Mutations in codons
510, 507, 531 were registered in 27, 24, 21% of isolates correspondingly.
We observed 5 alleles in codon 526, 3 alleles in triplets 507, 508, 513. 6
strains (19%) harboured single mutations placed in 526, 510 codons
while the rest of isolates had multiple mutations: double, triple and
quadruple mutations present in 34; 22, 3% of strains. 12% of strains
harboured 5 mutations.
For katG: 2 strain has not any mutation. In 20 strains mutation was
proved in codon 315 by three type of mutation consist of AGC→ACC
(Ser→Thr) (80%), AGC→AGG (Ser→Arg) (5%) and AGC→AAC
(Ser→Asn) (15%). Furthermore most mutations were proved in 311,
299, and 322 codons by one type of mutation. In 12 strains one mutation
in codon 315 was proved. In 7 strains 2, in 5 isolate 3, and in 2 strains
4 mutations were proved. Nine silent mutations was demonstrated in
codon 311 (GAC→TAC) with anything changes in amino acid. In 2
strains with any drug resistances any mutations was demonstrated too.
Thus, all IZN-r MBT had resistance-associated nucleotide changes
mostly in codons 315. Hence RIF-r MBT had resistance-associated
mutations predominantly in rpo B gene codons 523 and 510.
R2116 The rate of horizontal transmission of antibiotic resistant
plasmids is increased in food preservation-stressed bacteria
M.A.S. McMahon, I.S. Blair, J.E. Moore, D.A. McDowell
(Newtownabbey, Belfast, UK)
Objectives: Many modern food preservation processes involve the
continuous application of one or more bacteriostatic (sub-lethal) stresses
to slow or prevent bacterial growth in food within the food chain.
This is very different from the approach used in traditional preservation
systems, which usually apply single, brief, severe, bactericidal (lethal)
treatments, with the aim of killing or permanently inactivating most of
the bacteria present in the food, prior to its release into the food chain.
This study investigated the possibility that sub-lethal food preservation
stresses (high/low temperature, osmotic and pH stress) can alter the
rate of horizontal transmission of antibiotic resistance (ABR) plasmids
between E. coli strains and between E. coli and Salmonella typhimurium.
Methods: Plasmid-bearing E. coli donor cultures (NCTC 50021 –
F1 plasmid R386 or NCTC 50338 – Inc I1 plasmid TP307) and E. coli
recipient cultures (NCTC 35695 & NCTC 33694) and S. typhimurium
(wild type st11) recipient cultures were mated under a range of sub-lethal
environmental stress conditions (low temperature, high temperature, low
pH and high NaCl). A transfer rate was determined for each donor/
recipient/stress combination.
Results: The study found that the horizontal transmission rate of F1
plasmid R386 and Inc I1 plasmid TP307 is signiﬁcantly increased
(p< 0.05) when pre-stressed donor and recipient cells are mated under
conditions of environmental stress (high/low temperature, osmotic and
pH stress).
Conclusions: These results indicate that increased use of bacteriostatic
(sub-lethal), rather than bacteriocidal (lethal) food preservation systems,
may be contributing to the dissemination of ABR among important food
borne pathogens.
R2117 QRDR mutations and efﬂux activity of 87 clinical S. pneumo-
niae isolates collected during the MOTIV Study (2004–2005)
I. Knezevic, G. Weskott, S. Doerlemann, P. Surdakowski, E. Operschall,
P. Arvis, S.H. Choudhri, K. Ehlert, J. Ambler (Wuppertal, DE; Puteaux,
FR; West Haven, US)
Objectives: This study explored the mutation pattern of 87 S. pneu-
moniae isolates collected during the MOTIV study before antibiotic
therapy was started. Hospitalised patients with CAP (PSI classes, III,
IV or V) received 400mg IV/PO moxiﬂoxacin (MXF) q.d. or high
dose ceftriaxone (CTX) 2 g q.d. and IV/PO levoﬂoxacin (LFX) 500mg
b.i.d. for 7−14 days. MICs were determined for MXF, LFX, CFX,
clarithromycin (CLAR) and penicillin (PEN). Quinolone resistance
determining regions (QRDRs) of topoisomerase II and IV and efﬂux
of MXF, LFX and CFX were analysed.
Methods: MICs were determined by broth microdilution method (CLSI
methods). The QRDRs were ampliﬁed and sequenced. Strains were
tested for active efﬂux by the broth microdilution method with or without
10mg/mL reserpine. Strains for which there was 4-fold decrease in
MIC in the presence of reserpine were considered positive for reserpine-
inhibited efﬂux.
Results: All S. pneumoniae isolates were susceptible to MXF, LFX and
CFX. MXF showed the lowest MIC90 (0.25mg/L). 15% of isolates were
resistant to CLAR and 17% were intermediate or resistant to PEN.
No S. pneumoniae isolate possessed a ﬁrst-step mutation in Ser79 of
parC or Ser81 of gyrA. New mutations were found in gyrA (Asn137Ile)
and gyrB (Arg571Cys, Tyr525His and Val355Ile). Mutations were found
most frequently in parE (Ile460Val) and parC (Lys137Asn). 20 (23%)
strains were observed to have efﬂux activity; 17 of these were active on
CFX, of which 4 were also active on LFX and/or MXF. 2 strains had
efﬂux that was active on LFX but not on CFX, and one strain had efﬂux
with activity on LFX and MXF but not on CFX. All but one isolate with
efﬂux had the Ile460Val substitution in the parE gene.
Conclusion: No ﬂuoroquinolone resistance or Ser79/Ser81 substitutions
in parC/gyrA could be detected among 87 S. pneumoniae isolates
collected during the international MOTIV study. However, 4 new
mutations were found in the QRDR of gyrA and gyrB but these mutations
did not inﬂuence susceptibility to ﬂuoroquinolones. Efﬂux pump activity
was most prominent for CXF.
R2118 mef gene can be not enough for macrolide resistance in
Viridans streptococci clinical isolates
M. Herna´ndez Iglesias, J. Garcı´a Rodrı´guez, J. Mun˜oz Bellido
(Salamanca, ES)
Background: Our initial purpose was to know the role of pharyngeal
viridans streptococci (VS) as a resistance reservoir for pneumococci.
Thus, we determined the frequency of macrolide resistance, and
macrolide resistance genes among pharyngeal VS in healthy individuals,
and their capacity to be transformed to S. pneumoniae.
Methods: Pharyngeal swabs from 89 non-selected, healthy individuals
were spread onto antibiotic-free blood agar plates, and onto blood agar
plates with 0.5mg/mL of erythromycin (ERY). Alpha-haemolytic Gram
positive cocci growing in ERY plates, and 3−4 colonies among beta-
haemolytic Gram positive cocci growing in antibiotic-free plates, were
identiﬁed by usual methods, and by the API 20 STREP system. MIC of
ERY was determined by the agar dilution method. The presence of mef,
ermA, ermB and ermTR genes was determined by PCR. Transformation
to S. pneumoniae R6 was performed according previously described
methods.
Results: We isolated macrolide-resistant viridans streptococci (MRVS)
in 48 individuals (53.9%). 42 MRVS harboured mef genes (87.5%),
one ermB (2.1%), and 5 both mef and ermB genes (10.4%). No
isolates harboured ermA or ermTR genes. ERY MIC range of MRVS
was 1–128mg/mL (MIC50: 4mg/mL, MIC90: >28mg/mL). ERY MIC
range of macrolide-non-resistant (MSVS) isolates was 0.02−0.5mg/mL
(MIC50: 0.1mg/mL, MIC90: 0.2mg/mL). Among MSVS, we found
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4 S. mitis isolates (9.7%) harbouring a mef gene. Nevertheless,
their MICs of ERY were similar to mef(−) MSVS isolates (range:
0.05−0.5mg/mL). The genetic environment study suggests mef gene
might be included in a genetic element similar to MEGA. When we
performed transformation experiments, we got mef(+) S. pneumoniae
R6 transformants. Nevertheless, these transformants were ERY-resistant,
with ERY MICs similar to mef(+), MRVS isolates.
Conclusions: mef gene may be not enough for determining ERY-
resistance in VS clinical isolates. Nevertheless, their DNA seems to be
able to confer ERY-resistance to pneumococci.
R2119 Carbapenem resistance of Escherichia coli strains
R. Schaumann, D. Adler, A.C. Rodloff (Leipzig, DE)
Objectives: Carbapenem (CP) resistance of Escherichia coli strains is
extremely rare and seldomly discussed. The aim of the present study was
to investigate the resistance mechanisms of three recent clinical E. coli
isolates that were CP resistant.
Methods: MICs for imipenem (IMP), meropenem (MER), and
ertapenem (ERT) as well as ESBL or MBL production were determined
by Etest. Furthermore, the three strains were analysed for blaTEM,
blaSHV, blaampC, blaACC, blaVIM, and blaIMP by PCR and isoelectric
focusing and visualisation by nitroceﬁn and coomassie blue was carried
out. In addition, the strains were serially passaged on antibiotic free
columbia agar plates and MICs re-determined. Conversely the three
strains and – for control purposes – eight susceptible E. coli strains were
incubated on solid media containing IMP, MER, and ERT, respectively,
at twice their MICs. After incubation growing bacteria were harvested
and incubated at four times MICs. This procedure was repeated with
increasing antibiotic concentrations. The resulting MICs were conﬁrmed
by Etest.
Results: The MICs for the three resistant strains ranged from 4 to
>32mg/L. The other E. coli strains showed MICs between 0.004 and
0.38mg/L. After passages on antibiotic free medium, the MICs for the
three strains decreased to 0.38 to 16mg/L. However, after passages
on antibiotic containing agar plates the MICs were >32mg/L for all
three CPs tested. The resistant strains contained blaampC and blaTEM.
Isoelectric focusing demonstrated b-lactamases of various isoelectric
points while the MBL and ESBL tests were negative or not calculable
except for one strain. Furthermore, elevated MICs were inducible with
ERT and IMP in the susceptible strains but not with MER.
Conclusion: E. coli strains may posses various mechanisms such as
blaampC and blaTEM that in combination cause CP resistance. They
may loose their phenotypic resistance after several passages on antibiotic
free medium. Conversely, employing passages on antibiotic containing
medium led to reappearance of the resistant phenotype.
R2120 Characterisation of unusual patterns of MLS resistance
among Streptococcus pyogenes clinical isolates
L. Vitali, S. Rombini, D. Petrelli, S. D’Ercole, G. Pasquantonio,
C. Ripa, M. Prenna (Camerino, Rome, Ancona, IT)
Objectives: In Gram-positive cocci, macrolide, lincosamide, and
streptogramin B (MLS) resistance can be expressed either constitutively
(cMLS) or inducibly (iMLS) and is mediated by the presence
of erm genes. The present work sought to investigate the iMLS
and cMLS phenotypes of a group of erm(B)-positive Streptococcus
pyogenes clinical isolates showing non-standard behaviours in the
erythromycin (ERY)–clindamycin (CLI) double disk diffusion testing.
Methods: Eight clinical isolates coming from patients with pharyngitis
and two reference strains were analysed. Their ERY resistance phenotype
was determined by the double disk diffusion testing and by growth
in liquid medium using cells induced by preincubation with ERY
(0.1mg/L) followed by challenge with 50mg/L of CLI. Inoculum
preparation was accomplished by the two alternative procedures
suggested by CLSI. Muller–Hinton II (MH) and Brain-Heart-Infusion
(BHI), both supplemented with 5% sheep blood, were used as test media.
Cultures were incubated at 35ºC in an atmosphere of 5% CO2 for a
maximum of 24 h.
Results: Double disk diffusion testing, with the inoculum prepared by
direct colony suspension, assigned 50% of the strains to the cMLS
phenotype. Within this group three strains showed an inner hazy D-
shaped inhibition zone around the CLI disk (HD). Among the four
iMLS strains, three presented small colonies growing proximal to CLI
disk in otherwise essentially clear zone (D+). Induction experiments in
liquid medium showed that HD strains responded to some extent to
induction but only during the logarithmic phase of growth, while in the
D+ group even non-induced samples became resistant when cells reached
the stationary phase. To test weather the efﬁciency in the control of the
iMLS resistance was growth rate dependent, MH was replaced with
BHI and the inoculum prepared following the growth method. In these
conditions, D+ strains reverted to a plain iMLS and HD to a cMLS,
both in agar and in liquid. These effects were even more evident after
an incubation time of 6−8 h.
Conclusion: These results indicate that double disk diffusion testing
for MLS phenotype determination in S. pyogenes should be performed
starting with an inoculum prepared by the growth method and results
read also during the course of the experiment (e.g. at 6−8 h). The use
of BHI instead of MH further diminish difﬁculties in the assignment of
some S. pyogenes strains to the correct MLS phenotype.
R2121 In vitro activity of tigecycline and comparators against
Acinetobacter baumannii isolated from severe infections in
Italy
M. Mezzatesta, M. Trovato, V. Nicolosi, D. Nicolosi, G. Nicoletti,
A. Cassone, G. Fadda, G. Schito, S. Stefani (Catania, Rome, Genoa, IT)
Objectives: In a recent multi-centre survey (2003–2004), conducted
in 45 laboratories throughout Italy with the aim of monitoring
microrganisms responsible for severe infections and their antibiotic
resistance, Acinetobacter baumannii was isolated from the ICU of 12
centres as the third most frequent pathogen. Due to the increasing
importance of this microrganism in hospital epidemiology, which is
partly due to its success in acquiring resistance to carbapenem or showing
a multi-drug-resistance (MDR) phenotype, it is mandatory to look at the
activity of new antimicrobial agents.
Methods: Included in the study were 88 clinically signiﬁcant strains
of A. baumannii. Tigecycline and comparators were tested by MICs
following the CLSI guidelines. For the carbapenem resistant strains, a
preliminary phenotypic screening for the presence of metallo-enzymes
(MBL) was performed by Etest, and PCR was used to investigate the
presence of blaOXA, blaIMP and blaVIM genes. PFGE was performed
to test clonality.
Results: A. baumannii was a frequent cause of ventilator-associated
pneumonia and bacteraemia. Resistance to ceftazidime, ciproﬂoxacin
and aztreonam was widespread in almost 90% of strains; resistance to
imipenem was 51% and resistance to meropenem was 64%, amikacin
and gentamicin were active against 30% of strains and colistin was very
active.
Tigecycline had a MIC90 value of 2mg/L and our strains showed
a unimodal distribution of susceptibility, demonstrating that this new
drug is more active than other tetracyclines. Among the 45 imipenem-
resistant isolates (MIC gt; 16mg/L) only 17 strains showed a reduction
in the imipenem MIC with EDTA indicating MBL activity, but no
PCR products for blaIMP and blaVIM were obtained from the strains
analysed. Further studies are in progress for the characterisation of the
blaOXA resistance determinants. PFGE analyses showed the existence
of a multiresistant A. baumannii clone, widespread in different hospitals.
Conclusion: In conclusion, tigecycline showed a potent activity against
the MDR A. baumannii strains maintaining the same MIC90 of
2mg/L against the majority of carbapenem-resistant strains. The use
of additional molecular techniques to ﬁngerprint isolates will provide
further information on these clinically important MDR A. baumannii.
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R2122 Macrolide resistance by ribosomal mutation detected in
clinical isolates of Streptococcus pneumoniae isolated from
PROTEKT, 2000–2005
J.G.E. Northwood, L.R. Cossins, S.M. Forrest, D.J. Farrell (London,
Bollington, Macclesﬁeld, UK)
Objectives: PROTEKT is a global, longitudinal study of the antimicro-
bial susceptibility of bacterial pathogens associated with community-
acquired lower respiratory tract infections. We have been screening
clinical isolates from PROTEKT 2000–2005 for the genetic determinants
of macrolide resistance (Macr) (total of 9927 isolates) and have
discovered 166 isolates negative for known efﬂux or rRNA methylase
mechanisms. The aim of this study was to determine the molecular basis
of Macr in these strains.
Methods: Segments of the L4 & L22 riboprotein genes and the 4 copies
of the 23S rRNA (domains V and II) gene were ampliﬁed, sequenced
and mutations determined.
Results: [23s mutation, n/4 alleles, n isolates, erythromycin MIC mg/L].
A2058G, 2, 5, 128; A2058G, 3, 5, 32–128; A2058G, 4, 4, 128; A2059C,
4, 2, 128; A2059G, 1, 3, 1−16; A2059G, 2, 7, 4−64; A2059G, 3,
10, 16–128; A2059G, 4, 24, 16–128; C2611A, 4, 1, 1; C2611G, 3, 1,
128; G2057A, 4, 1, 0.5. [L4 riboprotein substitution and 23s mutation,
n/4 alleles, n isolates, erythromycin MIC mg/L] G95D, A2058G, 2,
1, 32, 128; G95D, A2059G, 4, 5, 32–128; A73T, A2059C, 4, 1, 128.
[L4 riboprotein substitutions, n isolates, ERY, CLARI, AZI MIC mg/L]
66_69InsRQKG, 1, 1, 0.5, 1; 68_69InsGK, 2, 0.5, 0.25, 4; 68−72 Del
KGTGR, 1, 1, 1, 4; G69E, T70A, 1, 0.25, 0.25, 1; E30Q, G69T, T70P,
G71S, V88I, 2, 128, 64, 128; G69T, T70P, G71S, V88I, 1, 128, 64,
128. Resistance mechanisms other than known efﬂux or rRNA methylase
mechanisms for Years 1, 2, 3, 4, and 5 were 1.7%, 1.6%, 1.5%, 1.6% and
2.0% respectively. Isolates without a detectable mechanism of resistance
for Years 1, 2, 3, 4 and 5 were 0.2%, 0.9%, 1.0%, 0.9% and 1.4%
respectively. The telithromycin MIC range for the 166 isolates was
0.004–1mg/L.
Conclusions: This study shows that the percentage of Macr S. pneu-
moniae with resistance mechanisms other than known efﬂux or rRNA
methylase mechanisms has not increased over the period of the study.
Resistance due to undetectable resistance mechanisms have increased
from 0.2% to 1.4%. The isolates are global in distribution. Telithromycin
MIC values remain low for all 166 isolates suggesting that riboprotein
mutations and the undetectable mechanisms of resistance do not have a
major effect on this new ketolide antimicrobial.
R2123 Carbapenem resistance among clinical isolates of
Pseudomonas aeruginosa and Acinetobacter baumannii
from hospitals in Cochabamba, Bolivia
E. Ferna´ndez, J. Zamora, M. Torrez, I. Rosales, C. Valderrey,
E. Sevillano, L. Gallego (Bilbao, ES; Cochabamba, Anzaldo, BO;
Leioa, ES)
Objectives: The aim of this work was to study the level of resistance to
carbapenems among clinical isolates of P. aeruginosa and A. baumannii
obtained from patients attended at different hospitals of the region of
Cochabamba, Bolivia.
Methods: The study included 58 isolates of P. aeruginosa and 5
A. baumannii obtained in the Microbiology Service of the Insti-
tuto Gastroenterolo´gico Boliviano–Japone´s from Cochabamba, Bolivia
during 2006 (January to October). Susceptibility to antimicrobial
agents was determined by the disc-diffusion method following the
NCCLS recommendations. The antibiotics tested were ceftazidime,
piperacillin, ceftriaxone imipenem, meropenem, amikacin, gentamicin
and ciproﬂoxacin. The presence of carbapenemases was detected by
Hodge test, Hodge+ZnSO4 test, double-disc synergy test (DDST) and
PCR analysis searching for blaOXA-40, blaIMP, blaVIM, blaSPM and
blaGIM genes.
Results: Total percentage of resistance was 11% to meropenem, 21% to
imipenem, 59% to amikacin, 62% to ciproﬂoxacin, 68% to gentamicin
and piperacillin and 97% to ceftriaxone and 98% to ceftazidime.
Nine P. aeruginosa and four A. baumannii isolates were resistant to
carbapenems and some of them showed carbapenemase activity. Table
1 shows patient data and results obtained in the carbapenem-resistant
isolates.
Code Source Patienta Resistance Carbapenemases
IP
M
M
E
M
C
A
Z
P
IP
C
R
O
A
M
K
G
E
N
C
IP
OXA-
type
MBLs
Pseudomonas aeruginosa
PB1 Wound F, 17 I − R I R R R R − −
PB2 Wound M, 35 I − R S I R R S − −
PB3 Ulcer M, 30 S I I R R I R R + −
PB4 Pharsec M R R S S R S S I − −
PB5 Urine M, 30 I S R R R R R R + −
PB6 Trasec M, 0.17 I R I S R S I S − −
PB7 Sputum F, 60 I I R I R R R R − −
PB8 Trasec F, 3 I S R S S R R R − −
PB9 Brsec F, 2 I I R S I S S S − −
Acinetobacter baumannii
AB1 Brsec M, 68 I − R R R R R R + −
AB2 Brsec F, 39 R − R R R R R R − −
AB3 Sputum F, 39 I S R R R R R R + −
AB4 Trasec M, 68M R R R R R R R R + −
aPatient data: gender, age. bBrsec, bronchial secretion; Phrsec, pharingeal
secretion; Trasec, tracheal secretion.
Conclusions: Imipenem and meropenem showed the best activity against
the isolates tested. The proporcional resistance to carbapenems was
greater in A. baumannii (4/5) than in P. aeruginosa (9/58). This is the
ﬁrst study which analyses the carbapenem resistance and carbapenemases
among Bolivian isolates.
R2124 Characterisation of the wild type AmpC b-lactamase CHE
A. Fernea, P. Mercuri, G. Arlet, M. Galleni (Lie`ge, BE; Paris, FR)
Objectives: AmpC-CHE is a chromosomal class C b-lactamase produced
by Enterobacter cloacae3. The most remarkable feature of this enzyme
is a 6 amino acid deletion (SKVALA, position 289–298) corresponding
to a deletion of 18 nucleotides in the gene. Furthermore the alignments
with other AmpC b-lactamase sequences shows that the 6 amino acid
sequence is conserved in the AmpC b-lactamases of Citrobacter freundii
and in the plasmid-mediated b-lactamases derived from. Our study
is focused on the determination of the inﬂuence of this deletion by
producing, purifying and undertaking kinetic characterisation of wild
type AmpC-CHE.
Methods: AmpC-CHE was isolated from a culture of Enterobacter
cloacae. The bacteria were grown at 37ºC in BHI media in the presence
of amoxicillin 20mg/mL. At an OD of 1.2 at 600 nm, cefoxitin (5mg/mL
ﬁnal concentration) was added to the media and the culture was incubated
for 4 additional hours. The bacteria were collected by centrifugation,
resuspended in 15mM sodium cacodylate pH 6 (buffer A) and lysed by
sonication. The crude extract was loaded on a SP sepharose equilibrated
in buffer A. The b-lactamase was eluted with a linear salt gradient.
The active fractions were collected, dialysed against 10mM sodium
phosphate buffer pH 6.8 (buffer B) and loaded on a hydroxyapatite
column equilibrated in buffer B. The AmpC enzyme was recovered
by elution of the column with a linear gradient (10–400mM sodium
phosphate pH 6.8). The N-terminal sequence and the exact molecular
mass of CHE were determined.
Finally, the kinetic proﬁle of the enzyme was characterised.
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Results: The puriﬁcation yield was estimated at 10%. The N-terminal
sequence of AmpC was in good agreement with the predicted cleavage
site of the pre-b-lactamase (TPSVE-). The mass of the mature form was
also in good agreement with the molecular mass determined by mass
spectrometry (38725 Da). The activity of AmpC-CHE was measured
against nitroceﬁn, cephalothin, benzylpenicillin, cefotaxime, cefepime
and cefpirome. The enzyme exhibited a broad spectrum of activity where
benzylpenicillin and nitroceﬁn were the best substrates.
Conclusion: No major difference in the catalytic properties could be
found when compared with the other enzymes of class C b-lactamases.
The impact of the deletion on the stability of the enzyme is in progress.
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R2125 Susceptibility of glycopeptide-resistant Enterococcus
faecium to tigecycline, dapto-mycin, linezolid, and
quinupristin-dalfopristin
J. Abb (Ludwigsburg, DE)
Objective: To study the in vitro activity of the glycylcycline tigecycline,
the lipopeptide daptomy-cin, the oxazolidinone linezolid and the
streptogramin quinupristin-dalfopristin against glycopeptide-resistant
Enterococcus faecium (GRE).
Methods: Sixty primary GRE isolates from hospitalised patients were
collected between January and December 2004. Minimum inhibitory
concentrations of vancomycin, tei-coplanin, tigecycline, daptomycin,
linezolid and quinupristin-dalfopristin against E. faecium strains were
determined by the E test. E. faecalis ATCC 29212 was used as a control
strain.
Results: MIC 50, MIC 90, and MIC range values are demonstrated
in the table. According to CLSI standard MS 100–S15 criteria all
GRE isolates were fully susceptible to tigecy-cline, daptomycin, and
quinupristin-dalfopristin. GRE strains, however, demonstrated a high rate
of only intermediate sensitivity (82 percent) against linezolid (MIC:
3.0 to 4.0mg/L), but none of the isolates was fully resistant to the
oxazolidinone.
MIC (mg/L)
Antimicrobial agents MIC50 MIC90 Range
Tigecycline 0.047 0.094 0.032–0.125
Daptomycin 1.5 1.5 0.5−3.0
Linezolid 3.0 4.0 0.75−4.0
Quinupristin–Dalfopristin 1.0 1.5 0.38−2.0
Teicoplanin 48 128 16−>256
Vancomycin >256 >256 128−>256
Conclusion: The present and previous in vitro studies show that
tigecycline, daptomycin, quin-upristin-dalfopristin, and linezolid may
be useful alternative agents for the treatment of patients with GRE
infections. The rapid emergence of E. faecium isolates with re-sistance
to the novel compounds, however, underlines the need for careful pre-
therapy susceptibility testing.
R2126 Microbial keratitis and antimicrobial resistance of the
isolates during a nine-year period
D. Mylona-Petropoulou, G. Ganteris, K. Tzanetou, E. Ziva,
D. Miltsakakis, D. Droutsas, H. Malamou-Lada (Athens, GR)
Objectives: To study the incidence and the aetiology of the microbial
keratitis and to examine the susceptibility of the isolates to antibiotics.
Methods: A retrospective study was performed of all isolates from
cases of keratitis between January 1, 1998 until August 31, 2006 at
Dept of Ophthalmology, Reference Center, Athens University, General
Hospital of Athens “G. Gennimatas”. Corneal scraping was performed
and processed for direct microscopy and culture for bacterial and fungal
isolates. MICs were determined using the VITEK II (boiMe´rieux) and
the E test (Biotest, Solna).
Results: During the nine years period 876 consecutive corneal samples
were obtained and 625 isolates were recovered in 515 positive cultures
(58.7%). Of these 429 (83%) had only bacterial growth (1−6 isolates),
56 (11%) had fungal growth (1−2 isolates) and 30 (6%) had mixed
fungal and bacterial growth. Polymicrobial infection was found in 90
(17.5%). Gram-positive bacteria dominated (447/625, 71%) followed by
Gram-negative bacteria (15%) and fungi (14%). Staphylococcus species
(Staphylococcus epidermidis was the predominant) and Pseudomonas
aeruginosa represented 36% and 6% respectively of the total bacterial
isolates. The commonest fungal pathogen was Fusarium spp. 20/86
(23%), followed by Aspergillus fumigatus 17/86 (20%), Acremonium
spp. 12/86 (14%) and Candida albicans 14/86 (16%). Although the
number of scraped corneal ulcers varied from 92 (2005) to 162
(2002) positive cultures, recovered bacteria and proportion of Gram-
positive, Gram-negative and fungal isolates per year remained constant
during the study period. There has not been an increase in the
proportion of isolates resistant to ﬂuoroquinolones and to gentamicin
and tobramycin from 2000, (9.5% and 14%), to 2006 (7% and 17%)
respectively. Staphylococcus species were resistant to methicillin in
19%, Pseudomonas aeruginosa isolates were sensitive to all tested
antibiotics during the study period. Streptococcus pneumoniae isolates
were penicillin resistant in 29%. In addition, voriconazole was the most
active antifungal agent.
Conclusion: The incidence, aetiology and susceptibility of the isolates
remained almost unchanged during the study period. Staphylococcus spp.
and Pseudomonas aeruginosa were the predominant bacterial pathogens
followed by fungi, with Fusarium spp. being the most common fungus.
Continued surveillance of the microbial keratitis is warranted.
R2127 Isotretinoin treatment in acne vulgaris has no inﬂuence on
the incidence of antibiotic-resistant Propionibacterium acnes
C. Oprica, L. Emtestam, L. Hagstro¨mer, C.E. Nord (Stockholm, SE)
Objectives: Isotretinoin is a synthetic retinoid and is a very effective
agent in the treatment of severe inﬂammatory acne, but also in moderate
acne in the presence of scars or psycho-social problems, affecting
all factors involved in its pathogenicity: sebum production, follicular
hyperkeratinisation, microbial colonisation by Propionibacterium acnes
and release of inﬂammatory mediators into dermis. The purpose was to
investigate the density and the antimicrobial susceptibility of P. acnes
skin strains isolated before, during and after treatment in patients with
moderate/severe acne with isotretinoin.
Methods: Twenty-four patients (17 men and 7 women, 15−35 years)
with moderate or severe inﬂammatory acne vulgaris participated in the
study. The patients received oral isotretinoin 1mg/kg/day in two doses
for 6 months. The drug is a potent teratogen and for women treated
with this drug a pregnancy test was performed and oral contraception
was started before and continued during the treatment period and 6
weeks post-therapy. Skin samples were taken at baseline, after 2, 4,
6 months of treatment and 2 months after the treatment had stopped
from ﬁve areas by using a soft gelatine with a cross-sectional area of
approximately 1 cm2 which was pressed against the skin surface for
10 seconds without rotation. Then a slice of the soft gelatine with the
bacterial bearing surface was cut off, put into a sterile glass tube with
pre-reduced peptone-yeast extract medium and immediately transported
to the laboratory for microbial cultivation, identiﬁcation, quantiﬁcation
and antibiotic susceptibility. The strains were tested for tetracycline,
clindamycin, erythromycin and linezolid and the breakpoints were
according to EUCAST.
Results: The treatment produced a signiﬁcant reduction in the total
P. acnes counts but tetracycline-resistant strains were acquired during
the 6-month treatment period. Two patients lost their resistant strains 2
months after the treatment had stopped. After 6 months of treatment,
patients carrying tetracycline-resistant P. acnes were found to be
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colonised with clindamycin-erythromycin-resistant strains more often
than patients with no tetracycline-resistant strains. No strain was found
to be linezolid resistant.
Conclusion: There is a complex relationship between antibiotic-resistant
P. acnes and treatment of acne vulgaris. Isotretinoin treatment has no
inﬂuence on the incidence of resistant P. acnes strains.
R2128 Antibiotic resistance amongst cutaneous propionibacteria
from Egyptian acne patients
T.S.M. El-Mahdy, M.M. Abd-Elaziz, M.H. El-Sayed, J.I. Ross, S. Abd-
Allah, H. Radwan, A.M. Snelling (Bradford, UK; Cairo, Ismailia, EG)
Objectives: Antibiotics are widely used to treat acne, with the aim of
reducing levels of Propionibacterium acnes on the skin. Unfortunately,
this species is rarely cultured and sensitivity proﬁles determined, before
prescriptions are written. Little work has been done in Egypt on drug
resistance in cutaneous propionibacteria, and there is no surveillance
data to inform clinical decisions. Anti-acne drugs are widely available,
including over the counter. This study aimed to 1) investigate antibiotic-
resistant propionibacteria amongst acne patients and controls in Cairo
and 2) screen for any resistance to triclosan, which is being increasingly
used in skin cleansers.
Methods: 52 acne patients (attending two dermatology clinics), 36 age-
matched controls from the community (no antibiotics taken in past
3mths), and 13 dermatology staff were sampled. Swabs of the face
were used to inoculate plates of tryptone yeast extract glucose (TYEg)
agar containing 6mg/L furazolidone ± breakpoint concentrations of
tetracycline (TET 5mg/L), erythromycin (ERY 0.5mg/L), clindamycin
(CLIN 0.5mg/L) and triclosan (TRIC 4mg/L). After anaerobic
incubation at 37ºC for 7 days, growth of colonies morphologically
resembling propionibacteria was scored.
Results: Propionibacteria were cultivated from the skin of all participants
except one control. For all three cohorts, CLIN was the most common
resistance encountered, being detected amongst 26.9% patients, 38.5%
staff, 41.7% controls. For ERY, the prevalences were 13.5, 23.1 and
33.3% respectively. Controls were more likely than patients to carry
ERY resistant strains (p = 0.016). In total, 18.8% of people had both ERY
and CLIN resistant strains. TET resistant strains were isolated from just
2 (3.8%) patients, compared to 7.7% of staff and 11.1% of controls.
Patients taking antibiotics were no more likely to carry resistant strains
than those who were not. Amongst the staff, 5 of 13 were colonised with
strains having at least one resistance, including all those who specialised
in treating acne. No resistance to TRIC was detected.
Conclusions: Commensal carriage of propionibacteria resistant to drugs
used to treat acne was common in this Egyptian survey. The ﬁnding of
CLIN resistance in the absence of ERY resistance for propionibacteria
is unusual, and the mechanism remains to be elucidated. The slightly
lower incidence of drug resistant strains amongst patients merits further
investigation of treatment practices in this area.
R2129 Antimicrobial resistance of clinical isolates Acinetobacter
baumannii in a university hospital
T. Stoeva, E. Savov, K. Bojkova (Varna, Soﬁa, BG)
Objective: to evaluate the antimicrobial resistance of 126 strains
A. baumannii, isolated from ICUs and non ICUs in Varna University
Hospital, Bulgaria.
Methods: for the period 2005–2006, 126 nonduplicate A. baumannii
strains, isolated from different clinical specimens, were studied: 44.6%
from respiratory system, 39.8% from wounds, 11.6% from urinary tract
and 6% from blood. The identiﬁcation was done by conventional, BD
BBL Crystal ID System and Mini Api System (bioMe´rieux, France).
The strains were tested to Ampicillin/sulbactam (A/S), Piperacillin (PIP),
Cefoperazone/sulbactam (SCF), Ceftazidime (CAZ), Cefepime (FEP),
Gentamicin (G), Amikacin (AM), Ciproﬂoxacin (CIP), Aztreonam
(ATM), Imipenem (IMP) and Meropenem (MEM), using Disk Diffusion
Method. CAZ and carbapenem resistant isolates from ICUs (51) were
tested for production of Metallo Beta Lactamases, using Hodge test and
E test with Imipenem (IP) and Imipenem/EDTA (IPI).
Results: The antimicrobials with the lowest level of resistance for the
studied period were: IMP (9.5%), MEM (13.4%) and SCF (44.4%).
The other groups of antibiotics were with resistance rates more than
50%. Isolates from ICUs were more resistant than the other isolates:
IMP (20%), MEM (23.6), A/S (69%), AM (70.9%), SCF (74.7%), FEP
(76.3%), CIP (83.6%), G (85.4%), PIP (92.7%), CAZ (92.7%), ATM
(92.7%). Multi-resistant (resistance to at least 4 of the tested drugs)
were 83.3% of the strains. The agent with the lowest level of resistance
among multi-drug resistant isolates was IMP (11.4%). G, CIP, and FEP
resistant isolates showed high levels of cross-resistance to other groups
of antimicrobials. All CAZ and carbapenem resistant strains from ICUs
(51), tested by the Hodge test, gave negative results. The E test detected
the presence of MBLs in 10 IMP resistant strains, for which the MIC
ratio of IP/IPI was >10.
Conclusions: the isolates showed considerable resistance to most of the
tested agents. Resistance rates to IMP and MEM were relatively low.
We observed high levels of multi-drug and cross resistance. The MBL
positive strains (19%) will be studied further, using PCR for detection
of bla IMP gene.
R2130 Antimicrobial resistance patterns of Acinetobacter
baumannii and Pseudomonas aeruginosa isolates in a
hospital in Algiers, Algeria
N. Ramdani-Bouguessa, F. Djennane, M. Neggazi, M. Tazir (Algiers, DZ)
Objectives: Acinetobacter baumannii and Pseudomonas aeruginosa are
a commonly isolated pathogens from nosocomial infections in intensive
care units (ICU). The aim of the study was to establish the frequency of
drug resistance of these pathogens and to prevent nosocomial infections.
Methods: A total of 355 A. baumannii and 638 P. aeruginosa
strains were collected between January 2004 to June 2006 from
different specimens and wards. Identiﬁcation was performed by the
API 20 NE system (bioMe´rieux, Marcy l’Etoile, France). Antimicrobial
susceptibility was determined by disc diffusion according to the CLSI
guidelines. Strains that were not susceptible to ceftazidime and imipenem
were tested by E test strips (AB Biodisk, Slona, Sweden).
Results: A. baumannii and P. aeruginosa isolates were originated from
pus, bronchial aspirates and urine in 79.4% to 78.5% respectively;
and from sterile sites, bloodculture and cerebrospinal ﬂuid, in 9.3%
to 6% respectively. The distribution frequency regarding wards for
A. baumannii and P. aeruginosa was as follows: 37.2% to 21% in medical
ICU and in 32.4% to 47% in surgery wards respectively.
Resistance rates are shown in the table. The highest rate of resistance
to ceftazidime (67%) for A. baumannii was observed in ICU and to
imipenem (43%) for P.aeruginosa in thoracic surgery. MICs 50 and 90
to ceftazidime and imipenem were 16 mg/mL and 256mg/mL for non
susceptible A. baumannii and P. aeruginosa.
Species T
ic
ar
ci
ll
in
P
ip
er
ac
il
li
n
C
ef
ta
zi
di
m
e
Im
ip
en
em
G
en
ta
m
ic
in
A
m
ik
ac
in
To
br
am
yc
in
O
ﬂ
ox
ac
in
A. baumannii (n = 355) 84% 90% 69% 2% 83% 66% 52% 48%
P. aeruginosa (n = 638) 12.5% 10% 4% 13.4% 22.6% 10% 12% 22%
Conclusions: A. baumannii show a multidrug resistance reducing dra-
matically the therapeutic options and imipenem resistant P. aeruginosa
increased. Failure of control measures enhanced the dissemination of
such highly resistant strains. Prevention of nosocomial infection is
needed by implementation of control measures and the rational use of
antibiotics.
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R2131 Antimicrobial activity of polymyxin B against
non-fermentative Gram-negative bacteria in Georgia
A. Nanuashvili, M. Kereselidze, T. Davitashvili (Tbilisi, GE)
Objectives: The polymyxins have activity against a wide variety of
Gram-negative bacilli, including non-fermentative isolates. Polymyx-
ins B and E were introduced into clinical practice during the 1950s for
the treatment of Gram-negative infections. However, the parenteral use of
these compounds was abandoned during the 1970s when better-tolerated
anti-pseudomonal agents became available. The emergence of multidrug-
resistant (MDR) isolates of Pseudomonas aeruginosa and Acinetobacter
spp. has required the expanded systemic use of these polymyxins. The
main objective of this study was to assess the activity and spectrum of
polymyxin B against the non-fermentative Gram-negative bacilli isolated
in Georgia.
Methods: In total, 257 isolates of Pseudomonas aeruginosa and 100
isolates of Acinetobacter spp. were collected between January 2000
and December 2005. All isolates were identiﬁed at the Microbiological
Laboratory, “Cito”. For the cultivation, microbiological identiﬁcation and
antimicrobial susceptibility testing “Bio Merioux” (France) test systems
were used. Isolates exhibiting resistance to piperacillin/tazobactam,
ceftazidime, cefepime, imipenem, ciproﬂoxacin and amikacin were
categorised as MDR.
Results: Susceptibility rates for the antimicrobial agents tested
ranged between 46.5% (ciproﬂoxacin), 64.5% (amikacyn), 69.7%
(piperacillin/tazobactam), 74.5% (ceftazidime), 77.3% (cefepime) and
89.5% (imipenem) for P. aeruginosa, and between 16% (ciproﬂoxacin),
34% (piperacillin/tazobactam), 40% (ceftazidime), 44% (amikacin),
67% (cefepime) and 95% (imipenem) for Acinetobacter spp. Only
polymyxin B demonstrated reasonable potency against Acinetobacter
spp. (100% susceptible) and P. aeruginosa (98.9% susceptible).
Conclusion: Polymyxin B remains very active against clinical isolates
of P. aeruginosa and Acinetobacter spp., including isolates resistant to
carbapenems. Polymyxin resistance has been documented rarely, but the
emergence of polymyxin-resistant P. aeruginosa and Acinetobacter spp.
would pose a serious therapeutic problem, since no new antimicrobial
agents are available currently for treatment of infections caused by MDR
Gram-negative bacilli.
R2132 Epidemiology of evolution and antibiotic resistance proﬁle
of Acinetobacter baumannii and Pseudomonas aeruginosa
in a Greek tertiary care hospital
E. Protonotariou, D. Vitti, M. Tsivitanidou, D. Soﬁanou (Thessaloniki,
GR)
Objectives: Infections with Pseudomonas aeruginosa (P. aeruginosa)
and Acinetobacter baumannii (A. baumannii) are of great concern for
hospitalised patients, especially with multidrug-resistant strains. The aim
of the present study was to determine the evolution of infections caused
by these bacteria and to deﬁne current and microbial susceptibility proﬁle
for a period of 7 year in our hospital.
Methods: Data was collected from patients admitted in Hippokration
General Hospital and infected either with A. baumannii or P. aeruginosa.
Bacterial identiﬁcation and susceptibility testing were achieved using
the VITEK 1 automated system (bioMe´rieux, France) for the period
1999–2001 and VITEK2 for the period 2002–2005. Ceftazidime
(CAZ), imipenem (IMP), ciproﬂoxacin (CIP), amikacin (AN) and the
combination piperacillin/tazobactam (PIP/TAZ) were tested.
Results: During the 7 year-time period a total of 7148 strains were
reviewed. The study comprised of 2382 A. baumannii and 4766 of
P. aeruginosa strains collected from wounds, bronchial secretions, blood,
urine, catheter tips and other clinical specimens. About A. baumannii,
the number of strains isolated ranged from 165 to 526 during 1999–
2005. In the same period, the antibiotic resistance rates (ARR) of CAZ,
CIP, PIP/TAZ and AN were quite high, from 77 to 90%. The resistance
rate of IMP increased signiﬁcantly from 22% in 1999 to 74% in 2005
(p< 0.001).
The number of P. aeruginosa isolates was between 513 and 840 and the
ARR to the tested antimicrobial agents ranged from 11 to 40%. About
IMP, the ARR never exceeded 30%.
Conclusions: Our study showed quite high resistance rates of CAZ,
CIP, PIP/TAZ and AN to A. baumannii throughout our study’s period.
During the same period the ARR to IMP increased signiﬁcantly. On the
other hand, the resistance of the above agents to P. aeruginosa increased
slightly and in some cases like in piperacillin/tazobactam even decreased.
The high rates of antimicrobial resistance, especially, of A. baumannii
to the tested antibiotics indicate that a) the broad use of these drugs
needs to be revised b) continuous surveillance studies in order to observe
changes in resistance of isolates which might help therapeutic choices
are necessary.
R2133 Antimicrobial resistance in Escherichia coli from pigs
in relation to incidence of post-weaning diarrhoea and
antimicrobial use
U.G. Andersson, B. Bengtsson, A. Franklin, S. Thyselius (Uppsala, SE)
Objectives: Post-weaning diarrhoea in pigs (PWD) is a multifactorial
disease comprising husbandry factors and where overgrowth of
Escherichia coli in the intestinal tract plays an important role. The
objectives of the study were to investigate the association between
antimicrobial resistance in E. coli from clinically healthy pigs and
incidence of PWD and use of antimicrobials.
Methods: From herds with more than 100 sows, 200 herds were
randomly selected and two growers in each herd (pigs< 16 weeks) were
sampled using rectal swabs. The herd veterinarian collected the samples.
Information on incidence of PWD (0%, <25%, <25%) of PWD, and use
of antimicrobials were recorded.
Results: Data presented are preliminary results from 101 herds sampled.
The herds were distributed according to incidence of PWD as follows:
0%: 31 herds, <25%: 60 herds and >25%: 10 herds. In 71 herds PWD
was treated with antimicrobials, among these 48% used trimethoprim-
sulphonamides, 28% tylosin, 20%, ﬂuoroquinolones and 20% used
colistin.
Resistance (%) in E. coli (190 isolates): ampicillin 13.2, cefotaxime
0, ceftiofur 0 chloramphenicol 7.5, ciproﬂoxacin 3.4, ﬂorfenicol 0,
gentamicin 0, nalidixic acid 3.8 sulphamethoxazole 21.8, tetracycline
15.3, trimethoprim 15.9. Microbiological cut-off values are according to
the Swedish veterinary antimicrobials resistance monitoring programme
(SVARM) [1].
No association between resistance patterns and herd incidence of PWD
or use of antimicrobials were found.
Conclusion: Sweden has a favourable with regard to resistance in
bacteria from animals (SVARM). Occurrence of resistance in this
study more common than in data presented for E. coli from pigs in
SVARM 2005. One explanation could be that in SVARM older pigs are
sampled and intestinal bacteria in younger animals usually display higher
antimicrobials resistance [2,3].
Reference(s)
[1] www.sva.se
[2] Mathew AG, Saxton AM, Upchurch WG et al. Multiple antibiotic
resistance patterns of Escherichia coli isolates from swine farms.
Appl Environ Microbiol 1999; 65: 2770−2.
[3] Khachatryan AR, Hancock DD, Besser TE et al. Role of calf-adapted
Escherichia coli in maintenance of antimicrobial drug resistance in
dairy calves. Appl Environ Microbiol 2004; 70:752−7.
R2134 Resistance dynamics and multidrug resistance among
Klebsiella spp. and Pseudomonas aeruginosa in severe sepsis
A. Slavcovici, M. Flonta, M. Lupse, N. Hagau, A. Almas, A. Dicea,
C. Cismaru (Cluj-Napoca, RO)
Objective: The aim of this study is to assess the prevalence and trends
of antibiotics resistance for Klebsiella spp. and P. aeruginosa strains
isolated during 8 years period from medical and surgical hospitals.
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Methods: There were isolated 288 Klebsiella spp. strains and 285
P. aeruginosa strains from patients with severe sepsis admitted on
medical and surgical wards between 1999–2002 and 2003–2006 in Cluj-
Napoca. Identiﬁcation was performed with API 20E and API 20NE.
Antibiotic susceptibility testing was performed by disk diffusion method
and API ATB. Expression according to CLSI Guidelines. Strains with
resistance at more than 3 antibiotic groups were considered multidrug
resistant strains (MDR).
Results: On that two periods, resistance of Klebsiella spp. strains to
ceftazidim and ciproﬂoxacin increased from 33% to 54% (p = 0.007)
respectively from 26% to 30.3%. Amikacin, carbapenems and colistin
resistance was constantly low. The frequency of ESBL strains
signiﬁcantly increased from 21% to 34.8% (p = 0.017). MDR strains
were detected in 21.8% respectively in 23% of cases. 50.6% of these
strains were isolated in nosocomial infections. There was signiﬁcantly
increasing resistance to ceftazidim and amikacin from 63% to 73%
and from 25% to 37.5% (p = 0.03) in P. aeruginosa strains. Colistin
and carbapenems resistance remain low. Comparing the two periods
we detected signiﬁcant increasing of MDR strains from 23.7% to
43.75% (p = 0.0003). 77.3% of these strains were isolated in nosocomial
infections.
Conclusions: Klebsiella spp. and P. aeruginosa strains isolated from
patients with severe sepsis demonstrate increasing trends of resistance
to ceftazidim, ciproﬂoxacin and amikacin correlated with nosocomial
infections. Carbapenems and colistin remains the only reliable antibiotics
against MDR strains.
R2135 Investigation of the gentamicin MIC values by e test method
in the Gram-negative bacteria isolated from different clinic
samples
F. Yildirim, G. Sengoz, K. Kart Yasar, O. Nazlican (Istanbul, TR)
Objectives: Pseudomonas and Acinetobacter species and enteric Gram-
negative bacilli isolated from various materials sent from intensive care
unit (ICU) and other clinics of our hospital were examined for their
gentamicin resistance.
Methods: The 100 bacteria examined within this study were identiﬁed
using conventional methods and API-ID 32E. Gentamicin resistance was
studied with E test according to the recommendations of CLSI.
Results: 48 of them were enteric Gram-negative bacilli (6 Klebsiella
spp., 7 Enterobacter spp. and 35 E. coli), and 40 of them were
Acinetobacter, and 12 of them were Pseudomonas. 51 of the strains were
isolated from the materials sent from ICU and 49 from other clinics. 85%
of the Acinetobacter strains were isolated from ICU. But the ratio of ICU
strains was 20% in enteric Gram-negative bacilli.
Pseudomonas strains isolated from the ICU and other clinics were
approximately the same rate. 29% of the E. coli strains were found
from urine and 20% of the Acinetobacter strains were isolated from
sputum and abscess. The resistance in Pseudomonas and Acinetobacter
strains was over 40%. In the Enterobacteriaceae family, the resistance
was 14.5%. Among Pseudomonas strains, resistance ratio was higher
in materials sent from ICU (57%) than materials obtained from other
clinics (20%). However in Acinetobacter strains there was an opposite
situation: the resistance in ICU samples was 38% and in other clinical
materials was 80%. These resistant strains from other clinics were taken
from diabetic foot wounds. Among the enteric Gram-negative bacilli,
the resistance rates were similarly low in strains isolated from ICU and
other clinics. (10% and 15.7% respectively)
Conclusion: In our hospital Since 1994 gentamicin has been adminis-
tered freely whereas usage of other agents have always been under control
of microbiologists. However almost for the last 10 years aminoglycoside
resistance declined considerably due to wide usage of quinolones.
R2136 Antibiotic resistance of Stenotrophomonas maltophilia in
children with cystic ﬁbrosis to the currently used antibiotics
H. Alexandrou-Athanasoulis, S. Doudounakis, K. Samantas,
J. Papavasiliou, C. Baclakou, A. Pangalis (Athens, GR)
Stenotrophomonas maltophilia (SM) is an important emerging pathogen
which has been cultured with increasing prevalence from the sputum of
patients with cystic ﬁbrosis (CF).
The aim of our study is to determine the resistance to currently used
antibiotics for the treatment of these patients.
Material and Method: Eighty seven Stenotrophomonas maltophilia
isolates from sputum and deep throat cultures, which were obtained
from 87 patients with cystic ﬁbrosis, during 2000–2006, were examined.
The isolates were stored at −70ºC, thawed and subcultured twice on
blood agar. The identiﬁcation of the isolates was made by the API 20NE
identiﬁcation system (bioMe´rieux, France) and the antibiotic resistance
was determined with the E test strips (AB Biodisk, Sweden) on Muller
Hinton agar according to CLSI recommendations.
Results: (1) The resistance (%) to ticarcillin/clavulanic acid, co-
trimoxazole, minocycline, ciproﬂoxacin, levoﬂoxacin and colistin were
25.3, 36.0, 1.6, 22.5, 7.8, and 48.3 respectively.
(2) The MIC50 and MIC90 of ticarcillin/clavulanic, co-trimoxazole,
minocycline, and levoﬂoxacin are seen in Table 1.
Table 1
Antibiotic MIC (mg/L)
Range MIC50 MIC90
Ticarcillin/clavulanic acid 0.5–256 8 128
Co-trimoxazole 0.125−32 0.75 24
Minocycline 0.125−16 0.75 2
Levoﬂoxacin 0.125−32 1 6
Conclusions: (1) The most effective antibiotic for our isolates of
Sm is minocycline, followed by levoﬂoxacin, co-trimoxazole and
ticarcillin/clavulanic acid. (2) The multidrug resistant isolates were 3.4%.
R2137 First report of methicillin-resistant Staphylococcus aureus
strain of animal provenience in the Czech Republic
J. Bardon, M. Kolar, P. Sauer, D. Koukalova, J. Petrzelova,
L. Cekanova (Olomouc, CZ)
Objectives: Bacterial resistance to antimicrobial agents has become
a serious problem both in human and veterinary medicine. It is not
unrealistic to presume that multiresistant bacteria may spread from
animal to human populations by foods of animal origin as well by
persons working e.g. in livestock breeding. Therefore, the study aimed
at determining the susceptibility of Staphylococcus sp., Enterococcus sp.
and Escherichia coli strains to antimicrobial agents in pigs bred in one
of the regions of the Czech Republic.
Methods: The tested strains were isolated from bred pigs (piglets aged 7
to 30 days). Bacterial species were identiﬁed by standard microbiological
techniques and susceptibility to antibiotics was determined quantitatively
by the standard microdilution method. Resistance of the Staphylococcus
aureus strain to oxacillin was conﬁrmed by detection of the mecA gene
and PBP2a. Susceptibility of staphylococci to penicillin was determined
by production of B-lactamase, using the chromogenic cephalosporin
method. Susceptibility to clindamycin, if simultaneous with resistance
to erythromycin, was veriﬁed by modiﬁed disk diffusion test.
Results: From the piglet rectal swabs, a total of 115 strains of
Staphylococcus sp., 61 strains of Enterococcus sp. and 111 strains of Es-
cherichia coli were isolated. In the case of staphylococci, the methicillin-
resistant Staphylococcus aureus strain (MRSA) was identiﬁed. Moreover,
higher frequency of coagulase-negative staphylococci with minimum
inhibitory concentration of oxacillin ± 0.5mg/L was noticed. Inducible
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resistance to clindamycin in the Staphylococcus hominis strain was
also detected. The strains of Enterococcus sp. exhibited high resistance
to tetracycline (98.5%), erythromycin (86.8%) and chloramphenicol
(54.4%). Vancomycin-resistant enterococci were not isolated. In the
case of Escherichia coli strains, higher frequency of resistant strains to
tetracycline (81.1%) and ampicillin (62.2%) was documented. Resistance
to ﬂuoroquinolones and production of broad-spectrum B-lactamases was
not noticed.
Conclusion: This is the ﬁrst described case of MRSA being detected in
pigs, and apparently in animals generally, in the Czech Republic.
The study was supported by the Czech Ministry of Health Grant Agency
project no.1A/8258-3.
R2138 Resistance to antibiotics in coagulase-negative staphylococci
in an infectious diseases hospital, Iasi, Romania
O. Dorneanu, E. Miftode, T. Vremera, O. Filip, E. Nastasa, V. Luca
(Iasi, RO)
Objectives: 1. To evaluate the resistance of coagulase-negative
staphylococci (CoNS) with clinical signiﬁcance, isolated in the Infectious
Diseases Hospital, Iasi, Romania. 2. To assess minimum inhibitory
concentration (MIC) of CoNS to oxacillin and vancomycin. 3. To
evaluate the accuracy of ATB STAPH 5 (bioMe´rieux, France) strips in
detection of susceptibility of CoNS to oxacillin and vancomycin.
Methods: We have investigated 98 CoNS strains isolated from blood
cultures (38 strains), catheters (8 strains), cerebro-spinal ﬂuid (4 strains),
pus (8 strains) and urine (40 strains), between 1.01.2004 and 1.11.2006.
Clinical signiﬁcance was supported by presence of prosthetic and
indwelling devices, immunocompromised patients’ status, isolation of
the strain in pure culture from the clinical specimen and the repeated
isolation of the same strain over the course of infection. Identiﬁcation
to species level was performed using ID 32 STAPH (bioMe´rieux,
France) strips and susceptibility testing with ATB STAPH 5 (bioMe´rieux,
France). MICs to oxacillin and vancomycin were detected using E test
(AB Biodisk, Sweden).
Results: The most frequently encountered CoNS species were S. epi-
dermidis (51.3%) and S. haemolyticus (33.3%). The overall resistance
to oxacillin was high, 63.2% (55% in S. epidermidis and 76.9% in
S. haemolyticus). Methicillin-resistant CoNS (60 strains) were also
resistant to ﬂuoroquinolones (60%), gentamicin (60%), erythromycin
(63.3%), tetracycline (60%). For S. epidermidis MIC50 of oxacillin
was 0.5mg/mL and MIC90 was 256mg/mL. For S. haemolyticus MIC50
of oxacillin was 2mg/mL and MIC90 was >256mg/mL. We have also
detected 2 CoNS strains with modiﬁed susceptibility to vancomycin
(4mg/mL). There were 10 disagreements between the susceptibility
testing to oxacillin by ATB STAPH 5 strips and E test, thus the accuracy
of the commercial method is 89.7%. None of the 2 strains with modiﬁed
susceptibility to vancomycin was correctly identiﬁed by ATB STAPH 5.
Conclusions: Resistance to antibiotics, especially to oxacillin represents
a problem in the management of CoNS infections. Vancomycin and
quinupristin-dalfopristin remain excellent alternatives for the therapy
of severe infections produced by methicillin-resistant CoNS strains.
Accuracy of ATB STAPH 5 (bioMe´rieux, France) strips is only
satisfactory for the detection of oxacillin resistance.
R2139 Diversity of bla-type genes in extended-spectrum
b-lactamases producing Klebsiella pneumoniae strains, iso-
lated in 2003 and 2004 at a hospital in Pretoria, South Africa
L. Meyer, M.M. Ehlers, M.G. Dove, G.F. Weldhagen (Pretoria, ZA)
Multidrug resistance is emerging in many Gram-negative bacteria
like Klebsiella pneumoniae, which is an important cause of severe
nosocomial infections. Since the ﬁrst extended-spectrum b-lactamases
(ESBLs) were reported in K. pneumoniae in 1983, the increasing
production of ESBLs has become a growing concern worldwide, because
of the association with signiﬁcant longer duration of hospital stay and
greater hospital costs. The b-lactamases produced by K. pneumoniae
has a broad spectrum of antibiotic resistance, and are typically resistant
to b-lactam antibiotics commonly used in the hospital setting. Only
a few studies have investigated ESBL production in bacterial isolates
collected in Africa while only Essack (2001) included K. pneumoniae.
The aim of this study was to determine the prevalence of the b-lactamases
TEM, SHV and CTX-M detected in K. pneumoniae isolated from
patients with nosocomial infections at Pretoria Academic Hospital. Fifty
K. pneumoniae isolates obtained from blood cultures reported to be
resistant to one or more of the oxyimino-cephalosporins, ceftazidime and
cefotaxime, were examined. Detection of the gene sequences coding for
TEM, SHV and CTX-M enzymes were performed with genomic DNA
extracted from the K. pneumoniae isolates. Polymerase chain reaction
(PCR) ampliﬁcation of the target DNA was performed and the resulting
gel-electrophoresis patterns were examined. The ESBLs for only the
TEM type b-lactamase of K. pneumoniae isolates represented 10% and
those positive for only the SHV type b-lactamase represented 18%. The
ESBLs that were negative for both TEM and SHV type b-lactamase were
6%. None of the 50 isolates examined were positive for the CTX-M
type b-lactamase. Since this is a pilot study which included only 50
isolates, it can only give a limited indication of the ESBLs present
in the K. pneumoniae isolates that may be circulating in the speciﬁc
nosocomial setting. A larger sample size will enable one to determine
the prevalence of the different ESBLs expressed by K. pneumoniae in
the Pretoria Academic Hospital.
R2140 Antibiotic resistance of Helicobacter pylori strains isolated
from gastric biopsy specimens in Iran
A. Mohabbati Mobares, F. Haghi Tomatari, M. Amini, R. Hosseini
Doust (Tehran, IR)
Helicobacter pylori is associated with gastritis, peptic ulcer, gastric
adenocarsinoma and mucosa-associated lymphoid tissue (MALT) lym-
phoma. Prevalence of high primary and secondary antibiotic resistance
of Helicobacter pylori is the most common reason for failure in its
eradication.
The aim of this study was to determine the incidence of resistance of
H. pylori to metronidazole, clarithromycin, amoxicillin, tetracycline and
cephtazidim.
Forty isolates of H. pylori obtained from gastric biopsy specimens.
After the culture of biopsy specimens, H. pylori identiﬁed by Gram
stain, colony morphology, and biochemical tests. Susceptibility tests were
performed with the MDDM (Modiﬁed Disk Diffusion Method) for all
antibiotics and E test for determines metronidazol MIC. Resistance rates
to metronidazole, clarithromycin, amoxicillin, tetracycline, cephtazidim
were 63%, 23%, 3%, 0% and 7% respectively.
Seventy two percent of metronidazole resistance strains had high-level
resistance (MIC >256mg/mL).
In conclusion our ﬁnding underlines the importance of local surveillance
to detect changing patterns of antibiotic susceptibility in H. pylori
isolates.
Molecular epidemiology of resistance and
resistance genes, strains or serotypes
R2141 Emergence of PER-1 extended-spectrum b-lactamase-
producing Acinetobacter baumannii clinical isolate in
Bulgaria
T. Strateva, V. Ouzounova-Raykova, A. Todorova, I. Mitov (Soﬁa, BG)
Objectives: Strains of Acinetobacter baumannii producing the extended-
spectrum b-lactamase (ESBL) PER-1 are widespread in Turkey and
Korea, and have also been reported from France and Belgium. Here
we describe the emergence of strain of A. baumannii producing PER-1
ESBL in Bulgaria.
Methods: A strain of A. baumannii 255−00 was isolated on 11 February
2000 from the wound of a male patient aged 65 years in a Clinic of
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surgery in Soﬁa. Antimicrobial susceptibilities were detected by the disk
diffusion method and Etest (AB Biodisk, Solna, Sweden) and interpreted
according to the NCCLS-2004 recommendations. The ESBL-production
was evaluated by the double-disk synergy test. Polymerase chain reaction
(PCR) ampliﬁcation and sequencing of blaPER-1 were performed.
Results: The studied strain of A. baumannii was resistant to ampi-
cillin/sulbactam, carbenicillin, piperacillin, ceftazidime, cefoperazone,
cefepime, amikacin and gentamicin, but remained susceptible to
imipenem, meropenem, ciproﬂoxacin and polymyxin B. A synergic
“ghost zone” was observed between the ceftazidime 30 mg disk
and the amoxicillin/clavulanic acid 20/10 mg disk. Using PCR, this
A. baumannii isolate was identiﬁed as PER-1-positive. PER-1 enzyme-
mediated resistance was conﬁrmed by sequencing.
Conclusions: The present work illustrates the inter-country spread of
PER-1-producing A. baumannii isolates. To our knowledge, this is the
ﬁrst report of PER-1 in clinical isolate of A. baumannii in Bulgaria.
R2142 Inducible clindamycin resistance in Staphylococcus aureus
isolates causing bacteraemia at a university hospital in
southern Taiwan
R. Janapatla, J. Yan, A. Huang, H. Chen, H. Wu, J. Wu (Tainan, TW)
Background: A major concern while prescribing clindamycin to treat
infections caused by inducible macrolide, lincosamide and group B
streptogramin (iMLSB) resistant strains is clinical therapy failure.
Objective: To determine the prevalence, mechanism and clonality of the
iMLSB phenotype in oxacillin resistant S. aureus (ORSA) and oxacillin-
susceptible S. aureus (OSSA).
Results: Among the 729 OSSA isolates collected from July 1995
to March 2006, 72 (10%) were clindamycin sensitive (Clis) and
erythromycin resistant (Ermr), and 55 (8%) had the iMLSB phenotype.
In the 709 ORSA isolates collected from January 1997 to March 2006,
31 (4%) were Clis and Ermr and 29 (4%) isolates demonstrated the
iMLSB phenotype. In OSSA ermC was the predominant (51 of 55
isolates) genetic determinant responsible for the iMLSB phenotype,
while in ORSA ermA was predominant (27 of 29). Pulsed-ﬁeld gel
electrophoresis showed that in ORSA isolates (n = 27) 8 pulsed types
(RA to RH) were present and in the OSSA (n = 24) isolates 14 different
pulsed types (SA to SN) were identiﬁed.
Conclusion: These results indicate that in Taiwan, the incidence of
iMLSB resistance phenotype is very high in Clis and Ermr S. aureus
isolates and the genetic determinants responsible for the iMLSB
phenotype vary in OSSA and ORSA.
R2143 Occurrence of CTX-M-3 extended-spectrum b-lactamase
producing Salmonella Brandenburg in Bulgaria
P. Petrov, G. Asseva, T. Kantardjiev, P. Padeshky, N. Vlahova, I. Ivanov,
A. Ivanov, M. Nikolova (Soﬁa, BG)
Objectives: to study the genetic proﬁle and resistance to antibiotics of
a rare serotype of Salmonella causing a cluster of cases among infants
and children in Bulgaria.
Methods: nine strains of Salmonella Brandenburg were isolated from
infants and children with acute enterocolitis in the beginning of 2005.
Culture, identiﬁcation, serotyping and antimicrobial susceptibility testing
to fourteen antibiotics have been performed. PCR with primers detecting
bla-CTX-M genes and PFGE after restriction with XbaI were applied.
Results: a single PFGE type of strains conﬁrmed the occurrence of a
cluster of cases caused by Salmonella Brandenburg among infants and
children. The strain was found to be multidrug-resistant. It produced a
CTX-M-3 extended-spectrum b-lactamase.
Conclusion: our ﬁndings proved the ethiological role of an unique
genetic variant of Salmonella Brandenburg in a cluster of cases among
infants and children. This is the ﬁrst report for Bulgaria of Salmonella
Brandenburg producing a CTX-M-3 extended-spectrum b-lactamase.
R2144 Molecular study of methicillin-resistant Staphylococcus
aureus bacteraemia in a tertiary care hospital
E. Platsouka, E. Kraniotaki, E. Belesiotou, A. Argyropoulou,
E. Perivolioti, O. Paniara (Athens, GR)
Objectives: Bacteraemia is a serious complication in hospitalised pa-
tients and nosocomial Staphylococcus aureus bacteraemia, in particular
with methicillin resistant S. aureus (MRSA) is a major problem with
treatment difﬁculties. A molecular analysis of representative MRSA
blood isolates of patients was carried out in a Greek tertiary care hospital.
Methods: Between March 2004 and October 2006 a total of 232
S. aureus blood isolates were collected, one isolate per patient.
Blood bottles were incubated in BACTEC-NR 9240 automatic system
according to standard recommendations. They were identiﬁed by
standard methods and MICs were determined by the broth microdilution
method, according to CLSI guidelines. Molecular typing was performed
by using PFGE technique, with digestion of genomic DNAs from the
staphylococcal isolates by the restriction endonuclease SmaI.
Results: Of 232 S. aureus blood isolates, 158 in Medical wards, 36 in
Surgical wards and 38 in ICUs, 121 (52.15%) were MRSA and 111
(47.85%) MSSA. The distribution of MRSA bacteraemia in the hospital
was: Medical wards 67 (42.40%), Surgical wards 23 (63.89%), ICUs
31 (81.58%). The resulting restriction endonuclease digestion patterns
showed four different genotypes with several common bands suggesting
a common epidemiologic background, according to Tenover criteria
(Tenover et al., 1995).
Conclusion: The incidence of MRSA bacteraemia is higher in ICUs
than in the medical and surgical wards. MRSA isolates in ICU patients
seems to belong to a common clone. Other typing techniques apart from
PFGE, will be performed in order to characterise completely the MRSA
clones in our hospital, since the presenting results are preliminary.
R2145 Clonality among high-level gentamicin-resistant
Enterococcus faecalis and Enterococcus faecium isolated
from clinical samples
M. Soltan Dalal, M. Hasibi, S. Aghaei, B. Mohajer Iravani,
M. Pourshaﬁe (Tehran, IR)
Objectives: During recent years, nosocomial infections caused by ente-
rococci have increased in different countries. Unfortunately enterococci
which acquire high level gentamicin resistance (HLGR) become non
curable by using the common effective antibiotictherapy protocoles.
Methods: We determined the prevalence of HLGR among clinical
enterococcal isolates with disc diffusion method by using Gm (120mg)
disk. 726 enterococcal strains were collected from different hospitals
and clinical laboratories. Clonality relation between HLGR strains were
determined by PFGE and Ribotyping techniques and AAC (6′)-APH(2′′)
genotype detection was performed by PCR method.
Results: The species distribution percents was 8.5% for E. faecium and
91.5% for E. faecalis. These ﬁgures in HLGR strain were 61.6% and
38.4 for E. faecalis and E. faecium respectively. PFGE, ribotyping and
PCR techniques classiﬁed these isolates in different genotypes.
Conclusion: Our results suggest dissemination of genetically related
HLGR strains in nosocomial infection and indicate that high prevalence
of HLGR enterococcal colonisation is an important problem in our
medical centres.
R2146 Detection of extended-spectrum b-lactamases, including
the CTX-M-type enzymes, among Enterobacteriaceae using
VITEK2 system and the Advanced Expert system
S. Ferreira, A. Paradela, A. Ribau, E. Ramalheira, S. Mendo (Aveiro, PT)
Objectives: The aims of the present study were to assess if the
VITEK2 AES could accurately detect ESBL in Enterobacteriaceae
isolates, comparing the ﬁnal data report with the results of phenotypic
and genotypic based methods. The susceptibility of ESBL producers to
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Ertapenem was also investigated. A special relevance was given to a new
emergent CTX-M-type ESBL.
Methods: From April 2006 to October 2006, 35 isolates of Enter-
obacteriaceae were recovered from 35 inpatients of different wards of
the Hospital Infante D. Pedro de Aveiro, Portugal, and identiﬁed as
extended-spectrum b-lactamases (ESBL) producers by the automatic
VITEK2 system and Advanced Expert System (VITEK2 AES)
(BioMe´rieux, Marcy L’Etoile, France). The antibiotic susceptibilities
were determined by VITEK2 and the susceptibilities reports were
edited after interpretation by AES of the inferred resistance phenotype.
ESBL were also detected by Etest® (AB Biodisk) ESBL with
Cefotaxime/Cefotaxime + Clavulanic acid and Ceftazidime/Ceftazidime
+ Clavulanic acid strips, according to manufacturer’s instructions.
Susceptibility to Ertapenem was tested using disc diffusion method
(DDM) (10 ug, Oxoid). PCR, sequencing and sequence analysis was
used to assess b-lactamase encoding sequences. Sequences obtained were
compared with others deposited in the GeneBank database.
Results: VITEK2 determined that: for CAZ, 32 isolates were resistant
and 3 were susceptible, for CTX, the same result was obtained. AES
edited these data as resistance phenotypes, suggesting the production
of ESBL. Using the Etest, 34 isolates presumable produced ESBL. One
isolate was indeterminate, according to the manufacturer’s guidelines. All
the isolates identiﬁed as ESBL producers were sensitive to Ertapenem.
PCR speciﬁc for CTX-M encoding sequences showed the presence of
this gene in 14.3% of the isolates bearing an ESBL.
Conclusion: This study demonstrated the capacity of VITEK2 AES to
detect and interpret resistance mechanisms, inferring with a high level
of conﬁdence the presence of isolates ESBL producers. Also shows that
Ertapenem is effective against ESBL producers. CTX-M-1 and CTX-M-
15 were the CTX-M-type enzymes found among the Enterobacteriaceae
population studied.
R2147 First detection of VIM-1 type metallo-b-lactamase in
a multidrug-resistant Klebsiella pneumoniae clinical
isolate from Turkey also producing the CTX-M-15
extended-spectrum b-lactamase
I. Yildirim, M. Ceyhan, D. Gur, C. Mugnaioli, G.M. Rossolini (Ankara,
TR; Siena, IT)
Currently the most prevalent and widespread acquired MBLs are the
IMP- and VIM-type enzymes, although other types (SPM, GIM and
SIM) have recently been identiﬁed.
In Turkey, the only MBL thus far reported is VIM-5, a variant of the
VIM-1-like sublineage, in clinical isolates of Klebsiella pneumoniae,
Pseudomonas aeruginosa and Enterobacter cloacae. During a survey
to detect acquired MBLs in 127 nonreplicate Gram-negative isolates
that were resistant or intermediate to carbapenems and/or resistant to
ceftazidime in a tertiary centre in, Ankara, Turkey, during the period
March 2005-March 2006, a single K. pneumoniae isolate was found
to be positive to the MBL phenotypic screening using the IPM-EDTA
combo disk test and the 2-MPA double-disk synergy test. Production of
MBL activity was conﬁrmed by spectrophotometric assay as described
previously. This isolate (K. pneumoniae HU41) was cultured from
the urine of a 3-year-old girl in May 2005. K. pneumoniae isolate
HU41 had also an ESBL-positive phenotype, as detected by CLSI
recommendations. The HU41 isolate was also resistant to carbapenems
(the MIC of imipenem was 128mg/L while the MICs of meropenem
and ertapenem were 16mg/L) Enterobacteriaceae producing MBLs have
often been reported to remain susceptible to carbapenems, despite
increased carbapenem MICs. This isolate, however, exhibited a frank
resistant phenotype to all carbapenems suggesting the presence of
additional resistance mechanisms such as decreased outer membrane
permeability.
PCR analysis, performed with primers speciﬁc for blaVIM and blaIMP
genes, yielded a 523 bp-ampliﬁcation product with the blaVIM-speciﬁc
primers. The presence of a class 1 integron was detected by PCR
ampliﬁcation with primers designed on 5′- and 3′-conserved segments
as described previously. An ampliﬁcation product of 2.3 kb was
obtained. Direct sequencing revealed the presence of two inserted gene
cassettes: blaVIM-1 and aac(6′)Iic with the same integron variable
region in an Enterobacter cloacae from Greece, which is currently the
European country most affected by dissemination of the VIM-1 MBL in
Enterobacteriaceae, suggesting a regional spread of the element carrying
the MBL gene. To our knowledge; this is the ﬁrst report of a VIM-1
type MBL enzyme in Turkey. PCR and direct sequencing for detection
of common ESBL genes (TEM-, SHV- and CTX-M-type) revealed the
presence of a blaCTM-15 gene that was consistent with the ESBL
phenotype.
R2148 Prevalence of low-level quinolone resistance mediating genes
in extended-spectrum b-lactamase producing Klebsiella spp.
and Escherichia coli strains from Slovenia
J. Ambrozic Avgustin, R. Keber, K. Zˇerjavic, T. Orazˇem, M. Grabnar
(Ljubljana, Maribor, SI)
The occurrence of plasmid-mediated low-level quinolone resistance
genes among uropathogenic extended-spectrum b-lactamase (ESBL)
producing Klebsiella sp. and Escherichia coli strains was studied.
74 non-repetitive Klebsiella sp.and 27 E. coli strains from various
sources in the Ljubljana region in Slovenia were screened by PCR
and conjugation. None of the known low-level quinolone resistance
mediating qnr genes was found, although the MICs of ciproﬂoxacin for
several transconjugants were almost uniformly elevated when compared
with the recipient strain J53Azr. The resistance determinant was
cloned, sequenced and identiﬁed as the aac(6′)-Ib-cr variant of the
aminoglycoside acetyltransferase gene aac(6′)-Ib.
Two single nucleotide substitutions in the wild type allele enable the
aac(6′)-Ib-cr gene product to confer low-level quinolone resistance
as it was described recently. A combined PCR-RFLP protocol was
prepared and used for detecting either the wild type or mutant
allele in the strain collection. The aac(6′)-Ib-cr allele was found in
50% of the ESBL Klebsiella sp. strains and in 40% of the ESBL
E. coli strains. The emergence of the aac(6′)-Ib-cr gene coincides
with increased number of ﬂuoroquinolone resistant ESBL strains and
the extinction of the intermediate resistance phenotype according
to the CLSI standards. This indicates a possible role of low-level
plasmid-mediated quinolone resistance determinants enhancing the
selection of chromosomal mutations and resulting in the occurrence and
dissemination of clinically relevant resistance levels. Thus, it is tempting
to speculate, that the aac(6′)-Ib-cr gene, being present with ESBL genes
in the same integron, may be at least one of the reasons for arising
ﬂouroquinolone resistance of ESBL strains in Enterobacteriaceae.
R2149 Clonal dissemination of vancomycin-resistant Enterococcus
faecium isolates in two Russian centres over a 3-year period
A. Mironova, G. Kliasova, A. Brilliantova, S. Sidorenko (Moscow, RU)
Background: The purpose of this study was to evaluate the molecular
relatedness of clinical isolates of vancomycin-resistant Enterococcus
faecium (VREF) collected from two haematological centres in Russia.
Methods: A total of 123 VREF strains were isolated from two centres
between January 2004 and September 2006. VREF included 119 strains
from centre I and 4 strains from centre II. Isolates were from stool (108),
urine (7), throat (3), blood (1), and other samples (4). Resistance genes
were detected by PCR. Macrorestriction analysis of SmaI digests was
performed by pulsed-ﬁeld gel electrophoresis. PFGE patterns were then
compared using BioNumerics 3.0.
Results: PFGE typing revealed 21 strain types of VREF. Among VREF
included in the study isolates carrying vanA genes were predominant 114
(93%), they belonged to 19 clonal types. Two PFGE types (A and F) were
most prevalent 69% and 11% respectively. Type A isolates were detected
in centre I in 2004, and appeared in centre II in 2006. Type F isolates
were detected in centre II in 2004 and appeared in centre I in 2005.
Clinically signiﬁcant infections caused by VREF were observed in three
patients in centre I, one caused by type A isolate and two – by type F
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isolates. In centre I strains of VREF were prevalent in two departments –
intensive care and haematology. Isolates from intensive care department
were more heterogeneous than from haematology department. vanB
genes were detected in 9 (7%) of VREF isolates. Eight of them belonged
to two PFGE types and were detected only in centre I, one remaining
isolate was clonally unrelated and was isolated in centre II. Two isolates
of the same PFGE type were carrying two different resistance genes (one
– vanA, and one – vanB).
Conclusion: The majority of VREF isolates belonged to the two
predominant PFGE types. Clonal inter- and intrahospital dissemination
was responsible for most of the spread of VREF.
R2150 Extended-spectrum b-lactamases and plasmid-mediated
AmpC enzymes among Enterobacter cloacae strains isolated
from cardiovascular prosthetic devices associated infections
R. Cernat, C. Balotescu, V. Lazar, O. Banu, D. Ivanescu, M. Bucur
(Bucharest, RO)
Objective: The purpose of this study was to establish the frequency of re-
sistance to broad-spectrum cephalosporins of E. cloacae strains isolated
from patients with cardiovascular prosthetic implants hospitalised in a
Romanian institution and to characterise the types of ESBL produced.
Material and Methods: During 2003–2006, 120 E. cloacae strains
were recovered. ESBL-producing enzymes were screened by double-
disk synergy test or positive ceftazidime and cefotaxime clavulanic
combination discs tests. MICs of 18 antibiotics were performed by
microdilution broth method against ESBL-positive strains. Isoeletrofo-
cusing (IEF) and PCR with speciﬁc primers were used to conﬁrm and
type b-lactamase genes in ESBL producers: blaTEM, blaOXA, blaSHV,
blaCTX-M and ampC. When IEF and PCR indicated concordant results,
ﬁnal identiﬁcation of ESBL enzymes was obtained by sequence analysis.
PFG with XbaI-digested genomic DNA established the diversity of
ESBL-positive clones.
Results: 46 of 120 (38.3%) strains were conﬁrmed as ESBL producers
and showed a multiresistance phenotype. All strains had the ubiquitary
blaCTX-M, blaTEM genes plus AmpC gene. Sequencing of blaCTX-M,
blaTEM amplicons identiﬁed that all the strains encode the TEM-1A
enzyme, 20 the CTX-M-15 and 5 the CTX-M-3; these enzymes were
characterised with pIs of 5.4 and between 8.0 and 9.0 respectively. PFGE
proﬁles of these strains indicated that only ﬁve clones were related.
Conclusion: This study illustrates a high frequency of polyclonal
dissemination of resistance to broad-spectrum b-lactams in a hospital
in Romania through CTX-M ESBL, most probably facilitated by mobile
elements such as gene cassettes for which preliminary results indicated
to be carried by the class 1 integrons. Our results suggest that in Romania
also the therapeutic options may be dramatically diminished if CTX-M
enzymes continue spreading among Enterobacteriaceae implicated in the
aetiology of bacterial infections occurred in hospitalised patients with
cardiovascular prosthetic devices.
R2151 Prevalence of mutations in PBP2x of Streptococcus
pneumoniae
S.A. Grudinina, T.A. Savinova, E.N. Ilina, S.V. Sidorenko (Moscow, RU)
Objectives: Mutations in penicillin-binding proteins (PBP) are the
main mechanisms of Streptococcus pneumoniae (Spn) resistance to
b-lactams, and PBP2x is a primary determinant. There are two groups of
PBP2x amino acid substitutions (AAS) in clinical strains: one group is
characterised by T338A substitution; other group composed of sequences
containing the Q552E substitution. The two groups of proteins display
reduced reactivity towards b-lactam owing to two different mechanisms
which may sometimes be combined as a few sequences can harbour
mutations at both positions 338 and 552. We evaluate the prevalence of
these and other AAS’s in clinical Spn isolates from Russia.
Methods: Spn isolates (n = 75) with different MIC’s of b-lactams were
studied. Mutations in PBP2x genes were detected in thermocyclic primer
extension reaction, followed by mass-spectrometric detection of the
products.
Results: Results of susceptibility testing and detection of AAS are shown
in the Table. All isolates lacking AAS of interest were susceptible to
cefotaxime (according to the current CLSI meningitis break-points), but
5 of them were intermediate to penicillin. PBP2x harbouring T338A
substitution in combinataion with other AAS’s are the most prevalent
among Spn isolates in Russia. Presence of four AAS’s (T338A, I371T,
R384G, N605T) predicts nonsusceptibility to penicillin, but in 11 of 34
isolates with current genotype MIC’s of cefotaxime was in susceptible
range. MIC’s of b-lactams against isolates with other combinations of
AAS’s including T338A were signiﬁcantly lower. MIC’s of b-lactams
against isolates with Q552E AAS’s were in susceptible/intermediate
range. We were able to ﬁnd only one isolate carrying both T338A and
Q552E AAS’s simultaneously.
AAS in PBP2x Distribution of isolates according
to Cefotaxime/penicillin MIC
(mg/L)
0.06 0.125−0.5 1.0 2.0−4.0
No AAS (n = 17) 14/12 3/5 0/0 0/0
T338A, I371T, R384G, N605T (n = 34) 2/0 9/6 16/3 7/25
T338G, I371T, R384S, Q552E, N605T (n = 1) 0/0 0/0 0/0 1/1
T338A, I371T, R384G (n = 1) 1/0 0/1 0/0 0/0
T338A, R348G, N605T (n = 3) 1/1 2/1 0/0 0/1
T338A, R384G (n = 10) 10/1 0/9 0/0 0/0
I371T, N605T (n = 1) 0/0 1/1 0/0 0/0
R384G, Q552E (n = 5) 2/0 3/5 0/0 0/0
Q552E (n = 3) 1/0 2/3 0/0 0/0
Conclusions: Detection of a limited number of AAS’s in PBP2x can be
used for the prediction of susceptibility to cefotaxime Spn meningitis
isolates.
R2152 Detection of class I integrons of Aeromonas ssp. strains
isolated from diarrhogenic disease
A. Pe´rez-Valdespino, E. Fernandez Rendon, M. Sanchez Mendoza,
E. Curiel Quesada (Distrito Federal, Pachuca, MX)
Introduction: Since the early 90’s an increase to antimicrobial resistance
in Aeromonas sp. has been observed worldwide. Aeromonas sp. has
showed to contain several resistance determinants like transposons,
plasmids and integrons. We have searched for these genetic elements
in strains isolated from patients with diarrhogenic diasease, in order to
characterise and relate them to those found in environmental and food-
born strains.
Methods: We have studied 41 Aeromonas sp. strains isolated from
diarrhogenic faeces. They were identiﬁed by 16S/rDNA PCR-RFLP.
Susceptibility tests for 28 antibiotics were performed by the Kirby Bauer
method (see Table 1). Plasmid DNA was extracted according to Birmboin
and Doly et al. Primers for PCR for 5′ and 3′ portions of class I integrons
were those described by Zhang et al. 2004. A set of primers were
designated to variable region of integron class I.
Results: From a total 41 strains we identiﬁed A. caviae (n = 27),
A. hydrophila (n = 10), A. veronii (n = 3), A. media (n = 1). All
strains were resistant to: ampicillin, amikacin, vancomycin, bacitracin,
oxacyllin, sulfadiazine and penicillin but sensitive to: cefotaxime,
norﬂoxacin, aztreonam, gentamycin, neomycin. The results of other
susceptibility tests are shown on table 1. 36% (15/41) strains yielded
the 920bp product of 5′CS region of the class I integrase gene. The
800bp product from the 3′CS of the integron was ampliﬁed only in
9 out of these 15 strains. Ampliﬁcation of the variable region yielded
bands ranging from 1800bp to 3700bp. 32% (13/41) strains contained
plasmids, all of 13 strains with plasmids showed different electrophoretic
patterns. 36.6% (15/41).
Conclusions: A third of the strains possess plasmids and class I integrons
was detected in nine strains. Currently, these genetics elements have been
characterising in order to know their relationship with the antimicrobial
resistance.
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Table 1. Resistance percentage in Aeromonas spp.
Antibiotic % Resistance (n = 41)
Imipenem 2%
Kanamicin 2%
Ciproﬂoxacin 3%
Azitromicin 5%
Chloramphenicol 5%
Erythromicin 12%
Piperacillin 12%
Streptomycin 17%
Tetracycline 39%
Nalidixic acid 41%
Trimetropim 53%
Rifampicin 88%
Mercurio 54%
In vitro antibacterial susceptibility &
drug interaction studies
R2153 Inhibitory effect of probiotic and non-probiotic
micro-organisms against Helicobacter pylori clinical isolates
J. Diaz-Regan˜on, T. Alarcon, D. Domingo, D. Monclus, M.J. Moreno,
M. Lopez-Brea (Madrid, ES)
Objective: To determine the effect of 15 probiotic, and 17 non-
probiotic (8 Gram-positive and 9 Gram-negative microorganisms) against
Helicobacter pylori clinical isolates.
Material and Methods: H. pylori strains were isolated from 35
gastric biopsies and processed by standard microbiological methodology.
Several probiotic and non-probiotic bacteria were obtained from several
specimens following standard microbiological procedures and were
identiﬁed by Gram stain and MicroScan (Dade–Behring). The following
bacteria were tested: probiotics: 3 Lactobacillus spp., 2 Lactococcus
lactis lactis, 4 Streptococcus spp., 2 Bacillus spp., 3 Enterococcus spp.
and 1 Saccharomyces cerevisiae, and non-probiotics: 8 Staphylococcus
sp., 2 E. coli, 2 Klebsiella spp., 1 P. aeruginosa, 1 Salmonella GDF9,
1 A. baumannii, 1 E. cloacae and 1 S. maltophilia.
The effect of these microorganisms on H. pylori was determined by
the “drop” method: A blood agar plate was completely inoculated
with H. pylori and a drop was deposited containing 10mL of
the microorganism after 0.5 McFarland concentrations. Plates were
incubated at 37ºC under microaerobic atmosphere for 3−5 days. Lecture
was made by the diameter of the inhibition zone observed after
incubation.
Results: Among probiotics 2 Lactobacillus spp. showed inhibitory
activity against 5 and 6 out of the 30 H. pylori strains tested, Bacillus
spp. inhibited 11 out of 27 tested, 1 E. faecium inhibited 1 out of 27
tested and S. cerevisiae inhibited 7 out of 27 H. pylori strains tested.
Staphylococcus spp. showed inhibitory effect against H. pylori strains:
S. hominis against 5 out of 35, 1 S. auricularis against 7 out of 27,
1 S. auricularis against the 37 strains tested, 2 S. epidermidis against
the 27 and 35 strains tested, S. warneri against 1 out of 35, S. cohni-cohni
against 1 out of 35 and S. aureus against 6 out of 35. Among Gram-
negative bacteria one E. coli strain was able to inhibit the growth of 1
out of 25 H. pylori clinical isolate tested. K. pneumoniae, A. baumannii
and Salmonella GDF9 were able to inhibit the growth of 4 out 25 strains
each. E. cloacae and S. maltophilia were able to inhibit the growth of
14 out 25 H. pylori isolates each.
Conclusions: 3 Staphylococcus spp. strains (1 S. auricularis and
2 S. epidermidis) were able to inhibit the growth of all H. pylori strains
tested. Several probiotic and non-probiotics bacteria were able to inhibit
some H. pylori strains.
Acknowledgement: The study was supported by FIS PI 052442.
R2154 ESBL-producing Enterobecteriaceae and in vitro evaluation
of tigecycline
E. Chinou, P. Davlouros, M. Georgouli, E. Skoutelli, A. Kamagiani,
P. Golemati (Athens, GR)
Objectives: This study was performed to investigate the prevalence of
ESBL producers in Enterobecteriaceae isolated from oncology patients
and to examine the in vitro activity of a new class of agents, tigecycline
against these strains.
Materials and Methods: We studied 156 nonreplicate isolates of
Enterobecteriaceae recovered over four months period (June to October
2006) from clinical specimens. Isolates were identiﬁed using Api 20E.
ESBL production was screened for by MIC analysis (Microscan Gram
negative) and conﬁrmed by the double-disk synergy test. To examine the
activity of tigecycline, we used the disk diffusion test on Mueller Hinton
agar.
Results: A total of 102 E. coli, 38 K. pneumoniae, 10 K. oxytoca
and 6 E. cloacae strains were detected among 156 Enterobecteriaceae
isolates. 33.3% of clinical isolates were identiﬁed as ESBL producers
(42 E. coli and 10 K. pneumoniae). The most efﬁcient antibiotics
for ESBLs were the carbapenems imipenem and meropenem (94.2%
sensitive), amicacin (90.5%) and ciproﬂoxacin (62%). Tigecycline was
active against all the tested strains of E. coli, K. oxytoca and E. cloacae.
5 strains of K. pneumoniae were resistant to tigecycline and sensitive
only to carbapenems.
Conclusions: We detect an increase of ESBLs isolates. Their expression
was usually associated with multidrug resistance. The invitro activity
of tigecycline against Enterobecteriaceae and especially against ESBL
producers was encouraging.
R2155 Antibiotic susceptibility of Yersinia strains in Kazakhstan
L. Nekrassova, T. Meka-Mechenko, A. Aikimbayev, G. Temiralieyva
(Almaty, KZ)
Objectives: Study of the regional peculiarities of sensitivity to antibiotics
of Yersinia strains may to serve the considerable requisite for the rational
using of antibacterial preparations in the treatment of Yersinioses.
Methods: The method of serial dilution on the agar was applied to
comparative assay of antibiotic sensitivity. It was determined antibiotic
susceptibility 200 strains different kinds of Yersinia.
Results: High sensitivity Y. pseudotuberculosis, Y. enterocolitica,
Y. kristensenii, Y. intermedia, Y. frederiksenii to streptomycin and to
a lesser degree to chloramphenicol is established. On the literary data
of signiﬁcant distinctions in sensitivity Yersinia to these antibiotics
is not present. Probably, this fact also speciﬁes territorial feature
of the activators of Yersinioses circulating in Kazakhstan. Now
there is no though some an appreciable tendency to development
resistance to streptomycin, chloramphenicol and tetracycline in strains
of Y. pseudotuberculosis, Y. enterocolitica.
However, the quantity resistant forms to these antibiotics in strains,
isolated in natural landscapes are a little bit lower. In number of areas of
Kazakhstan which anthropogenous inﬂuence has affected are found out
in strains of Y. pseudotuberculosis and Y. enterocolitica with resistance to
streptomycin, tetracycline. These strains were isolated from wild rodents.
Other species of Yersinia (Y. kristensenii, Y. frederiksenii, Y. intermedia)
were differed by the big number of resistance forms, irrespective of
source of isolation. Occurrence of a plenty resistance to streptomycin,
chloramphenicol and tetracycline forms of these species Yersinia can
be speciﬁc and territorial features of these species. It is impossible
to exclude penetration of resistance variants in the natural foci from
anthropurgical.
Conclusion: There are distinctions by quantity antibiotics resistance
forms in epizootic foci exposed and not exposed anthropogenous
inﬂuence. In the foci exposed to anthropogenous inﬂuence the quantity
of such strains is much higher.
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R2156 Analysis of tigecycline activity against Staphylococcus
aureus based on clinical specimen source
D. Draghi, M. Dowzicky, N. Brown, M. Jones, C. Thornsberry,
D. Sahm (Herndon, Collegeville, US; Breda, NL)
Objective: Tigecycline (TIG), the ﬁrst in class glycylcycline available
for clinical use, has been approved in the US (2005) and EU (2006)
for complicated skin and soft tissue infections and for complicated
intra-abdominal infections. Because the susceptibility patterns of target
pathogens can vary with the clinical specimen sources, the current
activity of TIG was analysed according to specimen source (SPEC) from
which S. aureus (SA) isolates were obtained.
Methods: SA isolates were collected from 64 hospital sites distributed
among all nine US Bureau of Census regions and 11 hospital sites
distributed across 4 countries in Europe (EU; Germany, Italy, Spain,
and France). All SA were isolated from clinical specimens in 2005–
2006 and centrally tested against TIG and comparators by broth
microdilution (CLSI guidelines M7-A7). The SPECs studied were blood
[BD], respiratory [RP], and skin and soft tissue [SST]). Additionally,
TIG activity was assessed according to oxacillin-susceptible (OX S) and
-resistant (OX R) populations. US FDA breakpoints (BPs) were applied
to results from isolates that originated from the US and EUCAST BPs
were applied to results from isolates that originated from EU.
Results: see the table.
SPEC Phenotype USA EU
Total MIC (mg/L) %S Total MIC (mg/L) %S
Range MIC90 Range MIC90
SST All 1004 0.008−1 0.25 99.9 233 0.03−0.5 0.25 100
OX S 475 0.008−0.5 0.25 100 196 0.03−0.5 0.25 100
OX R 529 0.06−1 0.25 99.8 37 0.03–0.25 0.25 100
RP All 451 0.06−0.5 0.25 100 86 0.015−0.5 0.25 100
OX S 200 0.06−0.5 0.25 100 62 0.015−0.5 0.25 100
OX R 251 0.06−0.5 0.25 100 24 0.06−0.5 0.25 100
BL All 347 0.06−0.5 0.25 100 66 0.03−0.5 0.25 100
OX S 162 0.06−0.5 0.25 100 57 0.03−0.5 0.25 100
OX R 185 0.06−0.5 0.25 100 9 0.06–0.25 100
Conclusions: Based on susceptibility patterns, TIG demonstrated a high
level of activity against SA including oxacillin-resistant isolates. This
level of activity did not vary with either the geographic (US or EU)
or clinical source of the isolates. While TIG currently exhibits potent
activity against SA, the ability of this organism to develop resistance to
a variety of antimicrobials warrants continued surveillance as TIG use
to treat infections increases.
R2157 Antimicrobial susceptibility of 2,254 isolates from different
body sites: Tigecycline Evaluation Surveillance Trial
(TEST) in South America, 2004–2006
R. Badal, S. Bouchillon, B. Johnson, M. Hackel, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Efﬁcacy of antimicrobials continues to be eroded by
development and spread of bacterial resistance. Surveillance studies can
help guide appropriate use of antimicrobials by understanding current
trends in susceptibility. The Tigecycline Evaluation Surveillance Trial
(TEST) is an ongoing global study that can serve to help recognize these
trends on many levels. This report evaluates differences in susceptibility
of strains collected from different body by investigators in South America
2004–2006.
Methods: 2,254 isolates were collected and identiﬁed from 2004–
2006 at 12 hospitals in Argentina, Chile and Brazil. MICs for each
strain were determined per CLSI guidelines at each facility using broth
microdilution. MIC50/90 values were analysed to identify any signiﬁcant
differences in antibiograms from different sources.
Results: Minimal differences were seen in susceptibility patterns of
evaluated pathogens and specimen sources. MIC50/90 values for all
organism/specimen source pairings were usually ± 2 dilutions of each
other, but statistical differences were noted between body site groups for
all drugs (p< 0.001) and the patterns varied by drug.
Conclusions: Antibiograms of bacteria isolated from different body
locations were generally similar, with signiﬁcant differences of
sensitivity patterns that varied by drug. TIG’s demonstrated broad
spectrum of activity and consistently low MIC90/MIC50 ratios, including
strains resistant to other drugs should establish its role as an important
addition to hospital formularies.
R2158 Antimicrobial susceptibility of Streptococcus pneumoniae
isolated from lower respiratory tract infections –
Therapeutic consequences
C. Popescu, G.A. Popescu, E. Benea, M. Popoiu, M. Ivan, L. Gavriliu,
A. Paise (Bucharest, RO)
We analysed the resistance rate of pneumococcal strains, isolated from
the patients with lower respiratory tract infections.
Methods: retrospective study of lower respiratory tract infections
admitted in Matei Bals Infectious Diseases Institute between 1.01.2004
and 31.03.2005.
Results: 47 cases: 37 cases of pneumonia and 10 cases of acute
exacerbation of chronic bronchitis; 5 cases had bacteraemia with
Streptococcus pneumoniae. The rate of antimicrobial susceptibility
were: 100% for moxiﬂoxacin (95%CI: 86.7–100%), ceftriaxone 92.3%
(95%CI: 79.7–97.5%), clindamycin 78.6% (95%CI: 64.1–88.3%),
erythromycin 69.4% (95%CI: 55–81.4%), tetracycline 68.4% (95%CI:
52.5–80.9%), penicillin 67.4% (95%CI: 53–79.1%), TMP/SMX 40%
(95%CI: 25.5–56.4%).
Conclusions: The resistance rate for co-trimoxazole, penicillin, ery-
thromycin and tetracyclin indicates that these antimicrobial cannot be
used like ﬁrst choice therapy in lower respiratory tract infections.
The failure risk for respiratory ﬂuorquinolones and third generation
cephalosporines is low.
R2159 A survey of multi-drug resistance clinical pathogens in
Turkey – T.E.S.T. Program, 2006
S. Bouchillon, R. Badal, M. Hackel, J. Johnson, D. Hoban, B. Johnson,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: The T.E.S.T. Program determined the in vitro activity of
tigecycline compared to broad spectrum antimicrobials against Gram-
negative and Gram-positive species collected from two hospitals within
Turkey throughout 2004–2006.
Methods: Clinical isolates were identiﬁed to the species level and
conﬁrmed by a reference laboratory. Minimum Inhibitory Concentration
(MICs) were determined by the local laboratory using supplied broth
microdilution panels and interpreted according to CLSI guidelines.
Results: Out of 347 isolates collect, 128 (37%) were determined to
be multi-drug resistant (MDR) as deﬁned by resistant to 3 or more
antimicrobial drug classes. A. baumannii had the highest percentage of
MDR strains with 26/30 (86%) followed in order by K. pneumoniae
22/43 (51%); E. cloacae 9/18 (50%); E. coli 25/54 (46%); P. aeruginosa
16/40 (40%) S. marcescens 9/23 (39%) and S. aureus 15/50 (30%).
Of these, 80% or better were nosocomial infections in adults over 30
years age. Tigecycline inhibited >98% of the Gram-negative MDR
strains (excluding P. aeruginosa) at 2mg/mL, equal to imipenem. All
16 MDR Gram-positive strains (13 MRSA, 3 E. faecium) were inhibited
by linezolide at 4mg/mL, vancomycin at 32mg/mL and tigecycline at
0.5mg/mL.
Conclusions: Turkey had the highest level of MDR strains (37%) of any
country seen to date in the T.E.S.T. Program. Tigecycline remained active
against more than 98% of all the MDR strains (excluding Pseudomonas)
from these sites with activity similar to linezolid and vancomycin against
Gram-positive strains and equal to or more potent than imipenem against
Gram-negative strains.
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R2160 Tigecycline antibacterial activity in current (2004–2006)
global population – A Gender Population Analysis –
T.E.S.T. Program 2006
S. Bouchillon, M. Hackel, J. Johnson, D. Hoban, B. Johnson, R. Badal,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Tigecycline (TIG), a new glycylcycline, has been shown to
have potent broad spectrum activity against most commonly encountered
species responsible for community and hospital acquired infections. The
T.E.S.T. Program determined the in vitro activity of TIG and comparators
against respective Gram-positive/negative species. Isolates were collected
from 272 hospital sites in 34 countries from 2004 to 2006.
Methods: A total of 48,068 clinically signiﬁcant isolates collected
worldwide were analysed in this survey. The isolates were identiﬁed
to the species level at the participating sites and conﬁrmed by the
central laboratory. MICs were determined by each site using supplied
broth microdilution panels and interpreted according to CLSI (formerly
NCCLS) guidelines.
Results: Selected pathogens tested against tigecycline are shown in the
table.
Organismsa Male Female
n %S MIC50 MIC90 n %S MIC50 MIC90
Acinetobacter spp. 1,906 na 0.25 1 1,416 na 0.25 1
EcKoKp 5,720 97.6 0.25 1 7,143 98.2 0.25 1
Enterococcus spp. 1,942 100 0.06 0.12 1,969 100 0.06 0.12
H. inﬂuenzae 1,738 na 0.12 0.5 1,293 na 0.12 0.5
S. aureus 3,331 100 0.12 0.25 2,536 100 0.12 0.25
S. pneumoniae 1,883 na 0.03 0.25 1,366 na 0.03 0.25
EcKoKp: E. coli, K. pneumoniae and K. oxytoca; na, breakpoint not available.
Conclusions: Tigecycline showed excellent inhibitory activity against
all pathogens and species groups regardless of gender. Tigecycline
MIC90 of 0.25mg/mL, 0.12mg/mL and 0.25mg/mL against S. aureus,
Enterococcus, and S. pneumoniae, respectively, and MIC90 of 1mg/mL
against selected Enterobacteriaceae and Acinetobacter spp. validate the
potent inhibitory activity of TIG against pathogens without respect to
gender.
R2161 In vitro activity of tigecycline in an outpatient vs. inpatient
Western European population
B. Johnson, R. Badal, S. Bouchillon, M. Hackel, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Tigecycline has been shown to have potent broad spectrum
activity against most commonly encountered species responsible for
community and hospital acquired infections. The T.E.S.T. Program
determined the in vitro activity of tigecycline compared to most
commonly prescribed broad spectrum antimicrobials against Gram-
negative and Gram-positive species collected during 2004 to 2006.
Methods: A total of 8,900 clinical isolates from ﬁve Western European
testing sites were identiﬁed to the species level. Minimum Inhibitory
Concentration (MICs) were determined by each site using supplied broth
microdilution panels and interpreted according to EUCAST guidelines.
Results: Selective results are presented in the tables.
E. coli and Klebsiella spp. Acinetobacter spp.
In-patients
(n = 1,913)
Out-patients
(n = 474)
In-patients
(n = 531)
Out-patients
(n = 88)
%S MIC90 %S MIC90 %S MIC90 %S MIC90
Tigecycline 95.0 1 98.1 0.5 naa 1 na 1
Amikacin 95.6 4 95.8 4 72.1 64 78.4 64
Cefepime 84.7 4 86.2 4 17.9 32 25.0 >32
Imipenem 99.6 0.5 100 0.5 83.4 >16 81.8 4
Levoﬂoxacin 80.7 8 80.2 8 60.3 >8 63.6 8
Pip-Tazo na 64 na 16 na >128 na >128
ana, breakpoints not yet available.
S. aureus Enterococcus spp.
In-patients
(n = 810)
Out-patients
(n = 248)
In-patients
(n = 643)
Out-patients
(n = 88)
%S MIC90 %S MIC90 %S MIC90 %S MIC90
Tigecycline 100 0.25 100 0.25 100 0.25 100 0.12
Levoﬂoxacin 69.8 16 82.7 8 54.6 >32 66.3 >32
Linezolid 100 4 100 2 95.5 2 97.5 2
Minocycline na 0.5 na 0.5 na 8 na 8
Vancomycin 100 1 100 1 95.0 2 97.5 2
*na = breakpoints not yet available
Conclusion: Tigecycline’s in vitro activity was comparable to or greater
than most commonly prescribed broad spectrum antimicrobials without
any demonstrable change in activity between in- and out-patient bacterial
study strains. Tigecycline’s inhibitory against E. coli, Klebsiella spp.,
and Acinetobacter spp. was comparable to imipenem. Against Gram
positive organisms, Tigecycline’s activity was similar to linezolid and
vancomycin.
R2162 Tigecycline antibacterial activity in current (2004–2006)
European population – An Age Population Analysis –
T.E.S.T. Program 2006
R. Badal, S. Bouchillon, M. Hackel, J. Johnson, D. Hoban, B. Johnson,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Tigecycline (TIG), a new glycylcycline, has been shown to
have potent broad spectrum activity against most commonly encountered
species responsible for community and hospital acquired infections.
The T.E.S.T. Program determined the in vitro activity of TIG and 10
comparators against respective Gram-positive/negative species. Isolates
were collected from 272 hospital sites in 34 countries from 2004 to 2006.
Methods: A total of 11,281 clinically signiﬁcant isolates collected across
Europe were analysed in this survey. The isolates were identiﬁed to
the species level at the participating sites and conﬁrmed by the central
laboratory. MICs were determined by each site using supplied broth
microdilution panels and interpreted according to EUCAST guidelines.
Results: Selected pathogens tested against tigecycline are shown in the
table.
Organisms n %Sus MIC50 MIC90
Paeds (NB-13)
Acinetobacter spp. 52 naa 0.12 0.5
E. coli/Klebsiella spp. 277 96.8 0.25 1
S. aureus 150 100 0.12 0.25
S. pneumoniae 178 na 0.03 0.5
Young adult (14−29)
Acinetobacter spp. 56 na 0.25 1
E. coli/Klebsiella spp. 164 98.2 0.25 0.5
S. aureus 118 100 0.12 0.25
S. pneumoniae 43 na 0.03 0.5
Adult (30−64)
Acinetobacter spp. 337 na 0.25 1
E. coli/Klebsiella spp. 1,146 95.3 0.25 1
S. aureus 500 100 0.12 0.25
S. pneumoniae 264 na 0.03 0.5
Geriatric (65+)
Acinetobacter spp. 337 na 0.25 1
E. coli/Klebsiella spp. 1,405 95.1 0.25 1
S. aureus 542 100 0.12 0.25
S. pneumoniae 258 na 0.06 0.5
ana, breakpoint not available.
Conclusions: Tigecycline showed excellent inhibitory activity against
all groups of pathogens regardless of age group. Tigecycline MIC90 of
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0.25mg/mL and 0.5mg/mL against S. aureus and S. pneumoniae,
respectively, and MIC90 of 1mg/mL against Enterobacteriaceae and
Acinetobacter spp. validate the potent inhibitory activity of TIG against
community/hospital pathogens in all age populations.
R2163 In vitro activity of tigecycline against common pathogens –
Eastern European Data – T.E.S.T. Program 2006
S. Bouchillon, R. Badal, M. Hackel, J. Johnson, D. Hoban, B. Johnson,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Tigecycline (TIG), a new glycylcycline, has been shown to
have potent broad spectrum activity against most commonly encountered
species responsible for community and hospital acquired infections.
The T.E.S.T. Program determined the in vitro activity of TIG and 10
comparators against respective Gram-positive/negative species. Isolates
were collected from 205 hospital sites in 30 countries from 2004 to 2006.
Methods: Clinically signiﬁcant isolates from East European testing
sites (Czech Republic, Poland, Hungary, and Latvia) were analysed
in this survey. The isolates were identiﬁed to the species level at the
participating sites and conﬁrmed by the central laboratory. MICs were
determined by each site using supplied broth microdilution panels and
interpreted according to EUCAST guidelines.
Results: TIG activity against selected pathogens and body sites are
shown in the table.
Conclusions: Tigecycline showed excellent inhibitory activity against
all groups of pathogens regardless of isolation site. Tigecycline MIC90
of 0.5mg/mL against Gram-positive pathogens (including resistant
phenotypes) and MIC90 of 1mg/mL against Enterobacteriaceae and
Acinetobacter spp. validate the potent inhibitory activity of TIG against
Eastern European community/hospital pathogens.
Organism (#) Tigecycline % inhibited at MIC
MIC50 MIC90 0.5 1 2 4
A baumannii (73) 0.05 1 74.0 95.9 100
E. faecalis (51) 0.12 0.12 100
EC, KO, KPa (225) 0.25 1 88.4 95.6 97.3 99.6
ESBLb (16) 0.5 4 62.5 68.8 75.0 93.8
Enterobacter spp.
(118)
0.5 1 86.4 94.1 96.6 100
H. inﬂuenzae (59) 0.12 0.25 100
P. auruginosa (96) 16 >16 0 2.1 9.4
S. agalactiae (47) 0.03 0.25 100
S. aureus (MR) (23) 0.12 0.25 100
S. pneumoniae (58) 0.12 0.5 100
aE. coli, K. oxytoca, K. pneumoniae. bExtended-spectrum b-lactamase
producers.
R2164 In vitro interaction of imipenem, sulbactam, colistin and
rifampin on 18 imipenem-resistant Acinetobacter baumannii
isolates
H. Antonopoulou, D. Kavatha, I. Galani, Z. Chryssouli, M. Lelekis,
H. Giamarellou (Athens, GR)
Objective: Imipenem-resistant strains of Acinetobacter baumannii (Ab)
are increasingly recognized worldwide, leaving colistin and, sometimes,
sulbactam, as the only alternative treatment. However, the use of colistin,
is limited, due to its adverse effects and poor pharmacokinetics so that
other therapeutic options are needed. The aim of this study was to
investigate, the in vitro activity of the interaction between imipenem
(IMP), colistin (CL), sulbactam (SUL) and rifampin (RIF), on IMP-
resistant isolates of Ab.
Methods: Eighteen clinical multidrug-resistant isolates from 12 hospitals
of Athens were selected. MICs were determined by broth microdilution
and E-tests, according to CLSI guidelines. All isolates were sensitive
only to colistin. Genetic analysis was performed by pulse-ﬁeld gel
electrophoresis (PFGE). Time-kill assays were performed for each
antibiotic and for the following combinations: CL+SUL, CL+RIF,
IMP+SUL, CL+SUL+RIF and CL+SUL+RIF. The concentrations of
antibiotics were selected according to their mean serum levels in clinical
practice; IMP: 0.02mg/L, SUL: 0. 03mg/L, RIF: 0. 0075mg/L and for
CL: 1×MIC. Bacterial growth was determined at 0, 1, 3, 5 and 24 hours
of incubation in shaking water bath at 37ºC. Synergy between tested
antibiotics was deﬁned as any more than 2 log10 decrease of viable cells,
compared to log10 decrease achieved by the most active single agent.
Results: Seven strains belonged to one major clone. Other seven strains
were possibly related to it. Two other different clones were detected
with three and one representatives respectively. Synergy between tested
antibiotics, in any time of growth, is shown in table 1. In all, except one
isolate, no regrowth was detected after synergy was appeared.
Table 1. Synergy between the tested antibiotics at 1, 3, 5 and 24 h of incubation
on the total of 18 isolates
Combination Incubation time Indifferent
result
1 h 3 h 5 h 24 h
CL+IMP – 9 (50%) 2 (11.1%) 6 (33.3%) 1
CL+SUL – 4 (22.2%) 7 (38.8%) 5 (27.7%) 2
CL+RIF 10 (55.5%) 6 (33.3%) – 2 (11.1%) –
IMP+SUL – 1 (5.5%) – 15 (83.3%) 2
CL+SUL+RIF 9 (50%) 4 (22.2%) 4 (22.2%) 1 (5.5%) –
CL+SUL+IMP – 8 (44.4%) 6 (33.3%) 3 (16.6%) 1
Conclusions: All tested combinations showed synergistic effect although
combinations with RIF seamed to express a faster synergistic effect
than those without RIF. All combinations were bactericidal. The triple
combinations tested, were not more effective than the double ones.
Further, other studies are required to determine the interaction of the
tested antibiotics in vivo.
R2165 In vitro activity of tigecycline and commonly-used
antimicrobials against clinical isolates collected from 2004
to 2006 in Spain and Portugal
R. Badal, S. Bouchillon, B. Johnson, M. Hackel, J. Johnson, D. Hoban,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Development of bacterial resistance continues to cause
concern world-wide, but availability of newer agents offers clinicians
options for therapy. Tigecycline (Tig) has a very broad spectrum of
activity, including strains resistant to other drugs. As part of the global
Tigecycline Evaluation Surveillance Trial, strains collected in Spain and
Portugal from 2004 to 2006 were evaluated for susceptibility to several
antimicrobials.
Methods: Strains were collected and identiﬁed at 8 sites in Spain and
Portugal. MICs were determined at each site using microdilution panels
following EUCAST guidelines.
MIC90
S. aureus
n = 215
Enterococci
n = 132
S. pneumoniae
n = 118
Amoc/Clav >8 >8 1
Ampicillin >16 >16 2
Ceftriaxone >64 >64 0.5
Imipenem 4 >16 0.5
Levoﬂoxacin 8 >32 1
Linezolid 2 21
Minocycline 0.5 >8 4
Penicillin >8 >8 1
Pip/Tazo >16 >16 2
Tig 0.25 0.12 0.5
Vancomycin 1 2 0.5
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E. coli/Kleb
n = 439
Enterobacter
n = 205
Acinetobacter
n = 116
Amikacin 4 2 >64
Amox/Clav 32 >32 >32
Ampicillin >32 >32 >32
Cefepime 4 2 >32
Ceftazidime 8 32 >32
Ceftriaxone 16 32 >64
Imipenem 0.5 1 >16
Levoﬂoxacin 8 0.25 >8
Minocycline 8 4 16
Pip/Tazo 16 32 >128
Tig 0.5 1 1
Results: The tables summarise results for all isolates, and for speciﬁc
key pathogens.
Conclusions: Tig had the lowest MIC90 vs. Gram-positive strains (incl.
MRSA, PRSP), and was essentially as active as imipenem vs. Gram-
negative strains (incl. ESBL+). It was also signiﬁcantly more active than
any comparators (other than linezolid) vs. enterococci and Acinetobacter.
R2166 Tigecycline in vitro activity against carbapenem-non-
susceptible Acinetobacter baumannii
J. Komarnicka, L. Naumiuk, A. Samet (Gdansk, PL)
Objectives: To evaluate tigecycline activity against carbapenem-resistant
and carbapenem intermediate susceptible Acinetobacter baumannii
isolated from patients of a university hospital in Poland.
Methods: Twenty two multidrug-resistant A. baumannii isolates which
were non-susceptible to carbapenems by disk-diffusion method were
selected for tigecycline activity determination. MICs to tigecycline
(TGC), imipenem (IMP) and meropenem (MEM) were determined by
E test.
EUCAST Enterobacteriaceae TGC susceptibility/resistance breakpoints
were used due to lack of ofﬁcial Acinetobacter speciﬁc breakpoints and
were as follows: susceptible 1 and resistant >2mg/L.
Results: Eleven isolates were intermediate susceptible to TGC (MIC
from 1.5 to 2mg/L), 10 were susceptible (MIC from 0.016 to 1mg/L)
and 1 was resistant (MIC=4mg/L) according to choosen breakpoints.
In 13 isolates resistant to both IMP and MEM (MIC 16mg/L)
TGC retained full activity in only 4, further 9 isolates remained
intermediate susceptible to TGC. There were 6 isolates with IMP-I
and MEM-R phenotype, ﬁve of them were susceptible to TGC and
one was intermediate. Each of 3 isolates which had IMP-I and MEM-I
phenotype, displayed different TGC phenotype: resistant, intermediate
and susceptible.
Conclusion: TGC was only partially active against carbapenem non-
susceptible A. baumannii in our hospital. The lowest TGC activity was
noted among isolates resistant to both IMP and MEM. TGC remains an
interesting alternative in treating multidrug-resistant Acinetobacter but
demands antimicrobial susceptibility testing in every case.
R2167 Antimicrobial susceptibility to third and fourth generation
cephalosporins and the prevalence of extended-spectrum
b-lactamase-producing isolates among Enterobacteriaceae
from different clinical specimens
B. Kocic, S. Mladenovic-Antic, G. Randjelovic, P. Stojanovic, M. Dinic
(Nisˇ, RS)
Infections that are caused by multiple antibiotic resistant organisms cause
signiﬁcant morbidity and mortality. ESBL-producing aerobic Gram-
negative rods are resistant to ﬁrst, second and the third generation
cephalosporins and penicilins, and may show simultaneous resistance
to ﬂuoroquinolones and aminoglicosides. They have rapidly emerged as
major pathogens around the world, and have compromised therapy with
b-lactam antibiotics, including third generation cephalosporins.
Objectives: To evaluate the antimicrobial susceptibility to third and
fourth generation cephalosporins, and to comprise the frequency of
ESBL-producing strains among the most common Gram negative rods
collected from different clinical specimens from the Institute for Public
Health in Nisˇ during the year 2005.
Methods: 1112 strains of Enterobacteriaceae were studied. Their
antimicrobial susceptibility was tested by the disk-diffusion method
according the CLSI guidelines. Screening for the detection for ESBL
from Enterobacteriaceae was carried out by the double-disk sinergy test
(DDST). The E-test ESBL was used as a conﬁrmation test.
Results: The species distribution as follow: E. coli 449 (40.02%),
Enterobacter spp. 215 (19.16%), Klebsiella spp. 161 (14.35%), Proteus
mirabilis 142 (12.66%), Morganella morganii 39 (3.48%), Citrobacter
sp. 39 (3.48%), Providencia spp. 19 (1.69%), Proteus vulgaris 18 (1.6%).
Antimicrobial resistance to b-lactam antibiotics was: to amoxicillin
clavulanic acid 60%, to ceftazidime 57.1%, to ceftriaksone 47.1%, to
cefotaksime 40.7%, and to cefepime 47.7%. ESBL production was
observed in 17.8% of all the isolates. The highest rates were for
Klebsiella spp.33%, E. coli 19.1% and Enterobacter spp. 27.4%. Seventy
ﬁve percent of ESBL-positive strains were nosocomial.
Conclusion: In our country, most of the investigated strains showed
high rates of resistance to third and fourth generation cephalosporins.
In addition, we have found an increase in the ESBL-positive strains of
Enterobacteriaceae, from 15.79% in 2002. to 17.8% in 2005.
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R2168 Anti-giardial activity of phenolic essential oils
C. Cavaleiro, B. Gaspar, L. Salgueiro, J. Poiares-da-Silva, M.C. Sousa
(Coimbra, PT)
Giardia lamblia, a parasitic ﬂagellated protozoan, is the most common
causative agent of diarrhoeal illness world-wide. Current therapy against
G. lamblia infection (giardiasis) is unsatisfactory due to high incidence of
undesirable side effects and a signiﬁcant failure in clearing parasites from
the gastrointestinal tract. Because of these problems, new compounds are
being screened for antigiardial activity, namely plant extracts.
Aromatic plants and their essential oils, mixtures of natural volatile
compounds isolated by distillation, have been used since antiquity to
heal microbial infections. Previous works showed that several essential
oils showed important antibacterial, antifungal and antiparasitic activity,
predicting therapeutic beneﬁts on diseases involving gastrointestinal,
mucosal, cutaneous and respiratory infections.
In the present work, we study the effect of essential oils obtained from
several aromatic plants (Thymus zygis ssp. sylvestris, T. pulegioides,
Thymbra capitata, Origanum virens and Lippia graveolens Thymus
capitelatus, Thymus mastichina, Mentha cervina and Mentha piperita)
on G. lamblia growth.
Essential oils were obtained by hydrodistillation from fresh plant
material and analysed by GC and GC-MS. Constituents were identiﬁed
from their retention indices on two different phases GC columns
(polydimethylsiloxane and polyethyleneglycol) and from their mass
spectra, which were compared with reference data. Culture trophozoites
of WB strain (ATCC 30957) were incubated in growth medium with
different concentrations of essential oils for 48 h at 37ºC under anaerobic
conditions. The inhibitory concentration (IC50) values were determined
by cell counting. The plant activities were compared with metronidazol
activity, considered a “gold standard” antibiotic used in therapy of
giardiasis.
Oils from plants with non-phenolic compositions did not revealed
anti-giardial activity. Contrarily, essentials oils from Thymus zygis
ssp. sylvestris, Thymus pulegioides, Thymbra capitata, Origanum
virens and Lippia graveolens inhibited trophozoites growth and were
classiﬁed as “active”. The IC50 values range from 0.07microL/mL to
0.15microL/mL. The compositions of these active oils are characterised
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by the predominance of phenolic monoterpenes, carvacrol and or timol.
These results suggest that phenolic compounds are responsible for the
antigiardial activity and have potential for use as therapeutic agents
against giardiasis.
R2169 Persistent suppression of bacterial growth after exposure
to high-frequency alternated current
C. Cassanelli, S. Roveta, A. Marchese, E.A. Debbia (Genoa, IT)
Background: The exposure of a bacterial suspension to the hight
frequency alternated current (HFAC) damages the bacterial envelope and
delayes cell division. In this study was veriﬁed if the HFAC generated by
Endox® Endodontic System, an instrument used in endodontic treatment
for disinfection of the root canal, produced a phenomenon similar to
postantibiotic effect.
Methods: P. aeruginosa and E. faecalis strains employed in this study
were clinical isolated belonging to the collection of this Laboratory.
A sample of 0.1ml of a saline bacterial suspension (105 cell/mL) was
exposed to HFAC (140msec, 500 kHz, 1200 kV) for three times and then
resuspended in 10ml of Mueller–Hinton broth. A suspension not treated
was employed as control. The suspensions were grown at 37ºC for 6−8
hours; plate counts were performed every 60 min. All experiments were
repeated for ﬁve times.
Results: A persistent suppression of bacterial growth of about 3 hours
was observed in the two bacterial species after exposure to HFAC. In
the control strains no growth suppression was noted.
Conclusion: The present ﬁndings suggest that HFAC generated by
Endox® Endodontic System produce a damage in the structure of
bacterical cells membrane. This phenomen can be usefull to study the
possible variations in the permeability of bacterial membranes and is
probaly responsable of bactericidal effect of this instrument.
R2170 Assessment of susceptibilities of a range of
antibiotic-resistant clinical isolates to Aloe vera inner gel
F.M. Habeeb, A.A. Dashti, D. Morrison, A.I. Gray, V.A. Ferro (Kuwait,
KW; Glasgow, UK)
Since the discovery of penicillin in 1928, by Alexander Fleming,
the emergence of antibiotic resistant bacterial strains has been a
growing problem. This has led to an urgent global call for new
antimicrobial drugs, particularly from natural resources. We investigated
the therapeutic potential of Aloe vera, a plant known anecdotally for
its anti-microbial properties. Aloe vera, has widespread use in health
and beauty products, toiletries and disinfectants, however, we wished
to determine if there was a scientiﬁc basis for its anti-microbial usage
and whether this could be exploited for use against antibiotic resistant
bacteria.
Objectives: To determine the effect of Aloe vera on a range of
clinical isolates identiﬁed as antibiotic resistant, including Gram
positive (Methicillin-Resistant Staphylococcus aureus, [MRSA] and
Enterococcus bovis) and Gram negative (Enterobacter cloacae) strains.
Methods: A standard broth tube dilution method, as recommended by
NCCLS was used to calculate the minimum inhibitory concentrations
(MIC) of a preservative free Aloe vera inner gel powder (Aloe vera
of America, Inc). The MIC is read as the lowest concentration
of antimicrobial agent, which inhibited bacterial growth. Minimal
bactericidal concentrations (MBC) were determined by inoculating 10
microlitres from each MIC broth tube without visible growth, on a
Nutrient agar plate. Plates were then incubated in an inverted position
at 37ºC. Following overnight incubation, the plates were examined for
colony growth. Lack of growth indicates that the tested drug was
bactericidal at that dilution and this was reported as MBC. Growth
indicates that the drug was bacteriostatic at that dilution.
Results: The results showed that the MIC of Aloe vera on MRSA 9,
MRSA 6, E. cloacae, and E. bovis was 25, 25, 25 and 12.5mg/mL
respectively. The MBC of Aloe vera on MRSA 9, MRSA 6, E. cloacae,
and E. bovis was 62.5, 125, 62.5 and 125mg/mL respectively.
Conclusion: Aloe vera has antimicrobial activity and it could be used in
healthcare settings. If a product contains 250mg/mL of Aloe vera this
will result in 10×MIC for MRSA 9, MRSA 6, E. cloacae, 20×MIC for
E. bovis, 4×MBC for MRSA 9 and E. cloacae and 2×MBC for MRSA 6
and E. bovis. This indicates that Aloe vera is active against these clinical
isolates and has the potential to be a source for new antimicrobials.
Epidemiology of MRSA, VRE & other
Gram-positives
R2171 Comparison of coagulase-positive and coagulase-negative
variants of MRSA strains isolated from hospital specimens
K. Kopron, S. Giedrys-Kalemba (Szczecin, PL)
Objectives: The purpose of the study was to estimate biochemical
characteristic, drug resistance and genotype patterns of coagulase-
positive and coagulase-negative HA-MRSA isolated from the same
hospital.
Methods: A total of 258 MRSA strains were determined as aetiological
agent of different kind of infections in Clinical Hospital in Szczecin
in the year 1999–2005. Isolates were collected from various materials
(blood, bronchoalveolar washings, sputum, secretion from wounds,
catheters, drains, liquids from pleura and peritoneum) and wards
(intensive care unit, surgery, internal medicine, urology, dermatology,
cardiology). The plasma coagulase tube test, the slide test for clumping
factor, thermonuclease test, API–STAPH kit, mecA and coa genes were
used for identiﬁcation. Susceptibility tests according to CLSI guidelines
were preformed for cefoxitin, erythromycin, clindamycin, tetracycline,
gentamicin, rifampicin, ciproﬂoxacin, cotrimoxazole, chloramphenicol,
fusidic acid, vancomycin. All isolates were subjected to the SmaI
genomic DNA macrorestriction analysis (PFGE) and the obtained
patterns were compared by software Molecular Analyst Fingerprinting
Software.
Results: All coagulase-positive MRSA were positive in tests for
thermonuclease but 19 isolates were CF negative (10%). HA-MRSA
coagulase-negative strains were isolated from clinical specimens with
a relatively high frequency – 29% (74 strains), mostly from intensive
care unit – 52% (39 strains). All these strains were positive in tests
for clumping factor and thermonuclease, most of them possess coa
gen. The coagulase-positive HA-MRSA strains were more resistant to
chloramphenicol and rifampicin than coagulase-negative, which were
more resistant to cotrimoxazole; the level of resistance to other drugs
was similar, about 90–100%. No vancomycin resistant HA-MRSA were
found. HA-MRSA strains belonged to 13 genotypes (A-M), grouped
2−48 isolates, and 6 unique patterns. Coagulase-negative strains were
identiﬁed in 3 types (C, F, G) only, however in those types coagulase-
positive MRSA were also found.
Conclusion: Coagulase-negative MRSA strains are becoming more
and more important problem in hospital infections. They belong to
multidrug resistant strains and to the same epidemic/endemic genotypes
as coagulase-positive MRSA. More attention should be given in their
identiﬁcation in routine diagnostic – phenotypic and genotypic methods
are recommended.
R2172 Antimicrobial resistance of Staphylococcus aureus
nosocomial blood isolates in Russian intensive care units
A. Dekhnich, E. Ryabkova, O. Kretchikova, N. Ivanchik (Smolensk, RU)
Objectives: To evaluate the susceptibility of nosocomial strains of
Staphylococcus aureus isolated from blood of patients hospitalised in
ICUs in different parts Russia.
Methods: A total of 143 strains of S. aureus isolated in 2004–2005
from patients with bacteraemia hospitalised in ICUs in 16 cities in
different parts of Russia, were studied. Antimicrobials tested included
chloramphenicol (CHL), ciproﬂoxacin (CIP), clindamycin (CLI), co-
trimoxazole (CTX), erythromycin (ERY), fusidic acid (FUS), gentamicin
Epidemiology of MRSA, VRE & other Gram-positives S629
(GEN), levoﬂoxacin (LEV), linezolid (LNZ), mupirocin (MUP),
oxacillin (OXA), rifampin (RIF), tetracycline (TET), vancomycin (VAN).
Antimicrobial susceptibility testing was performed by agar dilution
method according to CLSI/NCCLS guidelines (2005–2006). S. aureus
ATCC 29213 was used as a control strain.
Results: Results of susceptibility testing are presented in the table.
Antimicrobial I, % R, % MIC (mg/L)
MIC50 MIC90 Range
CHL 0.7 62.9 64 64 4–128
CIP 4.9 62.9 16 64 0.125–128
CLI 0 47.6 0.06 512 0.03–512
CTX 0 8.4 0.06 2 0.03−8
ERY 2.1 60.8 512 512 0.125–512
FUS 0 0 0.125 0.25 0.015–0.25
GEN 0.7 58.7 128 512 0.25–512
LEV 11.2 36.4 2 8 0.125−16
LNZ 0 0 2 2 0.5−2
MUP 0 0 0.25 0.25 0.125−0.5
OXA 0 86.0 64 256 0.25–512
RIF 2.8 26.6 0.015 64 0.015–256
TET 0 54.6 64 256 0.125–256
VAN 0 0 1 1 0.25−2
Conclusions: (1) very high rate of MRSA (86%) was found that do not
allow to use b-lactams in ICU patients with staphylococcal bacteraemia;
(2) the most active antimicrobials with all strains susceptible were
vancomycin and linezolid; (3) other antimicrobials with high in vitro
activity were fusidic acid and sulfamethoxazole/trimethoprim with 0%
and 8.4% of strains non-susceptible, respectively; (4) high rates of
resistance to ﬂuoroquinolones, lincosamydes, macrolides, tetracyclines,
gentamicin and chloramphenicol were detected.
R2173 Prevalence and clinical impact of Enterococcus spp. in
gynaecological department
V. Kolodjieva, R. Yafaev, A. Suvorov (Saint-Petersburg, RU)
Objectives: The aim of the study was to investigate features
of enterococcal infections and comparative molecular analyses of
Enterococcus virulence determinants of clinical strains obtained from
the patients of gynecological hospital and antenatal centre.
Methods: We investigated 890 women from the gynecological depart-
ment of the St. Mary Hospital and 180 women of antenatal centre. We
used PCR to detect the virulence factor genes (VFG). Genes encoding
for gelatinase (gelE), serine protease (sprA˚), extracellular surface protein
(esp), regulator, controlling expression of gelatinase and serine protease
(fsrA) and aggregation substances (asa) have been analysed. Assessment
of antibiotic susceptibility of enterococcal strains has been performed.
Results: Enterococci represented the most common pathogen isolated
from patients with genital infections in gynecological department.
This group included patients with the endometritis (65.8%), uterine
apparandages (28.5%). Enterococcal strains from the patients of
gynecological department were isolated more often than from women
supervised by antenatal centre (p = 0.0001). The VFG were represented
more often in the Enterococcus strains isolated from women with
infection than in the strains from the women without infection.
The rate of ampicillin resistance among clinical isolates of this species
was 73.8%, streptomycin (high-level resistance [HLR]) 78.5%, HLR
to gentamicin 58.9%, ciproﬂoxacin 63.2%, erythromycin 87.3%. Five
isolates were intermediate to vancomicin (IIE 8mg/mL).
Enterococcal infection sources include endogenous, as from the colon
(>40%), and exogenous such as nosocomial transmission via gloves
of personnel. Long-term (at 6 months) circulation of one clone using
VFG-carriage typing, phage typing and antibiogram in gynecological
department is shown.
Conclusion: Enterococcus spp. could cause NI. Clinical strains of
enterococci vary substantially by the presence of VFG. The lability
of properties allows them to adapt and to persist in conditions of a
hospital on objects of an environment, and also to gain a resistance to
the antibiotics used in the given hospital.
R2174 Screening for MRSA at hospital admission in Turkey
N. Baykam, H. Esener, P. Zarakolu, O. Ergonul, T. Cirkin, A. Celikbas,
S. Eren, B. Dokuzoguz (Ankara, Istanbul, TR)
Objective: To determine the prevalence of Methicillin Resistant
Staphylococcus aureus (MRSA) at the hospital admission and to predict
the risk factors for MRSA carriage.
Methods: Anterior nare cultures were obtained at the time of hospital
admission to identify patients colonised with S. aureus. To detect
methicillin resistance, oxacillin disk charged with 1mg was applied to
Mueller Hinton agar containing 4% sodium chloride. Panton-Valentine
leukocidin (PVL) gene was detected by PCR and Pulse Field Gel
Electrophoresis (PFGE) was performed to examine the clonal divercity
of the MRSA strains. A multivariate analysis was performed to detect
the risk factors of MRSA. Age, smoking, use of antibiotics within last
6 months, healthcare worker within the family, chronic obstructive lung
disease, history of hospitalisation within last year were included to the
model.
Results: Nine hundred patients were screened. The rate of females
was 46%, and the mean age was 43.5. Eleven (1.1%) MRSA strains
were detected. All the MRSA strains were positive for the mecA and
PVL gene. Three different clones of MRSA strains were detected in
pulse ﬁeld gel electrophoresis. The MRSA carrier patients were older
(p = 0.013), were using antibiotic on the admission (p = 0.009), had
diabetes (p = 0.031) and obstructive pulmonary lung disease (p = 0.008)
more commonly. Antibiotic use within the last 6 months was more
common among MRSA positive patients, but not statistically signiﬁcant
(p = 0.100). Intravenous drug use was not common among the patients
(2%). Six out of 11 MRSA positive patients did not stay in the hospital
within the last 12 months. However, 5 out of 11 PVL positive MRSA
carriers had the history of hospitalisation within the last 6 months.
Conclusion: The rate of community acquired MRSA colonisation is low
in Turkey. The PVL can not be deﬁned as the indicator of community
acquired MRSA. There is no strict and rigid line between hospital and
community acquired MRSA infections.
R2175 Differences in the features of staphylococcal bacteraemias
in adults with and without cancer
I. Kourbeti, J. Papadakas, G. Fanti, E. Kalavrytinou, E. Koutsounaki,
M. Rovithi, A. Christidou, G. Samonis (Heraklion, GR)
Background: Staphylococcus aureus and coagulase-negative staphylo-
coccal bacteraemias (SAB and CNSB) cause substantial morbidity and
mortality. Between 2003 and 2005 we contacted a prospective study
to investigate the differences in the features of SAB and CNSB in
adults with (ON) and without cancer (IM). Our goal was to compare
the outcome with emphasis on metastatic infections and the treatment
and hospitalisation days.
Methods: The medical records of the patients >18 years old hospitalised
in IM and ON words that were reported to have SAB or clinically
signiﬁcant CNSB were reviewed and the course of the patients was
followed. Data were abstracted to a standard form and analysed using
SPSS.
Results: During the aforementioned period a total of 33 SAB (27 in the
IM and 6 in the ON group) and 38 CNSB patients (12 in the IM and
26 in the ON group) were identiﬁed. The groups were balanced for age
and sex.
Signiﬁcant observations from the analysis of the data include the increase
in the percentage of MRSA in the IM Department from 18.2% in 2003,
to 89% in 2004 and 86% in 2005
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For the SAB the IM population required signiﬁcantly more days of
treatment (p< 0.05) and hospitalisation (p< 0.05). 66.7% of the SAB in
the ON group were catheter associated (CAB) (statistically signiﬁcant,
p< 0.001) and there was a trend for higher methicillin resistance
(p = 0.065). There were no differences in the clinical and laboratory
features (fever, WBC), the survival, the association with treatment in
the ICU, the metastatic infections and the mixed bacteraemias. The
metastatic infections most commonly seen included abscesses (22.2%),
endocarditis (18.5%) and septic arthritis (7.4%).
For the CNSB the IM population needed more days of treatment
(p< 0.05) and there was an association with prior ICU treatment
(p< 0.05). The ON population had more mixed bacteraemias (p< 0.05).
There were no differences in the fever, the WBC, the survival and the
metastatic infections.
Conclusions: The patients with cancer present with SAB as a result of
their indwelling central venous catheters (CVCs). Leukopenia is not a
predisposing factor. The length of stay was signiﬁcantly longer for the
IM group for both SAB and CNSB. The IM group required signiﬁcantly
longer antibiotic treatment for the SAB. SAB and CNSB are associated
with signiﬁcantly higher morbidity in the adults without cancer.
R2176 Prevalence of MRSA in a population of ambulatory patients
M. Szczyrek, A. Kopaczewska, A. Chudnicka (Lublin, PL)
Objectives: The aim of the study was to characterise drug resistance
of the Staphylococcus aureus strains isolated from clinical materials
obtained from ambulatory patients in Lublin, Poland, and to evaluate
the problem of methicillin resistance in the analysed group.
Methods: The study comprised 302 randomly chosen individuals, both
men (157) and women (145), who were infected with S. aureus.
Materials included specimen from nose, pharynx, ears, skin changes and
wounds. Specimens were collected with cotton swabs and cultured on
Columbia blood agar. The organisms were identiﬁed by using API Staph
identiﬁcation system (bioMe´rieux, France). Antimicrobial susceptibility
to several antibiotics (penicillin, doxycycline, erythromycin, Co-
trimoxazole, clindamycin, ciproﬂoxacin, and oxacillin) was determined
by Kirby Bauer disk diffusion method using Becton Dickinson disks,
according to NCCLS (National Committee for Clinical Laboratory
Standards).
Results: In the studied materials 305 catalase-positive bacterial strains
belonging to the species S. aureus were found. In 20 cases (6.5%)
isolated strains showed resistance against methicillin (MRSA). Among
the MSSA strains, resistance occurred against penicillin (87%),
doxycycline (39%), and erythromycin (23%). Most strains remain
susceptible to Co-trimoxazole (only 8% resistant), clindamycin (12%)
and ciproﬂoxacin (14%). Some of the isolated MRSA strains were
additionally resistant to antistaphylococcal drugs, teicoplanin and
mupirocin. No VRSA (Vankomycin Resistant Staphylococcus aureus)
or VISA (Vancomycin Intermediate Staphylococcus aureus) strains have
been found.
Conclusion: The study revealed that infections caused by MRSA in
Poland do occur outside hospitals, and can cause therapeutical failures
with empirical pharmacotherapy. Some of the isolated strains were
additionally resistant to other antistaphylococcal drugs. Those results
demonstrate the need for the aimed antimicrobial therapy in ambulatory
patients.
R2177 Molecular epidemiology of bacteriophages in group A
streptococcal strains belonging to serotype M49
E. Polyakova, S. Suvorov, B. Beall, J. Ferretti (St. Petersburg, RU;
Atlanta, Oklahoma, US)
Objectives: Group A streptococci (GAS) are pathogenic bacteria causing
various severe human diseases. It was determined that almost all GAS
strains carry temperate bacteriophages in their genome which might be
important for GAS biology including the pathogenic potential of the
strain. Streptococcal phages can carry various toxin genes, genes of
streptodornases and antibiotic resistances. Genetic analyses of temperate
phages in GAS promote understanding “fast” evolution mechanisms of
bacterial genomes. However at present very little is known regarding the
association of phages and speciﬁc GAS serotypes.
Goals of investigation: Analysis of M49 GAS strains for the presence
of bacteriophages carrying virulence factors genes.
Materials and Methods: 48 GAS (38 strains from serotype M49)
clinical isolates had been studied employing PCR and macro array
hybridisation. 27 phage genes encoding for toxins, integrases of phage
structural proteins were used as a probes or PCR targets.
Results: It was determined that M49 GAS strains are characterised by the
particular set of bacteriophages and virulence genes. The most common
phage toxin genes for M49 were speA, speI and speH. SpeK, speM
and speC were the rarest. Two types of integrases encoded by int5 and
int7 were found to be common in M49 GAS. There were no strains
from M49 serotype without the phage genes in the genome. M49 strains
collected from one geographical area during the 6 year period were found
to carry identical phage genes pattern. This ﬁnding allows considering
phage gene typing as potent tool for molecular epidemiological analysis.
R2178 The clinical signiﬁcance of Viridans streptococcal
bacteraemia in patients at a district general hospital
L. Tan, S. Lacey, M. Melzer (London, Essex, UK)
Objectives: Viridans streptococci (VS) are low virulent commensals
of the upper respiratory tract (URT). Community-acquired bacteraemia
occurs commonly but its clinical signiﬁcance in children and immuno-
competent adults has not been well studied. Our aim was to determine
the proportion of community-acquired bacteraemia caused by VS, their
signiﬁcance, sites of infection and 30-day mortality.
Methods: Patients with VS bacteraemia were identiﬁed from a database
at a UK district general hospital from September 2003-October 2005.
Available case notes were retrospectively reviewed for demographic and
clinical data. Cultures were classiﬁed according to deﬁnite, probable
or no clinical signiﬁcance, depending on the number of positive blood
cultures and compatible clinical syndrome. Patients with suspected
infection were treated empirically based on likely site and local antibiotic
policy. Following VS identiﬁcation, antibiotics were altered according to
site and sensitivities.
Results: VS caused 63/829 (7.6%) community-acquired bacteraemias,
50/723 (6.9%) in adults and 13/106 (12.3%) in children. 55 notes
were available for review. There were no neutropenic patients. Among
adults, four (9.3%) cultures were of deﬁnite clinical signiﬁcance,
17 (39.5%) of probable signiﬁcance and 22 (51.2%) not signiﬁcant.
There were four (9.3%) cases of infective endocarditis, one (2.3%)
possible endocarditis, seven (16.3%) lower respiratory tract (LRT)
infections and two (4.6%) female genital tract infections. Four (9.3%)
patients had URT symptoms. Non-signiﬁcant cultures included two
(4.7%) patients with poor dentition, one (2.3%) post seizure, and 19
(44.2%) with no identiﬁable source. Among children, ﬁve (41.7%)
cultures were of probable signiﬁcance and seven (58.3%) were not
signiﬁcant. There were two (16.7%) LRT infections and three (25%) URT
infections. Non-signiﬁcant cultures included four (33.3%) bacteraemic
episodes post seizure or febrile convulsion. Overall, one patient died
as a consequence of infection (LRT). 20% of isolates were penicillin
resistant, 25% erythromycin resistant and 4% amoxicillin resistant.
Conclusion: In adults, the lower respiratory tract is commonest
site of infection but infective endocarditis also occurs. In children,
the lower respiratory tract is the commonest site of infection and
febrile convulsions are commonly associated with non-signiﬁcant VS
bacteraemia. Despite penicillin resistance, mortality was low and
infections were easily treated.
Epidemiology of MDR-Gram-negatives S631
R2179 Increased resistance to ﬂuoroquinolones in Streptococcus
agalactiae isolated from urinary tract infections acquired
in the community
C. Freyre, M. Rodriguez-Iglesias (Cadiz, ES)
Objective: Streptococcus agalactiae is an important pathogen causing
serious neonatal infections, characterised by sepsis and meningitis
and also maternal infections. It is very important his detection in
urine of pregnant women due to can be responsible of prematurity
and/or pyelonephritis. Quinolones is a therapeutic option in allergic
patients to b-lactams. We have studied the resistance to ciproﬂoxacin in
S. agalactiae isolated from patients with urinary tract infections acquired
in the community.
Methods: We have selected 531 S. agalactiae strains among urinary
clinical isolates from 2000 to 2006. Clinical signiﬁcance was considered
with bacterial count >100,000 CFU/mL. Identiﬁcation and conventional
antimicrobial susceptibility test was done (Microscan, Dade–Behring).
E-test was used as conﬁrmatory test in selected strains. MIC >2mg/mL
was considered resistant and decreased sensitivity with MIC 1−2 mg/mL
according to CLSI breakpoints.
Results: Between 2000 and 2006 it was found 13 strains resistant to
ciproﬂoxacin (2.45%) and 24 presenting moderate sensitivity (4.52%).
Statistical differences between years were not found with the exception
of the last year. In 137 strains isolated from January to October we
found similar proportion in resistant strains (2.19%) but a strong increase
in moderate sensitivity (8.03%) was evident. Also, clindamycin has
increased the resistance level from 15 to 20% in the last year.
Conclusions: The selection and proliferation of non-targeted microor-
ganisms due to empirical use of antimicrobials, particularly quinolones,
is a growing problem. We have detected a strong increase in moderate
susceptibility to ciproﬂoxacin (MIC 1−2) although resistance levels are
maintained constant in the last 6 years (2% aprox.). This increase can
be the herald of future resistances and related with several mutations in
GyrA and/or ParC that could be to cause high-level resistance. They are
necessary more studies for to understand the importance of mutations
in GyrB and to establish analogies between number and location of the
mutation, similarly to other bacteria.
R2180 Effect of adequate empiric antibiotic therapy on survival
of patients with methicillin-resistant Staphylococcus aureus
bacteraemia
R. Hazzan, M. Paul, H. Shaked, M. Wattad, H. Konigsberger,
B. Rubinovitch, L. Leibovici, J. Bishara (Petah Tikva, IL)
Objective: Glycopeptides are the treatment of choice for methicillin-
resistant Staphylococcus aureus (MRSA) bacteraemia. We evaluated the
effect of empirical treatment with glycopeptides for MRSA bacteraemia
on mortality.
Methods: Retrospective chart review of prospectively identiﬁed patients
with clinically-signiﬁcant MRSA bacteraemia, in a primary and
tertiary care hospital. Empirical treatment was deﬁned as that initiated
during the ﬁrst 48 hours. Mortality was deﬁned as 30-day all cause
mortality. Variables evaluated included: age, sex, functional capacity,
healthcare acquisition of infection, presence of intravascular catheters,
urinary catheter, mechanical ventilation, recent surgery or invasive
procedures, steroid or cytotoxic therapy, neutropenia, source of infection;
Background conditions: diabetes, renal failure, hemodialysis, prosthetic
valve, pacemaker, other prosthetic device, malignancy, lung disease,
liver disease, wounds, heart and vascular disease, McCabe and Charlson
score; Infection presentation: temperature, shock, leukocytes, platelets,
creatinine, albumin, liver function tests. Univariate comparisons were
performed using the chi-square test or t-test. Multivariate analysis was
performed using forward conditional binary regression.
Results: We included 150 episodes of MRSA bacteraemia among
141 patients. Signiﬁcant risk factors for mortality are shown in the
table. Empirical glycopeptide (vancomycin) treatment was administered
to 44.9% of patients that remained alive at 30 days compared to
29.5% of those that died (unadjusted p = 0.06). Patients who were
given vancomycin empirically had signiﬁcantly more frequent repeated
episodes of bacteraemia, implanted catheters, diabetes, hemodialysis,
prosthetic valves, recent angiography, higher albumin and no malignancy.
Signiﬁcant risk factors for 30-day all cause mortality on multivariate
analysis included no empirical treatment with vancomycin (p = 0.03),
septic shock (p< 0.001) and total leukocyte count (p = 0.01). The small
number of cases evaluated limits our analysis.
Variable Alive Dead P-value
N episodes 89 61
Fuctional status (full unrestricted activity) 36 (41.4%) 14 (24.1%) 0.03
Decubitus ulcer, burns of chronic wounds 10 (11.2%) 20 (32.8%) 0.001
Septic shock 7 (8.4%) 27 (50%) <0.001
Temperature, ºC, mean (SD) 38.5 (0.71) 38.1 (1.15) 0.03
White blood cells, K/micl, mean (SD) 13.2 (0.76) 15.9 (0.70) 0.04
Empirical glycopeptide treatment 40 (44.9%) 18 (29.5%) 0.06
Conclusion: Among patients with MRSA bacteraemia, empirical
treatment including vancomycin reduced 30-day mortality.
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R2181 Risk factors for community-acquired urinary tract infection
due to quinolone-resistant uropathogens
I. Kometiani, B. Chazan, R. Colodner, R. Raz (Afula, IL)
Background: E. coli remains the most common pathogen in Community
Acquired Urinary Tract Infections (CAUTI).
The massive use of antimicrobials in general and quinolones in particular
increased the frequency of multiresistant uropathogens. The aim of this
study was to evaluate demographic and clinical risk factors associated
with CAUTI due to quinolone-resistant E. coli (QREc) in Northern
Israel.
Methods: During July – October 2005, clinical and demographic data of
150 consecutive urine cultures from outpatients which grew quinolone-
resistant E. coli isolates and 150 with quinolone-sensivitive E. coli
(QSEc) isolates at the Clinical Microbiology Department at Ha’Emek
Medical Center, were screened and analysed.
Results: By univariate analysis the risk factors associated with QREc
were: older patients, males, nursing home residents, bed ridden, demen-
tia, diabetes, cardiovascular diseases, immunosupression, nephrolithiasis,
recurrent UTI, invasive procedures, hospitalisation within prior 6 months
and antibiotic use (not only quinolones) taken within previous 6 months.
By multivariate analysis, recurrent UTI (O.R 4.7, 95%CI: 2.3–9.3;
p0.0001), previous invasive procedure (6.6; 3.0–14.7; p0.0001), use
of oﬂoxacin (7.5; 2.9–19.4; p0.0001), ciproﬂoxacin (20.6; 2.3–179.2;
p = 0.006) and previous hospitalisation (2.9; 1.4–6; p = 0.003) were
identiﬁed as independent risk factors.
Conclusions: In patients with one or more of the risk factors identiﬁed
here, the empiric use of quinolones should be avoided.
R2182 Inﬂuence of doxycycline resistance on outcome in Acine-
tobacter baumannii bacteraemia in an intensive care unit
R. Zaragoza, J. Camarena, S. Sancho, R. Gonza´lez, A. Artero,
J. Navarro, J. Nogueira (Valencia, ES)
Objective: The aims of this study were to identify the epidemiological
and clinical differences between doxycycline resistant Acinetobacter
baumannii bacteraemia (ABB) and doxycycline-susceptible episodes, to
know their prognosis, and ﬁnally to deﬁne if doxycycline resistance is
a factor independently associated to hospitality and related mortality in
critically ill patients with ABB.
Methods: From 1996 to 2006, 341 patients with a clinically signiﬁcant
bacteraemia were prospectively evaluated in an intensive care unit of
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a university hospital. Doxycycline resistant Acinetobacter baumannii
(DR) was deﬁned when MIC was mg/mL (E-test®). Clinical
and microbiological variables were studied. A multivariate analysis
was performed to determine the factors independently associated to
hospitality and related to bacteraemia mortality in critically ill patients
with ABB.
Results: Ninety-three (27.2%) of 341 ICU bacteraemias were due to
ABB. A sixty-eight percent of them were DR episodes. The mean age
of patients with ABB was 60.7 SD 16.2 years and the relation between
men/women was 3.3. APACHE II score was 19.2 SD 7.6. The incidence
of inadequate empirical antibiotic treatment was 54.7% in ABB patients.
The principal origins of ABB were: respiratory (49.5%), unknown
(23.2%) and catheter (12.6%). The global and related mortality rate for
ABB was 54.7% and 22.1% respectively. There were no differences
in presence of severe sepsis or septic shock, APACHE II or SOFA
score (admission and at the onset of ABB) between DR and susceptible
episodes. Although the incidence of inadequate empirical antimicrobial
treatment (48.4% vs 72.4%; p = 0.03) was statistically lower in DR group,
related mortality rates (28.1% vs 10.3%; p = 0.04) was signiﬁcantly
higher in DR group. Multivariate analysis conﬁrmed DR (OR 8.2;
95%CI 1.5 – 42.9.9; p = 0.01) as an independent predictor of related
mortality to ABB.
Conclusions: The prevalence of ABB is very high among critically ill
patients, and majority of them are DR. Although DR did not imply a
higher rate of inappropriate empirical antimicrobial treatment, DR was
independent associated with an increased related mortality to ABB in
critically ill patients.
R2183 Epidemiological study of infections caused by extended-
spectrum b-lactamase producing Escherichia coli and
Klebsiella spp. in a tertiary care hospital in Badajoz, Spain
(2003–2005)
E. Gardun˜o, M.A. Gala´n-Ladero, M.T. Mun˜oz-Lozano,
M. Sa´nchez-Gonza´lez, J. Blanco-Palenciano (Badajoz, ES)
Objectives: The aim of this study is to determine the prevalence
and antimicrobial resistance pattern of extended-spectrum b-lactamase
(ESBL) Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca
producing isolates over a 3-year period at our institution.
Methods: A retrospective study was performed from January 2003 to
December 2005. Identiﬁcation and antimicrobial susceptibilities were
determined using the WalkAway system (Dade–Behring), and ESBL-
producing bacteria were conﬁrmed by E-test method. Resistance rates
are described as percentage and analysed using Chi2-test. Statistical
signiﬁcance has been considered when p value was <0.05.
Results: Out of the 4,137 isolates studied 227 (5.48%) were ESBLs.
13.21% were isolated during year 2003, 14.53% during 2004 and 72.24%
during 2005. The distribution of the ESBL isolates was: 122 (53.74%)
E. coli, 103 (45.37%) K. pneumoniae and 2 (0.88%) K. oxytoca. Species
distribution by year was: 2003, 25 E. coli and 5 K. pneumoniae; 2004,
23 E. coli, 9 K. pneumoniae and 1 K. oxytoca and 2005, 74 E. coli, 89
K. pneumoniae and 1 K. oxytoca.
Overall, the infection was intrahospitalary in 85.91% of the cases, and
most of them in medical areas (38.03%), followed by surgical areas
(18.30%) and the ICUs (29.58%). E. coli was more frequently isolated
from outpatients (19.82%), whereas K. pneumoniae was was more
frequent in patients from ICUs (55.91%). The majority of E. coli was
obtained from urine (68.1%), whereas K. pneumoniae from respiratory
(39.8%) and invasive (24.7%) samples.
Sensitivity of ESBL-E. coli compared to non-ESBL E. coli was
as follows: trimethoprim-sulfamethoxazole (45 and 61%; p< 0.05),
fosfomycin (97 and 97%), gentamycin (87 and 92%; p> 0.05) and
ciproﬂoxacin (40 and 69%; p< 0.05). ESBL-K. pneumoniae vs. non-
ESBL K. pneumoniae was: trimethoprim-sulfamethoxazole (80 and 81%;
p> 0.05), fosfomycin (92 and 87%; p> 0.05), gentamycin (100 and 94%;
p> 0.05) and ciproﬂoxacin (80 and 86%; p> 0.05).
Conclusions: ESBLs have dramatically increased in our hospital over the
last three years. In 2005, the more prevalent species was K. pneumoniae
isolated from respiratory samples of patients in ICU, suggesting
clonal origin (data under further investigation). ESBL-E. coli isolates
showed higher and statistically signiﬁcant resistance to trimethoprim-
sulfamethoxazole and ciproﬂoxacin than non-ESBL E. coli.
Antibiotic usage
R2184 Antibiotic consumption in three hospitals, Latvia, 2005
S. Berzina, M. Ferech, L. Saule, D. Umbrasko, I. Jekabsone, H. Goosens
for ESAC (European Society of Antimicrobial Consumption)
Objectives: To collect the data on antibiotic consumption in the three
Latvian hospitals – Stradini Clinical University Hospital (CUH), which
is a many proﬁle hospital; Riga 1st hospital – also a many proﬁle
hospital; and Daugavpils hospital, which is a regional hospital in the
eastern part of Latvia, also many proﬁle hospital – according to the
ESAC data collection protocol (European Surveillance of Antimicrobial
Consumption, granted by DG SANCO of the EC).
Methods: The data on antibiotic consumption in the three hospitals for
2005 have been collected using ATC/DDD classiﬁcation (WHO, version
2005) and expressed in Deﬁned Daily Doses (DDDs) and in DDD per
100 bed days (DBD). Data were obtained from the hospitals pharmacies.
Results: The overall use of antibiotics in 2005 was – in Stradini CUH
109.0 DBD, in Daugavpils hospital 77.1 DBD, and in Riga 1st hospital –
81.7 DBD.
The most used antibiotics in Stradini CUH and in Daugavpils hospital
were penicillins with extended spectrum (mainly amoxicillin) – 33.0%
(104,745.0 DDDs) and 52.0% (87,187.5 DDDs), respectively, while in
Riga 1st hospital cephalosporins (mainly cefazolin) were mostly used –
32% (74,800.0 DDDs).
Combinations of penicillins (mostly amoxiclav) represented the second
mostly used antibiotic group in Stradini CUH – 28% (89,676.0 DDDs),
whereas their use was very limited in Daugavpils and Riga 1st hospital –
5% (8,383.5 DDDs) and 1% (2,337.5 DDDs), respectively.
The quinolones were frequently used in Stradini CUH – 12.8% (40,664.9
DDDs) and in Riga 1st hospital – 16% (37,400.0 DDDs), but were not
used in Daugavpils hospital at all.
From hospital antibiotics – cephalosporins – were used mostly – Stradini
hospital, Daugavpils hospital and Riga 1st hospital – 14.8% (46,976.7
DDDs), 16% (26,826.9 DDDs) and 32% (74,800.0 DDDs), respectively,
but cefazolin was the antibiotic which was used predominantely.
Monobactams (aztreonem) was not used, but other hospital, speciﬁc
antibiotics (carbapenems, aminoglycosides, glycopeptides) were used
much more less than those characterised before.
Conclusions: Three hospitals show very different patterns of AB use
partially due to their different proﬁles. Nevertheless mention most
striking variations not attributable to the hospital type, e.g., amoxiclav
vs. quinolones in Riga 1st hospital and Daugavpils hospital, also the use
of hospital-speciﬁc antibiotics have to be discussed.
R2185 Uniformity of antibiotic prophylaxis in surgical procedures
is associated with improvement of timing
I. Willemsen, R. van den Broek, T. Bijsterveld, P. van Hattum,
M. Winters, G. Andriesse, J. Kluytmans (Breda, NL)
Background: The Amphia Hospital is a 1370 bed teaching hospital
that was founded in 2001 after a merger of three hospitals. In
2005 the initiative was taken to standardise perioperative antimicrobial
prophylaxis (PAP) in surgical procedures.
Objectives: To implement a guideline for PAP, describing the choice of
the agent, the dosage and the timing.
Methods: Before and after the implementation the application of PAP
was measured. In the new policy cefazolin was the ﬁrst choice agent, if
necessary combined with metronidazol. Clindamycine was preferred as
an alternative for patients reporting an allergy to b-lactams. The guideline
was approved by all surgeons and anaesthetist and distributed within the
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hospital. It included for each type of procedure, the antibiotic agent and
the dosage.
Results: Before the intervention 153 procedures, from different
specialities were observed (in 2 series). Eight different antibiotics in
different dosages were used. In 22% of the procedures, PAP was given
after the incision. Two months after the intervention 147 procedures were
observed (in 3 series). Three different antibiotics, 135 times cefazoline
(92%), 11 times metronidazol (7.5%) and one time cefuroxime, were
given. All antibiotics were used in the correct dosage. In 12% of the
procedures, PAP was given after the incision. This was a signiﬁcant
improvement (p = 0.026).
Conclusion: This project shows that a uniform, simple and clear protocol
improves not only the choice and dosage of antibiotics but also the
timing. Furthermore, the switch to cefazoline resulted in net savings of
at least €40.000 a year.
R2186 Trends in antibiotic consumption in 5 Hellenic hospitals
over a three-year period: results of the Hellenic Network
for Nosocomial Antibiotic Consumption for the years
2003–2004–2005
M. Lelekis, C. Loupa, K. Katsimpris, I. Tzannou, G. Xylomenos,
C. Anitsakis, A. Provis, C. Efthymiou, P. Gargalianos (Athens, Rhodes,
Lesvos, Zakynthos, GR)
Objectives: Hellenic Network for Nosocomial Antibiotic Consumption
(HENNAC) is a network of 5 hospitals located in different parts of
Greece, established for monitoring antibiotic consumption in Hellenic
hospitals: “G. Gennimatas” General Hospital (GGH) of Athens (tertiary
care, 700 beds), “A. Fleming” General Hospital (AFH) of Athens
(300 beds), “A. Papandreou” General Hospital of Rhodes Island (RH,
Southeastern Greece, 335 beds), “Vostaneio” General Hospital of Lesvos
Island (LH, Northeastern Greece, 225 beds) and Zakynthos Island
General Hospital (ZH, Western Greece, 125 beds).
Methods: The antibiotic consumption for the years 2003, 2004 and 2005
was calculated in DDDs per 1000 patient days (ABC calc 3.0).
Results: Compared to 2003, in 2005: (1) Total consumption increased
in AFH (from 710 to 892), LH (from 1148 to 1299) and GGH (from 906
to 1117), decreased in ZH (from 1268 to 1060) and remained practically
stable in RH (from 1371 to 1346). (2) Concerning consumption of major
classes of antibiotics: A. Penicillins: increase in AFH and LH, stable in
RH and decrease in ZH, GGH. B. Cephalosporins + aztreonam: increase
in AFH, RH, decrease in GGH and stable in ZH, LH. C. Carbapenems:
increase in all but LH where it was stable. D. Penicillins+inhibitors:
increase in RH, LH, GGH, decrease in AFH, ZH. E. Aminoglycosides:
increase in LH, GGH, stable in AFH, decrease in ZH and RH. F.
Macrolides: increase in all but ZH. G. Glycopeptides: increase in all
but GGH. H. Quinolones: increase in AFH, GGH, decrease in ZH, RH,
LH. (3) Cephalosporins + aztreonam were the most popular antibiotics
for the year 2005 (being ﬁrst in 3 hospitals and second in other 2)
followed by penicillins + inhibitors, while for the year 2003 exactly the
opposite was the case.
Conclusions: A. While there is no uniform trend for antibiotic
consumption in the hospitals of the network, total consumption is high
in all of them, compared to hospitals of other European countries. B.
Cephalosporins + aztreonam are now the most popular antibiotic class. C.
Further studies are under way in order to explain local peculiarities in
antibiotic prescribing in the hospitals of the network.
R2187 Antibiotic usage and resistance development in an intensive
care unit
M.S. Lapatschek, A. Hartinger (Munich, DE)
Objectives: SARI (Surveillance of antibiotic usage and bacterial
resistance in intensive care units) is a German nationwide project
for monitoring the usage of antibiotics in intensive care units (ICUs)
and to compare it with the development of bacterial resistance to
these antibiotics. The long-term goal is to avoid unnecessary usage of
antibiotics and reduce the burden of highly resistant pathogens in these
ICUs.
Methods: The antibiotic usage of the 44 participating ICUs is registered
by the providing pharmacies and is send monthly to the study reference
centre at the University of Freiburg. There, the density of antibiotic
usage is calculated as deﬁned daily doses (DDD) per 1000 patient
days. As well, the microbiology labs are sending the resistance data for
selected bacteria (selection is conform to §23 Infektionsschutzgesetz) to
the reference centre.
The cumulated collected data is send back twice a year to the ICUs, so
that trends over months and years can be visualised.
Results: In our ICU, we were able to detect a correlation between
cephalosporin usage and emergence of ESBL-carrying Klebsiella and
between carbapenem usage and carbapenem resistant Pseudomonas
aeruginosa, which led to a change in antibiotic prescription policy.
Conclusions: The monitoring of antibiotic usage together with bacterial
resistance data can help to identify reasons for the spread of highly
resistant bacteria in the clinical setting and support awareness for the
sensible use of antibiotics in ICUs.
R2188 Main trends of outpatient antimicrobial consumption in
Russia, 2000–2005
A.A. Fokin, S.A. Ratchina, S.N. Kozlov, E.P. Shal, A.A. Ishmukhametov,
M.N. Denisova, L.P. Abramenko (Smolensk, Moscow, RU)
Objectives: To assess main trends of outpatient (OP) antimicrobials
(AM) consumption (Cons) in Russia in 2000–2005.
Methods: Data containing products names, ATC/DDD codes and values
(WHO, version 2006), drug forms, dosages and number of packages
were collected during pharmacy audit. The use of AM was expressed as
a number of deﬁned daily doses/1000 inhabitants/day (DID).
Results: From 2000 to 2005 OP AM Cons in Russia was 9.28, 8.28,
9.51, 9.57, 9.14 and 8.90DID, respectively. The leading groups were
sulfonamides and trimethoprim (J01E) in 2000–2002 and penicillins
(J01C) in 2003–2005. The proportions of J01C, quinolones (J01M),
macrolides, lincosamides (J01F) and other b-lactam antibacterials
(J01D) Cons increased during the study period by 7.2, 5.9, 1.3 and
1.3%, respectively, while J01E use decreased (10.3%). The latter was
predominantly due to twofold decrease in co-trimoxazole use (from 1.38
in 2000 to 0.68DID in 2005). The J01C Cons was characterised by
increasing in amoxicillin and amoxicillin/clavulanate and decreasing in
ampicillin use (from 0.26, 0.02 and 0.91 DID in 2000 to 1.28, 0.28
and 0.52 DID in 2005, respectively). The J01M Cons increase was
mainly due to cipro- and norﬂoxacin (from 0.46 and 0.15 in 2000 to
0.77 and 0.34 DID in 2005, respectively), similar trends were typical for
newer ﬂuoroquinolones (levo- and moxiﬂoxacin) (from 0.00003 in 2000
to 0.01 DID in 2005, respectively). As for J01F Cons, erythromycin
use decreased (from 0.27 in 2000 to 0.17 DID in 2005), whereas
azithro-, clarithro- and josamycin Cons was characterised by the opposite
trend (from 0.09, 0.02 and 0.012 in 2000 to 0.25, 0.14 and 0.03 DID
in 2005, respectively). Among cephalosporins the proportion of ﬁrst-,
second-, third- and fourth-generation was 75.1%/3.67%/20.9%/0.33% in
2000, 78.2%/3.56%/18.1%/0.14% in 2001, 81.1%/2.64%/16.1%/0.16%
in 2002, 81.4%/2.4%/16.0%/0.2% in 2003, 76.8%/2.38%/20.6%/0.22%
in 2004 and 71.0%/3.67%/25.1%/0.%23% in 2005, respectively.
Conclusion: Total OP AM Cons in Russia in 2000–2005 was rather
stable with the prevalence of the cheapest, old poor safety proﬁle drugs.
But in the dynamics some positive tendencies like the increasing of the
proportion of the newer AM usage were observed.
R2189 Antibiotic usage and resistance patterns in a Saudi tertiary
hospital
M. Al-Jamal, A. Al-Barrak, N. Elkhizzi (Riyadh, SA)
Background: The increasing difﬁculty in ﬁghting off microbes leads to
an increased risk of acquiring infections in hospitals or other settings.
One of the most important factors that could affect the increasing patterns
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of resistance in Saudi Arabia as well as the rest of the world is the
inappropriate use of antibiotics.
Objective: To evaluate the resistance patterns of Staphylococcus aureus,
Streptococcus pneumoniae, Escherichia coli, Pseudomonas aeruginosa
in 2005 at RMH comparing with 1997–1998 antibiogram.
Methodology: All isolates that have been reported in 2005 have been
reviewed and compared to 1997–1998. The isolates were classiﬁed to
outpatient, inpatient and intensive care unit (ICU). The isolates have been
identiﬁed at Riyadh Military Hospital (RMH) laboratory according to the
standard of the National Committee for Clinical Laboratory Standards
(NCCLS).
Results: A total of 11,492 isolates have been isolated from all sites
from both inpatient and out patient setting in 2005. About 42%
of these isolates were Gram-positive and 58% were Gram-negative.
Staphylococcus aureus isolates were 43% of isolated Gram-positive.
Of these, the Methicillin Sensitive Staphylococcus aureus (MSSA) was
73% and the Methicillin Resistant Staphylococcus aureus (MRSA) was
27%. Streptococcus pneumoniae isolates was 295 (16% were penicillin
resistant and 34% were intermediate). Escherichia coli was isolated
in 34% of Gram-negative isolates where Pseudomonas aeruginosa
isolates were 26%. Inpatient isolates have resistant patterns higher than
outpatients and the highest was in the ICU. These data were compared
with 1997–1998 antibiogram where we found that the resistant patterns is
signiﬁcantly increasing (p< 0.05). The antibiotics usage was signiﬁcantly
higher in 2005 compared to 1997–1998 period (p< 0.05).
Conclusions: The antibiotic resistance has been a problem as long as we
are overusing antibiotics. The resistant pattern is higher at hospitals with
the highest reported in ICU. These data was supported by that reported
in the literature. This might be due to poor compliance to infection
control measures were applied in ICU and the relative small, crowded
and busy space. Several measures have been applied in 2006 to control
infections and to prevent resistance. These include antibiotic restriction
protocol, in-service education programme, surgical prophylaxis policy
and continuing of implementing a good infection control strategy.
Molecular bacteriology
R2190 Comparison of real-time PCR and BDProbeTec ET system
for rapid diagnosis of tuberculosis patients
S. Bernal, C. Freyre, M.J. Torres, I.J. de la Calle, M. Rodrı´guez-Iglesias,
J.C. Palomares, E. Martı´n-Mazuelos (Sevilla, ES)
Objective: To evaluate the efﬁcacy of an “in house” real-time PCR
technique using the LightCycler system (Roche Biochemicals) compared
to the semiautomated BDProbeTec ET system (BD) (Becton–Dickinson)
and to acid-fast bacilli stain and culture to detect and identify
M. tuberculosis in DNA extracts from samples obtained from patients
with high suspicious of having TB. Final diagnosis of TB determined
on microbiological and clinical ﬁndings was used as “gold standard”.
Methods: The real-time assays ampliﬁes a region from the IS61110
sequence and the BD system ampliﬁes a region of the mycobacterial
16S rDNA. Conventional mycobacterial culture was performed with
Bactec MGIT 960 and Lowenstein–Jensen medium. A total of 93 clinical
samples (77 pulmonary and 16 extrapulmonary specimens) from 81
patients with high clinical and/or radiological suspicious of having
tuberculosis were processed by the three methods.
Results: TB diagnosis was conﬁrmed in 33 patients. Both methods
showed a 92.6% concordance. This concordance was of 84.4% for TB
cases and of 97.9% for TB negative cases. Twenty-two TB cases were
detected by both methods. There were ﬁve discrepancies, all of them in
smear negative/culture positive patients and 6 TB cases that were missed
by both methods. The global sensitivity, speciﬁcity, positive predictive
value and negative predictive value were 72.7%, 100% 100%, and 84.2%
respectively for real time PCR and 75.7%, 97.8%, 96.1% and 85.2%
respectively for BD system. For smear negative specimens the results
were 59%, 100%, 100%, and 84.2% for real time PCR and 63.6%,
97.9%, 93.3% and 85.4% for BD system.
Conclusions: (1) Both methods showed an excellent concordance.
(2) The real time PCR diagnosed the 59% of smear negative patients
in the same day of specimen’s reception. (3) A negative result of PCR
discard the TB diagnosis because the speciﬁcity was 100%.
R2191 Analysis of essential gene changes in MRSA and non-MRSA
strains inhibited by methanolic extract correlated to
membrane permeabilising peptide
M. Shamsudin, N. Alipiah, N. Vasantha, F. Yusoff, A. Arshad (Serdang,
MY)
Objective: In this study, a methanolic extract derived from a marine
organism was investigated for the effect on the growth of MRSA
resistant to b-lactam antibiotics. The nucleotide sequence changes of
essential genes inclusive of mecA, mecR1, 16sRNA, mprF and msR of
the inhibited MRSA strains were determined. A potential antibacterial
peptide with activity on permeabilising the membrane of MRSA strains
was investigated through a cellular bioassay.
Methods: S. aureus isolates (MRSA and non-MRSA) obtained from
patients of hospitals in Malaysia and environmental isolates were studied.
Anti-MRSA activity was determined through MIC and disc diffusion
assay. Membrane permeabilising property of the methanolic extract was
investigated by the penetration of the ﬂuorescence Sytox green dye
into MRSA cells. The RT-PCR analysis and nucleotide sequencing of
essential genes, followed by gene sequence analysis were conducted for
determining molecular mechanism of inhibition of S. aureus isolates.
Results: The methanolic marine extract showed variation in nucleotide
sequence changes of several essential genes namely the mprF membrane
gene in S. aureus (gene encoding for peptides involved in transportation
of lysine to phospholipids bilayer in membrane). The intensities of
SYTOX green ﬂuorescence dye in S. aureus cells treated with the
extract at the MIC values increases with time, similar to treatment with
polymyxin, the positive control antibiotic. The negative control fucidic
acid accordingly did not affect bacterial cell membrane permeabilisation
and thus showed constant ﬂuorescence intensity even after 6 hour
of incubation in the antibiotic. The ﬂuorescence intensities increase
drastically ﬁrst 120 minutes treatments indicating the membrane
permeabilising ability is affected and the dye coloured the nucleic acid.
Conclusions: This study demonstrates the anti-methicillin-resistant
Staphylococcus aureus (MRSA) activity of methanolic marine extract
by exhibiting substantial effect at both the molecular and cellular levels
elucidated through nucleotide sequence changes and Sytox green dye
penetration. Molecular correlation to cellular activity of extract is a
viable strategy to explore alternative anti-MRSA agents.
R2192 Investigation and sequencing of urease gene of H. pylori
cocoid forms after exposure to different environmental
conditions
F. Can, Z.C. Karahan, I. Dolapci, M. Demirbilek, A. Tekeli, H. Arslan
(Ankara, TR)
Objectives: The aim of this study was to investigate whether convertion
to the coccoid form under different environmental conditions resulted in
sequence differences in the Urease A gene in H. pylori strains
Methods: Helicobacter pylori standart strain NTCC 11637 was used
in this study. Transformation of the bacteria from helical to coccoid
form was carried out with different techniques; exposure to amoxicillin,
cold starvation, aerobiosis and aging of the culture. Urease activity was
measured by rapid urea test. DNA was extracted from all samples by
using Nucleospin DNA extraction kit (Clontech, CA). Urease A gene
was ampliﬁed by using the primers HPU1 (GCC AAT GGT AAA TTA
GTT CC) and HPU2 (GTA AAA ACA ATT AAG GAG). Bi-directional
sequence analysis was performed by using one of the primers in each
run by ABI Prism 310 DNA sequencer.
Results: Urease activity was determined in spiral and coccoid forms
of H. pylori. All samples yielded 411 bp amplimer by polymerase
chain reaction. For all sequence comparisons, spiral form of H. pylori
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11637 was used as the Standard. The sequence of the Standard strain was
compared to the sequence in GenBank (accession number M60398). The
standard strain had 6 silent mutations when compared to the Genbank
sequence. All the sequences of the coccoid forms had the same silent
mutations with the spiral shaped standard strain and the sequences of all
the samples were identical.
Conclusion: Coccoid forms of H. pylori had urease activity. Convertion
to coccoid form in various environmental conditions did not result in any
change in the ampliﬁed region of the Urease A gene of the H. pylori.
Molecular virology
R2193 Efﬁcacy of a commercial multiplex herpes viruses PCR in
the viral diagnosis of different clinical samples
J. Reina, E. Ruiz de Gopegui, A. Mena, M. Macia (Palma de Mallorca,
ES)
Objectives: To know the efﬁcacy of a commercial nested PCR in the
aetiological diagnosis of infections caused by the herpesviruses family
in different clinical samples.
Material and Methods: The different studied samples have been
analysed by means of a commercial herpesviruses (HSV, VZV, CMV,
EBV and HHV-6) multiplex nested PCR (Real, Durvitz, Valencia, Spain)
following the instructions of the manufacturer.
Results: During the period 2000–2006, 1,445 PCRs have been made;
being considered as positive 170 (11.7%). The percentage of positivity
have varied widely in the study period from 8% (2003) to 17% (2001),
as the number of clinical samples studied, 115 in the 2000 to 316 in
2005 (p< 0.05). The viruses ampliﬁed were: citomegalovirus (CMV) 90
(52.9%) (p< 0.05), herpes simplex (HSV) 55 (32.5%), varicella-zoster
(VZV) 19 (11.1%), Epstein-Barr (EBV) 4 (2.3%) and human herpesvirus
type 6 (HHV-6) 2 (1.1%). The clinical sample most studied was the CSF
with 1.087 (75.2%) (p< 0.05) from patients with the clinical diagnosis
of aseptic meningoencephalitis; being positive 57 (5.2%), corresponding
to 36 HSV (63.1%) (p< 0.05), 14 CMV (24.5%), 5 VZV (8.7%) and 2
HHV-6 (3.5%). The colon biopsies of patients with colitis or Crohn’s
disease have represented 117 samples (8.1%), being positive 53 (45.2%),
corresponding 45 CMV (84.9%), 4 HSV and 4 EBV. 93 bloods have
been studied (6.4%), being positive 13 (13.9%), corresponding to 12
CMV (92.3%) and 1 VZV. The ocular punctions (aqueous specimens)
represented 44 samples (3.1%), being positive 14 (31%), corresponding
to 7 CMV (50%), 4 HSV (28.5%) and 3 VZV. Other analysed samples
were 29 ammniotic ﬂuids (2%) with 4 positives (13.7%), 2 CMV and
2 VZV; 23 Bronchoalveolar lavage, BALs (1.5%) with 13 positives
(56.5%), 7 CMV (53.8%), 3 HSV and 3 VVZ. In the other 52 (3.5%)
diverse samples, 16 positive were detected (30.7%), corresponding to 8
HSV (50%), 5 VVZ (31%) and 3 CMV (19%).
Conclusions: The commercial nested PCR studied has shown a high
diagnostic efﬁcacy specially in the samples of central nervous system
(CSF) and in the diagnosis of viral encephalitis. This method must be
recommended in all those samples in which a low viral load exists.
R2194 Evidence of Epstein-Barr and cytomegalovirus co-infection
in ulcerative colitis
M. Pape, K. Mandraveli, D. Papadopoulou, I. Sidiropoulos,
D. Koliouskas, S. Alexiou-Daniel (Thessaloniki, GR)
Objective: The aim of our study was to emphasize the possible role of
infectious agents (EBV, CMV) in persistent ulcerative colitis (UC).
Methods: We report a case of exacerbation of ulcerative colitis in a
female patient who admitted to the gastroenterology clinic of AHEPA
University Hospital due to frequent bloody diarrhoea (>10 times a day).
The patient had a pre-existing history of refractory ulcerative colitis and
was treated with corticosteroids or immunosuppressants during acute
attacks. A full-length colonoscopy was performed and multiple biopsies
were obtained for histological examination of inﬂammation and inclusion
bodies and for extraction of DNA for PCR. Computed tomography (CT),
general laboratory (WBC, AST, ALT, TKE, CRP) and serological tests
were also performed. Using Real-time PCR, biopsy and peripheral blood
specimens were tested for the most frequently identiﬁed viral pathogens
of colitis (CMV, EBV, HSV, VZV).
Results: The abdominal computed tomography (CT) scan did not
revealed any abnormalities. The endoscopic and histological ﬁndings
(severe erosive and edematous mucosa throughout the colon, heavy
inﬂammatory inﬁltrate with epithelial ulceration) were consistent with
UC. No CMV inclusion bodies were detected. The initial laboratory tests
were normal except a slightly increased level of CRP. Serological tests
for anti-CMV, anti-EBV, anti-HSV and anti-VZV IgG/IgM antibodies
excluded primary infection or reactivation. EBV and CMV viral genome
was detected only in tissue samples (2.4×104 copies/mL, 1.3×103
copies/mL, respectively). In blood samples no viral genome was detected.
The patient was started on treatment with acyclovir at an oral dosage
of 800mg, ﬁve times daily for 5 days, with good resolution of the
symptomatology. A further colonoscopy examination showed a clear
improvement in the previous picture, with no evidence of inﬂammation.
At that time, PCR on biopsy materials was once more performed, but no
EBV or CMV genome was traced. The patient has remained symptom-
free since then.
Conclusion: UC patients undergoing immunosuppresive therapy are
exposed to an excessive risk of viral infection. We believe that patients
with refractory UC should be tested for virus infection before increasing
the dose or the number of immunosuppressive drugs. PCR techniques
considered to be the most sensitive tool for virus detection and
management of infections of the gastrointestinal tract.
R2195 Distinct genotypic distribution of cytomegalovirus (CMV)
envelope glycoprotein B in a Cuban cohort of patients with
different CMV diseases
V. Kouri, E. Gonza´lez, P. Martı´nez, V. Capo´, R. Gonza´lez, L. Pe´rez,
L. Cardella´, U. Hengge (Havana, CU; Dusseldorf, DE)
Human cytomegalovirus (hCMV) is ubiquitous and seropositivity in the
adult population over 40 years of age rates between 60–100% worldwide.
The virus is responsible for a wide range of diseases in neonates and
immunocompromised patients as well as the most common viral cause
of congenital malformations in developed countries.
To investigate the association between human CMV glycoprotein B (gB)
genotypes and CMV disease in a Cuban Cohort of Patients with Different
CMV Diseases.
We retrospectively analysed 73 biological samples (urine, PBMC, serum
CSF and tissues) from 56 Cuban patients with different CMV-related
diseases using a multiplex nested PCR for detection of the reported ﬁve
gB genotypes.
All four main genotypes 1 to 4 were found in the clinical samples
while no genotype 5 was detected. Among the individuals analysed
genotype gB-2 was the most prevalent (37.5%) followed by gB-1
(30.3%) and mixed infections (16.1%) being mainly detected among
immunosuppressed patients (7 out of 9) although there was no
association between mixed infections and CMV rejection in transplant
recipients. Genotype gB-4 was the least frequent (5 patients), which was
almost exclusively detected in mixed infections (4 out of 5, p< 0.0001).
Genotype gB-1 was more frequently detected in AIDS patients (47.7%)
although it was not statistically signiﬁcant while 66.7% of transplant
patients showed mixed infections (p< 0.05).
This study represents the ﬁrst report of human CMV gB genotypes in
Cuban patients. This result has allowed us to identify that the main four
CMV genotypes are present in the Cuban population with genotypes 2
and 1 being the most frequent strains.
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Molecular typing
R2196 Antimicrobial susceptibility and AP-PCR typing of
Acinetobacter spp. strains isolated from three teaching
hospitals, Tehran, Iran
N. Sadeghifard, J. Zaeimi Yazdi, R. Ranjbar, A. Ahmadi, A. Ghasemi,
A. Rostamzad (Ilam, Yazd, Tehran, IR)
Objectives: This study was designed to establish antimicrobial
susceptibility and AP-PCR typing of Iranian isolates of Acinetobacter
spp.
Methods: During this study, 67 Acinetobacter isolates (including
21 A. baumannii and 46 non-Acinetobacter baumannii strains, were
obtained from three University hospitals in Tehran. The site of these
isolates were included the blood, urine, wound, and respiratory tract.
Their susceptibility to 17 antibiotics was tested and then all A. baumannii
isolates were typed by AP-PCR method.
Results: Results showed that all Acinetobacter baumannii isolates were
resistant to multiple antibiotics including cefoprazone, ceftazidime,
ticarcillin/clavulanic acid, aztreonam, meropenem, ceftizoxime, carbeni-
cillin, ceﬁxime, ceftriaxone, ticarcillin, cephotaxime, but were sensitive
to colistin. The results of molecular typing by AP-PCR method
demonstrated 7 different patterns in the isolates.
Conclusion: Our study as the ﬁrst report in Iran, established AP-PCR
assay as a molecular typing method for multi-drug resistant clinical
Acinetobacter baumannii strains. Upon our results, because of the
presence and spread of multi-drug resistant Acinetobacter spp. in the
hospitals, more care should be taken for preventing them from producing
nosocomial infections in Iran.
Molecular biology, including diagnostics –
others
R2197 Detection of three Candida albicans virulence genes in a
C. krusei isolate from Nigeria
F. Okungbowa, R. Chowdhury, K. Pal (Benin City, NG; Kolkata, IN)
Objectives: Candida species have become increasingly of medical
importance due to the high prevalence in man, of serious health
conditions caused by them, especially in immunosuppressed individuals.
Moreover, previously uncommon species such as C. krusei are now
not only commonly isolated but often associated with resistance to
antifungal drugs. The expression of three Candida albicans virulence
genes (Tec1, Tup1 and Rad6) was determined in a C. krusei strain with
cell morphology resemblance to C. albicans isolated from a human male
urethra in Benin City, Nigeria, in order to ascertain how the level of
virulence in the strain would compare with that of C. albicans.
Methods: Chromosomal DNA was isolated from the strain and
ampliﬁcation was done for 40 cycles. Reverse-Transcriptase Polymerase
Chain Reaction was also performed.
Results: No ampliﬁcation of Tec1 and Rad6 genes was detected when
chromosomal DNA was used. But the RT-PCR analysis indicated
that substantial rRNA synthesis occurred under the growth conditions
employed but the virulence genes tup1 and rad6 were not expressed in
both the C. krusei strain and the clinical C. albicans strain that was used
concurrently. However, tec1 was detected in the C. krusei but not in the
C. albicans.
Conclusions: An intron (important in Candida resistance to antifungal
drugs) may be present within the tec1 gene in the C. krusei strain. Further
investigation is needed to elucidate this. Also, the RT-PCR technique
seems to be a more effective method of detecting these genes in Candida
species.
R2198 Genomic diversity of Leishmania parasites isolated by
RAPD-PCR
B. Nomanpour, S. Ardehalli, M. Motazedian, N. Sobhani (Kermanshah,
Siraz, IR)
Objectives: Cutaneous leishmaniasis (C.L.) is prevalent in different parts
of world. Clinical manifestations of cutaneous leishmaniasis vary from
a simple to multiple Lesions and chronic forms. Studies have revealed
the presence of genetic diversity among leishmania parasites. For better
understanding of these diversities characterisation and phylogenic study
seem to be necessary.
Methods: In the present study. 82 isolates of cutaneous lesions
from different provinces of Iran were cultured on suitable media and
characterised by using 8 primers. DNA was extracted for further studies
using RAPD-PCR. DNA ﬁngerprints of various isolates were studied by
calculating inter and intra-species polymorphisms bands and also genetic
distance by Jacquard’s distance coefﬁcient.
Results: Leishmania major and L. tropica were isolated and charac-
terised from Esfahan, Tehran, Pars and Kerman provinces; L. major from
Khuzestan province; L. infantum from Boushehr and Estern Azerbaijan
provinces.
Leishmania tropica characterised from Yazd, Khorasan and Golestan
provinces where no characterisation of the organisms has previously been
reported.
Phylogenic studies demonstrated ﬁve main groups within L. tropica
strains.
A strain isolated from a chronic patient with nine years history of CL
in Tehran had 0.35 genetic distances as compared to others and showed
some of L. infantum polymorphism bands. The possibility of this isolate
being a hybrid can not be ruled out.
Leishmania major isolates comprised four main groups by maximum
genetic distance of 0.40. A strain of L. major isolated from an Afghan
refugee had genetic distance of 0.40 which differed from those isolated
and studied from Iran.
Three strain of L. infantum isolated from Boushehr and Azerbaijan
(Meshkin shahr) provinces had genetic distance of 0.37 compared with
the standard strain. The inter-train of genetic distance among these
organisms were 0.27. The reason for such a difference may be due to
different source of standard strain. (Borkinafaso)
Conclusion: Hybridisation seems to be a form of genetic exchange
among Leishmania species and strains. Geographical proximity, pop-
ulation mobility and the nativity of species and strains may be among
the factors involved in possible genetic exchange.
R2199 Plasma is to be preferred above whole blood for automated
nucleic acid extraction using the Nuclisens EasyMag system
(Biome´rieux)
D. Ursi, K. Bergs, H. Goossens, M. Ieven (Edegem, BE)
Objectives: To evaluate the performance of the NucliSens EasyMag
NA extraction system on whole blood and plasma samples compared to
Qiagen DNA extraction on whole blood as the reference method.
Methods: All samples were spiked with Phocine Herpes virus (PhHV)
to monitor the efﬁciency of extraction. In a ﬁrst experiment, 10 EDTA
blood samples were extracted in duplo with the Qiagen DNA extraction
procedure. Four aliquots of these blood samples were extracted the same
day with the NucliSens EasyMag, twice using the generic protocol and
twice using the speciﬁc protocol A for cell-rich clinical specimens.
Input and elution volumes were 200 mL and 110mL respectively for the
3 extraction methods.
In a second experiment, 28 EDTA blood samples positive for CMV were
extracted with Qiagen using an input volume of 200mL and an elution
volume of 75mL. Plasma was separated from the blood samples and
extracted with the NucliSens EasyMag, using the generic protocol with
an input volume of 500 mL and an elution volume of 25 mL.
All extracted DNAs were subjected to real-time PCR for PhHV and
CMV detection.
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Results: The mean Ct value for PhHV detection of the ﬁrst experiment
was 32.81, 34.12 and 37.02 with a standard deviation of 0.25, 0.46 and
1.00 for Qiagen extraction, EasyMag extraction with protocol A and with
the generic protocol respectively. Six of the ten blood specimens were
repeatedly positive for CMV after Qiagen extraction, of which 4 were
repeatedly positive with EasyMag protocol A and 3 with the generic
protocol. Mean Ct values were in all cases equal or lower with Qiagen
extraction.
In the second experiment, Ct values for CMV were lower in 26/28 plasma
samples extracted with EasyMAG compared to the results of whole blood
extracted with Qiagen, with a mean Ct difference of 1.19. The mean Ct
value for PhHV detection was 30.70 and 32.35 with a standard deviation
of 0.14 and 0.38 for EasyMag extraction of plasma and Qiagen extraction
of whole blood respectively.
Conclusions: With an input volume of 500mL and an elution volume
of 25mL, plasma is to be preferred above whole blood for automated
nucleic acid extraction using the NucliSens EasyMag system. Moreover,
the time needed for plasma isolation and EasyMag extraction for 24
samples is about 1 hour, with a hands-on time of less than 30 min. The
method is thus superior in speed and sensitivity compared to Qiagen
extraction on whole blood.
R2200 Use of the human albumin gene as an internal control for
multiplex real-time PCR in bone marrow transplant patient
routine screening
E. McCulloch, K. Harvey-Wood, B. Jones, G. Ramage, C. Williams
(Glasgow, UK)
Objectives: Real-time PCR methods to monitor bone marrow transplant
patients for viral pathogens are established as part of recognized
screening protocols. Real-time PCR for fungal pathogens are being
developed. Real-time PCR assays are used because of their high negative
predictive value. However to provide conﬁdence in the negative results,
the PCR assay must be closely controlled. The use of an albumin gene,
found in blood of patients, even those who are profoundly neutropenic,
has the advantage over spiking samples with foreign DNA, as it provides
a marker that will conﬁrm both success of the extraction process and
the PCR reaction. This is particularly important in fungal PCR due to
the increased processing of whole blood samples, which require pre-
treatment with buffers that remove various components of the blood and
disrupt cells prior to automated extraction of DNA.
When using any internal control it is important that this is part of
a multiplex reaction rather than separate single ampliﬁcations, which
provide opportunity for error.
Methods: In our Aspergillus real-time PCR assay, DNA is extracted
using the EZ1 BioRobot (Qiagen) and a tissue extraction kit, then
ampliﬁed and detected using an ABI Prism 7000 sequence detector
and Taqman probes (Applied Biosystems). Each sample is performed in
duplicate using a duplex reaction with which simultaneously ampliﬁes
the Aspergillus target and albumin gene allowing detection of the internal
control and the DNA of interest in a single well.
Results: Our results show that the real-time PCR reaction for albumin
and Aspergillus can be successfully multiplexed without decreasing the
sensitivity of the ampliﬁcation. This allows Aspergillus PCR results
to be reported with conﬁdence as true negatives or true positives.
Samples where negativity is present with a decreased detection of
albumin suggests PCR inhibition or ineffective extraction of the sample.
Conversely positive Aspergillus with a negative albumin indicates fungal
contamination in the assay, in both these cases the samples could be
repeated.
Conclusion: The use of human albumin gene in a multiplex real-time
PCR limits the margin for error and provides greater conﬁdence in the
negative results obtained. This gene could be used in many other real-
time PCR assays.
R2201 Enterobacter aerogenes strains misidentiﬁed as Klebsiella
pneumoniae and correct identiﬁcation by sequencing of the
QRDR region of the gyrA gene
J. Agu¨ero, M.C. Conejo, A. Sa´ez, M. de Cueto, L. Martı´nez-Martı´nez,
A. Pascual (Santander, Seville, ES)
Objective: To verify by genotypic methods the identiﬁcation of four
clinical isolates initially identiﬁed as Klebsiella pneumoniae showing
unusual phenotypic characteristics for this species.
Methods: Four isolates from the same patient were obtained from two
blood cultures (isolates 1, 2 and 3, 4) performed within 8 days, during
which the patient was treated with imipenem. Initial identiﬁcation and
susceptibility testing was done with the VITEK2 system. Subsequent
identiﬁcation was performed with the WalkAway System and API 20E.
Carbapenem activity was also determined with Etest. The presence
of plasmid-mediated AmpC b-lactamases (pACBL) was analysed by
multiplex PCR. Sequences from segments of the16S rRNA, rpoB and
gyrA (QRDR region) genes were analysed by GenBank database.
Results: The four isolates were identiﬁed as K. pneumoniae by
the VITEK2. API 20E identiﬁed K. terrigena (isolates 1, 3, 4) or
Enterobacter aerogenes (isolate 2). The WalkAway identiﬁed isolates
1 and 3 as K. pneumoniae, isolate 2 as E. aerogenes and isolate 4 as
uncommon phenotype. MICs for isolates 1, 2, 3, 4 were: 16, 1, 16, >16
(ceftazidime); 8, 1, 32, >32 (cefotaxime); 1, 1, 1, 8 (cefepime);
1, 1, 8, >8 (imipenem); 1, 1, >4, >4 (ertapenem) and >2, 1, >2,
>2 (ciproﬂoxacin). All were resistant to both amoxicillin-clavulanate
and cefoxitin. MICs of oxyimino-cephalosporins did not decrease with
clavulanate. pACBL were not detected. The AmpC induction test positive
in all 4 isolates. Isolates 1, 3 and 4 presented the same REP-PCR
type; isolate 2 showed a different one. Isolates 3 and 4 expressed only
an OmpA-like outer memprane protein (OMP). Isolate 1 presented an
additional OMP of ca.36 Kda, and isolate 2 two OMPs of ca.35 and
36 Kda. One single b-lactamase band of pI 8.1–8.2 was observed in all
4 isolates. 16S rDNA and rpoB sequences did not differentiate Klebsiella
sp from Enterobacter sp. The gyrA-QRDR sequences of test isolates was
highly similar to that of E. aerogenes (98%) but not that of Klebsiella
sp. (95%).
Conclusions: Two strains identiﬁed as K. pneumoniae/terrigena
following conventional methods caused bacteraemia in a single patient
treated with imipenem. The more resistant strain was later isolated
presenting resistance to carbapenems. Additional phenotypic tests
and gyrA sequencing demonstrated that the isolates were actually
E. aerogenes which developed carbapenems resistance after porin loss.
R2202 Touchdown PCR as a tool for improved detection of
invasive candidosis
P. Angelov, T. Kantardjiev, V. Levterova, E. Zamﬁrova, M. Lesseva,
R. Vacheva, S. Bobcheva, E. Shopova (Soﬁa, BG)
Summary: A touchdown conventional PCR based on the internal
transcribed spacer sequence (ITS1) was developed for the detection of
Candida albicans and ﬁve other Candida species. The assay precisely
identiﬁes C. glabrata, C. parapsilosis, C. lusitaniae, C. guilliermondii,
and C. krusei, which are clinically most frequent causative agents of
systemic infections. An evaluation of the assay with artiﬁcially prepared
samples revealed a detection limit of 2−4 genomic copies for C. albicans
and the other species.
Background: Invasive candidosis poses a major cause of morbidity
and mortality in severe immunocompromised and hospitalised patients.
Regarding the high mortality rates, there is necessity for rapid
and accurate diagnostic methods for rapid diagnostics. The internal
transcribed spacer sequences (ITS) are localised between the genes for
small subunit r RNA and 5.8S r RNA, and large subunit r RNA, which
are conserved among all fungi, but vary among different species, posing
suitable target for diagnostic aims.
Aims: To study the ability of touchdown PCR to improve the detection
of invasive candidosis and species identiﬁcation of the pathogen.
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Methods: Reaction conditions were optimised, using referent Candida
strains DNA, and the product was visualised on ethidium bromide-
stained agarose gel electrophoresis.
Serum samples from 11 patients with proven invasive candidosis were
obtained, and 200 microliters from each sample were subjected to DNA
extraction using DNA Puriﬁcation Kit® (Fermentas®).
Touchdown PCR-assay was developed, using universal fungal primers
ITS1 and ITS2 (1), which targets ITS1 region. 40 cycles of the reaction
was performed, at annealing temperature ranging 68−58 degrees for the
ﬁrst 10 cycles, and being constant during the next 30 cycles.
Results: The assay reached sensitivity equal to 2–4 C. albicans genomes,
allowing identiﬁcation of six Candida species.
The touchdown PCR was able to detect fungal DNA in all tested
specimens, and C. albicans, C. krusei, C. parapsilosis and C. glabrata
were identiﬁed, proving the identiﬁcation results, achieved with the blood
culture system Bac T/ALERT FA®.
Conclusion: A sensitive and speciﬁc touchdown PCR-based assay was
developed for the detection of six Candida species in serum specimens.
Four of the most relevant pathogenic species were successfully identiﬁed
in serum specimens from patients with sepsis.
Reference(s)
[1] Hibbett D. Ribosomal RNA and fungal systematics. Trans Mycol
Soc Jpn. 1992; 33: 533–556.
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R2203 Osteoarticular complications of brucellosis (melitensis)
N. Taghavi, M. Haghighi (Tehran, IR)
Objectives: Bone and joint involvement in brucellosis is one of the
most common complication that is reported in 20−85% of the cases.
This study has been carried out to determine the rate of osteoarticular
complications in patients who have been admitted in “Booali Hospital”
due to brucellosis in 2003–2005.
Methods: 109 patients had entered this descriptive study. Brucellosis
was determined based on clinical picture accompanying the raised titer
of speciﬁc antibody measured by standard agglutination test (STA).
Radiography and bone scans were obtained as needed.
Results: Of 109 patients, 72 (66%) were presented with osteoarticular
complication. Spondylitis, sacroiliitis, and knee involvement were the
most common complications. 39 (42.2%) patients had experienced the
involvement of more than one joint at the same time. 40 (36%) patients
were affected with spondylitis. Most of them (75%) were in the range of
55−60 years old. Bone scan was more sensitive for detecting spondylitis.
Conclusion: Spondylitis was the most common osteoarticular compli-
cation of brucellosis that was seen more in older patients. Radiography
(sensitivity 48.7%) and particularely bone scan (sensitivity 64%) are
highly recommended in susceptible cases.
R2204 Panchlamydia PCR for detection and identiﬁcation of
Chlamydia trachomatis, Chlamydophila pneumoniae, and
Chlamydophilia psittaci by LightCycler PCR
T. Juretzek, J. Buder, W. Ba¨r (Cottbus, DE)
The aim of this study was to evaluate the performance of a panchlamydia
real time PCR for screening of the human pathogenic Chlamydia,
such as Chlamydia trachomatis, Chlamydophila psittaci, Chlamydophila
abortus and Chlamydophila pneumoniae in clinical specimen. This study
included patients with respiratory affects, lung cancer, neonates with
respiratory affects with possible participatipon of Chlamydia trachomatis
or C. pneumoniae, patients from the ophthalmology clinic, gynaecology,
urology as well as pregnant women were examined. In total3281
Specimens were routinely investigated. 0.96% (16/1662) of adults with
respiratory affects were infected by C. pneumoniae, 0.3% (5/1662) with
C. psittaci.
5.8% (34/581) of the pregnants carried Chlamydia trachomatus and
0.3% (2/581) C. abortus. 2.2% (8/368) of the neonates were infected
by Chlamydia trachomatus 0.27% (1/368) with C. pneumoniae. 2.8%
(18/625) of the children carried C. pneumoniae in the respiratory tract.
6.6% (3/45) Chlamydia trachomatus were detected in swab of eges. The
melting curve analysis feature of the Lightcycler allowed identiﬁcation of
Chlamydia trachomatus and C. pneumoniae directly, whereas C. psittaci
and C. abortus were conﬁrmed by 16 sRNA gene sequencing. The
Panchlamydia PCR detecteds all 4 above-mentioned chlamydia within 3
to 4 h. Due to this PanChlamydia PCR it was possile to reduce the cost
for PCR and also rare found bacteria like C. abortus or C. psittaci were
detected.
R2205 Prevalence of enteropathogenic and shiga toxin-producing
Escherichia coli among children with and without
diarrhoea in Iran
M.Y. Alikhani, M.M. Aslani, A. Mirsalehian, B. Fatollahzadeh
(Hamadan, Tehran, IR)
Objectives: The aim of the study was to determine the rates of detection
of enteropathogenic Escherichia coli (EPEC) and Shiga toxin-producing
Escherichia coli (STEC) strains among children in two randomly-
selected populations in Iran.
Methods: In total, 1,292 randomly-selected faecal samples from children
aged less than 10 years were screened for EPEC and STEC. Of the
1,292 cases participated in the study, 184 had diarrhoea, and 1,108
were healthy/asymptomatic children. The conventional culture method
and slide agglutination with 12 different commercial EPEC antisera
were used for the detection of EPEC. The colony sweep polymyxin-B
extraction method, non-sorbitol fermentation (NSF) phenotype, and slide
agglutination with O157:H7 antisera were used for the screening and
detection of STEC.
Results: Of EPEC belonging to 11 different serogroups, O111 and O127
were most commonly found in 36.4% of the diarrhoeal cases and 7.2%
of the asymptomatic children. A signiﬁcant association (p< 0.05) was
found between isolation of EPEC and diarrhoea. 8.7% of the diarrhoeal
cases and 2% of children without diarrhoea were infected with STEC,
but none of the isolates belonged to the O157:H7 serotype. A signiﬁcant
association (p< 0.05) was found between STEC and diarrhoeal cases.
Conclusion: Based on these ﬁndings, it can be concluded that different
EPEC serogroups may be agents of endemic infantile diarrhoea, and
STEC strains are an important enteropathogen among young children.
R2206 Anti-neutrophil cytoplasmic antibodies in severe infection
– a neglected association
C. Morath, J. Sis, M. Zeier, V. Schwenger, K. Andrassy (Heidelberg, DE)
Objectives: C-ANCA with target antigen proteinase 3 (PR3-ANCA) and
P-ANCA with target antigen myeloperoxidase (MPO-ANCA) are highly
sensitive and speciﬁc markers for systemic small vessel vasculitides with
renal involvement (M. Wegener and microscopic polyangiitis). Although
ANCAs have been considered to be highly speciﬁc for vasculitides,
positive ANCAs have also been observed in patients with severe systemic
infections.
Methods and Results: Recently, we observed a female veterinary
medical student who was admitted with pneumonia, crescentic glomeru-
lonephritis (S-creatinine 3mg/dl) and highly elevated ANCA (P-ANCA
1:1260, normal <1:20, MPO 33, normal <2), which turned out to
be acute Q-fever infection (coxiella IgG 504 U/L; IgM +++). Renal
histology revealed crescentic and necrotic immune complex nephritis
(postinfectious glomerulonephritis). Under long-term treatment with
doxycycline and levoﬂoxacine, coxiella titers declined slowly from 504
U/L to 90 U/L. Within 6 months renal function improved (S-creatinine)
from 3mg/dl to 1.3mg/dl and proteinuria decreased from 3.1 g/day to
1.2 g/day. Although crescentic glomerulonephritis is usually treated by
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immunosuppression, we avoided this therapy in our patient because of
possible harmful effects on the course of Q-fever infection. Whereas
Q-fever infection was cured with this regimen, renal function declined
progressively, becoming strongly impaired in the follow-up. A second
renal biopsy revealed chronic sclerosing glomerulopathy with advanced
tubulo-interstitial ﬁbrosis.
Discussion: ANCA with the classical target antigens PR3 or MPO
in infectious diseases were shown ﬁrst by our group in patients with
endocarditis, HIV and by other investigators in patients with amoebiasis,
leprosy and hepatitis C. ANCA with other target antigens, e.g. elastase
and BPI (bacterial permeability inhibitor) could be demonstrated in other
bacterial infections (e.g. osteomyelitis, cystic ﬁbrosis).
Conclusion: (1) ANCA are not only markers of small vessel vasculitides,
they can also be (false) positive in patients with systemic infections,
(2) Determination of target antigens for ANCA are indispensable, (3)
Interpretation and therapeutic decisions concerning ANCA associated
diseases should only be performed within the clinical context.
R2207 MRSASelect applied on enrichment broths signiﬁcantly
increases the sensitivity of MRSA detection in screening
samples
M. Ieven, M. Michiels, H. Jansens, J. Breughelmans, H. Goossens
(Edegem, BE)
Background: Early identiﬁcation of MRSA carriers among hospitalised
patients is crucial to prevent its spread.
Our objective was to evaluate the performance of a chromogenic
medium, MRSASelect (BioRad) for MRSA detection on surveillance
samples both by direct plating and on enrichment broths in comparison
with conventional cultures.
Methods: A total of 264 surveillance swabs from 84 patients, previously
colonised, were cultured on blood agar (BA), mannitol salt agar (MSA)
and MRSASelect (MS) and subsequently into a MRSA enrichment broth
containing Brain Heart Infusion, NaCl 7% and oxacillin 4mg/mL. After
24 hrs incubation at 35ºC broths were subcultured onto a secondary
MSA and MS plate. All plates were read after 24 and 48 hrs incubation
for colony morphology and colour production on MS. Identiﬁcation and
methicillin resistance of pink colonies on MS suspected for MRSA were
conﬁrmed by tube coagulase test and oxacillin resistance.
Results: A total of 69/264 (26%) specimens were MRSA positive.
After 24 hours incubation, 47/69 (68%) were recovered on the primary
MS compared to 61/69 (88%) on routine culture media (RC). Further
incubation of the primary plates for 48 hrs resulted in the detection of
53/69 (77%) of MRSA on the MS plate. After enrichment overnight in
broth and subculturing for 24hrs on MS agar a total of 60/69 (87%)
MRSA were isolated, an increase of 28% compared to the detection
on the primary plate. Another 2/69 (3%) were detected after incubation
the broth subcultures for another 24 hrs. Compared to the results of
culture on BA and MSA, the sensitivity, speciﬁcity and negative and
positive predictive values of MRSASelect for the detection of MRSA
on the primary plate were 67%, 97%, 91% and 87% after 24 hrs, 77%,
97%, 93% and 88.6% after 48 hrs incubation and from broth 85%, 96%,
96% and 87% after 24 hrs and 89%, 96%, 97% and 87% after 48 hrs
respectively.
Considering a specimen as a true positive for MRSA if identiﬁed and
conﬁrmed by any of the culture methods, sensitivity of MS was 68%
and 77% on the primary MS plate after 24 and 48 hours, and 87% and
90% after 24 and 48hrs from broth respectively.
Conclusion: Although direct inoculation on MRSASelect results in the
detection of only 68% of MRSA after 24hrs, identiﬁcation is already
conﬁrmed after overnight incubation. Broth enrichment subcultured on
MRSASelect increases the yield of MRSA detected by 28% compared
to direct plating but postpones time to detection by 24hrs.
R2208 Evaluation of two new tests for the detection of Helicobacter
pylori in stool specimens
S. Blanco, A. Lacoma, M. Forne, C. Prat, I. Latorre, M. Cuesta,
J. Viver, V. Ausina, J. Dominguez (Badalona, Terrassa, ES)
Objectives:
1. To evaluate the usefulness of 2 new stool antigen assays, a
immunochromatographic tests Letitest H. pylori CARD (Laboratorios
leti, Madrid, Spain) and an EIA test Immundiagnostik ELISA
(Immunodiagnostik AG, Bensheim, Deutschland) in the diagnostic
of Helicobacter pylori infection and to conﬁrm H. pylori eradication
after treatment.
2. To compare their accuracy with four stool antigen assays: Im-
munoCard STAT! HpSA and Premier Platinum HpSA (Meridian
Diagnostics, Cincinnati, OH), Ampliﬁed IDEIA Hp StAR and RAPID
Hp StAR (DakoCytomation, Cambridge, UK).
Methods: We evaluated stool samples from 80 patients diagnosed with
H. pylori infection and from 40 patients without infection. To conﬁrm
H. pylori eradication we evaluated 40 patients who received H. pylori
treatment, eradication was conﬁrmed with 13C-urea breath test 6 weeks
later.
The assays were performed according to the speciﬁcations of the
manufacturer. Sensitivity, speciﬁcity, and positive and negative predictive
values were calculated.
Results: The sensitivity, speciﬁcity, and positive and negative predictive
values of the tests are shown in the table. In the 40 patients evaluated
6 weeks after eradication therapy, the overall agreement between urea
breath test and the antigen tests were: Letitest 85%, ImmunoCard STAT!
HpSA 82.5%, RAPID Hp StAR 75%, Immundiagnostik ELISA 82.5%,
Ampliﬁed IDEIA Hp StAR 90% and Premier Platinum HpSA 75%.
Sensitivity
(%)
Speciﬁcity
(%)
PPV
(%)
NPV
(%)
Letitest H. pylori CARD 83.8 66.6 91.2 48
Immundiagnostik ELISA 87.3 83.3 95.8 60
RAPID Hp StAR 78.8 55.5 88.7 37
ImmunoCard STAT! 52.5 94.4 97.7 30.9
Premier Platinum HpSA 92.5 72.2 93.7 68.4
Ampliﬁed IDEIA Hp StAR 95 66.6 92.7 75
Conclusions: Our results indicate that Letitest and Immundiagnostik
ELISA are helpful procedures to determine H. pylori infection.
Compared to the 13C UBT, both new test shows a comparably good
correlation to assess the success of eradication therapy.
R2209 Liaison® VZV IgG and VZV IgM assays: a comparative
study
P. Huynen, P. Melin, M. Hayette, J. Mathieu, P. De Mol (Liege, BE)
Varicella-zoster virus (VZV) belongs to the Herpesvirus family. Varicella
is the full-blown primary infection and zoster is caused by the
reactivation of latent VZV. Varicella and zoster are mainly diagnosed
clinically but serology plays an important role, especially when the
course of disease is non-typical.
Objectives: VZV serology is currently carried out by microplate
analysers in our institute. The aim of this study was to evaluate
if the LIAISON® VZV IgG and VZV IgM (DiaSorin, Saluggia,
Italy), two fully automated immunoassays, based on chemiluminescence
technology (CLIA) could be an alternative method, quick and easy to
perform, whose performance meets our current quality requirements.
We therefore performed a comparative evaluation and investigated the
overall agreement between LIAISON® VZV IgG and IBL VZV IgG
ELISA (Immuno Biological Laboratories, Hamburg, Germany) as well
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as between LIAISON® VZV IgM and Enzygnost VZV IgM ELISA
(Dade Berhing Enzygnost, Marburg, Germany).
Methods: The performances of LIAISON® VZV IgG and IBL VZV
IgG ELISA were compared for a total of 165 selected routine serum
samples (139 positive, 19 negative, 7 indeterminate). For interpretation
of results of the LIAISON® assay, a cut-off value of 150mIU/mL was
used, in order to achieve the highest diagnostic speciﬁcity and sensitivity.
Discordant results were solved by Euroimmun VZV IgG (Euroimmun
AG, Luebeck, Germany) ELISA.
The performances of LIAISON® VZV IgM and Enzygnost VZV IgM
ELISA were compared for a total of 160 selected routine serum samples
(22 positive, 114 negative, 24 indeterminate). Discordant results were
solved by Euroimmun VZV IgM and NovaTec VZV IgM ELISA
(NovaTec Immunodiagnostica GmbH, Dietzenbach, Germany).
Results: The comparative study between LIAISON® VZV IgG and
IBL VZV IgG ELISA as well as between LIAISON® VZV IgM and
Enzygnost VZV IgM ELISA showed overall agreement of 89.7% and
80% respectively. When Euroimmun VZV IgG, Euroimmun VZV IgM
and NovaTec VZV IgM tests were used and that a consensus between
at least two out of three tests was applied, those values were 96.4% and
97.5% respectively.
Conclusions: The LIAISON® VZV IgG assay is a valid alternative
for the quantitative detection of VZV IgG antibodies, since the kit
performance is at least equivalent to that of the kits currently available
on the market.
With its high speciﬁcity, the LIAISON® VZV IgM test, a fully automated
method, is also a good alternative for the detection of IgM antibodies.
R2210 Study in changes of CSF in 50 patients with bacterial,
viral, and TB meningitis
N. Taghavi, M. Haghighi (Tehran, IR)
Background: Bacterial meningitis is one of the most life threatening
condition which without therapy has a high mortality. Differentiation
between viral and bacterial meningitis is crucial for appropriate
treatment.
Methods: This prospective study was performed on csf changes in 50
patients with bacterial, viral and TB meningitis in infectious department
of “Booali Hospital” between year 2002 and 2005. Protein, glucose and
cell count of csf samples were analysed.
Results: From 50 patients, 30 cases had bacterial meningitis (proven
by culture) 14 cases had viral and 6 cases had TB meningitis. In csf
study in bacterial meningitis we had protein >100mg in 66.6%, csf
GLC/serum GLC <20% in 46.6%, leukocyte count in range of 1000–
10,000 in 53.3% and PMN dominancy in 93.3% of patients. In patients
with viral meningitis we had normal protein in 71.4%, normal GLC
in 85.7% and leukocyte count in range of 100–500 in 57.1% with
mononeuclear dominancy.patients with TB meningitis had csf protein
45–100mg in 66.6%, csf GLC/serum GLC <20% in 100%, leukocyte
count in range of 100–500 in 100% with mononeuclear dominancy.
Conclusion: concerning the importance of distinguishing of septic and
aseptic meningitis, and in the absence of established diagnosis, the csf
GLC/serum GLC ratio can be used as a sensitive test to determine the
probable septic aetiology. The cutpoint of csf GlC/serum GLC below 25
can be rational reason to start empirical treatment.
R2211 Gram-positive anaerobic bacteria: frequency of isolation
and antimicrobial resistance pattern
P. Giannopoulou, A. Kyratsa, I. Graphakos, E. Kontekaki,
A. Chondrothanassi, P. Saﬁoleas, K. Zambou, E. Trikka-Graphakos
(Athens, GR)
Objectives: To evaluate the incidence of Gram(+) anaerobic bacteria
isolated from clinical specimens and their susceptibility pattern.
Methods: During a two-year period (2005–2006) we evaluated
Gram(+) anaerobic bacteria isolated from documented infections. For
anaerobic culture the following media were used: Brucella Blood agar
enriched with vitaminK1 and hemin, Kanamycin-Vancomycin Laked
Blood agar, Bacteroides Bile-Esculin agar and Cooked Meat Broth.
Preliminary identiﬁcation was based on Gram stain, colony morphology
and susceptibility to high potency discs (colistin10mg, SPS1000mg,
kanamycin1000mg, vancomycin 5mg). Species identiﬁcation was per-
formed by API20A & RapidID32A system. Beta-lactamase production
was tested by nitrocephin discs. Antibiotic susceptibility was performed
by E-test in the National Reference Center according to CLSI guidelines.
Results: A total of 48 clinical strains were isolated as follow:
PeptoStreptococcus spp. (23), Clostridium spp. (19) and Eubacterium
spp. (6). 12 strains were isolated from patients suffering from
bacteraemia with C. perfringens being the most common isolate, 6
from patients with bacterial peritonitis, 7 with pelvic inﬂammatory
disease, 4 with burns, 3 from patients with gas gangrene and ﬁnally
19 from wounds and soft tissue infections with PeptoStreptococcus spp.
as the commonest isolate. Among clostridial infections stands out one
case of fatal spontaneous bacterial peritonitis in a cirrhotic patient due
to C. tertium and 3 cases of gas gangrene due to C. septicum and
C. sporogenes, without underlying malignancy. All strains of Clostridium
spp. were sensitive to penicillin, while resistance to clindamycin
was 12.9% (MICs of 4−>256mg/mL) & for PeptoStreptococcus spp.
12.1% (MICs> 256mg/mL). Metronidazole, piperacillin/tazobactam and
imipenem were highly effective to all isolates. Resistance to ceftriaxone
was detected in 4 isolates. All but one isolates were sensitive to
tetracycline.
Conclusions: (a) Penicillin remains the drug of choice for clostridial
infections, while metronidazole or imipenem are prudent alternatives.
(b) Clostridium and PeptoStreptococcus spp. showed low resistance to
clindamycin. (c) Resistance to ceftriaxone and tetracycline require closer
surveillance.
R2212 Evaluation of Rubella IgG and IgM assays on the new
Vidia® instrument
M.C. Medici, V. Albonetti, M. Martinelli, C. Chezzi, G. Dettori (Parma,
IT)
Objective: The aim of the present study was to evaluate the performance
of the new VIDIA® Rubella IgG and IgM assays on the fully automated
VIDIA instrument, easy to use with a high level of traceability.
Methods: Sensitivity and speciﬁcity of the VIDIA RUB IgG and IgM
(bioMe´rieux, France) were evaluated in a retrospective study on 209
serum samples belonging to 195 subjects and in a prospective study
on 211 serum samples belonging to 210 subjects, in comparison with
VIDAS® RUB IgG and IgM (bioMe´rieux, France), AxSYM® Rubella
IgG and IgM (Abbott, USA) and LIAISON® Rubella IgG and IgM
(DiaSorin, Italy) assays.
The samples for which at least one equivocal result have been found
whatever the method have been excluded for the analysis, as well as the
non resolved samples.
Discrepancies were resolved considering individual clinical data, when
available, and/or with repetition of the test as well as with IgG Avidity
test for IgM discrepancies.
Results: Sensitivity: For VIDIA RUB IgG, sensitivity was 100% in
comparison with 2 out of 3 methods in the retrospective study and
with all methods in the prospective one. For VIDIA RUB IgM, in
the retrospective study, sensitivity was 100% only in comparison with
VIDAS RUB IgM. After resolution of discrepancies, the absolute
sensitivity was 100% for all methods except AxSYM Rubella IgM which
was 33.33%. In the prospective study the sensitivity was not determinable
as no positive serum was obtained.
Speciﬁcity: For VIDIA RUB IgG, the speciﬁcity has been established
at 100% compared to VIDAS RUB IgG and AxSYM Rubella IgG in
both retrospective and prospective studies. In comparison with LIAISON
Rubella IgG it was 97.29% and 95.24% in the retrospective and
prospective studies, respectively. After resolution of discrepancies the
absolute sensitivity was found 100%.
The relative speciﬁcity of VIDIA RUB IgM compared to VIDAS
RUB IgM, AxSYM Rubella IgM and LIAISON Rubella IgM assays
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was 99.49%, 98.44 and 99.47, respectively, in the retrospective study.
Taking into account clinical information and Avidity results, the absolute
speciﬁcity was closed to 100%. In the prospective study the speciﬁcity
of VIDIA RUB IgM was found 100% for all the three methods.
Conclusion: The two evaluated assays, VIDIA RUB IgG and VIDIA
RUB IgM, show an excellent sensitivity and speciﬁcity.
R2213 Comparison of different culture media and growth condi-
tions for the recognition of Arcanobacterium haemolyticum
C. Garcia, A.B. Campo-Esquisabel, F. Unda, C. Ruiz de Alegria,
N. Benito, L. Martinez-Martinez (Santander, ES)
Objectives: A. haemolyticum (AH) would be easily missed or
unrecognized in routine cultures. The aim of this study was to perform
qualitative and quantitative comparisons of six culture media and
different growth conditions for recognition of AH colonies.
Methods: Forty-seven clinical isolates and the reference strain ATCC
9345 of AH were selected for this study. Identiﬁcation as AH was
accomplished by conventional biochemical tests and sequencing of
16S rDNA. For each strain, a suspension was prepared with a ﬁnal
concentration of approximately 103 ufc/mL. All strains were plated onto
sets of three plates of the following commercial media: (I) Trypcase Soy
Agar with 5% Horse Blood (TSH), Trypcase Soy Agar with 5% Sheep
Blood (TSS), Columbia Agar with 5% Sheep Blood (COS), Schaeleder
Agar with 5% Sheep Blood (SCS) from bioMe´rieux. (II) Columbia Agar
with 5% Horse Blood (CH) from Beckton Dickinson. (III) Columbia
Sheep Blood Agar with colistin/nalidixic (CNA) from Biomedics. Plates
were incubated in air, CO2, and anaerobiosis for 72 h at 37ºC with a ﬁrst
reading after 24 h. Five isolated colonies from each plate were measured
with a micrometer of a dissecting microscope, and the average colony
size was recorded in millimeters. Analysis of variance (ANOVA) was
used to compare colony size on differents media, atmosfera and time
of incubation. Quality of media performance was assessed as presence
of beta-haemolysis and signiﬁcance was determined by the Chi-squared
test.
Results: After 24 h of incubation the mean colony diameter was 0.2mm
(SD 0.003). The average colony size was signiﬁcantly greater on TSH,
CH and COS (aerobic and CO2 incubation) and SCS (CO2 incubation)
than under the other media and atmosphere conditions (p< 0.001).
Haemolysis was visible more often on TSH with CO2 incubation (61%)
than in the other conditions. After 48 h, the mean colony diameter was
larger on TSH with aerobic and CO2 incubation (0.77mm in both cases)
than in the other situations (p< 0.001); haemolysis was detected in 100%
of strains incubated in TSH. After 72 h of incubation, the average colony
size remained greater on TSH – speciﬁcally with CO2 – than on the other
media and atmosphere conditions (1.2mm, SD 0.02).
Conclusions: In TSH larger colony sizes, and earlier appearance of
colonies and of beta-haemolysis was observed in comparison with the
remaining evaluated media.
R2214 Evaluation of Helicobacter pylori stool antigen test for the
detection of H. pylori infection in paediatric patients
G. Gonzalez Mediero, J.M. Ramos, J.I. Garcı´a, I. Otero Varela, T. Del
Blanco, J.A. Sanchez Conde (Vigo, ES)
Objective: Helicobacter pylori plays an important role in the
pathogenesis of some several extra or intragastroduodenal diseases. The
assessment of H. pylori antigen in human stools has been proposed
as a valuable non-invasive diagnostic tool. The aim of this study was
to evaluate the usefulness of H. pylori stool antigen (HpSA Premier
Platinum HpSA, Meridiam Diagnostics, Cincinnati, USA) in diagnosis
of H. pylori infection in children patient.
Methods: 1270 patients have been consulted in the Gastroenterol-
ogy Paediatric unit as news patients during a period of 4 years
(1/01/02−31/12/05). Seventy two patients aged 3−15 years with chronic
pain abdominal and suspicion of infection for H. pylori were studied in
this work; sixty one (4.8% of total patients) were included in this study
and eleven discarded for not advice. Stool samples were taken before
antibiotic treatment. The patients were evaluated in two stages, the ﬁrst
one for symptoms as pattern of pain abdominal chronic (per-umbilical,
epigastria) and study for HpSA and the second one with gastrointestinal
gastroscopy for assessment study mucosa for histology, ureasa test and
serology (ELISA). Patients were deﬁned as H. pylori positive infection
if histology was conﬁrmed as gastritis chronic antral and H. pylori was
showed in the biopsy.
Results: 31 patients were positive for H. pylori (50.8%). The media
optical densities at 450 nm were 1.088 (range 0.064–3.500) and 0.088
(0.004–0.444) in the patients positive and negative for H. pylori antigen
respectively. The sensitivity and speciﬁcity of method were as follows
respectively; ureasa 86.3% and 89.9%, serology 63% and 78% and
HpSA was 99% and speciﬁcity 40.3%. Predictive value of positive and
predictive value of negative test respectively is ureasa 96% and 75%,
serology 85% and 67% and HpSA 51% and 98%.
Conclusion: Helicobacter pylori antigen test is non-invasive, easy to
perform and it can be a test to exclude negative cases when the result is
negative, but it can not be considered as a diagnostic test in paediatric
group in our area in Vigo (Galicia, Spain). We considered that positive
patients who gastrointestinal gastroscopy was negative, must be revised
and to evaluate the evolution and prognosis. Until October 2006 none of
them were request consultant or revision.
Acknowledgements: All test for Helicobacter pylori has been performed
by Elena Saavedra as technical personal.
R2215 Routine use of blood culture bottles can reduce detection
time in PD peritonitis
V. Cleeve, T. Poole, M. Fitzpatrick, F.K. Gould, T.H.J. Goodship
(Newcastle upon Tyne, UK)
Objectives: Peritonitis is a recognized complication of peritoneal dialysis
and may result in Tenchkoff catheter removal. Our aim was to assess
whether the addition of a blood culture bottle inoculated with PD
efﬂuent improved the rate of detection of causative organisms in cases
of suspected peritoneal dialysis peritonitis and whether the time to a
positive result was more rapid compared to results obtained by direct
culture alone.
Methods: A retrospective review was performed of all PD efﬂuents
sent for culture from July 2005 – June 2006. Direct samples had
been processed using a lysis-centrifugation technique using saponin,
inoculated onto a range of agar plates and incubated for 48 hours. Blood
culture bottle samples were incubated using a continuous monitoring
BacT/Alert system for a maximum of 5 days. Times to positive results
were obtained using data from the blood culture computer records and
specimen forms. Clinical information was obtained using peritoneal
dialysis unit records.
Results: A total of 136 direct samples of peritoneal dialysis efﬂuent were
sent for culture and 20 of these were sent with an additional sample in a
blood culture bottle. Of the 20, 9 became positive relating to 7 episodes
of peritonitis. All 9 bottles grew the same organisms as the corresponding
direct sample except in one case where the blood culture bottle sample
grew Streptococcus vestibularis in addition to the Coagulase negative
Staphylococcus isolated directly. No direct sample sent with a paired
sample in a blood culture bottle was positive without the blood culture
sample also being positive.
All 9 samples in blood culture bottles ﬂagged positive within 25 hours.
The quickest time was 10 hours. As a number became positive during the
night the samples were processed the following morning but a provisional
Gram stain report was available by the next day in all 9 cases. Of the
corresponding direct samples 5 had provisional culture results the next
day but 2 samples required 2 days to obtain a result, 1 sample 3 days
and another 4 days.
Conclusion: During this time period the addition of a sample of PD
efﬂuent in a blood culture bottle did not improve the detection of
causative organisms in cases of suspected peritonitis compared to culture
of direct samples but the numbers were small. However, the additional
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sample did provide more rapid provisional results for the clinicians
without a high increased rate of contaminated samples.
R2216 One-year surveillance study in patients with pulmonary
infections caused by anaerobic bacteria
S. Marinkovic, I. Marekovic, M. Jakopovic (Zagreb, HR)
Objectives: Anaerobic bacteria are relatively common pulmonary
pathogens. Anaerobic infections are very often polymicrobial, including
also microaerophilic and facultative anaerobes. Some studies have
shown that patients with underlying carcinoma have high incidence of
Gram-negative aerobic pathogens. The purpose of this study was to
determine the frequency of different anaerobic bacterial species and
their susceptibility to antimicrobial agents. In patients with underlying
carcinoma we wanted to determine if Gram-negative aerobic bacteria
are frequently present together with anaerobes, which could have
implications on empirical treatment of these infections.
Methods: This study was conducted during year 2005 in Department
for Microbiology, University Hospital for Lung Diseases “Jordanovac”.
Anaerobic bacteria were isolated in patients with clinical and radio-
graphic signs of pulmonary infection from specimens obtained mostly
at ﬁber-optic bronchoscopy, either by bronchoscopic aspiration or by
bronchoalveolar lavage (BAL). Antimicrobial susceptibility was tested
with E-tests in order to determine minimal inhibitory concentrations
(MIC) according to NCCLS (CLSI) standards.
Results: Total of 108 anaerobes was isolated in 27 female and 64
male patients. The most frequent isolates were Gram-positive non-
spore-forming bacilli (30.56%). Anaerobes alone were detected in 61
(67.03%), and anaerobic and aerobic bacteria together were observed in
30 (32.97%) cases. An average of 1.65 bacterial species per patient was
obtained. Underlying carcinoma was present in 24 (26.37%) patients. In
20 (83.3%) of these patients anaerobes were present alone. The level
of resistance to metronidazole, ampicillin and clindamycin was 59.3%,
8.3% and 6.5%, respectively. To imipenem and ko-amoxiclav there were
no resistant strains.
Conclusion: Anaerobic bacteria are found more often in male patients
with pulmonary infection. The most frequent anaerobes in our patients
were Gram-positive non-spore-forming bacilli. In most of our patients
multiple isolates were found. In contrast to the ﬁndings of some studies
in patients with underlying carcinoma, anaerobes were more frequently
present alone and Gram-negative aerobic bacteria were uncommon. High
percent of resistance to metronidazole indicates that clindamycin and
b-lactams are better choice when anaerobic infection is suspected.
R2217 Elimination of false negativity of internal ampliﬁcation
control in PCR assay
M. Sayan, Z. Yumuk, S. C¸elebi, A. Willke (Kocaeli, TR)
Objectives: Polymerase chain reaction (PCR) is a nucleic acid
ampliﬁcation technique commonly used in routine laboratories as a
rapid, sensitive and speciﬁc diagnostic tool. However PCR inhibitory
components may effect the PCR assay and false negative results may be
obtained. To detect false negativity, internal ampliﬁcation control (IAC)
is used in diagnostic laboratories, but various PCR inhibitors (such as
heparin, heme, leukocyte DNA etc.) may adversely effect ampliﬁcation
procedure. In this study we evaluated the effectiveness of various pre-
PCR processing procedures on IAC in paralel with the serum samples
of hepatitis B and hepatitis C patients.
Methods: From January 2005 through October 2006, hepatitis C virus
(HCV) RNA (ﬂuorion HCV QNP v2.1 kit-Iontek Ltd. Sti, Istanbul-
Turkey) and hepatitis B virus (HBV) DNA (ﬂuorion HBV QNP v2.0
kit-Iontek Ltd. Sti, Istanbul-Turkey) tests were performed by quantitative
real-time PCR (iCycler IQ, v 3.0a – BioRad Laboratories, Hercules,
CA-USA) to 1440 and 2754 patient samples respectively. We used
silica-gel based spin column (SC) and silica-coated magnetic particle
(MP) as extraction methods. After then, in the sera which was seen no
ampliﬁcation of IAC, we re-performed PCR tests after using; (1) freeze-
thawing, (2) sample dilution, (3) a new sample and (4) a new lot of IAC
consecutively.
Results: Totally 211/1440 (14.6%) of HCV RNA PCR assay (SC:
122/905, MP: 89/535) it was seen no ampliﬁcation in the IAC.
Considering HBVDNA PCR results, false negativity was found to be
15/2754 (0.5%) (SC: 6/1724, MP: 9/1030). Comparison of two extraction
methods namely SC and MP for both HBVDNA and HCV RNA PCR
tests there was no statistically signiﬁcance related with false negativity.
False negativity ratio in IAC has decreased from 14.6% to 6.0% in HCV
RNA group and from 0.5% to 0.0% HBVDNA group after applying all
four inhibitor elimination methods.
Conclusion: In routine laboratories in PCR assay, inhibitory substances
may lead to several problems such as re-test the same sample, higher
cost and delayed results. Therefore in this case, the test should be
re-performed after freeze-thawing and diluted procedure. If no result
obtained, it will be beneﬁcial to re-performed the test with a new sample
or new lot of internal control.
R2218 Evaluation of a rapid new stool antigen test for diagnosis
of Helicobacter pylori infection in adult patients
R. Krausse, G. Mu¨ller, M. Doniec (Kiel, DE)
The overall objective of this study was to evaluate the performance of a
rapid new stool antigen test (Rapid Hp StARTM, Dako) for the diagnosis
of a H. pylori infection in adult patients in our region. The accuracy of
the test was deﬁned in relation to the different clinical entities and to
the age of the patients. The study included 72 dyspeptic adult patients
(37 women, 35 men, mean age 58.4±15 years, range 24−88 years)
and was conducted in the years 2002 and 2003. Biopsies were taken
for culture, histology and/or rapid urease test. Out of 72 patients, 28
(38.9%) were H. pylori positive, 44 (61.1%) were H. pylori negative. 18
(64.3%) of the 28 H. pylori positive patients had gastritis (n = 11, 39.3%)
or gastroduodenal ulcers (GDU) (n = 7, 25.0%) and all other (n = 10,
35.7%) patients had a normal mucosa (NM). Gastritis, GDU and NM
were determined in 11 (25.0%), 2 (4.5%) and 31 (70.5%) of the Hp
negative patients. Faecal specimens were collected from all the patients
and examined for the presence of H. pylori. The Rapid Hp StARTM stool
antigen test yielded positive results in 13 and 20 of the 28 H. pylori-
positive patients (46.4 and 71.4%) after a reading time of 20 and 30 min,
respectively. Within the H. pylori-negative group of patients (n = 44) the
test identiﬁed 2 (4.5%), and 7 (15.9%) as H. pylori positive after 20 and
30 min, respectively. The sensitivity, speciﬁcity, positive and negative
predictive value and accuracy were 59.1%, 93.1%, 86.7%, 75.0% and
78.4% after a reading time of 20 min and 76.9%, 82.9%, 74.1%, 85.0%
and 80.6% after 30 min. The test achieved the highest sensitivity and
speciﬁcity among the patients with duodenal ulcers, followed by patients
with normal mucosa and gastritis. Moreover, the age (<45 vs> 45 years)
and the gender of the patients inﬂuenced the efﬁciency of the test.
Conclusion: This new monoclonal rapid stool antigen test can be used
as an alternative non-invasive method to detect H. pylori infection.
However, a longer incubation time (30 min) is recommended when
negative results occur within 20 min; further studies with a greater
number of different patient groups are required to conﬁrm its accuracy.
R2219 Comparative study of group B Streptococcus differential
agar versus LIM broth for detection and identiﬁcation of
Streptococcus agalactiae in pregnant women
A. Adler, C. Block, D. Engelstein, D. Hochner-Celnicier, R. Drai-Hasid,
A.E. Moses (Jerusalem, IL)
Objectives: Our goal was to compare BD Group B Streptococcus
Differential Agar (GBSDA, Becton Dickinson), a commercially available
modiﬁcation of Granada medium, with inoculation into LIM broth and
subculture onto blood agar plates (LIM-BAP) as a method for GBS
screening in pregnant women.
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Methods: First, we compared the detection threshold and the ease of use
of GBSDA with LIM-BAP by inoculating known numbers of GBS mixed
with approximately 107 colony-forming units (cfu)/mL of other bacteria
(E. faecalis ATCC 29212, S. epidermidis ATCC 12228, P. mirabilis
ATCC 7002 and a clinical isolate of Lactobacillus sp.). Second, we tested
the production of carotenoid pigment in 159 GBS blood culture isolates.
Finally, we compared GBSDA, LIM broth with direct GBS antigen
detection (LIM-AG) and LIM-BAP as methods for GBS screening in
pregnant women presenting in labour to the delivery room. Suspect
colonies were identiﬁed as GBS by a commercial agglutination test.
Identiﬁcation of non-haemolytic GBS included a positive CAMP test
and failure to hydrolyse esculin on bile-esculin agar.
Results: GBS colonies were easily detected on GBSDA (ﬁgure) at a
threshold of 2000 cfu/mL in a mixed culture. In contrast, GBS was not
detected in a mixed culture on BAP subcultured from LIM broth with
initial inocula of up to 104 cfu/mL. Orange pigment was produced in 149
of 159 GBS blood culture isolates, including one non-haemolytic isolate.
Pigment was not produced in 8 non-haemolytic and 2 haemolytic strains.
GBS was detected by GBSDA in 49 out of 226 women (21.6%) but in
only 42 (18.5%) and 36 (16%, p< 0.05) women by using LIM-BAP and
LIM-AG, respectively.
Conclusion: GBSDA was faster, easier to use and more sensitive for
the detection of GBS from vaginal swabs, compared with LIM-BAP.
Although non-haemolytic strains are usually missed by this method, it
appears that enrichment in LIM broth offers no advantage for detection
of these strains. Therefore, GBSDA may be the culture method of choice
for GBS screening in pregnant women.
R2220 Evaluation of a new rapid method for microbial growth
analysis and antimicrobial susceptibility test in human
biological ﬂuids
A. Tessari, S.G. Parisi, A. Cavallaro (Padua, IT)
Objectives: The Uro-Quick system is an automated rapid method for
bacteriuria screening which uses laser nephelometry to detect bacterial
growth. We evaluated the Uro4 HB&L system for a rapid micro
organisms detection and antimicrobial susceptibility test (AST) directly
performed on human biological ﬂuids.
Methods: 233 human biological samples counting respiratory (36%),
articular, peritoneal and other drainages (64%), were analysed for
culture with Uro-4 system. Gram stain microscopy and plate subculture
analysis was performed on every sample analysed with Uro-4 after
6 hours incubation. Sixty-nine samples (57 mono and 12 polimicrobial)
detected positive by Uro-4 were then processed for a direct AST (3
hours incubation). Four different antimicrobial panels were designed for
Enterobatteriaceae, Streptococcus, Staphylococcus and non fermenting
Gram negatives. Culture and AST performed on Uro-4 were compared
with traditional culture methods on agar plates and with VITEK2 system
for AST.
Results: 136 samples were concordant positive. Microbial growth
analysis performed on Uro-4 showed 94.4% sensitivity and 93.3%
speciﬁcity compared with the traditional culture method. Uro-4 test
coupled with Gram stain microscopy after incubation gave 100%
sensitivity. Positive counted monomicrobial samples (76%), including
69% Gram positive bacteria, 24% Gram negative and 7% yeast,
and polimicrobial samples (24%). Direct AST performed on 26
monomicrobial Gram positive cultures resulted in 95% agreement
with the reference method (Streptococcus/Enterococcus panel 100%,
Staphylococcus 92.4%) meanwhile AST conducted on 31 monomicrobial
Gram negative samples revealed a 96% agreement (Enterobacteriaceae
94.9%, non fermenting 97.3%). No very major error (sensible vs.
resistant) was detected. Polimicrobial samples gave discordant results by
reason of the variable composition of the mixture and the small number
of analysis.
Conclusion: Uro-4 is able to perform bacterial growth analysis and a
subsequent AST within 7−9 hours, with a great saving of time respect to
the traditional cultural and AST methods. The system revealed optimal
performance on microbial agents detection when coupled with Gram
stain analysis. The Uro-4 AST showed an high level agreement with
the reference method when the test was conducted on mono microbial
samples. Further investigations are pending for polimicrobial samples.
R2221 Comparison of MacConkey agar with ceftazidime and
CAURI agar for isolation of strains with extended-spectrum
b-lactamases
I. Sˇtrumbelj, Z. Horvat Sˇardi, M. Maucec Ivanic, D. Sabotin (Murska
Sobota, SI)
Objectives: MacConkey agar with ceftazidime (CMAC) was used in
several published studies for isolation of strains with extended-spectrum
b-lactamases (ESBL) from faeces. We formulated new agar for the same
purpose: CAURI. Objective of the study was to compare both agars.
Methods: Media: CMAC agar was MacConkey agar (Biokar) with
ceftazidime (1mg/L); CAURI agar was Uriselect 4® agar (Biorad) with
ceftazidime (1mg/L) and ampicillin (10mg/L). Specimens: during an
ESBL outbreak we screened 39 specimens from patients for presence
of ESBL strains in faeces. Each faeces was inoculated on CMAC and
CAURI agar. Isolates were identiﬁed by standard methods, presence of
ESBL was determined by CLSI method (cefotaxime and ceftazidime
disks with and without clavulanic acid). Sensitivity of each agar was
determined by dividing number of ESBL isolates on each agar with
number of ESBL isolates on any agar. Sensitivities of CMAC and CAURI
were compared (chi-square test, statistical signiﬁcance: p< 0.05).
Results: Twenty ESBL isolates were isolated from 14 specimens;
two different ESBL species from one specimen were isolated from
6 specimens. Identiﬁcation of ESBL isolates: 12 Escherichia coli,
7 Klebsiella pneumoniae, and 1 Klebsiella oxytoca. Number of ESBL
isolates on CMAC: 17 out of 20 (sensitivity 0.85). Number of ESBL
isolates on CAURI: 19 out of 20 (sensitivity 0.95). Difference in
sensitivity was not signiﬁcant (p = 0.3).
Conclusion: Compared to CMAC, sensitivity of CAURI was not
statistically different, but only twenty isolates in speciﬁc epidemiological
circumstances were studied. Further studies are necessary to determine
possible role of CAURI in detection of ESBL carriers in faeces.
R2222 Serologic diagnosis of human brucellosis using Wright,
Rose Bengal, Brucellacapt and Elisa tests in a nonendemic
area in Greece
G. Vrioni, S. Kouvardas, A. Pagarliota, N. Charalampaki, A. Tarpatzi,
L. Zerva (Athens, GR)
Brucellosis is a widespread zoonosis of great public health impor-
tance and economic signiﬁcance, especially in countries around the
Mediterranean basin. Because clinical ﬁndings are usually non-speciﬁc
and blood cultures’ sensitivity is low depending on the disease stage,
diagnosis is principally based on speciﬁc antibodies detection. The
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aim of this study was to compare the results of Rose Bengal test
(RB), Wright seroagglutination test, an immunocapture-agglutination
test (Brucellacapt) and an enzyme-linked immunosorbent assay IgG and
IgM against smooth lipopolysaccharide from Brucella melitensis 16M
in patients with suspected brucellosis. A total of 606 patients were
examined by RB and Wright tests in the General University Hospital
“Attikon” (which serves the west area of Attiki with a population of
600,000) from February 2004 to November 2006. Thirty-two of them
had positive RB and/or Wright tests (5.3%). Brucellacapt and Elisa tests
were performed in 19 out of 32 patients. All patient sera were positive in
the Brucellacapt test, while 8 sera had negative either RB or Wright test
results. Fourteen patients (11/19, 57.6%) had a Brucellacapt titer >1/640,
while only 3 patients had a Wright test titer >1/640 (3/19, 15.8%). No
prozone phenomenon was observed in the samples. As regard Elisa test
results, 14 patients had positive IgG antibodies and 6 IgM antibodies.
So, in our territory with low endemicity of human brucellosis, RB and
Wright tests were still efﬁcient methods for serological diagnosis of the
disease, while Brucellacapt test was appeared to be an effective method,
increasing the chance of brucellosis diagnosis.
R2223 Comparative study of the instrument robustness of
automated blood culture devices: BD BacTecTM versus
bioMe´rieux BacT/AlertTM
D. Heyneman, C. Van der Linden (Antwerp, BE)
Instrument robustness of the Becton Dickinson (Sparks, MD)
BACTECTM and the bioMe´rieux (Durham, NC) BacT/AlertTM auto-
mated blood culture devices was assessed by interviewing 278 laboratory
managers and senior lab technicians in 5 European countries over a
period of less than one month. The main question was “When was
the last time you had to call the company for a repair or technical
problem (not including normal maintenance)”. 101 or 36.3% of the
interviewees reported at least one technical intervention since the year of
installation of their device. Speciﬁc attention was paid to comparability
of the test population for both systems. Based on these data it can
be concluded that the BacT/AlertTM device requires signiﬁcantly more
interventions than the BD BACTECTM device. Also the time since last
call to the supplier for a technical intervention was signiﬁcantly shorter
for the BacT/AlertTM device than for the BACTECTM device. When
intervention was needed the BacT/AlertTM device was “completely
down” just as much times as the BACTECTM device. The most common
problems with automated blood culture devices are hardware related.
However, these problems have little impact on patient care because of
the availability of back-up and data-retrieval systems.
Methods for antibacterial susceptibility
testing
R2224 Are susceptibility testing results for clindamycin from
microdilution automated systems reliable for therapeutic
decisions?
M. Trevin˜o, L. Moldes, C. Garcia-Riestra, M. Go´mez-Rial, M. Jorge,
B. Regueiro (Santiago de Compostela, ES)
Objectives: Clindamycin has long been an option for treating
both, methicillin-susceptible (MSSA) and methicillin-resistant (MRSA)
S. aureus infections, particlularly skin and soft tissue infections.
Missidentiﬁcation of inducible MLSB resistance may lead to clinical
failure of clindamycin therapy. We studied the prevalence of MLSBi in
community- and hospital-associated S. aureus isolates, including MRSA
and MSSA, at our institution.
Methods: We prospectively collected sequential nonduplicate S. aureus
isolates exhibiting erythromycin resistance and clidamycin susceptibility,
as determined by broth microdilution using an autommated system
(VITEK System, boiMe´rieux, France) from April to November 2006.
Testing for MLSBi was accomplished by the agar diffusion (D test)
method in accordance with the recommendations of the Clinical and
Laboratory Standards Institute (CLSI).
Results: Among 63 S. aureus isolates, the overall prevalence of MLSBi
was 77.8%, with 75% of MRSA and % 78 of MSSA isolates exhibiting
MLSBi. CA-MRSA was not found. Prevalence of MLSBi hospital
associated MRSA was 83.3%. CA-MSSA has a lower prevalence of
MLSBi than hospital associated MSSA (72.4% versus 83.3%).
Conclusions: Susceptibility results for clindamycin using methods that
do not detect induced resistance are not reliable in order to avoid clinical
failures in patient who receive clindamycin for S. aureus infections with
MLSBi.
Public health and community-acquired
infections
R2225 Cost analysis on common cold adult patients treated by
private general practitioners in Sri Serdang, Malaysia in
April 2005
Z. Sekawi, M. Osman, M.H. Juni (Serdang, MY)
Background: Though common cold mortality is not of great concern,
its morbidity is enormous in terms of economic loss due to missed days
from school and work. $40 billion was spent on its treatment and lost
of work hours yearly in the USA. In Malaysia, the quantum cost of
common cold is not known.
Objective: To estimate the average cost of its treatment in a locality and
eventually, postulate the total cost in Malaysia.
Methods: This was a clinic-based, cross-sectional study. Data was
obtained through face-to-face interview at four private general prac-
titioner clinics in Sri Serdang, Selangor in April 2005. The clinics
and patients were selected by using convenient sampling method and
universal sampling method respectively.
Results: A total number of 222 adult patients were recruited.
Majority (48.6%) are in the 20−29 years old age group. Male slightly
predominated female (52.3% and 47.7% respectively). The Malay
ethnic group accounted for the highest number of respondents (81.5%).
Majority had tertiary education (51.0%) and within income range of
RM1,000.00–2,000.00 (US$260–520) (45%). The incidence of adult
patients who were treated with common cold at private clinics in Sri
Serdang is 4.92%. The average direct cost per patient was estimated to be
RM39.82 (US$10.48). The average total cost per patient was RM116.39
(US$30.63) per consultation. Based on information from the Ministry
of Health Malaysia, the total cost for common cold among adults in
Malaysia was estimated about RM250,921,809.40 (US$66,032,055.10)
a year.
Conclusion: This study indicates that the economic impact of common
cold in Malaysia is also huge albeit done in a small scale. This study
provides a preliminary estimate and hence, future research is needed to
obtain a more precise economic burden of common cold in the country.
R2226 Microorganisms prevalence in urethritis in primary
attendance
M.A. Orellana, M. Aramendi, G. Galera, M.T. Sanchez, T. Fernandez,
L. Bustillo, C. Caballero, M.A. Amerigo (Madrid, ES)
Objective: Urethritis is the most frequent sexually transmitted disease
symdrom. The aim of this study is to know the prevalence and tendency
of microorganisms producing urethritis in primary attendance.
Methods: Cross-sectional study. It is studied the urethral exudate of 1371
patients, 1248 men and 123 women, for 3 years (January 2003–December
2005). The samples were studied for: GRAM stain, culture in habitual
plates, Chlamydia trachomatis detection by inmunocromatography
method CHLAMY-CHECK-1 (GRIFOLS) and U. urealyticum and
M. hominis by Mycoplasma IST2 method (bioMe´rieux).
Results: The percentage of positive samples was 36.98%. The isolated
microorganisms were: N. gonorrhoeae 6.56%, U. urealyticum 13.42%,
M. hominis 1.68%, Chlamydia trachomatis 4.45%, H. parainﬂuenzae
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1.90%, H. inﬂuenzae 1.17%, E. coli 2.19%, S. agalactiae 1.46%,
S. aureus 0.58%, Ec. faecalis 0.29%, K. pneumoniae 0.29%, S.pyogenes
0.22%, Candida sp 1.75% and other 0.73%. Two or more microorgan-
isms were isolated in 3.36%. In women, the percentage of positive
samples was 69.11% and 32.69% in men. In 2003 the percentage
of positivity was 28.03% and N. gonorrhoeae the most frequent
microorganism (5.94%). In 2004 was 40.58% and U. urealyticum the
most frequent (16.36%) and in 2005 was 41.76% being U. urealyticum
the most frequent (17.34%).
Conclusions: The isolated microorganisms with more frecuency were:
U. urealyticum, N. gonorrhoeae and Chlamydia trachomatis. The most
frequent association was U. urealyticum + M. hominis. Women had
more percentage of positive samples than men. In men, the isolated
most frequently microorganisms were: U. urealyticum, N. gonorrhoeae,
Chlamydia trachomatis, H. parainﬂuenzae and E. coli, while in women
were: U. urealyticum, M. hominis and Candida sp. The percentage of
positive samples were increasing for the years, from 28% in 2003 to
41.76% in 2005.
R2227 Coxiella burnetii seroprevalence in the rural part of Bolu,
a city located in the western Black Sea region of Turkey
O. Karabay, E. Kocoglu, G. Baysoy, S. Konyalioglu (BOLU, TR)
Objective: The aim of this study is to determine the seroprevalence of
Coxiella burnetii in the rural part of Bolu located in the western Blacksea
region of Turkey.
Materials and Methods: The city is located in the western part of
Blacksea region of Turkey with a population of 270.654. It has nine
districts in which cattle and sheep breeding and raising is a common
activity. The people who were included in the study were chosen by
proportionate stratiﬁed sampling according to the age and population
density of districts of Bolu among the people or their children who
breed or raise cattle and sheep. Blood samples were drawn from peoples
with the help of local health centres of each district. A questionnaire
was ﬁlled for each subject enrolled in the study. Blood samples were
centrifuged and serum samples were kept at –20ºC until the analysis.
C. burnetii phase II IgG antibodies were studied by using IFA test with
a commercial kit. IgG antibodies were accepted as positive in case of
titers equal to or greater than 1/64. Statistical analysis was performed by
using Epi Info Ver 6.0. This study was approved by the ethical committee
of Abant Izzet Baysal University. Informed consent was obtained from
each subject or their parents in case of children.
Results: Until now, 293 samples were obtained in this ongoing study.
According to the results, C. burnetii phase II Ig G antibody positivity
was 20.8%. For those above the age of 18 (n = 248), 59 of them (23.8%)
were tested positive whereas this rate was only 4.4% for those below the
age of 18 (P< 0.001). There was no signiﬁcant difference regarding to
Coxiella positivity between male and female (P> 0.05).
Conclusion: In this ongoing study, C. burnetii seroprevalence was found
to be 20.8% in the rural area of a city from the western part of the
Blacksea region of Turkey.
• Seroprevalence increase was found to be parallel to the age.
• It was thought that because 50% of the affected population remains
asymptomatic, the disease is not widely recognized in this region
of Turkey. However C. burnetii was found to be an important and
common infectious agent for this region.
• Although seroprevalence rates are higher Q fever was underreported
in Turkey. For this reason, physicians and local health departments
have to remember this important and prevalent infectious agent and
Q fever must be taken into consideration in patients with a suitable
clinical course.
This study was funded by the AIBU (ABU-BAP-Project No:
2005.08.03.210).
R2228 Study of the incidence of respiratory infectious diseases
after the Bam earthquake in 2004
N. Jonaidi jafari, M. Izadi (Tehran, IR)
Objectives: Disasters that result in large areas of standing water
potentially lend themselves to increased rates of vector-borne disease.
Although vector-borne disease epidemics rarely occur following natural
disasters, a theoretical risk exists if ﬂooding provides more breeding
sites and if extensive damage to homes allows increased exposure. In
this research, we report the incidence of vector-borne disease after the
Bam earthquake.
Methods: This is a descriptive follow up study. Considering that, this
study was done during a ﬁxed period (in a one month duration a week
after the earthquake from 2nd Jan. 2004 to 1st Feb. 2004). All of the
patients which refer to the healthcare centres of Bam (either Iranian or
other countries) considered and included in our project. For doing this
research we go to Bam where was stricken by earthquake and collect
data of respiratory infectious diseases such as acute respiratory infection,
suspected to measles, and tuberculosis which refer to the healthcare
centre after one week of the disaster.
Results: During the study period 6241 cases refer to clinic because of
acute respiratory tract infection and incidence of it in one month was 693
in 10000 populations (6.86% of total population). in our study only 11
cases were suspected to tuberculosis. Also there was no any conﬁrmed
case of measles and only 10 cases were suspected.
Conclusion: Cold weather, lack of appropriate shelter and heating
system and lack of appropriate housing, over crowded population in
camps were reasons for increase the incidence of respiratory infectious
diseases. There were two major reasons for low incidence of tuberculosis:
(1) sufﬁcient supervision of previous tuberculosis patients by the
healthcare centres settled in Bam. (2) It is probable that there was no
sufﬁcient time to show the clinical manifestation of tuberculosis in the
contacted people because of the short study period. Also because of the
widespread project of measles vaccination – mass vaccination against
measles and rubella (MR vaccination) has been done in Iran before
earthquake-cases of suspected measles were rare and there was no any
conﬁrmed case of measles.
R2229 Human brucellosis as an emerging disease in Korea
C-S. Lee, B-K. Baek, C-W. Lim (JeonJu, KR)
Objectives: In order to characterise the incidence of humans brucellosis,
which is a serious emerging public health and socio-economic problem
in Korea.
Methods: Blood samples (n = 87) were collected from 73 individuals
with a history of exposure to bovine brucellosis, and from 14
healthy individuals with no history of contact with infected cattle.
All samples which were collected from the provinces of Chungnam
and Chonbuk, categories as farmers and their family members
(n = 34), practicing veterinarians (n = 18), assistants in the Veterinary
Service Laboratory (n = 8), Livestock Health Control Association (n = 3),
artiﬁcial inseminators (n = 3), livestock traders (n = 7) and others (n = 14).
Clinical cases included 17 individuals who had been on antibiotic
treatment for 6 weeks. The sera were isolated and screened for Brucella
reactivity using the ELISA, the Standard Agglutination Test (SAT),
2-Mercaptoethanol Agglutination Test (2-ME), and Western blot (WB).
Result: Based on ELISA (n = 87), 16.09% of the suspected cases
were positive (n = 14), 5.74%, equivocal (n = 5) and the remaining 54
samples (OD: 0.2196–0.154, Student’s t = 9.8376 <0.0001) were negative
(78.16%). Of the individuals on antibiotic treatment (n = 20), 47.05%
(n = 8) remained serologically positive, 17.6% (n = 3) were equivocal, and
the remaining 35.2% (n = 6) were serologically negative for brucellosis.
The highest risk group included farmers and their families, assistants in
Veterinary Service Laboratory and practicing veterinarians, they were
29.4%, 25% and 11.1% positive, respectively. All the other serum
samples were negative. ELISA results 100% sensitivity with the cut
off 1:160 in SAT (n = 22) and 2-ME (n = 22) and speciﬁcity 76.65%
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and 75.56%, respectively. WB using extracts of Brucella abortus 2308
as the target antigen revealed serum antibodies that recognized several
speciﬁc bands (16, 26 & 37 kDa) in clinically proven cases only. Serum
from individuals that had successful chemotherapy for brucellosis gave
negative WB results and was similar to those among healthy uninfected
persons.
Conclusion: This is the ﬁrst time that a comparison of these serological
tests has been applied to the diagnosis of brucellosis in Korean persons.
Since serology generally indicates evidence of exposure, deﬁnitive
diagnosis requires isolation of Brucella organisms and/or demonstration
of speciﬁc Brucella DNA.
R2230 Chlamydophila pneumoniae antibodies in Greek patients
with neurological disorders
M. Pape, K. Mandraveli, M. Paschalidou, M. Gelagoti, N. Taskos,
S. Alexiou-Daniel (Thessaloniki, GR)
Objective: Chlamydophila pneumoniae (CP), an intra-cellular parasite,
has been implicated in the pathogenesis of a variety of neurological
disorders, including atherosclerosis, Alzheimer’s disease, optic neuritis
(ON), Guillain-Barre (GB) and multiple sclerosis (MS). The correlation
of CP with pathogenesis and course of neurological diseases has been
studied, but has so far yielded controversial results.
The aim of our study was to investigate a possible relationship between
CP infection and neurological disorders in Northern Greek patients.
Methods: Cerebrospinal ﬂuid (CSF) and paired blood samples (S) taken
in the acute and the convalescent phase were available from a total
of 60 neurological patients (19 males, 31 females). 24 patients had a
diagnosis of clinically deﬁnite MS, 6 had (ON), 11 had (GB) and 19 had
other neurological disorders (OND). Blood specimens and cerebrospinal
ﬂuid were tested for the presence of IgG/IgM antibodies against CP
using the IFA and the ELISA assay. All the sera were also tested
for Coxiella burnetii, Rickettsia typhi, Rickettsia conorii, Bartonella
henselae/quintana, Cytomegalovirus, Epstein Barr virus, Respiratory
syncytial virus, Mycoplasma pneumoniae and Legionella pneumophila
to exclude cross reactions. We also determine the seroprevalence of CP
among 60 healthy individuals (control group, 30 men-30 women).
Results: CSF samples were all negative for CP IgG and IgM antibodies.
Of the 60 patients, 29 (48%) were seropositive for CP IgG antibodies,
having the following diagnoses: MS 15 (25%), ON 3 (5%), GB 7 (12%),
OND 3 (5%). Titers 1/64, 1/128, 1/256 were found in 58% (17/29),
28% (8/29), 14% (4/29) respectively. Serological diagnosis of acute CP
infection was conﬁrmed by seroconversion only in two GB cases. The
seropositivity in the healthy population was 55%.
Conclusions: No signiﬁcant difference was found in the serology among
neurological patients and healthy individuals. CP IgG antibodies were
found positive in patients belonging to all groups. This excludes a
direct aetiologic relationship between a certain neurological disorder
and CP infection. It is possible that a persistent CP infection may
play a signiﬁcant role in the development of the disease by inducing
autoimmune reactions.
A surprisingly high rate of CP IgG antibodies was found among patients
with ON. Considering that ON may develop to MS, this ﬁnding needs
to be further investigated.
R2231 Surveillance of bacterial pathogens including Listeria
monocytogenes associated with acute diarrhoeal disease in
the Tyrol
I. Heller, K. Grif, M.P. Dierich, R. Wu¨rzner (Innsbruck, AT)
Objectives: An epidemiological survey of acute diarrhoea was
conducted in the Tyrol to determine the prevalence of bacterial
enteropathogens including Listeria monocytogenes.
Methods: From December 2004 to November 2006, more than 1000
stool samples from patients with gastroenteritis were arbitrarily collected
and examined for the presence of Salmonella, Shigella, Campylobacter,
Yersinia and Listeria spp.
Results: A bacterial pathogen was detected in 24% of all samples, the
most commonly identiﬁed agents were Campylobacter spp. (12%) and
Salmonella (11%). In two samples Yersinia enterocolitica was detected.
Nine Listeria isolates were recovered, 3 were L. monocytogenes, 5 were
L. innocua and 1 was L. grayi.
Conclusion: Campylobacter and Salmonella spp. were the most
frequently isolated bacterial pathogens, whereas sporadic gastroenteritis
due to L. monocytogenes appears to be an uncommon illness in the Tyrol.
R2232 Patient demand for antibiotic prescription. An often-
neglected cause of antibiotic resistance in the community
A. Alevizos, D. Perimeni, G. Larios, C. Mihas, D. Fanou,
M. Papathanasiou, K. Trifynopoulou, K. Stamatiou, K. Kintzoglanakis,
A. Mariolis (Athens, GR)
Background: A small, yet important number of patients are inadequately
prescribed antibiotic treatment for viral upper respiratory tract infections
(VURTIs). General Practitoners (GPs) are one of the main sources
of such antibiotic prescriptions. Insistent patient demand has been
associated with such antibiotic prescriptions. In the present study we
tried to estimate the impact of patients’ demand on physicians’ decisions
in an urban primary healthcare centre in Athens, Greece, a country
which currently presents one of the worst antibiotic resistance patterns
in Europe.
Methods: The material of our study consisted of 21 GPs of the Health
Centre of Vyronas, who were asked to document their rationale for
prescribing antibiotics in patients with VURTI, as recorded to the ofﬁcial
registry of the Health Centre in a 6-month period, from October 2005
to March 2006, with the typical seasonal peaks in viral respiratory tract
infections. The physicians were asked to state the medical reasons as well
as the patient demand-related reasons that inﬂuenced them the most in
making their decisions.
Results: 58 prescriptions of antibiotics in patients with VURTI were
found in our registries. 27 out of 58 (46.5%) of prescriptions were
documented as necessary by the health status or by other various
concomitant medical conditions of the patients (COPD exacerbations,
asthma, diabetes, immunosuppression, etc.). According to the physicians’
responses, from the remaining 31 prescriptions, 12 (38.7%) were made
because of diagnostic uncertainty reasons, while the remaining 19
(61.3%) were actually prescribed because of persistent patient demand.
Interestingly, most of the physicians stated that a far greater number
of patients with VURTI examined during the same period were not
prescribed antibiotic treatment despite their insistent demand.
Conclusion: Patient demand, although not being the most important
factor, greatly inﬂuences physicians and has a signiﬁcant effect on
antibiotic prescribing for VURTIs. Adequate practice guidelines and
intervention strategies from health policy makers aiming to ameliorate
antibiotic prescribing patterns in primary healthcare have to take such
effect into consideration in order to effectively decrease the expansion
of antibiotic resistance in the community.
R2233 Evaluation of continuous ambulatory peritoneal
dialysis-related peritonitis attacks in Ankara
R. Ozturk, C. Bulut, G.R. Yilmaz, H. Parpucu, H. Irmak, S. Kinikli,
M. Duranay, A.P. Demiroz (Ankara, TR)
Objectives: Peritonitis is a serious and potentially life-threatening
complication of continuous ambulatory peritoneal dialysis (CAPD).
The aims of this study were to assess demographic aspects, rates
of peritonitis, causative organisms, clinical outcomes and treatment
approach for continuous ambulatory peritoneal dialysis (CAPD)-related
peritonitis cases.
Methods: All peritonitis cases treated in Infectious Diseases and Clinical
Microbiology Department between February 2006 and June 2006 were
enrolled into this study. The patients with cloudiness of the peritoneal
dialysis ﬂuid and/or abdominal pain and with more than 100 white blood
cells/mL in their dialysate ﬂuid were accepted as having peritonitis. Gram
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stain, and cultures, complete blood count, serum procalcitonin (PCT) and
C-reactive protein (CRP) levels were obtained. Conventional methods
were used for identiﬁcation of microorganism. Disc diffusion method
was used for antimicrobial susceptibility tests.
Results: Fifty-six episodes of peritonitis occurred in 50 patients. The
mean age of the patients was 48.4 years (range: 18−83 years). The overall
incidence of peritonitis was 1.6 episodes/patient-year. In 42% of patients,
there was only one peritonitis attack; whereas 58% of them had two or
more attacks. The most common presenting symptoms of the patients
were abdominal pain, cloudiness of the peritoneal dialysate ﬂuid, nausea
and vomiting. The median white blood cell count of peritoneal dialysate
ﬂuid was 1275/mL (range: 170–7900/mL) in 56 episodes. Cultures
were positive in 40 (71.4%) peritonitis episodes; coagulase-negative
Staphylococcus was the most common organism (20.7%), followed by
Staphylococcus aureus (4%). In all of the episodes, the empirical therapy
administered to the patients was intraperitoneal cefazolin and gentamicin.
Antibiotherapies of 18 patients were changed according to antimicrobial
susceptibility test results. Two culture negative patients did not respond
to initial therapy and the therapy was switched to an empirical therapy
with a glycopeptide antibiotic.
Conclusion: Despite all technical improvements during recent decades,
peritonitis is still the major reason for CAPD failure. For the
accurate treatment of peritonitis attacks, causative organisms and their
antimicrobial susceptibilities must be known.
R2234 Clinical features of acute Q fever in a southern area of Spain
J.D. Ruı´z, J. De La Torre, J.L. Prada, A. Del Arco, M.D. Martin,
L. Merida, I. Escot, J. Garcı´a-Alegrı´a (Marbella, ES)
Objectives: The aim was to describe the clinical features and outcome
of inpatients suffering from acute Q fever (AQF) in an area in the south
of Spain.
Methods: Retrospective analysis of clinical and epidemiological data
from patients suffering from AQF admitted at Costa del Sol Hospital
(Marbella, Malaga), between 1997 and 2005. Diagnosis of AQF
was based on detection of antibodies against phase II by indirect
inmunoﬂuorescence test (IFA).
Results: 23 cases were admitted. There was a signiﬁcantly higher
sex ratio of males to females (11.5:1). Mean age was 45.6+13.5
years (range 25 to 77 years). Professional risk factors were found
in 13% and 21.7% came from rural background. AQF was slight
commoner in spring (34.8%). Regarding to clinical features: 91% had
only fever (mean duration: 11.3 + 5.5 days), malaise (56.5%), severe
headache (34.8%), diarrhoea (34.8%), abdominal pain (21.5%), cough
(21.7%), arthralgia/myalgia (19%) and hepatomegaly (43.5%). About
lab-data AST/ALT were elevated in 47.8%, an elevated erythrocyte
sedimentation rate in 34.7% and trhombocytopenia (17.3%). Chest X-
ray were anormal in 17.4%. Clinical features was isolated fever (39.1%),
hepatitis (43.5%), pneumonia (8.7%), hepatitis plus pneumonia (4.3%)
and pericarditis (4.3%). A patient had a pulmonary thromboembolism
related with positive anticardiolipin antibodies. Doxycicline was used in
87%, doxycycline with quinolone in 17.2%. Antibiotherapy mean time
was 19.2 + 5.2 days. Two patients had a relapse. All patients were totally
recovered within one year. The mean hospital stay was 9.6 + 4.7 days.
Conclusions: AQF was more frequent in male and more cases were
diagnosed in spring. In our study AQF clinical presentation was
principally only fever and hepatic involvement. The small number of
pneumonia cases suggest a C. burnetii strains or an infection way
different to other geographic areas.
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R2235 Study of infectivity of Crimean-Congo haemorrhagic fever
cases in Sistan va Baluchestan province of Iran, 2003–2004
K. Holakouie Naieni, S. Izadi, M. Salehi, S. Chinikar (Tehran,
Zahedan, IR)
Objectives: To determine the infectivity of Crimean-Congo haem-
orrhagic fever (CCHF) Virus in usual and routine contacts with
serologically conﬁrmed cases.
Methods: A cross sectional study was performed during the year 2004
in Zabol and Zahedan districts of Sistan-va-Baluchestan province of Iran.
During study serum sample of 57 ﬁrst or second degree relatives of 8
ELISA conﬁrmed CCHF cases, were tested and all probable routs of
transmission (touch, contact with blood, sexual contact, having meal,
room mate, home mate with index cases) and also contacts with known
risk factors were questioned and recoded during an interview with all
participants. All ELISA tests were performed in Pasture Institute of Iran.
Results: Of all 57 people, only one was serologically IgG positive. The
descriptive characteristics of the studied people shows high frequency of
contact with known risk factors of the disease.
Conclusion: With regard to date of sampling and type of antibody in
the serum of the seropositive subject, it is obvious that there is no
relationship between infection in this person and the index case in his
family. And generally it seems that the infectivity of this virus in usual
routine contacts with infected subjects is low.
R2236 First fatal infection due to c-MRSA in Austria
M. Hell, F. Wimmer, R. Lenzhofer, G. Pauser, A. Zimmermann,
H. Mittermayer (Salzburg, Schwarzach, Linz, AT)
Objectives: Community aquired MRSA (c-MRSA) infections are
registered since the year 2002 in Austria. In our region in the middle
of Austria (county of Salzburg) c-MRSA is investigated for its PVL-
positivity systematically since 2004. The typing is done in a reference
laboratory in Linz.
We report the ﬁrst fatal infection due to an PVL-positive MRSA in a
34-year old woman in Austria from our region in 2005. Returning from
a home holiday from the Philippines she developed high fever being
pregnant 2 weeks before delivery. A cesarian section was performed in
the local hospital. The patient developed a foudroyant pneumonia and
for that reason was transferred to the next teaching hospital.
After 10 days intensive care treating pneumonia was still progredient
and therefore she was transferred to the university hospital Salzburg.
Antimicrobial therapy was switched from Amoxi/clavulanic acid to
Linezolid + Imipenem + Clarythromycin. Pneumonia was accompanied
by abscess formation in the lung under this regimen. After another day
of treatment she died unfortunatly due to a septic shock and multi-organ
failure.
Methods: Routine samples were taken from the tracheal secretions
during intensive care treatment. MRSA was found in the ﬁrst samples and
also viral investigations were done. The MRSA isolate was investigated
for PVL (Panton-Valentine Leukocidin) and subtyping was performed.
Results: Lung abscesses and necrotising pneumonia were due to
a superinfection with a PVL-positive MRSA-ST30-subtype 2 (south
westpaciﬁc clone). Underlying disease was caused by a inﬂuenza A
infection. During hospitalisation in all 3 hospitals no transmission of
this MRSA was obvious.
Conclusion: This was the ﬁrst time in our country such a severe infection
due to PVL-positive MRSA was seen. Severe community acquired
pneumonia has to be redeﬁned in its therapeutic strategies including
now also multiresistant organsisms such as c-MRSA.
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R2237 Periorbital cellulitis: two-year review of eleven hospitalised
patients
S.S. Gundes, S.S. Cetin Akhan (Kocaeli, TR)
Background: Bacterial periorbital cellulitis (BPC) is an uncommon
infection associated with severe complications. The aim of this study
was to analyse medical outcomes, including risks for complications and
mortality, in eleven patients hospitalised for BPC.
Methods: A chart review of all patients admitted to Infectious Diseases
Department with the diagnosis of PBC for the period Jan 2005 to Nov
2006 were done.
Results: diagnosis was made clinically with radiological conﬁrmation.
The mean age was 39.1 years with female predominance (8/11). Two
of the patients hospitalised at least three times for the last year. The
infection was documented microbiologically in ﬁve (45.4%) cases.
Staphylococcus aureus (four cases) and Streptococcus pyogenes (one
cases) were the causative pathogens. None of the blood cultures were
positive. The mean CRP volue was 11mg/dl, sedimantation rate was
54/h. Overall, two patients discharged early (4 days) and nine patients
were hospitalised for more than 4 days. Only one patient died. Four of
the patients required surgical drainage. When comparing the two study
groups (patients discharged early without complications and patients
developed complications or died), low risk group were less likely to have
multiple comorbid conditions. Factors associated with bad prognosis
were male sex, presence of neutropenia (four cases), chronic leukaemia
(three cases), diabetes (three cases), obesity and renal insufﬁciency.
Treatment was either by iv b-lactam/b-lactamases alone or with surgery
to drain abscesses.
Conclusion: BPC occurs in any age goup with female predominance.
In most of the patients, there is an underlying comorbidity. Prompt
diagnosis and treatment can decrease the known signiﬁcant morbidity
rates. Bad prognostic ﬁndinds can be usefull in stratifying the admitted
patients and deciding the most appropriate means of care including
antibacterial treatment, debridement and hospitalisation.
R2238 Seroprevalence of Crimean-Congo haemorrhagic fever
virus in humans at risk group in an endemic area
Z. Ozkurt, N. Yilmaz, M. Ertek, A. Ertu¨rk, A. Aydemir, S. Toprak,
S. Kara (Erzurum, Ankara, TR)
Objectives: Recently, Crimean-Congo haemorrhagic fever (CCHF) has
been seen in some geographic area in Turkey. A seroepidemiological
survey was carried out to determine the prevalence of CCHF virus
activity in humans at risk group at an endemic area during 2004.
Methods: Sera samples were obtained from a total of 250 people consist
of 114 farmers, 80 healthcare workers, 44 slaughterhouse workers and
12 veterinarians. CCHF virus immunoglobulin G (IgG) antibody was
investigated by ELISA technique.
Results: Anti-CCHFV IgG was found in 19 of 114 (16.6%) farmers,
16 of 80 (20%) healthcare workers, 6 of 44 (13.6%) slaughterhouse
workers, 3 of 12 (25%) veterinarians. In healthcare workers anti-CCHFV
antibodies were detected in 7/20 (35.0%) nurses, 5/35 (14.2%) laboratory
technicians and 3/25 (12%) physicians.
Conclusion: These data showed that humans may have been inapparent
CCHF infection when they exposure the virus. Persons at risk group
should be trained, and contact precautions should be strictly applied for
prevention of the disease.
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R2239 Study of urinary tract infection in diabetic and non-diabetic
patients and antibiotic sensitivity pattern of isolated
organisms
H. Alimohammadi asl, N. Fouladi (Ardebil, IR)
Objectives: The main objective of this study was to determine whether
there are any differences in the bacteriological pattern of UTI and
the antibiotic sensitivity patterns of the pathogens concerned between
diabetic and nondiabetic patients.
Methods: Over a period of one year, a total of 1510 patients suspected
to have urinary tract infections (UTI) were studied.
Results: of the test patients 452 of them were diabetics. 102 (22.5%)
of 452 diabetic patients had UTIs from which 72 patients (70.5%) were
female. In non diabetic group (control group) 120 patients were selected
out of 1058 non diabetic patients as having UTI. Regarding age and sex
of the patients on diabetic and nondiabetic patients meaningful statistical
difference, were found. the infections in both groups were further divided
into community acquired and nosocomial acquired UTI in non diabetic
patients (73.3%), this organism was isolated in 43.6% of the community
acquired UTI in diabetic patients and this ﬁnding indicates a meaningful
statistical difference in two groups.
The organisms isolated from nosocomial UTI in diabetics showed a
signiﬁcantly greater preponderance of klebsiella spp. (41%) as compared
to non diabetics (29%) which statistically is a meaningful difference.
Most of the UTI in diabetics, especially in female, were asymptomatic.
In 31 E. coli strains isolated from diabetic and non diabetic patients
type 1 ﬁmberia also investigated, which in diabetic patients 43.7%
of the isolated strains showed this type of ﬁlmberia as compared to
E. coli strains isolated from non diabetic patients (73.3%) indicating a
meaningful difference.
Antibiotic sensitivity patterns of the isolated strains were determined
using some of the routine antibiotics used in UTI treatment, some of
third generation cephalosporins and quinolones, but the results showed
no statistical differences. Although when WBC conuts in 1mm3 of the
infected test urines were compared in diabetic and nondiabetic patients,
the sensitivity of the test recorded as 58.3% and 92%, respectively,
but the sensitivity of nitrate reduction test in the both groups was not
statistically signiﬁcant.
Conclusions: Most of the UTI in diabetics, especially in female, were
asymptomatic. sensitivity and bacteriological patterns between diabetic
patients and control group were different. Routine urine culture can
be recommended for diabetic women even when there is no urinary
symptom.
R2240 Study of epidemiological determinants of occupational
exposure to HIV, HBV, HCV in healthcare workers in Iran
A. Hadadi, S. Afhami, M. Karbakhsh, N. Esmailpour (Tehran, IR)
Introduction: Healthcare workers (HCWs) are at substantial risk of
acquiring blood borne infections through contact with blood and
other products of patients. Our main objectives were to determinant
epidemiological characterists of occupational exposure to blood/body
ﬂuids and its related risk factors.
Methods: This cross sectional study was conducted on healthcare
workers at risk of exposure to blood and other body ﬂuids in three
hospitals of Tehran University of Medical Sciences. Using a structured
interview, all selected HCWs who were at risk were questioned about
the exposure to blood born pathogens in the preceding year (Dec 2003–
Dec 2004).
Results: Of the 900 HCWs, 391 (43.4%) had at least one occupational
exposure to blood and other infected ﬂuids during the previous year,
with the total number of 467 exposures (52.88%) with annual rate
of 0.5 exposure per HCW. The highest rate of occupational exposure
was found among nurses (26.1%) and housekeeping staff (20.2%) and
occurred most commonly in the medical and emergency wards (23.3%,
21% respectively). The rate of exposure in HCWs with less than 5 year
experience was 53.8%.
Percutaneous injury was reported in 280 participants (58.8%). History
of hepatitis B vaccination was positive in 85.93% of HCW among
exposed workers. Sixty one percent had used gloves at exposure time.
Hand washing was reported in 91.38% and infectious diseases specialist
consultation in 29.38%. There were 72 exposures to HIV, HBV, HCV
and exposure to HBV was the most common and in 237 of enrolled
cases source was unknown.
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Conclusion: Sharp injuries among HCWs are a widespread occupational
problem. In this study, job categories, work experience and hospital
ward were the most important risks for exposure. An effective and
goal oriented education programme targeting HCWS, use of protective
barriers, vaccination against hepatitis B are important way to prevent
viral transmission among HCWs.
R2241 Preventing healthcare-associated infections: the experience
of a 3-year educational programme in the nursing homes
of Trentino
I. Caola, P. Dallape`, L. Scartezzini, G. Noro, A. Calı`, M. Giordani,
E. Negri (Trento, IT)
Objectives: To prevent healthcare-associated infections in nursing
homes (NH) of Trento province, Italy, and to reduce the infection risk
in the healthcare network.
Methods: In 2004 a three years long programme for education and
training of nurses and physicians, co-ordinated by the public institution
UPIPA, started. In the ﬁrst year a residential educational programme
was carried out on healthcare workers (HCW) related infections,
universal precautions, bacterial antimicrobial resistance, management of
microbiological samples. In the second year an inquiry form was sent
to all nursing homes to survey data on residents, invasive procedures,
required microbiological tests, criteria used for deﬁning infections.
On the basis of collected data, the project “Management of urinary
catheterisation: procedures auditing for improvement in quality of care”
was planned in the third year.
Results: 108 nurses and physicians attended to the residential
educational programme in the ﬁrst year. In 2005, 53.3% of nursing homes
returned data on 61.5% of institutionalised population (2486/4040):
2/3 female, 82% over 75 years, 5.8% bedfast. In a prevalence
survey, 751 invasive procedures were reported with a 25% of urinary
catheterisation (UC). Since UC represents the most frequent invasive
procedure with infective risk in NH, an educational project, with
residential and “on job” training, was planned for 2006 to improve
catheter management. 14 NH (31%) and 56 HCW were involved.
The problem of urinary tract infection in the elderly and infection
deﬁnitions for the surveillance in NH were elucidated in residential
educational session. Five multiprofessional working groups developed
local practice guidelines for catheter management that incorporated
evidence-based advices for preventing infections in clinical activities.
After the supervision of the tutors (external infection control nurses)
the guidelines were applied. Two prevalence studies on urinary tract
infections were carried out (before and after six months from protocol
application). Data are on evaluation.
Conclusion: The incidence of preventable healthcare-associated in-
fections is strictly associated with speciﬁc education of HCW. The
effectiveness of an interventional programme improves when HCW are
directly involved in their educational process. The adopted strategy for
the development, application and revision of guidelines by HCW promise
to be effective in modifying professional behaviours and reducing
infection risk.
R2242 Effects of education on the importance of blood cultures
by an infection control team: experience in two community
hospitals, Kyoto, Japan
T. Saito, Y. Aoki, A. Matsuoka, Y. Iinuma, S. Takakura, N. Fujiwara,
F. Kohi, M. Noguchi, S. Ichiyama (Kyoto, Takamatsu, JP)
Objectives: Blood culture is the only method for detecting bloodstream
infections. Infection control team at each hospital grasped through ward
round that blood culture examinations were not carried out sufﬁciently.
The infection control team of each hospital educated medical staff about
the importance of blood culture examinations.
Patients and Methods: This study was conducted from January
2003 to December 2003 at A hospital (179 beds) and from October
2003 to September 2005 at B hospital (500 beds). Each hospital was
acute-phase community hospital. The yields of microorganisms and the
characteristics of patients with clinical signiﬁcant bacteraemia and/or
fungaemia were compared for pre-education (January to June, 2003 at
A hospital and October 2003 to September 2004 at B hospital) and post-
education periods (July to December, 2003 at A hospital and October
2004 to September 2005 at B hospital).
Results: During the pre-education period, 193 blood cultures were taken
from 111 patients, compared to 467 blood cultures (2.4-fold increase)
from 245 patients (2.2-fold increase) during the post-education period
at A hospital. Of these, 40 positive cultures were obtained from 30
patients in the pre-intervention period, compared to 65 positive cultures
(1.8-fold increase) were obtained from 55 patients (1.7-fold increase)
in the post-intervention period. At B hospital, during the pre-education
period, 1159 blood cultures were taken from 667 patients, compared
to 2175 blood cultures (1.8-fold increase) from 1141 patients (1.7-fold
increase) during the post-education period. Among these, 139 positive
cultures were obtained from 112 patients in the pre-education period,
compared to 213 positive cultures (1.5-fold increase) were obtained from
166 patients (1.4-fold increase) in the post-education period.
Conclusion: The present study has shown that cases of bacteraemia
or fungaemia may be overlooked if blood culture examinations are not
performed. We consider that the importance of blood cultures must be
emphasized and education needs to be continued.
R2243 Occurrence of Mycoplasma hominis in amniotic ﬂuid of
pregnant women
M. Vydrzalova, P. Lyskova, J. Mazurova (Pardubice, CZ)
Background: Intrauterine infection is a major cause of preterm delivery,
perinatal morbidity and mortality of fetus. Intrauterine infection is
present in approximately 25% of all preterm births. The most common
microorganisms involved in intrauterine infections are Ureaplasma
urealyticum and Mycoplasma hominis. M. hominis is commonly isolated
microorganism from the female genital tract. This microorganism can
be found in 21% to 53% of sexually active women. The transmition
from the mother to the developing fetus can happen in uterus during the
pregnancy or during the delivery.
The relationship between detection of Mycoplasma hominis in mid-
trimester amniotic ﬂuid and subsequent pregnancy outcome was
investigated. Data collected included indication for amniocentesis,
gestational age at amniocentesis, gestational age at delivery, pregnancy
outcome and low birth weight of infants.
Method: The amniotic ﬂuids of 184 women who underwent a
transabdominal amniocentesis at weeks 15−22 of pregnancy were tested
for M. hominis by cultivation method on PPLO agar and broth with
arginine. The isolates ofM. hominis were conﬁrmed by polymerase chain
reaction.
Results: M. hominis were identiﬁed in 20 (11%) samples of the amniotic
ﬂuid. A total 8 infants had the birth weight below 2500g. Two of them
were born to mothers whose amniotic ﬂuid was positive for M. hominis.
Nine of the women delivered preterm and one of them was positive for
M. hominis.
Conclusion: The aim of this study was to investigate the occurrence
of M. hominis in amniotic ﬂuid of pregnant women. The presence of
M. hominis in amniotic ﬂuid could be associated with low birth weight of
infants which was conﬁrmed by other authors. This work was supported
by MSM 0021627502
R2244 Group G beta-haemolytic streptococci of human and
animal origin
P. Lyskova, M. Vydrzalova, T. Kroupa, J. Mazurova (Pardubice, CZ)
Background: Group G beta-haemolytic streptococci form heterogeneous
group of microorganisms. They have been recognized as the cause of
various infections, such as skin, urogenital and respiratory infections
and otitis externa, in dogs, cats and other animals. In 1935 were group
G streptococci ﬁrst isolated from human material taken from patients
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with puerperal sepsis. In humans, they may colonise pharynx, skin,
gastrointestinal and female genital tract. In recent years, they have been
reported with increasing frequency as a cause of variety of human
infections, such as endocarditis, arthritis, meningitis, pharyngitis and
sepsis. The aim of the present work is to study group G beta-haemolytic
streptococci isolated from various clinical specimens of animal (86
strains) and human (107 strains) origin.
Method: Each collected sample was cultivated on Blood agar. After
incubation (37ºC, 24 hours) colonies compatible to group G beta-
haemolytic streptococci were subjected to biochemical tests. The
susceptibility to antibiotics was determined according to the NCCLS
recommendations.
Results: All strains recovered from animals were according to their
growth, serological and biochemical properties identiﬁed as S. canis.
Out of total 107 strains of human origin, 101 were identiﬁed as
S. dysgalactiae ssp. equisimilis and 6 as S. canis. Species differed
especially in production of beta-glucuronidase (99% of S. dysgalactiae
ssp. equisimilis strains positive × 17.4% of S. canis strains positive),
alpha-galactosidase (1% of strains positive × 91.3% of strains positive)
and in trehalose fermentation (98% of strains positive× 20.7% of strains
positive). All isolated strains were susceptible to penicillin and ampicilin.
The least effective antimicrobial agent was found to be tetracycline
(20.7% susceptible strains).
Conclusion: Although group G beta-haemolytic streptococci don’t
belong among common streptococcal species, their importance should
not be underestimated. S. dysgalactiae ssp. equisimilis is associated
with 5−8% of human streptococcal infections, including serious, life-
threatening states. S. canis, important animal pathogen, may cause
similar symptoms when infecting human.
This work was supported by MSM 0021627502.
R2245 Elimination of Staphylococcus aureus nasal carriage in
healthcare workers of a burn centre: effect on incidence
of S. aureus of burn wound colonisation
A.M.D. Kooistra-Smid, M.K. Nieuwenhuis, E. Zanten van, J. Hiddingh,
G.I.J.M. Beerthuizen, W.H.M. Vogels, A. Belkum van, H.A. Verbrugh
(Groningen, Rotterdam, NL)
Objectives: Staphylococcus aureus colonisation and infection of burn
wounds increases morbidity and delays wound healing. S. aureus burn
wound colonisation may result from nasal and pharyngeal colonisation
of patients as well as healthcare workers (HCW). The aim of this study
was to evaluate the effect of eradication of nasal S. aureus in HCW with
mupirocin on the incidence of S. aureus burn wound colonisation.
Methods: HCW nasal S. aureus was eradicated with one course of
mupirocin in July 2004. From July 2003 to June 2006 patients were
extensively screened on admission for S. aureus carriage and burn
wounds were cultured weekly. S. aureus burn wound colonisation during
the year following mupirocin treatment (July 2004 to July 2005, n = 72)
was compared with two control periods, C1 (July 2003 to June 2004,
n = 54) and C2 (August 2005 to June 2006, n = 57).
Results: Forty-three (93%) HCW have received the mupirocin course.
Nasal eradication was proven successful in 13/15 (87%) of the nasal
carriers. HCW nasal carriage rate dropped from 35% to 2%, and
gradually increased from 12% after 6 months to 25% after one year.
The incidence of burn wound colonisation during admission in the year
after the mupirocin course was 27/56 (48%) and for control groups C1
and C2 12/42 (29%) and 14/44 (32%) respectively.
Conclusion: Eradication of S. aureus nasal carriage among healthcare
workers did not reduce S. aureus burn wound colonisation.
R2246 Molecular epidemiology of Gram-negative rods isolated
from neonatology ward
K. Kopron, A. Jurczak, J. Jursa-Kulesza, S. Giedrys-Kalemba (Szczecin,
PL)
Objectives: Infections in neonatology wards are becoming more
and more serious problem, not only clinical and economic but
also organisational and legal ones. They are closely related to
invasive diagnostic and therapeutic procedures as well as long-term
hospitalisation. The aim of this study was to assess the genetic similarity
of Gram-negative rods isolated from neonate intensive care unit (NICU)
and neonatology ward (NW) for a period of one year.
Methods: The analysis included all neonates (953) born between 1
January 2003 and 30 December 2003 in Clinic of Obstetrics and
Perinatology in Szczecin. Infection was found in 55 neonates – 5.77%;
2 neonates dead – 0.20%. Gram-negative rods dominated among
aetiological agents. They were isolated from different clinical materials
(blood, cerebrospinal ﬂuid, bronchoalveolar lavage, urine, faeces, and
swabs from nosopharynx, ear, anus) of infected and healthy newborns:
Klebsiella pneumoniae (29), Klebsiella oxytoca (29), Enterobacter
cloacae (17), Serratia marcenscens (12) and E. coli (7). All strains
were typing with using PFGE method and XbaI (Klebsiella), SpeI
(Enterobacter, Serratia), NotI (E. coli) restriction enzymes (Bio-Rad).
Results: The occurrence of 4 genotypes and 8 unique patterns of
K. pneumoniae, 3 genotypes (3 unique) K. oxytoca, 5 genotypes
E. cloacae, 1 genotype (1 unique) S.marcescens, and 1 genotype (5
unique) E. coli was conﬁrmed. The particular genotypes grouped from
2–12 isolates. The same genotypes were isolated in NICU and NW, from
infected newborns (mainly acquired infections but intrauterine also; the
most common clinical forms were systemic infections and pneumonias)
and from healthy individuals (colonisation) in different months of the
year.
Conclusion: The presence of strains showing apparent genetic similarity
suggests that epidemic/endemic strains of Gram-negative rods existed in
ward ecosystem and were responsible for clonal character of newborn
infections and colonisation of others. This situation provoked that strict
sanitary discipline was applied in both wards.
R2247 Adherence to surgical site infection guidelines in Italian
heart surgery units
A. Pan, L. Ambrosini, S. Lorenzotti, L. Soavi, L. Signorini on behalf
of the GIS-INFCARD investigators
Objective: data regarding adherence to surgical site infection (SSI)
prevention guidelines in Italian cardiac surgery units are lacking.
Methods: a multiple choice questionnaire, structured into 8 sections
following the Centers for Disease Control 1999 surgical site infection
(SSI) guidelines was prepared and sent to 24 units participating to a
National study group (GIS-INFCARD) Answers were stratiﬁed based
upon strength of recommendations: class IA (10 questions), class IB (52
questions), class II (11 questions).
Results: 17 of the 24 units answered to the questionnaire. The responding
centres performed in 2005 10249 surgical procedures, that represent
about 20% of all heart surgery procedure in Italy. Adherence to
class IA recommendations varied between 0 and 100%. The lowest
level of adherence was related to hair removal, that is performed
systematically in all male patients (0% adherence), contrary to guidelines
recommendations. Timing and method of hair removal were adherent to
guidelines in 29 and 41% of questionnaires, respectively. While 94%
of units had written guidelines on antibiotic prophylaxis, timing of
antibiotic administration was adequate in 65% of units only. Adherence
to class IA recommendations was 69±34%, with 5 units (29%) showing a
80% adherence. Answers to class IB recommendations were consistent
with guidelines in 29 to 100% of questions, with an average of 65±26%;
one single unit (6%) showed a 80% adherence. Adherence to class II
recommendations was 71±28%.
Conclusions: Adherence to CDC SSI guidelines in Italy is fair.
Organisational improvements, especially regarding hair removal and
timing of antibiotic prophylaxis, should be implemented in most
hospitals. Low level of adherence to timing of antibiotic prophylaxis
despite the existence of National guidelines since 2003 indicates that
new instruments to improve antibiotic prescribing need to be searched
for.
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R2248 Syphilis prevalence within a population of intravenous drug
users in Lisbon, Portugal
R. Matos, R. Neves, A. Matos, J. Santos, C. Benoliel, A. Moniz (Lisbon,
PT)
Syphilis is an infectious disease caused by the spirochete Treponema
pallidum subspecies pallidum. The prevalence of cases in the Portuguese
population is about 13 per million inhabitants (0.0013%). The main
means of transmission is the sexual contact with infected partner.
However, transmission is also frequent by contact with contaminated
body ﬂuids, such as blood, among intravenous drug users (IDUs). The
objective of this work was to evaluate the prevalence of syphilis among
intravenous drug users during the past 5 years (2002–2006).
A total of 3118 different individuals were included in this study (mean
age 35 years). These individuals were intravenous drug users who
attended two mobile drug users support stands in Lisboa (centre). The
VDRL assay was used for screening and conﬁrmations were done with
TPPA. A VDRL titer  32 dils was used to assume a recent infection
status.
The main prevalence observed in this population was 8.7% (0.7% recent
infections).
Both the positive prevalence rates and the recent infection rates have
shown a tendency to decrease during these years (positive infections:
11.1 to 8.3%; recent infections: 0.96 to 0.31%, p< 0.01).
The positive cases prevalence has been decreasing since this IDU support
programme started (2001), perhaps as a result of several disease control
policies, such as syringe exchanges programmes for example.
The recent infections prevalence, albeit it’s decrease, is 200 times higher
than the estimated for the Portuguese population 0.0013%, as expected
in this high risk population.
The control of transmissible diseases can only be overcome with the
health control of high risk populations, such as the intravenous drug
users. The syphilis situation presented is a good example that the work
being done in the IDU’s ﬁeld seems to have good results but is still
insufﬁcient for a proper disease control.
R2249 Antimicrobial resistance in strains isolated in 2005 by
Romanian National Sentinel System for Nosocomial
Infections Surveillance
I. Codita, M. Oprea, A.M. Petrescu, D. Tatu-Chitoiu, V. Ungureanu,
M. Ghita, D. Lemeni, R. Oancea, D. Brehar-Cioﬂec, A. Romaniuc
(Bucharest, Timisoara, Iasi, RO)
Objectives: to obtain microorganisms involved in nosocomial infections;
to identify them; to test their antimicrobial susceptibility in order to
create a local and national data base for better orienting antimicrobial
therapy and nosocomial infection prevention; to evaluate hospital
laboratories capacities
Methods: Nosocomial infection sentinel system surveillance was done
using the methodology recommended by the National Centre for
Prevention and Control of Communicable Diseases and involved 17
hospitals, 11 District Public Health Directorates, 4 Public Health
Institutes and the National Institute for R&D in Microbiology and
Immunology “Cantacuzino”.
Results:
1. The National Institute received via Public Health Institutes 438
strains from 10 hospitals: 161 Pseudomonas aeruginosa (Ps. ae.),
110 Enterobacteriaceae, 97 Staphylococcus spp., 54 non-fermentative
Gram negatives, 13 Enterococcus strains, 2 fungal strains and
1 anaerobic strain.
2. 10 hospitals sent 4 to 74 bacterial strains. Most laboratories did not
send but few from their isolates. Only 4 hospitals sent over 30 strains
belonging to the same species; it seems that interest of every hospital
was directed towards different, speciﬁc microorganisms.
3. 60% of Staphylococcus aureus strains (Nr. 84) showed methicilline
resistance.
4. 15.5% of Ps. ae strains were resistant to all antimicrobial substances
tested using CLSI (formerly NCCLS) M100-S15 standard.
5. ESBL were present in: 11 from 16 Enterobacter strains, 44.8% from
29 Klebsiella strains, and 21.6% from 37 Escherichia coli strains.
6. One Enterococcus faecalis strain was penicilline resistant.
Conclusions:
1. Generally, high percentages of all isolated microorganisms sent to
the national laboratory were resistant to one or more antimicrobials,
conﬁrming EARSS national data.
2. Conclusions should be locally formulated by every participant
hospital laboratory for different microorganisms
3. Laboratories isolated few number of enterococci and anaerobic
bacteria.
4. Local microbiological data should be integrally collected by the
national laboratory in order to elaborate the further study strategy.
R2250 The effectiveness of hand disinfectants in decontaminating
Candida hand carriage in volunteer healthcare workers
M. Yildirim, I. Sahin, I. Sencan, A. Kucukbayrak, S. Cakir, C. Ozaydin
(Duzce, Ankara, TR)
Objectives: The hands of healthcare workers (HCWs) are considered
to be important for colonisation and infection of Candida spp. Aim
of the study is to evaluate the effectiveness of three different types of
hand disinfectants in decontaminating candida hand carriage in volunteer
healthcare workers.
Materials and Methods: In the controlled, prospective study, eighty (50
female, 30 male) HCWs who had candida hand carriage were included
to the study and used the disinfection procedures for four weeks, in
Duzce University medical faculty hospital. Mean age of the objects
was 29.1±8.09. Study objects were divided into four groups according
to used disinfectant agents (alcohol based hand rub, 4% chlorhexidine
gluconate, 7.5% povidon-iodine, and control group who were not used
any disinfectant). HCWs who did not use the disinfectants properly were
excluded from the study. The hands of all participants were tested by
culture with the broth wash technique. Candida species were identiﬁed
by the germ-tube test, CHROMAgar Candida (CHROMAgar Company,
Paris, France), and by API-20C identiﬁcation kits (bioMe´rieux-VITEK,
France). The chi-squared test was used for statistical evaluation.
Results: In a month of follow up, candida hand carriage were decreased
to 50% (13/26) in control group; 78.9% (15/19) in alcohol based
disinfectant group; 89.5% (17/19) in 4% chlorhexidine gluconate group
and 81.3% (13/16) in 7.5% povidon-iodine group. Candida hand carriage
was decreased signiﬁcantly in 4% chlorhexidine gluconate group
(x2=7.70, p = 0.006), 7.5% povidon-iodine group (x2=4.10, p = 0.0439)
and alcohol based rub group (x2=3.91, p = 0.048) compared to control
group. There was not found any side effect (such as contact dermatitis,
allergic reactions) that caused to end the hand disinfection procedure in
HCWs.
Conclusions: Hygienic hand disinfection (especially with 4% chlorhexi-
dine gluconate) was efﬁcacious in removing candida carriage present on
the hands of HCWs. It is recommended that HCWs should perform hand
hygiene especially in units (such as intensive care units and neonatal care
units) that have high risk for candida infections.
R2251 Comparative evaluation of internists’ behaviour regarding
hand hygiene in the emergency room and in the wards of
a tertiary university hospital in Greece
E. Giannitsioti, S. Athanasia, O. Koulouri, A. Kolias, A. Papadopoulos,
H. Fitrou, H. Giamarellou (Athens, GR)
Background: This study was launched in order to compare how hand
hygiene policies inﬂuence the internists’ behaviour in the emergency
rooms and in the wards of a Department of Internal Medicine at a tertiary
hospital in Athens.
Methods: The study was conducted from May to June 2006. Behaviour
of internists in the wards and the emergency room regarding the use of
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gloves and the use of alcohol-based hand-rubs during medical procedures
was assessed by two independent observers via a standardised registry
form. Medical procedures were divided into invasive (i.e blood puncture,
catheterisations) and non-invasive (i.e. clinical examination) ones. A bed-
railed system of alcohol based hand rubs was installed in every ward.
Dispensers of hand rub antiseptic were installed on each table in the
emergency room. Statistical analysis was done by Chi-square and Fischer
exact test for categorical variables.
Results: There was no difference regarding the use of gloves among
internists in the emergency room (22/73, 30.2%) and the Department
wards (30/84, 35.7%) while changing gloves between patients reached
95.5% and 93% respectively. However, among internists who did not
wear gloves, the adequate use of antiseptic before and after contact with
each patient was efﬁcient only in the wards (28/54, 51.8%). Internists
in the emergency used antiseptic only before (5/51, 9.8%) or only after
(13/51, 24.5%), but never before and after contact with the patient. Rates
of invasive procedures did not differ between the emergency rooms and
the wards.
Conclusions: Internists were prompt to appropriately use hand rub
antiseptic only when they were working in the wards but not in
the emergency. This issue may be mainly attributed to the internists’
stress during the work in emergency. Moreover, although antiseptic was
available in both departments, the bed-rail hand rub dispensers existed
only in the wards and presumably enhanced the internists’ compliance
with hand hygiene rules.
R2252 Evaluation of reported percutaneous/mucocutaneous
injuries in a tertiary care hospital
D. Kanyilmaz, A. Erbay, N. Avci, D. Oztas, H. Bodur (Ankara, TR)
Objectives: Healthcare workers (HCW) have the risk of occupational
exposure to bloodborne pathogens. This study is planned to examine the
characteristics of exposures in HCW.
Methods: Prospective surveillance of percutaneous, mucous membrane,
and cutaneous contacts. A structured survey form was administered
to HCW by person-to-person interview, who sought medical advice
following the injury from The Infection Control Department (ICD).
Results: There were 2938 HCW including housekeeping staff in
ANEAH. Thirty-six HCW applied to ICD following the injury from Oct
2005 to Oct 2006 and 34 of them were interviewed. Mean age was 31.8
(range 18−52) and 17 (50%) were female. HCW of the surgical wards
were accounted for 35% of the injuries. Most of the injured HCW were
working as housekeeping staff (44%). Half of the HCW were working
more than ﬁve years in their job, no statistically signiﬁcant difference
was obtained between the employment duration of the injured HCW.
Almost all of the HCW (88%) described themselves as an experienced
staff at their job. Although 94% of the HCW told that they were not
tired at the time of the injury, most of the injuries occurred at the last
hour of the shift (p = 0.039) and most of the injuries occurred on Friday
(27%) but no statistically signiﬁcant difference was found between the
days of the week. Needle stick injuries were the most common type.
Of the injured HCW, 82.6% were using personal protective equipment.
Among HCW surveyed, 82.4% of them had blood screening test for
hepatitis B, C and HIV in last 6 months; but only 52.4% had been
previously vaccinated against HBV. The main reason for the unvaccinated
status was personal neglectfulness (50%). HCW sought medical advice
following the injury by attending (71%) and phone call (21%) to ICD.
The serologic proﬁles of the source patients were unknown in 44%,
HBsAg was positive in 32%, HCV was positive in 12% and HIV was
positive in 3%. Eleven of the HCW injured from a HBsAg positive
patient had received postexposure prophylaxis against HBV, including
immunoglobulin and vaccination within 72 hours of injury. Also sixteen
HCW who were negative screening tests for hepatitis B were enrolled
to vaccination programme.
Conclusion: Housekeeping staff injuries ranked ﬁrst at our facility
and most of these injuries caused by devices discarded inappropriately.
Hepatitis B immunisation, universal precautions training, barrier
protection, and safer disposal systems should be implemented.
R2253 Trends in nosocomial bloodstream infections
L. Galani, V. Sakka, K. Kouvelas, D. Plachouras, H. Kalogeropoulou,
A. Gika, H. Fytrou, L. Zerva, H. Giamarellou (Athens, GR)
Purpose: To describe the incidence of nosocomial bloodstream infec-
tions (N-BSI), the predominant pathogens, antimicrobial susceptibilities
and the trend during a two year period, in a tertiary care teaching hospital
in Greece.
Methods: All N-BSIs were identiﬁed retrospectively, as a surrogate
marker for nosocomial infections, among adult inpatients in three six-
month periods between September 2004-February 2005, March 2005–
August 2005 and September 2005-February 2006. Comparisons were
performed between the ﬁrst and third period with Fisher‘s exact test.
Results: During the three study periods, 1524, 1657 and 1769 blood
culture sets were received, resulted in 246 (16.1%), 245 (14.7%) and 265
(15%) positive blood cultures, with 76 (31%), 59 (22%) and 64 (24%)
to be considered as contaminants respectively. The incidence of N-BSI
per 1000 admissions was: N-BSI 11.3 (86 episodes), 8.9 (94 episodes)
and 6.6 (90 episodes) respectively (p< 0.001). Mean age of patients with
N-BSI was 62.7, 66.3 and 66.1 years and median hospitalisation time
was 43, 44 and 42 days respectively.
Rates of BSI according to pathogen per 1000 admissions in the three
periods were as follows: Gram-positive bacteria 3.4, 2.3 and 3.1 (p NS)
[including Staphylococcus aureus 1.3, 0.5 and 0.7 (p NS), Enterococcus
spp. 0.26, 0.6 and 1.03 (p< 0.001)], Gram-negative bacteria 8.4, 3.78 and
3.9 (p< 0.001) and fungi 1.18, 0.94 and 0.66 (p< 0.001). Antimicrobial
susceptibility proﬁles are shown in Table 1.
Table 1
Pathogen Number (%) susceptible
1st period 2nd period 3rd period
MRSA 2/10 (20) 1/6 (17) 4/10 (40)
VRE 0/2 (0) 2/7 (28) 4/14 (29)
Pseudomonas spp. ImRa 1/5 (20) 7/9 (77) 6/14 (43)
Klebsiella spp. ESBL 14/21 (67) 3/7 (42) 2/6 (33)
ImRa 10/21 (48) 0/7 (0) 0/6 (0)
Acinetobacter spp. A/S Rb 11/15 (73) 2/8 (25) 8/13 (62)
ImRa 12/15 (80) 2/8 (25) 11/13 (85)
E. Coli ESBL 2/4 (50) 1/16 (6) 1/11 (9)
aImR: imipenem resistance; bA/S R: ampicillin/sulbactam resistance.
Conclusions: A steady and signiﬁcant decrease of N-BSI was observed
probably due to a strict infection control policy (bed-rail disinfectant
solutions, continuous staff interventions). However an increase in
enterococcal N-BSI, especially VRE and the high incidence of multidrug
resistant Gram(−) bacteria are a cause of concern.
R2254 Implementation of “signiﬁcant organism precaution” in a
teaching hospital: ﬁrst experience in Iran
A. Nateghian, L. Mehrali, N. Hamdarsi (Tehran, IR)
Introduction: nosocomial infection due to multiple drug resistant
organisms is a concerning problem in Iran, particularly in large teaching
hospitals. A speciﬁc type of contact isolation termed as “signiﬁcant
organism precaution (SOP)” has been proposed to limit the extent of
problem, however, no previous experience in terms of such an isolation
programme, coordination for it’s implementation and executive barriers
was available in our country.
Methods and Patients: After holding three workshops for introducing
SOP to physicians, nurses and other healthcare workers, we decided
to start SOP for all cases with MRSA, VRE & MDR Gram-negative
bacilli (deﬁned as resistant by disk diffusion methods to all members of
three major groups of antibiotics usually effective in their therapy (i.e.,
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aminoglycosides, new quinolones and 3th generation cephalosporins) in
Rasul Akram hospital, a 800 beds teaching hospital in Tehran during
2004. For all cases of SOP, data regarding the demographic issues
and type of organisms as well as sites of colonisation or infections,
availability of required items for SOP and rate of compliance were
recorded by an observer throughout their admission.
Results: 183 cases needed SOP during a 6 months period of study and
observation.60 cases (33%) were female.mean age of cases was 43.5
(± 16) and most common sites of isolation were urinary tract, ulcers
or incisions & blood stream (23%, 19% & 13.5% respectively). MDR
Gram-negative bacilli were the most common isolates for which SOP
was necessary (86%) followed by MRSA (13%) and VRE (1%). Except
for disposable gloves and individual thermometer for each case which
were available for most cases, scrub betadine, gowns, masks, personal
stethoscopes and isolated rooms were not present or could not provided
for most of cases in non intensive care wards and units. For most of
these cases, physicians and nurses believed that such interventions and
programmes were necessary, however just in 12% of cases they were
fully compliant to SOP programme. Rates of availability of required
items and compliance were much better for cases admitted to various
intensive care units.
Conclusion: SOP programme is a necessary item at least in large
teaching hospital in Iran particularly for large number of MDR Gram-
negative bacilli but more educational efforts, budget and facilities should
be provided if proper implementation of such a programme is to be
happen.
Clinical epidemiology of nosocomial
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R2255 Antimicrobial resistance proﬁles of Acinetobacter baumannii
strains isolated in intensive care units
M. Naim, M. Chabani, D. Tiouit (Algiers, DZ)
Objectives: Acinetobacter baumannii formely bacterium saprophyte is at
present a redoubtable nosocomial pathogen in intensive care units (ICU)
because its virulence and of its multidrug resistance. The purpose of
this short study is to estimate the proﬁles resistance of Acinetobacter
baumannii isolated in military hospital’s ICU during 3 months.
Methods: 20 strains isolated in different samples obtained from
inpatients hospitalised in ICU over a period going from January
till March 2006. The identiﬁcation of Acinetobacter baumannii was
performed using classical bacteriological methods (API 10S, API 20NE
boiMe´rieux) associated to the other additional tests (incubation 44ºC,
catalase. . . ). The antimicrobial susptibility testing were performed using
NCCLS methods. Twelve common used antimicrobial agents were tested:
ticarcillin (TIC), piperacillin (PIP), ceftazidim (CAZ), imipenem (IMP),
gentamicin (GM), amikacin (AN), trimethoprim-sulfamethoxazol (SXT),
ticarcillin+clavulanic acid (TCC), ciproﬂoxacin (CIP), netilmicin (NET),
tobramycin (TB), colistin (CS).
Results: The isolates included in our study originated from: wounds
(45%), urine (25%), bronchial aspirates (20%), haemocultures (10%).
The almost totality of strains presented a simultaneous multidrug
resistant to 8 antibiotics with rates from 70–100%: TIC 100%, PIP 100%,
AN 100%, GM 100%, CAZ 95%, IMP 80%, TCC 70%, SXT 70%.
The rates of resistance to other antibiotics were included between
45−55% (TOB, NET, CIP)
Colistin were the only antimicrobial agent active to all isolated strains.
Conclusions: These results show distrubing emergence and fast
evolution of multidrug resistant in our hospital, that what we have been
reported in a poster published in ECCMID 2005.
Is important to say that multidrug resistant concern the major antibiotics
as imipenem and amikacin often ending in a therapeutic impasse and a
fatal outcome
R2256 Acinetobacter infections: a growing threat for critically ill
patients
M.E. Falagas, E. Karveli, I. Siempos, K. Vardakas (Athens, GR)
Objective: There has been a concern regarding an increase of
Acinetobacter infections in critically ill patients in various parts of the
world.
Methods: We extracted information regarding the relative frequency of
Acinetobacter pneumonia and bacteraemia in patients with intensive care
unit (ICU) acquired infection from 41 relevant studies (25 prospective,
8 surveillance, 8 retrospective) and regarding the antimicrobial resistance
of Acinetobacter clinical isolates from 32 in vitro susceptibility studies
identiﬁed in Pub Med, Cochrane, and Current Contents database
searches.
Results: Acinetobacter infections most frequently involve the respiratory
tract of intubated patients. The available data suggest that Acinetobacter
pneumonia has been more common in critically ill patients in Asian
(ranging from 4% to 44% among patient with ICU acquired infections)
and European (0%–35%) hospitals than in USA hospitals (6%–
11%). The data also suggest the presence of a gradient in Europe
regarding the proportion of ICU acquired pneumonias that are caused
by Acinetobacter (very low in the countries of Scandinavia, and
gradually higher in Germany and the UK, France, Spain and Italy,
and ﬁnally Greece and Turkey). A higher proportion of Acinetobacter
isolates from patients in Asian and European than USA ICUs were
resistant to various antimicrobial agents, including aminoglycosides and
piperacillin/tazobactam.
Conclusions The data suggest that Acinetobacter (mainly Acinetobacter
baumannii) is a growing threat affecting a considerable proportion of
critically ill patients in several parts of the world, especially Asia and
Europe.
R2257 The relationship between the antibody titre of
Chlamydophila pneumoniae and clinical presentation, in
patients with respiratory tract symptoms
K. Ueda, T. Nakamura, T. Morikawa, A. Moriyama (Yamatokouriyama,
JP)
Objectives: Persistent infection by several microorganisms such as
Helicobacter pylori has been shown to be associated with diseases other
than infectious diseases. There have been reports that persistent infection
by Chlamydophila pneumoniae is a risk factor for cardiovascular diseases
but the relation is not clear. We reported at the 2005 Annual Meeting of
The Japanese Society of Internal Medicine that when anti-C. pneumoniae
IgA and IgG in patients with respiratory tract symptoms were measured,
the ratio of patients considered to have acute C. pneumoniae infection
constituted about 10% (12.8%) and patients that were IgG antibody
positive constituted about 70% (70.4%). In this study we noticed that
there were cases in which IgA or IgG was maintained at strong-positive
for half a year or longer. After careful examination, we had an impression
that these were serious. Here we studied the difference in clinical
presentation between antibody negative and strong-positive to investigate
whether infection by C. pneumoniae infection is associated with other
diseases.
Methods: We investigated IgG in 244 specimens and the clinical
presentation of the patients (total 207; 93 males; 114 females; age 16−99;
average age 70.4) whose IgG was measured due to their presentation of
respiratory tract symptoms at our hospital from 1 August 2004 to 31
August 2006. A speciﬁc antibody measuring kit which uses the ELISA
method in which the outer membrane complex of C. pneumoniae is the
antigen (HITAZYME C. Pneumoniae: Hitachi Chemical Co., Ltd.) was
used. An index 3 or above was deﬁned as strong-positive and less than
0.9 was deﬁned as negative.
Results: 59 cases (28.5%) were negative and 13 cases (6.3%) were
strong-positive. The average age of the negative was 61, and 82 in the
positive, indicating that the negative were younger (P< 0.01). The ratio
of deaths by 31 October 2006 was 15.3% in negative and 61.5% in
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strong-positive, indicating a higher ratio in the strong-positive (P< 0.01).
The cases of cerebrovascular disorder were found in 25.4% of negative
and 38.5% in strong-positive (P = 0.42).
Conclusion: The strong-positive patients for C. pneumoniae antibody
were signiﬁcantly older in age compared to the negative, and signiﬁcantly
more of the strong-positve patients died within 2 years of the
measurement as compared to the negative. Although statistically not
signiﬁcant, there were more cases of cerebrovascular disorder in the
strong-positive cases.
R2258 Evaluation of nosocomial infections in the hospitalised
patients of intensive care unit of a university hospital,
Kashan, Iran
A. Khorshidi (Kashan, IR)
Background and Objective: Nosocomial infections is a great problem
in hospital that increased cost, duration of hospitalisation and mortality,
Regarding to inaccessibility to accurate information of NI and the
bacterial agents. antibiotic resistance pattern in Hospital University of
Kashan (Iran), this study was done from May 2005 to Apr 2006.
Material and Methods: This descriptive study was conducted by
evaluation of all ﬁles of admitted patients of ICU in Central Hospital
University of Kashan from May 2005 to April 2006, after of ﬁnding of
infection cases according to symptoms with or without positive culture,
The results and demographic characteristic were registered then results
of research were presented by descriptive analysis.
Results: Research showed that prevalence of nosocomial infections
in ICU was (10.12%) (39 cases of 289 Persons) range of aged in
hospitalised infection was 75−45 years.
The most prevalence of NI was: respiratory infections (56.59%), UTI
(26.58%), Bacterimia (6.52%), surgical wound infections (4.3%).
The most common Pathogen were determined: Escherichia coli
(23.3%), Pseudomonas and Enterobacter (20%), Klebsiella (16.60%),
Staphylococcus aureus (13.3%). E. coli and Pseudomonas showed
the most resistance to ciproﬂoxacin, cefteriaxon, ceftazidim, amikacin,
gentomycin, imipenem.
Conclusion: Considering the high prevalence and increasing of
antibiotics resistance particularly in ICU comparing with others studies,
it is necessary to consider the predisposing factors of nosocomial
infectons in ICU like appropriate use of medical equipment, prevention
of Irrational prescription of antibiotics and sedative and regarding
improved attention to hygienic principles. Incidentally It is better that
Procedure of treatment start on the last information of bacterial agents
and antibacterial resistance patterns and suggested to organised an
Infection Control Committee in this Center.
R2259 Catheter-related bacteraemia in intensive care unit patients
J. Komarnicka, H. Grezlikowska, E. Naumiuk, A. Sledzinska, A. Samet,
M. Wujtewicz (Gdansk, PL)
Objectives: Analysis of aetiology and clinical characteristics of central
venous catheter-related bacteraemia (CRB).
Methods: Microbiological results of proven CRB (isolation of the
same pathogen from blood culture and from catheter tip) in patients
hospitalised in 12-bed Intensive Care Unit in tertiary care hospital were
evaluated, in the period from January 2003 to September 2006. Catheter
tips – 3 cm, were examined by Maki technique. Blood cultures were
performed in BacT/Alert automated system.
Results: From 1th January 2003 to 30rd September 2006, 2442 blood
cultures were performed (16.5% positive). 36 of 84 examined catheter
tips were positive. 15 patients were considered as proven CRB and two
of them had more than one CRB during hospitalisation (total 17 CRB).
Aetiological agents were: 8 coagulase negative staphylococci (CNS),
2 A. baumannii, 2 S. maltophilia, 2 Candida albicans, 1 E. cloacae,
1 P. aeruginosa and 1 E. faecalis. In further 10 patients only catheter
tip was positive, without a blood culture: 4 CNS, 1 Candida sp.
1 C. albicans, 1 E. cloacae, 1 E. faecalis, 1 A. baumannii and
1 P. mirabilis.
In patients with proven CRB six suffered from sepsis and nine had fever
only. All infections were nosocomial.
Conclusion: Most of isolated aetiological agents were multiresistant
hospital pathogens (except E. faecalis). Because of small number of
proven CRB prospective surveillance is essential as well as examining
of every catheter tip in situation of removal due to suspicion of infection.
R2260 Epidemiology and antibiotic resistance of bacterial isolates
from patients with bacteraemia in an intensive care unit
E. Ikonomopoulou, P. Georgakoloulos, P. Michail, S. Paratiras,
G. Stavropoulou, C. Verra, V. Dondou, A. Regli (Patras, GR)
Objectives: The aim of this study was to carry out the prevalence and the
antibiotic resistance of bacterial isolates from patients with bacteraemia
in the intensive care unit (ICU) of our hospital.
Methods: Blood cultures from ICU patients were performed using the
Bactec 9120 (Becton Dickinson) and the Bact – alert (bioMe´rieux)
during 2003 and 2004–2005 respectively. The identiﬁcation and the
antimicrobial resistance of bacterial isolates were carried out by the
VITEK system (bioMe´rieux). MBL production was performed by E-test
(Imipenem, Imipenem and EDTA). Colistin sensitivity was performed
by E-test (AB–Biodisc).
Results: During a three year period (2003 –2005) 155 patients
(99 males/56 females) hospitalised in our ICU and 30 (19.4%) had
one or more episodes of bacteraemia. A total of 53 bacterial strains
were isolated. The most prevalent pathogen was P. aeruginosa 14
(26.4%) followed by K. pneumoniae 8 (15%), Coag− staphylococci 8
(15%), Acinetobacter baumannii 7 (13.2%), Candida spp. 6 (11.3%),
E. faecalis 3 (5.7%), Stenotrophomonas maltophilia 3 (5.7%), S. aureus
2 (3.8%) and E. coli 2 (3.8%). 5 P. aeruginosa strains produced MBLs
and 4 K. pneumoniae strains produced ESBL. Resistance rates of
P. aeruginosa and K. pneumoniae for commonly used drugs respectively
were: amikacin 21.5%/0%, aztreonam 36%/12.5%, cefepime 29%/50%,
ceftazidime 21.5%/50%, ciproﬂoxacin 21.5%/75%, imipenem and
meropenem 36%/0%, piperacillin/tazobactam 36%/12.5%. All Acineto-
bacter baumannii strains were multiresistant (resistance rate: 83% to
amikacin, cefepime, imipenem and 100% to aztreonam, piperacillin/
tazobactam, gentamycin, netimicin, tobramycin and ceftazidime). All
Acinetobacter baumannii strains were sensitive to Colistin. Among
staphylococci all isolates were resistant to oxacillin but they were
susceptible to glycopeptides. Candida spp. (C. albicans 4 strains, 1 strain
C. sake and 1 strain C. glabrata) were sensitive to Amphotericin B,
Fluconazole and Flucytocine.
Conclusions: Bacteraemia happens in 19.4% of ICU patients and
multiresistant strains are mainly responsible so we must be careful in
antibiotic usage in order not to increase the antibiotic resistance of
bacterial isolates.
R2261 Venous access ports. Prospective study to analyse
use-related complications
A. Serrera, M. Alonso, J.L. del Pozo, S. Hernaez, A. Martinez,
I. Bilbao, A. Aguinaga, A. Ramos, J. Leiva (Pamplona, ES)
Objectives: Venous access ports (VAP) are used in patients receiving
long parenteral treatments. The aim of this prospective and observational
study was to analyse the complications of VAP use, and to describe the
role of different culture techniques for diagnosing VAP-related infection.
Methods: Over a 12-month period all VAPs removed in our hospital
were microbiologically examined by the following procedures: culture
of the catheter tip (sonication method). Culture of the internal lumen
of the port (chamber swabbing and septum sonication). Besides, a
macroscopic analysis with search for deposits inside the reservoir was
performed. We also analysed the records of all patients (age, sex, clinical
diagnosis, underlying conditions, date of VAP insertion and removal,
number of days in use, reasons for removal and all signiﬁcant events
during treatment).
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Results: From August 2005 to the end of July 2006, 121 VAPs were
removed from 121 patients (median age, 48; range, 4 81 years). The
mean duration of implantation of the VAPs was 618 days (range, 0
3301 days). The mean VAP uses were 7 (range, 0–45 uses). VAPs were
removed at the end of treatment in 99 cases; with 8% of VAP positive
cultures. S. epidermidis was the most frequent isolated microorganism
(66.6%). Eleven VAPs (9.1%) were removed from 11 patients because
of suspected VAP-related bloodstream infection. Septum culture was
positive in 90.9% of the patients while catheter tip culture was only
60% positive. The isolated microorganisms were as follows: S. aureus
(3 patients), yeasts (3), Gram-negative bacilli (3), coagulase-negative
staphylococci (1), and A. fumigatus (1). The overall incidence of
VAP-related bloodstream infection was 0.11/1000 VAP-days. Eleven
patients had a VAP removed because of mechanical complications;
with 50% of positive VAP cultures. S. epidermidis was the most
common isolated microorganism (87.5%). The overall incidence of VAP-
related mechanical complication was 0.11/1000 VAP-days. In 26 patients
(21.49%) we found deposits in the internal lumen of the reservoir (84.6%
in end-use removal, 7.6% in VAP-infection and 7.6% in VAP-mechanical
complication).
Conclusions: Incidence of associated VAP-use complications is low in
our hospital. On the basis of data from the present study, it looks that
the reservoir is the key piece of the catheter for the diagnosis of VAP-
related infections. S. epidermidis might play a role in the genesis of
some mechanical complications.
R2262 Genotypic structure and susceptibility to antimicrobial
agents of Acinetobacter baumannii and Pseudomonas
aeruginosa in Russian burn intensive care units
A. Goncharov, A. Solomenny, B. Aslanov (Saint-Petersburg, Perm, RU)
Objectives: At ﬁrst we studied the epidemic situation and the genetic
structure of hospital population of Acinetobacter baumannii developed
(during 2002–2004 yrs) in two burns intensive care units in St. Petersburg
and Leningrad region. We observed in these hospitals chronic epidemy
of an acinetobacter infection linked to contamination by bacteria from
mattresses and functional beds on an “air pillow”. The aim of this
study was to investigate the genotypic structure and susceptibility to
antimicrobial agents and bacteriophages of MDR A. baumannii and
P. aeruginosa.
Methods: A total of 56 clinical isolates of A. baumannii and 11 isolates
of P. aeruginosa from 2 burn ICUs (BICU 1 and BICU 2) were
characterised with respect to antimicrobial agents and bacteriophages
susceptibility. 17 bacteriophages of A. baumannii and 12 bacteriophages
of P. aeruginosa have been isolated from clinical specimens and tested
for their antimicrobial activity.
Results: Typing by RAPD-PCR with the M13 primer showed the hospital
population of Acinetobacter presented as a restricted number of clonal
lines, four (13, 10, 5 and 4 isolates) in BICU 1 and two (7 and 6
isolates) in BICU 2, circulating for the prolonged time (>2 yrs.). No
identical ampliﬁcation pattern was indicated in the clone predominating
in BICU 1 and BICU 2. Class 1 integron variable segments (2.5 kb
in size) were determined in predominating in BICU 1 clonal line.
Prevalence of resistance to cefaclor, cefotaxime, ceftriaxone, ceftazidime
and gentamicin was signiﬁcant in BICUs strains. The integron-positive
isolates were sensitive to imipenem or polymyxin only. Only one clonal
line of P. aeruginosa was detected in two burn ICUs using RAPD-PCR.
44.4% of acinetobacteria and 75.0% of P. aeruginosa were susceptible
to bacteriophages.
Conclusion: The large-scale researches on search and selection of
bacteriophages, for their application as a therapeutic agent are necessary.
R2263 Infection control investigations and treatment of discharged
patients following exposure to scabies in a tertiary hospital
M. Schousboe, K. Armstrong (Christchurch, NZ)
Objective: Review of an outbreak of scabies originating in an infected
patient with Bullous Pemphigus Vulgaris (BPV).
Methods: A 58-year-old woman admitted to a cardiology ward with
arrhythmia and cardiac symptoms had a history of BPV, diabetes
mellitus and cellulitis of the legs. She stayed 54 days in ﬁve wards
in two hospitals and mainly admitted into multi-bed rooms with no
restriction of her movements. She was treated with methylprednisolone
and cyclophosphamide.
“Norwegian” Scabies was diagnosed 16 days before her death. She was
isolated with contact precautions and the infection treated topically and
given oral ivermectin. However, microscopy of skin scrapings for the
scabies mite remained positive until her death.
The infection caused staff and patient exposure, but no transmission
was found until a city laboratory reported a further case to the Infection
Control Service. A “look back” of patients who could have been exposed
to the index case was carried out and information was sent to General
Practitioners.
Results: During the subsequent four months, 31 patients were diagnosed
with scabies. Age groups were 40−96 years mean age 75. 8 scabies
infections were known to have been diagnosed by microscopic
identiﬁcation of the scabies mite or the eggs. The others were a clinical
diagnosis.
Contacts were treated with permethrin cream. 6 were known to require
several applications. The Infection Control Service (ICS) became the
contact for follow-up for 5 patients of which 3 required referral to a
specialist for alternative treatment including oral ivermectin.
Several staff consulted the ICS and were treated.
Conclusion: Scabies is difﬁcult to diagnose in immunosuppresed
patients or in the presence of dermatological disease. Elderly people
have few reactions to the mite. “Norwegian scabies” is a crusted highly
contagious form of scabies. It is often overlooked, lacking the itchiness
and lesions seen in people with normal immunity.
The outbreak showed spread via formites in hospitals. Scabies is often
not considered by medical practitioners. Steroids used as symptomatic
treatment will aggravate the infection. Technical skill is required by
laboratory staff when recovering and identifying the mite from skin
scrapings.
R2264 Epidemiologic characteristics of Clostridium difﬁcile
infection in a tertiary hospital in Korea
B-M. Shin, H.M. Yoo, E-Y. Kuak, S.J. Yoo (Sanggye, KR)
Introduction: Clostridium difﬁcile is one of the most important
pathogens responsible for nosocomial diarrhoea. The disease is mediated
by two toxin, designated as A and B; therefore, identiﬁcation of toxin
is also important for diagnosis, treatment and infection control of
C. difﬁcile. The purpose of this study is to provide the basic features
of the microbiological, clinical and endoscopic ﬁndings in a tertiary
hospital in Korea for controlling C. difﬁcile infection.
Methods: We evaluated 384 C. difﬁcile positive cases that were
cultured from Jan. 2004 to June 2005. We tested toxin A enzyme
immunoassay using VIDAS CDA II. We ampliﬁed toxin A gene in
culture positive cases to differentiate toxin A positive, variant and
negative strains. Sigmoidoscopic/colonoscopic ﬁndings, departments of
admission, underlying diseases and histories about antibiotic usages were
evaluated.
Results: Of 384 culture positive cases, C. difﬁcile were mainly isolated
in medical and neuro-surgical parts. According to the age and gender,
C. difﬁcile were highly positive in elderly patients (>60 years; 67%) and
no statistical difference was observed between male and female. Toxin A
gene PCR assay revealed that the proportion of positive, variant and
negative strains were 31%, 54% and 15%, respectively. Among culture
positive cases, only 40% were underwent sigmoido/colonoscopy and 61%
of them were diagnosed as pseudomembranous colitis (PMC)/colitis.
Toxin A variant strains were highly associated with PMC instead of intact
toxin A positive strains. No statistical differences were found in colitis
between toxin A positive strains and variant strains. Among antibiotics,
cepholosporin and aminoglycoside were the most frequently used agents.
The highly associated underlying diseases were cerebrovascular diseases,
malignancy, diabetes mellitus and cardiovascular diseases.
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Conclusion: We shoud be aware of the C. difﬁcile infection in elderly
patients with underlying diseases (cerebrovascular diseases, malignancy,
diabetes mellitus and cardiovascular diseases) and long-term usage
of antimicrobial agents, especially cepholosporin and aminoglycoside.
Toxin A variant strain was more important risk factor in PMC compared
with toxin A positive strains.
R2265 Hospital-acquired bloodstream infections in a teaching
hospital: a ﬁve year follow-up
C. Bulut, M.A. Yetkin, F.S. Erdinc, G.R. Yilmaz, M. Yu¨cel, N. Tu¨lek,
E.A. Karakoc (Ankara, Samsun, TR)
Objectives: Hospital acquired bloodstream infections are major causes
of morbidity and mortality. The aim of this study was to evaluate
the clinical and epidemiological features of the patients with hospital
acquired bloodstream infections and the risk factors for mortality
attributable to that infection in our hospital.
Methods: A prospective active laboratory based surveillance was
performed in our hospital between January 2000 to December 2004.
Bloodstream infection was diagnosed according to the CDC criteria.
Microorganisms isolated from the the blood were identiﬁed by using
conventional methods. Disc-diffusion method was used for antimicrobial
susceptibility test according to NCCLS.
Results: A total number of 234 nosocomial bloodstream infections were
detected in 221 patients during the study period. The mean age of the
97 male and 114 female patients were 58.8±15.4 years and 61.2±16.2
years, respectively. The most common causes for hospitalisation
were cerebrovascular diseases, malignancy and cardiovascular diseases.
Fortysix percent of the patients were hospitalised on the medical wards,
whereas 38.2% and 18.1% of the patients were hospitalised on ICU and
the surgical wards, respectively. The history of prior antibiotic usage was
present on 32 patients. The mean length of stay between admission and
occurrence of bloodstream infection was 15.4±13.1 days.
A total of 264 pathogens were isolated (58.3% Gram-positive cocci,
22% Gram-negative rods, 16.3% nonfermenter rods, 3.4% fungi).
Staphylococcus aureus, Enterococcus spp., Acinetobacter spp. were
the most common isolated microorganisms. Methicillin resistance
was detected in 49.2% of Staphylococcus isolates. Carbapenems,
netilmisin and tobramisin were the most effective antimicrobials against
Acinetobacter isolates.
The overall infectious mortality was 40.7%. Clinical factors associated
with mortality were evaluated and older age (60 years), being an
ICU patient, presence of coma and mechanical ventilation were found
as independent risk factors in multivariate logistic regression analysis
(p< 0.05).
Conclusion: Mortality rate attributable to bloodstream infection was
high in our study. It is important to know the aetiological microorganism
and antimicrobial susceptibility pattern in order to plan the optimal initial
empirical antimicrobial therapy.
R2266 Outbreak of Corynebacterium striatum infection in an
Italian general intensive care unit
C. Iaria, G. Stassi, S.G. Spinella, G.B. Costa, C. Biondo, E. Gerace,
F. Ricciardi, A. David, A. Cascio (Messina, IT)
Background: Intensive care units (ICUs) are known to be a focus
for the emergence and dissemination of multiresistant bacteria mainly
because the most severely-ill patients can be found in the ICU, and
almost all of these patients will have been exposed to intense antibiotic
pressure and exogenous bacterial colonisation. Corynebacterium spp.
are widely disseminated in the environment and constitute part of the
normal skin and mucous membrane ﬂora. Although both C. amycolatum
and C. jeikeium are currently recognized as important pathogens, the
signiﬁcance and prevalence of C. striatum as a causative agent of disease
are not well understood. We describe an outbreak occurred in the ICU
of our University hospital and try to evaluate the clinical signiﬁcance of
C. striatum infection and risk factors associated with it.
Case report: In ﬁrst months of 2006 13 strains of Kocuria kristinae were
isolated from 8 patients admitted in ICU. Routine diagnostic cultures
of the clinical specimen had been used and identiﬁcation performed
using Biomeieux VITEK2 system GP card. Antibiotic sensitivity test
was performed using the disc diffusion method according to Clinical
and Laboratory Standards Institute guidelines for Staphylococcus. All
the isolates exhibited the same pattern of antibiotic resistance being
sensitive only to vancomycin, teicoplanin and linezolid. Considering that
in our lab K. kristinae had never been isolated before and that using
standard biochemical analysis misidentiﬁcation of coagulase negative
Staphylococcus as Kocuria had been reported, a genotypic assay (16s
rRNA) was performed. Surprisingly, all the strain tested were identiﬁed
as C. striatum.
Overall C. striatum was isolated from 7 bronchial aspirates relative to 5
patients, one from a central venous catheter tip and from 5 blood cultures
relative to 5 patients. The demographic and clinical data of the patients
are reported in table 1. In no one of the patients in which C. striatum
was isolated from bronchial aspirate a diagnosis of ventilatory associate
pneumonia was made. Patients n.4 had the parameters of sepsis and died
notwithstanding he was treated with appropriate antibiotic therapy.
Patienta Underlying illness Clinical specimens Days
in ICU
T
(ºC)
Pulse WBC
×103
Therapy Outcome
1, M/73 Cranial trauma N.3 bronchial
aspirates
7 37 90 12.5 Teicoplanin Died
2, M/16 Multiple trauma CVC tip 9 37 117 27.2 Ceftazidime Recovered
3, M/59 Stroke bronchial aspirates 19 37 90 10.0 Teicoplanin Recovered
4, F/16 Multiple trauma N.3 blood cultures 5 38.2 100 10.3 Teicoplanin
Meropenem
Died
5, M/33 Multiple trauma bronchial aspirate 9 38 78 16.6 Teicoplanin Recovered
6, F/80 Stroke N.2 blood cultures 60 37 90 14.4 Piperacillin
Teicoplanin
Recovered
7, M/69 Stroke bronchial aspirate 5 40 103 19.6 Linezolid
Levoﬂoxacin
Recovered
8, F/55 Cerebral metastasis bronchial aspirate 24 38.5 90 17 Teicoplanin Died
a ID, Gender/Age.
Conclusions: Our report highlights the importance of C. striatum
as a potential human pathogen in ICU patients even if its pathogen
role remains to be clariﬁed. Furthermore, we signal the possible
misidentiﬁcation of C. striatum as K. kristinae using the bioMe´rieux
VITEK2 GP card.
R2267 Repeated prevalence surveys of surgical site infections in
a Turkish university hospital
O. Yildiz, E. Alp, S. Yucel, B. Kiran, B. Tucer, E. Ok, B. Aygen
(Kayseri, TR)
Objectives: The aim of this study was to clarify factors inﬂuencing the
prevalence of surgical site infections (SSI) undergoing general surgery
and neurosurgery, as well as to determine the effectiveness of infection
control measures for SSI.
Methods: Two prevalence surveys were carried out during the ﬁrst
six months of 2005 and 2006, after implementing infection control
measures in an 1136-bedded teaching hospital. A total of 3924 surgical
patients (2263 in general surgery and 1661 in neurosurgery wards) were
investigated, the number of patients in the two studies were 2026 in
2005 and 1898 in 2006. The patients were assessed for SSI by review of
medical records and by discussion with ward nursing and medical staff.
The changes in infection control activities during the 18-month period
included educational programmes to healthcare workers, increasing the
number of infection control nurses, implementing published guidelines
on prevention and control of hospital associated infections, postoperative
incision and intravascular catheter care.
Results: During the period of observation, 5.5% of 3924 patients had
SSI, 16 (0.4%) had superﬁcial incisional SSI, 117 (3%) had deep
incisional SSI and 81 (2.1%) had organ space SSI. The infection rate was
4.4% for clean and clean-contaminated surgery, 14.8% for contaminated
and dirty surgery; 4.1% for American Society of Anaesthesiologists
(ASA) score I, 5.7% for ASA score II, 9.7% for ASA score III, 9.8%
for ASA score IV and 33.3% for ASA score V. The prevalence of SSI
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decreased signiﬁcantly from 6.5% in 2005 to 4.4% in 2006 (p = 0.005). In
general surgical patients, the SSI rate in 2006 was signiﬁcantly lower than
that of 2005 (5.1% and 7.6%, respectively, p = 0.017). During the same
period, the SSI rates were not signiﬁcantly different for neurosurgical
patients (3.4% in 2006 and 4.9% in 2005, p = 0.151).
Conclusion: The risk factors for SSI were higher degree of wound
contamination, poor physical status according to ASA classiﬁcation,
prolonged duration and type of operation, inappropriate use of antibiotics
for surgical prophylaxis and use of surgical drains.
Implementation of infection control policies can have a signiﬁcant impact
on the prevalence of SSI, and their effectiveness could be measured by
repeated prevalence surveys.
R2268 Enterococcus bacteraemia: striking high mortality
M. Suppli, R. Aabenhus, Z. Harboe, L. Andersen, M. Tvede, N. Kirkby,
J. Jensen (Copenhagen, DK)
Objective: To assess the character and degree of underlying disease
in patients with enterococcal bacteraemia compared with E. coli
bacteraemia. Additionally to determine if such differences can explain
variations in mortality between the two bacteria.
Methods: All patients identiﬁed with E. faecium, E. faecalis or E. coli
bacteraemia at Rigshopitalet, Copenhagen, were included in the study.
Demographic, diagnostic and mortality data were compared for patients
with Enterococcus and E. coli bacteraemia. Patients were excluded from
mortality analyses if: (a) younger than 16 years, (b) suffering from
haematologic cancer or (c) with an unregistered date of death. Statistical
analyses were performed using Student’s test and Mann–Whitney U-
test to compare continuous variables and chi-squared test for equal
proportions or Fisher’s exact test to compare categorical variables.
Results: 326 patients with E. faecium and E. faecalis bacteraemia
and 225 patients with E. coli bacteraemia were included in the study.
Mortality at 90 days after the ﬁrst positive bloodculture was 36.7%
among Enterococcus bacteraemia patients, and 25.9% among E. coli
patients (p = 0.03). There was no difference in mortality at 10 and
30 days, (p= 0.57 and 0.45 respectively). No differences in age were
observed and median age were 60.5 and 60.0 years in the two groups
(p = 0.54). Acute renal failure, respiratory insufﬁciency, peritonitis,
congestive heart failure and endocarditis were more common in patient
with Enterococcus bacteraemia (P< 0.05), while solid cancer were more
common among E. coli patients (p = 0.057).
90-days morality
Dead Alive Mortality
Enterococcus 76 131 36.7%
E. coli 45 129 25.9%
P= 0.03 (Fischer). OR(Dead by Enterocococcus bacteraemia): 1.66
[1.07–2.59] (Woolf’s approximation).
Conclusions: The observed differences in mortality between Entero-
coccus and E. coli at 90 days are unrelated to age and haematological
malignancies. Also of interest is that solid cancers were more frequent in
E. coli bacteraemia. Patients with Enterococcus bacteraemia had a higher
frequency of congestive heart failure and endocarditis. The present
ﬁndings suggest that Enterococcal bacteraemia is a strong independent
predictor of death. Further investigations are needed to explore whether
pathogenic processes in the heart are involved in the death of patients
with Enterococcus bacteraemia, even when endocarditis is not diagnosed.
R2269 Quantitative cultures of endotracheal aspirate in the
diagnosis of ventilator-associated pneumonia
F. Ioannidou, A. Kyratsa, I. Graphakos, E. Kontekaki, V. Mamali,
A. Chondrothanassi, A. Xaritou, E. Trikka-Graphakos (Athens, GR)
Ventilator associated pneumonia (VAP) is a common complication in
patients requiring mechanical ventilation. Invasive and non invasive
diagnostic techniques have been used for the diagnosis of VAP.
Quantitative culture of endotracheal aspirate is a non invasive procedure,
useful and inexpensive.
Objectives: To evaluate the validity of quantitative endotracheal aspirate
(QEA) in patients with suspected VAP.
Methods: We investigated 2,119 endotracheal aspirates (EA) of patients
undergoing mechanical ventilation for more than 72 hours, in the
Intensive Care Unit of our hospital, in a 4 year period (2003–
2006). EA were obtained by sterile means using an aspiration
catheter, placed in sterile containers and dispatched immediately to the
laboratory for quantitative culture. Bacterial pathogens in concentration
of 106 cfu/mL, were considered to be the causative agents of VAP.
All isolates were identiﬁed by standard laboratory methods, while MICS
were determined by phoenix automation system (BD).
Results: The most commonly isolated bacteria were Acinetobacter bau-
mannii (56%), Pseudomonas aeruginosa (28%), Klebsiella pneumoniae
(8%), Staphylococcus aureus (5%) and others (3%). The antimicrobial
resistance pattern is presented in the table. A total of 21 out of
43 Klebsiella pneumoniae isolates were b-lactamase producers. All
Acinetobacter baumannii isolates were sensitive to colistin.
Pathogen Resistance ratesa (%)
AN FEP CAZ CIP GM IPM MP TZP
A. baumannii 90.4 97.4 98.2 97.4 68.6 87.8 70.2 93.9
P. aeruginosa 55 80 73.3 70 63.3 68.3 70 61.6
K. pneumoniae 5.6 55.6 72.2 77.7 5.6 11.1 11 66.69
aAN, Amikacin; FEP, Cefepime; CAZ, Ceftazidime; CIP, Ciproﬂoxacin;
GM, Gentamicin; IMP, Imipenem; MP, Meropenem; TZP, Piperacillin/
tazobactam.
Conclusions: (1) Acinetobacter baumannii was the predominant isolate
with high resistance rates to all tested antimicrobials. (2) QEA is a
simple, non invasive and easily repeatable procedure. Early use of QEA
is helpful to clinicians in decision making with regard antibiotic use.
R2270 Risk factors of hospital-acquired infections in a
neurology-neurosurgery intensive care unit in a tertiary
care hospital, Turkey
C. Bulut, G.R. Yilmaz, M.A. Yetkin, F.S. Erdinc, C. Ataman Hatipoglu,
E. Yildiz, E.A. Karakoc, A.P. Demiroz (Ankara, TR)
Objectives: Intensive care unit (ICU)-acquired infections are associated
with high mortality, excessive length of ICU and hospital stay, and high
hospital costs. The risk factors for nosocomial infections may differ
according to the type of ICU. The aim of this study was to evaluate
the risk factors for ICU-acquired infections in the patients treated in
neurology-neurosurgery ICU.
Method: The study was conducted in Ankara Training and Research
Hospital, from May 2006 to November 2006. The patients treated for
more than 48 hours in 14-bed neurology-neurosurgery ICU were enrolled
into the study. The patients were followed until death or three days after
discharge by prospective daily surveillance. Nosocomial infections were
identiﬁed according to CDC criterias. Risk factors for ICU-acquired
infections were analysed with a logistic regression model.
Results: Seventy-one ICU-acquired infections occurred in 52 (30.4%)
of 171 patients during 1440 patient-days. The overall rate of ICU-
acquired infection was 37.4/100 patients and 44.4/1000 patient-days.
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The most common site-speciﬁc infections were pneumonia (36.0%),
urinary tract infections (31.3%), and bloodstream infections (24.0%).
Urinary catheter-associated urinary tract infection rate was 15.0/1000
urinary catheter-days; central line-associated bloodstream infection rate
was 23.7/1000 central line-days and ventilator-associated pneumonia
rate was 40.6/1000 ventilator-days. The utilisation ratios of urinary
catheter, central line catheter and ventilator were 0.92, 0.38 and 0.19,
respectively. In univariate analysis, age “d60 years, glasgow coma scale
score” T10, being a neurology patient, presence of nasogastric tube,
central venous catheter, heart failure, and the presence of two or more
underlying diseases were determined as signiﬁcant risk factors for ICU-
acquired infections (p< 0.05). Multi-variate logistic regression analysis
revealed, being a neurology patient (p< 0.01), presence of nasogastric
tube (p< 0.05), and presence of central venous catheter (p< 0.01) as
independent risk factors.
Conclusion: In that study, ICU-acquired infection rates were found
higher when compared with NNIS results. In interpretation of device-
associated infection rates, the rates of device-use should be known those
high rates made us to take immediate precautions both for decreasing
device utilisation and emphasizing the importance of device application
and care practices.
R2271 Diarrhoea by Clostridium difﬁcile toxin
J.L. Prada, F. Moreno, J. De La Torre, A. Del Arco, J. Aguilar,
J.D. Ruı´z (Marbella, ES)
Introduction: Clostridium difﬁcile (Cd) toxin is a cause of diarrhoea in
patients treated with antibiotics. Any antibiotic may produce this problem
which start during the antibiotic treatment or even 4 days after its end.
Objectives: to study in our centre the clinical proﬁles and outcomes of
Cd associate colitis.
Method: Retrospective study of all the in-patients suffering from
diarrhoea and Cd toxin conﬁrmation in stools between 2000 and 2004.
We have used the Microbiology Lab Database and the patient clinical
records. Immunocromathographic quickly test in direct stool sample was
used to detect toxin A (InmunoCard Stat! Toxin A Meridian)
Results: Cd toxin test was required in 325 samples with positive results
in 21 patients (6.8%), one of them with two samples. Average age was
58 years (15−80) and 36.4% were males. 31.8% were diabetics, 22.7%
oncology patients without chemotherapy, gastroenterology diseases in
22.7%, bronchial diseases in 22.7%, chronic steroids therapy in 13.7%
and chemotherapy in 2 cases (9.1%). Active or previous antibiotic
treatment were described in 81.8% (n = 18), and there was no references
in 3 cases. Betalactamics were the source of the problem in 62.5%
(piperacilin/tazobactam was the ﬁrst cause with the half of the cases)
and quinolones in 37.5% (ciproﬂoxacin and levoﬂoxacin). The previous
infection-diagnosis was in the hospital in 72.7%. Outcomes were
satisfying in 90.9% (2 death by no-infectious causes) Cd colitis was
the main diagnosis in 27.2% of deﬁnitive medical reports. In 6 cases
(27.3%) there were a hospital admission in the previous 2 months. Colitis
treatment was described in 77.3% of medical records, metronidazol was
the central therapy with 15 of 17 cases, and vancomycin was used in the
other 2. The average of metronidazol-treatment-time was 10 days (5−16)
with doses between 250 and 500mg tid. By departments 45.5% were in
General Internal Medicine and 36.4% in the Gastroenterology Unit.
Conclusions: Colitis by Cd is not a common cause of diarrhoea, but
must be taken in mind in all in-patients receiving antibiotics, or with
previous antibiotics therapy, overall in diabetics.
R2272 Clinical correlates of Mortality Probability Model MPM II
and the outcome of a Burkholderia cepacia bacteraemia
outbreak in an intensive care unit in Guatemala, Central
America
I. Cazali, F. Ramirez, C. Mejia, C. Ramirez, M. Silvestre, R. Gordillo
(Guatemala City, GT)
Background: The prevalence of multidrug resistance (MDR) Gram-
negative bacteria is on the rise, but its effect on patients outcomes is
not well established. We assessed the impact of Burkholderia cepacia
with MPM II on the outcomes of critically ill patients with bacteraemia.
Objectives: To evaluate the outcome and risk factors of Burkholderia
cepacia bacteraemia according to the MPM II in critically ill patients.
Methods: 17/665 adult critically ill patients with Burkholderia cepacia
bacteraemia were evaluated retrospectively and compared to a control
group with Gram-negative bacteraemia. Demographics, baseline MPM
scores, appropriateness of empiric therapy were examined in relation to
infection-attributed mortality and clinical cure.
Results: The incidence of bacteraemia was 145.86× 1000 patients
in eight months. 97/306 (31.7%) blood cultures were positive; 17/97
(17.5%) due to B cepacia in 10 patients. 9 cases were analysed and
compared with 9 controls with bacteraemia due to Gram-negative
bacteria. There were no signiﬁcant differences among cases and controls
including: age (SD) 44 and 45.8 years, gender, antibiotics use and
the MPM II score (49.5% vrs. 46%). 2 (22%) cases vrs. 9 (100%)
controls received appropriate antibiotics for bacteraemia. Mortality rate
was 37.5% for cases and 66.6% for controls. No B. cepacia was found
in the intensive care facilities.
Conclusions: In the adult critically ill patients with Gram-negative
bacteraemia, Burkholderia cepacia was associated with a lower rate of
infection-attributed mortality, after adjusting for the severity of illness
as compared to other Gram-negatives. Inappropriate empiric therapy or
no therapy at all was not associated with mortality. Our results warrant
further investigations and conﬁrmation with a prospective study.
Travel medicine, tropical and parasitic
diseases
R2273 Prevalence of enteric parasites in people with and without
gastrointestinal symptoms in Gonbad, Iran
E. Nazemallhoseini-mojarad, F. Mesgariyan, A. Haghighi, M. Zali
(Tehran, IR)
Objective: Geographical conditions and poor nutritional and socioe-
conomic status contribute to making the Islamic Republic of Iran a
favourable area for parasitic infections.
The aim of this study is to investigate the prevalence of intestinal
parasitic infection in Gonbad city in Iran.
Method: From February 2005 to July 2006, ﬁve hundred and ﬁfty one
faecal samples were examined for intestinal parasites. All samples were
tested to detection and analysis the parasite by standard method.
Result: Out of 551 faecal samples (81%male and 19%female), 72
isolates (13.1%) including pathogen and non pathogen parasites were
positive. The results of this study showed a frequency rate of 48 (8.7),
31 (5.62%), 3 (0.54%), 3 (0.54%), 2 (0.36%), 2 (0.36%), 2 (0.36%) for
Giardia lamblia, Endolimax nana, Ascaris lumbricuides, Hookworm,
Enterobius vermicularis, Hymenolepis nana and Entamoeba histolytica
respectively.
Discussion: In this study G. lamblia showed the most prevalent rate in the
infections and E. nana was higher among the nonpathogenic protozoa.
Base on the result of present study, stool examination should be taken
for high-risk populations in the low level hygiene to increase knowledge
of people about personal and community health and hygiene.
R2274 Current concepts of malaria in Romania
S. Florescu, C. Popescu, M. Cotiga, L. Raduta, C. Voinea, E. Ceausu,
P. Calistru (Bucharest, RO)
Objective: Epidemiological, clinical, laboratory and therapeutical
aspects of imported malaria in Romania.
Methods: Retrospective study of 22 patients with malaria admitted in
the Clinical Hospital of Infectious and Tropical Diseases “Dr. V. Babes”
between January 1st, 2004 and October 31st, 2006.
Results: 8 patients were hospitalised in 2004, 7 in 2005 and 7 in 2006.
19 were romanian citizens and 3 were foreigners. Sex ratio: M/F-20/2. 18
patients traveled to Africa (5 to Nigeria, 3 to Guineea, 2 to Ivory Coast,
Resistance & mechanisms of action of antifungals S659
Camerun and Mozambic, respectively, and 1 to Ciad, Uganda, Mali and
Tanzania, respectively); 2 patients traveled to Papua New Guinee, and 1
to India and French Guinee, respectively. Age limits were between 24 and
70 years old. Travel length limits in the endemic zone were 2 weeks and
2 years, with a mean travel duration of 8 months. The interval between
arrival in Romania and clinical onset ranged from 3 days to 5 months, and
the period from the clinical onset and positive diagnose ranged from 1
day to 2 months. 15 patients had previously malaria. Only 3 patients had
malarial chemoproﬁlaxy. The aetiological distribution was as follows:
13 patients with P. falciparum, 5 patients with P. vivax, one patient with
P. malariae; in 3 patients we diagnosed double ethiology (P. falciparum
+ P. vivax – 2 patients, P. falciparum + P. malariae – 1 patient). The thin
and thick blood smears were the standard for the positive diagnose in
all the patients. The highest value for the parasitaemia was 300‰ (most
of the highest values in the P. falciparum malaria cases). 15 patients
had thrombocytopenia, 6 had anaemia, 8 had hyperbilirubinaemia, 5
had high levels of ALAT, and 3 had high creatinin levels. Ethiological
treatment consisted of: Quinine for 11 patients, artemisine derivatives
in 10 patients, Atovaquone+Proguanil in 3 patients, Meﬂoquine in 2
patients, and Artemether+Lumefantrine in 1 patient. 2 patients with
P. falciparum, and P. falciparum + P. malariae, respectively, had severe
forms of malaria (coma and acute renal failure). 2 patients had high
grade resistance (R2) to quinine. All patients survived.
Conclusions: Our clinic admittes a relatively constant number of
imported malaria cases. P. falciparum malaria is a possible lethal form
of the disease, thus the rapid diagnose and treatment is compulsory.
The ethiological treatment must take into account the specie of P., the
endemic zone, but also the possibility of the quinine resistance.
R2275 Haemophagocytic lymphohistiocytosis associated with
visceral leishmaniasis
A. Tapisiz, N. Belet, E. C¸iftc¸i, E. Ince, U¨. Dogru (Ankara, TR)
Visceral leishmaniasis (VL), is a systemic disease caused by
the dissemination of protozoan parasite Leishmania throughout the
reticuloendothelial system. It may mimic or lead to several types
of haematological disorders including hemophagocytosis. Infection
associated hemophagocytic syndrome implicating Leishmania is very
rare and often difﬁcult to diagnose. Here, we describe a child with
hemophagocytic lymphohistiocytosis (HLH) associated with VL.
A 2-year-old boy presented with a 1 month history of high fever,
fatigue, poor feeding, weight loss, pallor and abdominal distension. On
physical examination, he was febrile (39.6ºC) and pale. There was severe
weight loss and failure to thrive. He had hepatomegaly (4 cm below
the right costal margin) and splenomegaly (8 cm below the left costal
margin). Neither lymphadenopathy nor bleeding signs were observed.
Haematological investigation revealed hemoglobin 5.1 g/dL, white blood
cell count 3,300/mm3 (%16 neutrophils, %76 lymphocytes and %8
monocytes), platelet count 55,000/mm3. Erythrocyte sedimentation rate
was 55mm/hour, C reactive protein was 9.52mg/dL and ferritin was
6364 ng/mL. Fibrinogen level was normal. Serum triglycerides were
increased to 266mg/dL with normal cholesterol, and the serum lactate
dehydrogenase level was elevated at 2762 U/L. Serological markers
for Epstein–Barr virus, cytomegalovirus, parvovirus B19, toxoplasmosis,
hepatitis A and B viruses, HIV, salmonella and brucella agglutinins were
all negative and blood cultures could not demonstrate any infectious
agent.
On bone marrow aspiration hemophagocytosis and leishmania amastig-
otes were observed. The patient was diagnosed with HLH associated with
VL. Liposomal amphotericin B 3mg/kg/day was administered on 1−5,
14, 21 days. Treatment was well tolerated, no side effects were observed.
Symptoms and clinical ﬁndings improved gradually. Fever was controlled
on the 3rd day of treatment. After 5 days of treatment laboratory testing
revealed hemoglobin 8 g/dL, white blood cell count 4,500/mm3, platelet
count 144,000/mm3. One week later, the hepatosplenomegaly gradually
regressed. On discharge, physical examination was normal, with no
enlargement of spleen. No relapse was seen in a 6 months follow up
period.
VL should be considered for the aetiology of HLH. Awareness of this
association and early diagnosis of visceral leishmaniasis may prevent
prolonged hospitalisation and potentially harmful investigations and
treatments.
Resistance & mechanisms of action of
antifungals
R2276 Multicentre study of antifungal susceptibility patterns of
yeast isolates and their species distributions in Bulgaria
Z. Ivanova, T. Kantardjiev, A. Kouzmanov, L. Boyanova (Soﬁa, BG)
Objectives: The National Reference Laboratory of Mycology has started
for the ﬁrst time a survey on fungal infections in Bulgaria to get insight
in the species distribution and their antifungal susceptibility pattern.
In the current study is determined the ﬂuconazole and voriconazole
susceptibility of yeast strains mainly from genus Candida with the use
of E-test and micro-dilution kit Micronaut-AM (Merlin). The strains
with high minimal inhibitory concentrations (MICs) for ﬂuconazole and
voriconazole are additionally conﬁrmed with the referent broth micro-
dilution method NCCLS (currently CLSI) M27-A2.
Methods: A total of 235 clinical isolates has been collected in six
participating medical centres from January to November 2006. All yeast
strains are isolated from diverse body site, of immunocompetent and
immunocompromised patients, including HIV infected ones. Etest MICs
are determined with Mueller–Hinton agar containing 2% glucose and
0.5mg of methylene blue per l and were read after incubation for 24
and 48 h at 35ºC.
Results: Sixty-six percent of the isolates are identiﬁed as Candida
albicans, followed by C. glabrata (26%), C. parapsilosis (6.8%),
C. krusei (4.7%), C. tropicalis (3.4%) and other C. non-albicans
strains (7.2%). Low susceptibility to ﬂuconazole is detected among
C. albicans strains (3.2%, MIC> 256mg/L), C. glabrata (46%,
MIC16−32mg/L; 23%, MIC> 256mg/L), C. krusei (45.5%, MIC32−64;
36.4%, MIC> 256mg/L). No resistance to ﬂuconazole and voriconazole
is detected in C. parapsilosis, C. tropicalis and C. lusitaniae strains.
Resistance to voriconazole is detected only in C. glabrata (15.4%,
MIC> 32mg/L) and C. albicans (2.6%, MIC> 32mg/L) strains.
Voriconazole showed good activity to most of the tested isolates with
MICs in the range of 0.064−0.5mg/L.
Conclusion: This study conﬁrmed the high percentage of isolated
C. non-albicans strains and showed that species distribution of Candida
isolates is similar to that in other European countries. An important
concern is the low antifungal susceptibility detected in C. glabrata and
C. krusei and their high prevalence.
R2277 Antifungal susceptibility patterns of Candida isolates
recovered from bloodstream infections: a 3-year study
O. Zarkotou, K. Kopsari, V. Avramioti, G. Chrysos, D. Gianneli
(Athens, GR)
Objectives: To determine the prevalence of candidaemia in bloodstream
infections (BSIs), to deﬁne the species distribution among candida
isolates and to evaluate the antifungal susceptibility proﬁles.
Methods: During a 3-year period (11/03−10/06) a total of 1263
episodes of BSIs were studied. The blood cultures were incubated
in BACTEC 9240 Automated Blood Culture System (Becton and
Dickinson). The identiﬁcation of candida isolates to species level
was based on Fungichrom kit (International Microbio, France), until
April 2006. The isolates recovered after April 2006 were identiﬁed to
species level by VITEK2 Compact automated system (bioMe´rieux).
The antifungal susceptibility testing was performed by a colorimetric
microdilution method (Sensititre YeastOne Test Panel, UK) which is
based on NCCLS M-27-A2 standards and gives MIC results for 6
common antifungal agents: amphotericin B, ﬂuconazole, itraconazole,
ketoconazole, ﬂucytosine and voriconazole. The breakpoints for azoles
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and ﬂucytosine were those suggested by NCCLS. The strains with MICs
>1 for ampotericin B and voriconazole were considered resistant.
Results: During the study period a total of 58 episodes of candidaemia
in 56 patients were identiﬁed. Candidaemias accounted for 4.6% of
BSIs (58/1263) and 5.8% of the patients (56/964) developed BSI
due to candida species. The majority of candidaemias were observed
in ICU-patients (33/56) followed by surgical patients (14/56). The
species distribution study proved a clear predominance of Candida
albicans (40/58 isolates, 69%). The most prevalent among non-albicans
species was Candida parapsilosis (9/58, 15.5%). All candida isolates
were susceptible to amphotericin B. Susceptibility to all antifungals
tested was detected in 46.6% of the strains. Resistance to ﬂuconazole
and itraconazole was observed in 15.5% and 17.2% of the isolates
respectively, while 6.9 and 15.5% of them were susceptible dose-
dependent. The resistance rate to voriconazole was 13.8%. Resistance to
all azoles tested was detected in 5 Candida albicans and one Candida
glabrata isolate.
Conclusions: Candida albicans prevails among fungal isolates in
candidaemias in our hospital. The necessity of surveillance for detecting
trends in species distribution and antifungal susceptibility patterns is
emphasized by the increasing incidence of resistance to antifungals.
R2278 Determination of the antifungal activity of itraconazole,
voriconazole, posaconazole, amphotericin B and
caspofungin against 45 clinical isolates of zygomycetes
using the CLSI M-38A procedure
M. Torres-Narbona, J. Guinea, J. Martı´nez-Alarco´n, T. Pela´ez,
M. Guembe, E. Bouza (Madrid, ES)
Objectives: An increase in the incidence of Mucormycosis has been
reported during the last few years in some institutions. However, the
“in vitro” antifungal susceptibility proﬁle of clinical zygomycetes has
received little attention. The aim of our study was to determine the
activity of amphotericin B (AMB), itraconazole (ITC), voriconazole
(VC), posaconazole (POS) and caspofungin (CAS) against a collection
of clinical isolates of zygomycetes.
Methods: We evaluated the activity of AMB, ITC, VC, POS and CAS
against 45 clinical strains of zygomycetes collected during an 18-year
period in our hospital. The isolates were identiﬁed according to standard
methods. The antifungal activity was obtained by means of the CLSI
M-38A microdilution procedure. The ﬁnal concentration of the VC,
ITC, POS and AMB in the wells ranged from 0.03 to 16 mg/mL. The
ﬁnal concentration of CAS ranged from 0.25 to 256mg/mL. The trays
were incubated for 24 and 48 hours at 35C degrees. The MIC endpoint
was deﬁned as the lowest concentration producing complete inhibition
of growth (MIC-0) for all the antifungal drugs studied. The minimal
effective concentration (MEC), which was also calculated for CAS, was
deﬁned as the lowest concentration at which an abnormal growth was
observed.
Results: The distribution of the isolates studied was as follows:
Absidia (8), Cunninghamella (4),Mucor (19), RhizoMucor (1), Rhizopus
(11) and Syncephalastrum (2). We calculated the MIC90, MIC50, MEC
and range for each species and the results are summarised in the table:
POS was the most active drug, followed by AMB, ITC/VC and CAS.
We did not ﬁnd signiﬁcant variations between the MIC90 obtained at
24 and 48 hours of incubation, with the exception of the MICs of
POS against Absidia (1mg/mL and >16mg/mL, respectively). Absidia
and Mucor showed the highest MICs for POS. In addition, Absidia and
Cunninghamella were less susceptible to AMB than the other species.
VC and CAS were inactive against all the isolates tested.
Conclusions: AMB and POS showed potent in vitro activity against
zygomycetes whereas voriconazole and caspofungin presented very poor
activity. With the exception of POS and Absidia, the antifungal activity
of the drugs studied presented a slight variation between 24 hours and
48 hours of incubation.
Jesu´s Guinea Pharm D, PhD, is contracted by the Fondo de Investigacio´n
Sanitaria (FIS), contract number CM05/00171.
Susceptibilities of 45 strains examined.
Anti- 24 h 48 h
fungal MIC (mg/L) MEC MIC (mg/L) MEC
MIC50 MIC90 Range (mg/L) MIC50 MIC90 Range (mg/L)
AMB 1 2 0.125−4 1 4 0.125−>16
ITC 1 >16 0.25−>16 4 >16 0.5−>16
VC 16 >16 4−>16 >16 >16 8−>16
POS 0.5 1 0.125−2 0.5 2 0.25−>16
CAS 256 >256 64−>256 128 >256 >256 128−>256 128
R2279 Susceptibilities of different clinical isolates of Candida spp.
to voriconazole, itraconazole and ﬂuconazole
R. Cisterna, G. Ezpeleta, K. Ibarra, A. Morla (Bilbao, ES)
Objectives: There has been an increasing rate of fungal infections during
the last two decades that has created a need for standardised methods
for determining the in vitro susceptibilities of new and established
antifungal agents. The aim of this study is to describe the susceptibility
pattern of different Candida spp. strains to voriconazole, itraconazole
and ﬂuconazole isolated between January 2003 and January 2006.
Methods: 1791 isolates of Candida species from different sites were
collected for in vitro susceptibility testing to voriconazole using E-
test and broth microdilution (BMD) methods. The CLSI (formerly
NCCLS) BMD method used RPMI 1640. E-Test MICs were determined
with Mueller–Hinton agar containing 2% glucose and 0.5 micro g of
methylene blue per ml (MBE agar). All plates were incubated at 35ºC
with readings taken after 24 and 48 hours. E-Test MICs of voriconazole
read at 24 and 48 hours were compared to BMD MICs read at the
same time. MICs were read at the 24 and 48 hours. The interpretative
breakpoints described by the CLSI were used to determinate the
correlation between the E-test and BMD results.
Results: We observed positive statistical signiﬁcant (p< 0.01) correla-
tions between 93% and 98% between E-Test and the BMD method.
The general susceptibility pattern revealed that most of the isolates were
sensible to ﬂuconazole (Sensible (S): 87.94% Sensible dose dependant
(SDD): 8.23% Resistant (R: 3.83%) but this rate decreased when the
isolate considered was not a C. albicans (S = 68.84%;SDD= 21.3%; R:
9.86%). Voriconazole had a very good susceptibility pattern with less a
2% of isolates exhibiting a SDD or R MIC to this drug. Itraconazole
exhibited a rate of 1.1% of resistant stains and a nearly 4% of isolates
with SDD MIC.
Conclusions: These statistical results suggest that E-Test have very good
correlation with other methods like BMD to establish the susceptibility
of a fungal isolate to different azole drugs. Fluconazole remains to be a
good choice in case of Candida albicans infection but other azole drugs
must be considered when the strain isolated is not a C. Albicans. At
this point itraconazole but specially voriconazole could be the drugs of
choice for successful treatment of the infection
R2280 Surveillance of azole resistance among Candida non-albicans
clinical isolates from patients with invasive fungal infections
E. Kazakos, E. Moschous, E. Tsiakiri, S. Alexiou-Daniel (Thessaloniki,
GR)
Objectives: The aim of the present study was to document the
in vitro susceptibilities of Candida spp. representing predominantly
invasive forms of candidiasis, to currently available triazole agents and
ketoconazole in order to assess the rates of resistance per species and
identify possible implications for antifungal therapy selection.
Materials and Methods: A total of 68 isolates (4 C. ciferrii
, 6 C. dubliniensis, 3 C. famata, 10 C. glabrata, 1 C. haemulonii,
3 C. krusei, 5 C. kefyr, 4 C. lusitaniae, 24 C. parapsilosis, 2
C. sphaerica, 6 C. tropicalis) were included. The strains originated
from blood, respiratory tract specimens, surgical wounds and normally
sterile sites and each of them represented a unique infectious episode.
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Identiﬁcation to species level was achieved by the VITEK2 automated
system with greater then 98% probability. Antifungal susceptibility
testing to itraconazole, voriconazole, posaconazole, ﬂuconazole and
ketoconazole was performed using the Etest assay according to the
manufacturers’ instructions. MIC data were interpreted by applying the
CLSI breakpoints (document M27-A2) and tentative MICs’ previously
published.
Results: Overall, the rates of resistance recorded among all isolates
were 26.4% for itraconazole, 19.6% for posaconazole, 13.2% for
voriconazole, 16.1% for ﬂuconazole and 10.1% for ketoconazole.
All ﬂuconazole-resistant strains exhibited resistance to posaconazole
(MIC8ug/mL) whereas 72.2% of those strains appeared to be less
susceptible to voriconazole (MIC2ug/mL). Extended rates of cross-
resistance were also documented between ﬂuconazole and itraconazole
(100% of ﬂuconazole resistant isolates). Pan-azole resistance was evident
in 1 C. famata, 5 C. glabrata and 1 C. parapsilosis isolates.
Conclusions: Although our study is limited by the small number of
invasive Candida isolates from a single institution, our data provides
further evidence regarding the patterns of triazole cross-resistance,
previously reported. The degree of resistance recorded highlights the
need for introduction of antifungal susceptibility testing in routine
practice and raises important clinical issues related to therapeutic options
in patients with invasive candidiasis.
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R2281 Pneumocystis carinii pneumonia in HIV-negative patients
D. Kofteridis, M. Velegraki, M. Antoniou, G. Papazoglou,
T. Anastasopoulos, D. Alegakis, G. Samonis (Heraklion Crete, GR)
Purpose: Pneumocystis carinii (renamed jirovecii) pneumonia (PCP), is
a life-threatening opportunistic infection occurring in immunocompro-
mised hosts. The aim of this study was to investigate the predisposing
factors, clinical features and outcome of PCP in HIV-negative patients.
Materials and Methods: The medical records of 18 hospitalised
adult patients with PCP during a 3 year period (2004 to 2006) were
retrospectively reviewed using a standardised questionnaire.
Results: Twelve men (67%) and 6 women (33%) were identiﬁed
suffering of PCP.
Their median age was 65 (range 25−80 years). Eight patients had
haematologic malignancies, 5 solid tumours, 2 rheumatoid arthritis,
1 systemic lupus erythematosus and 2 patients had type 2 diabetes,
as underlying diseases. Cytotoxic and/or immunosuppressive drugs
including steroids were used in 14 (78%). One patient did not
have any known immunosuppression. Only ten patients (55%) had
absolute lymphopenia at the time of PCP onset, ranging from 100–700
lymphocytes/mm3 (median 300/mm3). In 7 (70%) out of 10 patients
having a high-resolution computed tomography the ground-glass pattern
was a characteristic ﬁnding suggestive of PCP. All 18 cases were
conﬁrmed microbiologically by direct immunoﬂuorescence technique.
On admission only 3 patients (17%) was receiving trimethoprim-
sulfamethoxazole prophylactically. Six patients (33%) developed severe
symptoms, required mechanical ventilation and were admitted to the
intensive care unit. All patients received appropriate therapy consisting of
trimethoprim-sulfamethoxazole (sulfamethoxazole 100mg/kg/day) and
corticosteroids. Improvement occurred only in 9 (50%) who survived,
whereas the remaining 9 patients died. PCP was the clear cause of death
in 5 (26%).
Conclusions: PCP is a life-threatening disease with poor prognosis in
patients treated appropriately. The infection occurs mainly in patients
treated with immunosuppressives, especially corticosteroids. However it
can also occur in patients with no apparent immunosuppression. PCP
prophylaxis should be considered in patients treated with corticosteroids
and those with malignancies receiving antineoplastic chemotherapy.
R2282 Isolation of Cryptococcus humicolus from an
immunocompromised HIV-negative patient
S. Baka, S. Antonopoulou, P. Salomidou, S. Meretaki, G. Kaparos,
S. Demeridou, A. Velegraki, E. Kouskouni (Athens, GR)
Objectives: Cryptococcosis is a disease caused usually by Cryptococcus
neoformans, an encapsulated yeast-like organism. The number of species
included in the genus Cryptococcus has increased over the last years.
Cryptococcus humicolus is a rare opportunistic yeast which starts to
be implicated more often in diseases of severely debilitated hosts.
Prevalence data are not available since the reports in the literature are
scarce. We report a case of cryptococcaemia by C. humicolus in an
immunocompromised HIV-negative surgical patient.
Methods: A 39-year old man was referred to our hospital with
a history of sigmoidectomy and colostomy 2 months ago because
of permeative peritonitis on the ground of acute diverticulitis. Two
explorative laparotomies and drainage of the intraabdominal collection
were also performed. He presented in a septic condition and 2 sets of
blood cultures were sent to the laboratory on admission in the ICU.
Identiﬁcation of the pathogen was performed using the API System
(boiMe´rieux, France) and susceptibility testing was carried out with 2
different methods (NCCLS and E-Test).
Results: Blood cultures became positive after two days of incubation
and C. humicolus was identiﬁed by means of colonies’ characteristics,
Gram stain morphology and ID 32 API (boiMe´rieux, France). The
isolated strain was sensitive to the antifungal agents studied: NCCLS
(amphotericin B, ﬂuconazole, voriconazole) and E-Test (amphotericin B,
5-ﬂuorocytocine, ketoconazole, ﬂuconazole, itraconazole). Two new
antifungal agents, caspofungin and posaconazole, were tested and the
MIC for caspofungin was 4 in both methods while for posaconazole
0.125 and 0.064, respectively. The patient was immediately put on
liposomal amphotericin B, voriconazole and ﬂuconazole. Clinical
improvement was seen after 3 weeks of treatment and the patient was
discharged from the ICU.
Conclusions: It seems that C. humicolus emerges as an important
pathogen in HIV-negative patients. Diagnosis must rely on positive
cultures followed by identiﬁcation of the pathogen. Early recognition
and proper therapy after appropriate susceptibility testing may improve
clinical outcomes.
R2283 Mycotic peritonitis in Saint-Petersburg, Russia
L. Pestova, N. Klimko, T. Bogomolova, I. Vibornova, A. Saturnov,
A. Priadko, I. Zuzgin, L. Plahotnyuk, G. Palval (Saint-Petersburg, RU)
Objectives: To determine epidemiology, underlying diseases, clinical
symptoms, treatment and outcomes of MP in patients (pts) in Saint-
Petersburg.
Methods: We have analysed prospectively demographic, clinical and
microbiological data for 29 pts with MP in 6 hospitals, during 1998–
2006. Diagnosis of MP was established on EORTC/MSG 2002 criteria.
Results: Male 14, female 15. Age: 3 months–78 years (median 47).
Nineteen pts (66%) were hospitalised in surgical ICUs and 10 (34%)
in dialysis units. Underlying diseases in surgical pts were pancreatitis
(5, 26%), ulcer disease (4, 21%), colon cancer (3, 16%), gallstone disease
(2, 11%), abdominal injury (2, 11%), liver transplantation (1, 5%),
congenital disease of GI system and kidneys (1, 5%), tuberculosis of
kidneys and urinary bladder (1, 5%). Underlying diseases in dialysis
patients were chronic glomerulonephritis (4, 40%), diabetes mellitus
(3, 30%), cystic disease (1, 10%), methylmalonic aciduria (1, 10%),
agnogenic chronic renal insufﬁciency (1, 10%). Main clinical signs
of MP were abdominal pus or unclear dialyzate (100%), fever >38C
(93%), septic shock (17%). Fungaemia and/or focal sites were detected
in 45% of pts. Forty-one fungal strains were isolated from 29 pts.
The most common species were Candida albicans 34%, followed by
C. parapsilosis 25%, C. glabrata 18%, C. krusei 8%, C. tropicalis 5%,
C. zeylanoides 2%, C. lusitaniae 2%, C. kefyr 2%, Trichosporon
mucoides 2%, T. cutaneum 2%. Monoinfection was in 62% of pts. The
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disease was caused by 2 different fungi in 38% of pts. Susceptible
to ﬂuconazole were 52% of strains, SDD 17%, resistant 31%. In 86%
of pts abdominal catheters were removed/changed and these patients
received antimycotic therapy: ﬂuconazole (84%), amphotericin B (32%),
caspofungin (12%), liposomal amB (4%). Therapy with two antimycotic
drugs was conducted in 32% of pts. Overall mortality rate was 31%.
Mortality rate in patients with removed/changed abdominal catheters
who received antimycotic therapy was 20%, 4 untreated patients died
(100%) (p = 0.003).
Conclusion: Mycotic peritonitis develops in surgical ICUs and dialysis
units’ pts. Main aetiologic agents are Candida spp. (96%), 31% of strains
are ﬂuconazole resistant. Effective antifungal treatment, removing of
abdominal catheters are important in the management of these infections.
R2284 Aspergillus endophthalmitis in an immunocompetent
woman: intra-ocular penetration of oral voriconazole
S. Logan, E. Graham, M. Rajan, E. Johnson, J. Klein (London, Bristol,
UK)
Aspergillus fumigatus is a recognized cause of endophthalmitis in the
immunocompromised. We report a case in an immunocompetent patient.
There are only three previous reports in the literature of endogenous
spread of Aspergillus species to the eye in apparently immunocompetent
individuals.
Voriconazole penetration into the vitreous has not been assessed in the
inﬂamed eye.
Initial management with oral voriconazole produced good results. We
were able to demonstrate equivalent voriconazole concentrations in
serum and vitreous samples by means of a bioassay.
Despite negative fungal culture of the vitreous ﬂuid after treatment
with voriconazole the appearance of the eye worsened and she required
enucleation.
This case report serves to highlight the potential for endogenous
Aspergillus endophthalmitis to occur in immunocompetent individuals.
Voriconazole appears to penetrate the inﬂamed eye well, the prognosis,
however, remains poor.
R2285 Comparison of antifungal susceptibility test methods for
yeasts using broth microdilution, EtestTM and Fungitest
O. Perovic, C. Rosmarin, J. Wadula, S. Gould, K. McCarthy, D. Orton,
D. Antelme, L. Bhagoobhai, A. Duse (Johannesburg, ZA)
Introduction: Antifungal drug resistance is likely to be a result of
the increased use of antifungal agents as treatment and prophylaxis
and is associated with high morbidity and mortality. Appropriate initial
therapy for invasive fungal infections may require the introduction of
susceptibility testing for selected isolates. Reference guidelines are based
on a broth microdilution method. Agar dilution, EtestTM, disk testing,
and modiﬁed broth microdilution technique, have been deemed to be
easier to perform, time efﬁcient and less laborious. An evaluation of
three test methods was proposed in our hospitals to select for the most
optimal test.
Objectives of our study were to determine the susceptibility of mucosal
and invasive isolates of Candida species using the broth microdilution
technique and to compare the EtestTM and Fungitest® test methods to
the reference method.
Methods: Test evaluations were performed at the Johannesburg, Chris
Hani Baragwanath hospitals and Mycology Reference Unit during 2006.
Eighty eight invasive clinical isolates of Candida species including
albicans, glabrata, parapsilosis, tropicalis, krusei, dublinsiensis, guiller-
mondii, were analysed.
The CLSI broth microdilution method M27-A2, EtestTM and Fungitest
were performed.
Antifungal susceptibility proﬁles were compared amongst ﬂuconazole,
and amphotericin B. All assays were carried simultaneously and results
read at 24 h as well as 48 h of incubation. The tests were performed
according to manufacturer instruction.
Results: MIC 90 and 50 for amphotericin B and ﬂuconazole for all
our isolates are presented in the Table. For amphotericin B all three
test methods had a high concordance. For ﬂuconazole there was poor
agreement between Fungitest® and broth microdilution test and a high
number of major errors were identiﬁed.
Susceptibility of Candida spp. to antifungal agents determined by CLSI
M27-A2 broth dilution MIC reference method
Species No. tested Antifungal agent MIC (mg/mL)
MIC50 MIC90
Candida albicans 46 Amphotericin B 0.125 0.25
Fluconazole 2 8
Candida dubliniensis 1 Amphotericin B 0.125 0.25
Fluconazole 32 64
Candida glabrata 13 Amphotericin B 0.25 32
Fluconazole 0.5 64
Candida guilliermondii 1 Amphotericin B 0.5 1
Fluconazole 32 64
Candida krusei 9 Amphotericin B 0.25 0.5
Fluconazole 32 64
Candida parapsilosis 5 Amphotericin B 0.25 0.5
Fluconazole 8 16
Candida tropicalis 4 Amphotericin B 0.25 0.5
Fluconazole 16 32
The best agreement was observed with the EtestTM 48hours for Candida
species where correlation was 88% at 48 h compare to 58.7% at 24 hours.
Fungitest® showed 6.25% and 46.87% at 24 h and 48 h respectively.
Conclusion: We founded that the EtestTM for ﬂuconazole performed
better in predicting resistance than the Fungitest®. Also, results of
EtestTM at 24 hours were equivalent to 48 hour readings, thus allowing
for a more rapid result, a feature not found for the Fungitest®. Therefore
the EtestTM would be more suitable and efﬁcient in a routine academic
microbiology laboratory.
R2286 The frequency of isolation and the susceptibility to
antifungals of Candida species in a large academic hospital:
three-year surveillance
M.C. Ghezzi, G. Raponi, C. Mancini (Rome, IT)
Objective: The pattern of Candida species commonly isolated in various
clinical settings is continuously changing. Purpose of this study was to
analyse the frequency of isolation of different species of Candida and
the variation of their susceptibility to antifungals, during a three years
surveillance study.
Methods: Candida species were isolated from clinical samples of
patients hospitalised at the “Azienda Policlinico Umberto I” Academic
Hospital of Rome, Italy during three years (2003–2005). Strains were
identiﬁed by germ tube test and by API 32C®. The susceptibility testing
was performed by Sensitre Yeast One® test on clinically based request,
and the results were interpreted according to the manufacturer’s and
CLSI guidelines.
Results: A total of 3022 strains of Candida were identiﬁed during
the study period. The specie most frequently isolated was C. albicans
(83.9%) followed by C. glabrata (7.8%), C. tropicalis (5.1%) and other
Candida species (4.2%). The frequency of isolation of C. albicans
steadily decreased during the study period, starting from 90% in 2003
to 80% during 2004 and 2005. Instead, the isolation of C. glabrata
and C. tropicalis doubled in the same period from 4.5% to 9.5% and
from 2.2% to 4.8% respectively. Antifungal tests were performed on
110 strains isolated from blood stream (50.9%), lower respiratory tract
(26.3%), wounds (16.4%) and urinary tract (6.4%). C. albicans showed
very low frequency of resistant isolates, with 3 strains in 2004 and one in
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2005 resistant to at least one antifungal. Conversely, C. glabrata showed
low susceptibility to itraconazole (18%), to ﬂuconazole (59%), and, to
a lower extent, to amphotericin B (88.3%) and to voriconazole (94%).
Furthermore, the number of C. glabrata strains resistant to at least one
antifungal steadily increased from 0 in 2003 to 10 strains in 2005.
Conclusions: The results of this study indicated that the pattern of
Candida species isolated during the years varied in our clinical setting,
showing an increasing incidence of non-albicans species, particularly
C. glabrata and C. tropicalis. The susceptibility data evidenced that
strains of C. albicans were highly susceptible to the test drugs, together
with an increasing rate of C. glabrata strains resistant to antifungals. The
usage of azoles in the prophylaxis of fungal infections in our hospital
probably inﬂuenced the diffusion of non-albicans species, some of which
are frequently resistant to these drugs.
R2287 Antifungal utilisation in a haematology unit in Turkey: a
part of the FUNGOBASE Study
A. Azap, O¨. Kumbasar, H. Akan (Ankara, TR)
Objective: To evaluate antifungal (AF) usage in haematology unit of a
tertiary care hospital.
Methods: The study was conducted in 60 bed haematology unit of
Ankara University Medical School. The unit has 20 beds for stem
cell transplantation. AF prescriptions in 2004 and 2005 were analysed.
Data were collected retrospectively by the help of an AF prescription
surveillance programme (FUNGOBASE). Renal toxicity was described
as 50% increase in the basal serum creatinin level.
Results: AFs were used in 215 febrile episodes not responding to broad
spectrum antibiotics in a two years period. Amphotericin B deoxycholate
(AmB-d) was the initial therapy in 192 (89%) episodes. In 109 (56%)
of 192 episodes no other AF was used during the course of neutropenia,
and the median duration of AmB-d therapy was 12 days (4−46 days).
In 32 (17%), 38 (20%), and 13 (7%) of 192 episodes AmB-d was
stopped due to infusion related toxicities, nephrotoxicity, and treatment
failure, respectively. The most common AF choice in patients who did
not tolerate AmB-d (nephrotoxicity and infusion related toxicities) was
lipid formulations of amphotericin B (AmB) (74%) and caspofungin
(11%). Lipid formulations were used for a median duration of 15 days
(3−76 days). Combination AF therapy was used as initial treatment in
2 patients and for salvage in 13 patients. Combination therapy succeded
in 7 (46%) patients.
Conclusion: AmB is a broad spectrum antifungal agent. The reasons
limiting AmB-d use are nephrotoxicity and infusion related toxic effects.
Its main advantage on other AF agents is low cost. In our setting AmB-d
was well-tolerated by 56% of the patients. Despite its disadvantages
AmB-d is still the main drug in the treatment of invasive fungal infections
especially in countries with limited sources.
R2288 Mycological and pathological ﬁndings of sinus material
from patients with chronic sinusitis
F. Can, M. Demirbilek, L. Ozluoglu, N. Haberal, B. Akkuzu, E. Aydin,
H. Arslan (Ankara, TR)
Background: Fungi are important aetiologic agents of sinusitis but
incidence and fungal types have not been systematically studied. This
study was designed to evaluate the incidence of fungi and dispersal of
species in chronic sinusitis another aim of the study was to saw the
correlation among microbiological and pathological ﬁndings.
Methods: Specimens of mucin, sinus secretions, and/or tissue were
obtained intraoperatively from 60 cases of chronic sinusitis (without
diabetes mellitus and/or immunosupression) and sent to the mycology
and pathology laboratory. For microbiological ﬁndings; specimens were
treated with Sputolysin and cultured on Sabouraud’s dextrose agar,
Mycosel agar, and Brain-Heart Infusion agar plates; and incubated at
30ºC (and 37ºC) for up to 6 weeks. Identiﬁcations were made according
to standard procedures. For pathological ﬁndings; conventional H&E and
Gomorie’s methamine silver (GMS) stain were employed in all cases.
Results: The fungal species were demonstrated in 21 of 60 specimens.
Aspergillus spp. was the commonest isolate (48%) and it was followed
by dematiaceous fungi which found in 7 patients. Candida albicans were
isolated from 2 patients and Curvularia lunata, Paecilomyces lilacinus,
Chrysosporium spp. were isolated from one patient each.
Although allergic fungal sinusitis was detected in 17 of 21 patients (81%)
that fungi were isolated by culture, it was found to be 51% (20 of
39) in fungal culture negative patients in histopathological examination
(p< 0.5). According to the histopathological ﬁndings one patient had
chronic invasive fungal sinusitis and Chrysosporium spp. was isolated
from that patient.
Conclusion: Our data showed that allergic sinusitis was the most
common part of chronic sinusitis (37 of 60) and fungi was isolated from
46% of them. Aspergillus spp. and dematiaceous fungi are most relevant
species. These data would be important for clinicians while choosing the
empiric drug therapies for chronic sinusitis.
R2289 Epidemiology of candidaemia and antifungal susceptibility
patterns in a Turkish university hospital
S. Serin Senger, M. Demirbilek, O. Kurt Azap, F. Timurkaynak,
H. Arslan (Ankara, TR)
Objective: Candida species are the fourth most common cause of
hospital-acquired bloodstream infection. Our objective was to evaluate
the Candida species and antifungal drug resistance.
Methods: The study was conducted retrospectively from Feb. 2005 to
Oct. 2006. Antifungal susceptibility test was performed according to
CLSI M27-A protocol and MIC values were also determined by using
E-test and RPMI 1640 agar with 2% glucose.
In vitro susceptibilities of bloodstream Candida spp. isolates.
Antifungal agent MIC (mg/L)
MIC50 MIC90a Range
C. albicans (n = 25)
Fluconazole 0.25 1 0.06−16
Itraconazole 0.02 0.09 0.008–0.25
Voriconazole 0.012 0.064 0.002–0.64
Caspofungin 0.03 0.06 0.012–0.25
Amphotericin B 0.047 0.12 0.002–0.125
Non-albicans Candida spp. (n = 7)
Fluconazole 0.75 ND 0.12−>256
Itraconazole 0.03 ND 0.016−0.5
Voriconazole 0.016 ND 0.003–0.19
Caspofungin 0.03 ND 0.002−>32
Amphotericin B 0.094 ND 0.003−0.5
Total (n = 32)
Fluconazole 0.25 1 0.06−>256
Itraconazole 0.02 0.09 0.008−0.5
Voriconazole 0.016 0.064 0.002–0.64
Caspofungin 0.03 0.06 0.002−>32
Amphotericin B 0.047 0.12 0.002−0.5
aND, not determined.
Results: A total of 32 candidaemia episodes were encountered in
31 patients. Overall, 25 (78.1%) episodes were due to C. albicans,
followed by 2 (6.3%) of C. tropicalis, 2 of C. famata, and 1 (3.1%)
of C. parapsilosis, C. glabrata, and C. guillermondii each. The invitro
activities of all tested agents are outlined in the table. Only one
C. albicans strain (4%) was susceptible dose-dependently (SDD) to
ﬂuconazole, all others were susceptible. The same strain was also SDD to
itraconazole, but the voriconazole MIC value was <1mg/L. MIC values
of non-albicans strains were higher than C. albicans strains. Resistance
to ﬂuconazole was detected in the C. parapsilosis strain and this
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strain was SDD to itraconazole. C. guillermondii strain was resistant to
caspofungin (MIC> 32mg/L). None of the other strains of Candida spp.
had MIC value greater than 1mg/L to caspofungin, amphotericin B and
voriconazole. Twenty four (77.4%) of the patients were in ICU, 6 (19.4%)
of whom had burns. CVC were in place in 29 (93.5%) patients. Prior
antibiotic usage was present in 30 (96.8%) patients. Fifteen (48.4%)
patients were subject to total parenteral nutrition. As an underlying
condition, 8 (25.8%) had prior abdominal surgery, 10 (32.3%) had
malignancy, and 10 (32.3%) had chronic renal failure. Prior ﬂuconazole
usage within a month of the ﬁrst positive blood culture for Candida spp.
was present for 22 (71%) patients, two of whom had ﬂuconazole-resistant
or -SDD candidaemia. 11 episodes were treated with ﬂuconazole and 18
with caspofungin. The overall mortality rate was 45.2%.
Conclusion: C. albicans was found as the most common cause of
candidaemia. Our study suggests that ﬂuconazole resistance has not
emerged among bloodstream isolates of C. albicans, although isolated
from patients at high risk. Although number of non-albicans Candida
strains is too low, ﬂuconazole resistance was detected in one strain
(14.3%). Present study shows that even for the patients at high risk,
ﬂuconazole still remains the drug of choice for C. albicans strains.
R2290 A four-year epidemiological study of aetiological agents of
yeast infections and antifungal susceptibility proﬁles in the
centre of Portugal
C. Paulo, J. Marques, C. Moura˜o, A. Melic¸o-Silvestre, A. Florindo,
T. Gonc¸alves (Coimbra, PT)
Objectives: The objective of this study was to characterise the
aetiological agents of yeast infections in the Portuguese population,
together with the antifungal susceptibility proﬁles.
Methods: Yeast isolates were collected from October 2002 to October
2006, from patients attending or hospitalised at the Centro Hospitalar
de Coimbra. Species identiﬁcation was primarily obtained using
the commercial methods Bichro-latex Albicans Fumouze (Fumouze
Diagnostics, France) and Api ID 32C (BioMe´rieux, Portugal), and
antifungal susceptibilities using the ATB Fungus 2 INT (BioMe´rieux,
Portugal) and the Fungitest (Sanoﬁ Pasteur). Then, all the conﬁrmed
aetiological agents were subjected to re-identiﬁcation by RFLP of the
5.8 S-ITS and/or by sequencing the contiguous D1/D2 fragment from
the rRNA 26 S gene. All the isolates were deposited in a pathogenic
yeast collection, the PYM collection. The following patient data was
collected and registered in a database: age, gender, underlying disease,
specimen collected.
Results: A total of 727 yeast isolates were obtained, and conﬁrmed as
aetiological agents of yeast infections, during the four-year surveillance
study. Half of the samples studied belong to patients older than 60
years. The most represented specimens in this survey were isolated
from respiratory system infections (292), followed by urine (152),
blood (48), catheters (49), gynaecological (47), intra-abdominal (20) and
skin lesions (54). Among these, only 2% were not correctly identiﬁed
using the commercial methods described above, when conﬁrmed
by the molecular biology techniques. As expected, the predominant
pathogen is Candida albicans (60%), followed by C. tropicalis,
C. parapsilosis and C. glabrata. Moreover, other species belonging to
the Candida genus were also found as aetiological agents, together
with Saccharomyces cerevisiae, Geotrichum capitatum, Cryptococcus
neoformans. The isolated pathogens proved, in vitro, to be susceptible to
the tested antifungals, included in the methods used. Infrequently, some
isolates exhibited resistance to itraconazole (21 isolates).
Conclusion: The data obtained during this study represents the ﬁrst
broad epidemiological study on yeast infections in the Portuguese
population. As expected from similar studies in different countries the
predominant pathogenic yeast is C. albicans. Albeit, these results showed
that there are some regional speciﬁcities in what regards yeast infections
aetiology.
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R2291 HIV infection, HAART, and gynecomastia. Epidemiological,
clinical, and potential pathogenetic correlates
R. Manfredi, L. Calza (Bologna, IT)
Introduction: Gynecomastia (G) is an emerging untoward event in
patients treated with HAART.
Patients and Methods: Through a cross-sectional study performed
on around 1,000 HIV-infected patients (p) treated with antiretrovirals
at our reference centre in Bologna (Italy), we identiﬁed all cases of
G related to the administration of at least 12 consecutive months of
HAART, to assess possible correlations of G with a spectrum of clinical,
laboratory, and therapeutic variables (and including all adverse effects
of HAART itself). All p with true G (as distinguished from lipomastia
by an ultrasonography assay) were considered evaluable, while p with
other predisposing conditions (endocrine disease, alcohol abuse, liver
cirrhosis, and use of drug possibly predisposing to G), were carefully
ruled out.
Results: Twenty-one out of 616 evaluable HIV-infected male p (3.4%
of our p population), developed a true G when aged 12−58 years.
Seven p out of 21 never received protease inhibitor (PI)-containing
therapies, while efavirenz-based regimens apparently prompted G in
7 p who were naı¨ve for PI, and worsened this disturbance in three
further p who abandoned PI for efavirenz. Considering nucleoside
analogues (NA), two p developed G during treatment conducted with
dual isolated NA. Comparing the different administered NA, stavudine
seemed to be the most commonly used compound, also taken for the
longest time (p< 0.01). A complete hormonal workup did not detect
signiﬁcant abnormalities, save in one p, who had slight serum FHS,
LH, and testosteron abnormalities (with normal prolactin levels). When
considering the eventual correlation with the most common HAART-
induced disturbances, some forms of lipodystrophy was concurrent in
all the 21 p with G, while hypertriglyceridaemia, hypercholesterolaemia,
and hyperglycaemia were found in 15, 9, and 3 p, respectively. During
the subsequent 12−36-month follow-up, a spontaneous ameliorement of
G was never observed, notwithstanding eventual HAART modiﬁcations.
Due to local hypersthesia, tenderness, and discomfort, two p resorted to
surgery.
Conclusions: G is probably an underestimated problem in the setting
of HAART. The frequent association of G with other HAART-related
dysmetabolism suggests a possible common pathogenetic causes.
R2292 Aetiology of withdrawal lopinavir/ritonavir in a group of
HIV-infected patients and evolution of subjects changed to
other treatments in a simpliﬁcation strategy
V. Moreno, E. Valencia, I. Jime´nez-Na´cher, J. Gonza´lez Lahoz (Madrid,
ES)
Objectives: (1) To analyse the aetiology of withdrawal Lopinavir/ritona-
vir (LOP/r) in a group of HIV infected patients with prolonged viral
suppression and (2) to analyse the evolution of subjects changed to other
treatments in a simpliﬁcation strategy.
Methods: We reviewed the clinical history of 101 HIV+ patients treated
with LOP/r who were switched off to other treatment when they were
with complete viral suppression. A data base was developed and the
epidemiological, clinical, serological and laboratory characteristics were
studied. All the simpliﬁcation cases were separately analysed and the
subjects with treatment failure were reviewed. Statistical study was done
by SPSS 13.0.
Results: Causes of LOP/r withdrawal were: toxicity in 7 cases, treatment
interrupttion in 3 and simpliﬁcation in 61 (65%). Two patients died,
10 were lost and in 8 was no possible to ﬁnd the aetiology. Mean
age in 61 patients who were simpliﬁed was 42 years (r: 27−59) and
52 (85.2%) were men. They had been receiving LOP/r for at least
12 months, 73.8% were heavily pre-treated and mean CD4+ cell was
613±343mm3 (r: 108–1800). Twelve patients (19.7%) had AIDS and 24
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(39.3%) had hepatitis C virus (HCV) co-infection. Twenty ﬁve patients
were simpliﬁed to receive a protease inhibitor (PI) free schedule (13
TrizivirR, 10 efavirenz and 2 nevirapine) and 36 received another PI:
25 atazanavir/ritonavir (ATZ/r), 8 ATZ and 3 fosamprenavir/rito-navir
(FOS/r). One year, after simpliﬁcation, virological failure developed in
11 cases (18%) and mean time was 6 months. Forty seven subjects
(77%) continued with complete viral suppression, 1 patient withdrew
recommended treatment and 2 were lost. All failures took place in pre-
treated patients and the most frequent were in TrizivirR (46%) and
efavirenz (30%) group. Patients simpliﬁed to nevirapine and FOS/r
continued with undetectable viral load. Only two of 33 subjects receiving
ATZ (one without ritonavir) developed virological failure (6%). The
results did not depend on HCV co-infection or having AIDS but previous
treatments and the presence of resistance mutations inﬂuenced the
evolution. After LOP/r withdrawal, there were statistical differences in
metabolic and hepatic parameters without clinical signiﬁcance.
Conclusions: Simpliﬁcation was the main cause of withdrawal LOP/r
in patients with suppressed viral load. This strategy should not be
considered in pretreated persons overall if PIs-free schedule is going
to be used.
R2293 Prevalence of genotypic resistance to nucleoside analogues,
non-nucleoside analogues and protease inhibitors in
HIV-infected persons in Athens, Greece
G. Panos, G. Charatsis, V. Paparizos, M. Kazantzi, M. Falagas (Athens,
GR)
Objective: To study the prevalence of genotypic resistance to nucleoside
analogues (NRTIs), non-nucleoside analogues (NNRTIs) and protease
inhibitors among HIV-1 infected persons in Athens, Greece.
Methods: Patients followed at 2 HIV Units were examined for
emergence of antiretroviral resistance mutations (ARMs) in this
observational study where complete therapy history was available. HIV-1
genotypic resistance was performed by using the HIV-1 TRUGENE®
Genotyping kit and ViroSeqTM HIV-1 Genotyping system. All mutations
were recorded according to the October/November 2005 IAS-USA Drug
Resistance Mutations Figures.
Results: Our data are from 234 patients that underwent genotypic testing
out of 2069 followed during 1987–2004. The most frequently observed
ARM of each drug category were to NRTIs at codons M184V [present
in 149 tests (63.6%)], M41L [79 tests (33.8%)], K70R [66 (28.2%)],
M184VI [58 (24.8%)], T215YF [53 (22.7%)], D67N [82 (35.0%)],
T215Y [72 (30.8%)], K219Q [47 (20.1%)], K219E/Q [54 (23.1%)],
and L210W [49 (20.9%)], respectively. The most prevalent mutations
related to NNRTIs were K103N [present in 59 tests (25.2%)], G190A
[50 (21.4%)], and Y181C [48 (20.5%]. Mutations in the protease gene
showed that the ARM at residue L63P was the most prevalent present in
119 samples (50.9%). Other protease mutations commonly found were
V82A/F/T/S [85 (36.3%)], I54L/M/V [93 (39.7%)], L90M [62 (26.5%)],
M46I/L [67 (28.6%)], I84V [27 (11.5%)], L33F [16 (6.8%)], and D30N
[12 (5.1%)].
Conclusion: L90M (26.5%) was among the most frequently observed
key protease mutations in our series, probably attributed to the steady
increase in prevalence of non-B subtypes in Greece (mainly subtype A).
R2294 Helicobacter pylori infection in symptomatic HIV-
seropositive and seronegative patients: a case-control study
G. Panos, E. Xirouchakis, V. Tzias, G. Charatsis, I. Bliziotis,
V. Doulgeroglou, N. Margetis, M. Falagas (Athens, GR)
Objective: We conducted this study to evaluate the prevalence and
morbidity of Helicobacter pylori infection in HIV seropositive patients.
Methods: Case-control study of HIV seropositive and seronegative
patients in a tertiary care hospital in Greece.
Results: HIV seropositive patients were infected by H. pylori less often
than HIV seronegative controls [12/58 (20.7%) versus 38/58 (65.5%),
p< 0.001]. The mean CD4 count was lower for H. pylori negative than
H. pylori positive HIV infected patients (p< 0.007). Also, among HIV
patients, prior use of antibiotics or proton pump inhibitors was more
common in those without H. pylori infection, a result that almost reached
statistical signiﬁcance (p = 0.06). The grading of the density of H. pylori
infection and the grading of the histomorphological ﬁndings according
to Sydney classiﬁcation were similar between HIV seropositive and
seronegative patients with H. pylori infection.
Conclusion: Our data suggest that HIV seropositive patients are infected
by H. pylori less often than the general population. In addition, among
patients with HIV infection, these with decreased CD4 cells are less
likely to be co-infected with H. pylori.
R2295 Study of the genotypic-resistant pattern in plasma of a group
of HIV-infected Cameroonian pregnant women and children
O. Turriziani, G. Russo, M. Lichtner, M. Bucci, A. Stano, I. Sauzullo,
F. Mengoni, A. Ialungo, V. Vullo, G. Antonelli (Rome, IT)
Objective: To study the genotypic resistance pattern in plasma-HIV
RNA derived from HIV-1 infected Cameroonians pregnant women and
children.
Patients The samples used in this study derived from a cohort of
HIV infected mothers and their children who participated in a PMTCT
programme (Prevention mother to child transmission) based on HIV-
NET protocol. 49 Cameroonians HIV-1 infected pregnant women and 7
HIV-1 infected children.
Methods: RNA was extracted from 140 mL of plasma using a QIAmp
Viral RNA kit (Qiagen, Milan, Italy) following the manufacturer’s
instructions. Sequencing was undertaken using CLIP, a DNA sequencing
technique for direct sequencing of small quantities of ampliﬁed template
(TruGene HIV-1, Bayer Diagnostics).
Results: Eight out of 49 pregnant women examined and 4 out of 7
children who underwent the treatment develop resistance to NVP. Three
of the 4 children harbour a resistant virus different from that of the
mothers who indeed harbour a wild variant of the virus. This indicates
that the virus has not been transmitted by the mothers but they develop
resistance after the treatment received after birth. Since the mothers and
children have been treated once and with a single dose of nevirapine,
the data also show that NNRTI resistant variants persist also in absence
of the drugs.
The sequence analysis of the protease region also revealed the presence
of minor PI mutations in 44 of 49 mother’s samples studied (median
5 mutations; range 0−7). Interestingly the PR sequence from children
revealed the same PI substitutions in 4 cases, while in 3 children
the mutations detected were different from those revealed in mother’s
samples.
Conclusions: These data conﬁrm that one dose of NVP is sufﬁcient
to select NNRTI resistant variant which can persist for long time also
in the absence of the selective drug. Furthermore our results show that
HIV-1 from Cameroonian patients seems to display a peculiar pattern of
minor substitution associated to PI resistance. Further studies are needed
to verify whether the use of PIs in Cameroon may result in the rapid
emergence of PI resistant strain.
R2296 Antiretroviral drug resistance among drug-naive
HIV-infected patients in Korea
S-H. Lee, E-K. Rheu, D-H. Cah, S-J. Lee, H-S. Rheu, H-H. Kim,
G-J. Cho (Busan, KR)
Objectives: The prevalence of HIV drug resistance mutations in durg-
naive patients has been shown to differ with geographic origin. The
purpose of this study was to assess the prevalence of transmitted
antiretroviral drug resistance mutations in drug naive patients in Korea.
Methods: Genotypic resistance was determined by using ViroseqTM
Genotyping System in 51 antiretroviral treatment naive HIV-infected
patients between March 2005 and September 2006. Transmitted drug
resistance was estimated according to the IAS-USA 2006 deﬁnition,
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taking into account only major mutations in protease and all mutations
in reverse transcriptase including revertant mutaions at codon 215.
Results: The median age was 42 years and 46 (90%) were male. Median
CD4 cell count was 131/mm3 and mean plasma RNA level was 4.98 log
copies/mL. Among 51 patients studied, 46 (90%) were newly diagnosed
patients. None of them were recent seroconverters. 46 (90%) were
infected with subtype B and 5 (10%) with the non-B subtype strains
(3 as CRF01_AE; 1 as CRF02_AG; 1 as subtype A). Of all 51 subjects
tested, we did not ﬁnd any primary mutations of NRTI, NNRTI as well
as PI regions, resulting in an estimated prevalence of 0% in this study.
Although no primary mutations were found, V118I was found in 2
patients and T69S in 1 patient for NRTI, V179D/E in 3 patients and
A98G in 1 patient for NNRTI, and 50 of 51 (98%) patients carried one
or more secondary PI mutations/polymorphisms.
Conclusion: Prevalence of transmitted antiretroviral drug resistance in
drug-naive patients was still low in Korea.
R2297 Pharmacokinetics of atazanavir in HIV-HCV co-infected
patients with or without cirrhosis
F. Gatti, A. Loregian, P. Nasta, S. Pagni, K. Prestini, A. Matti, S.G. Parisi,
L. Biasi, M. Puoti, C. Boldrin, G. Palu`, G. Carosi (Brescia, Padua, IT)
Objectives: To evaluate the inﬂuence of liver cirrhosis on
atazanavir (ATV) pharmacokinetics (PK) in HIV/HCV co-infected
patients (pts) treated with atazanavir ± ritonavir (ATV 400mg QD or
ATV/r 300/100mg QD).
Methods: 14 HIV/HCV co-infected pts receiving ATV/r 400/100mg QD
and 4 pts receiving ATV 400mg QD were included. According to
liver stiffness (LS) value obtained by ﬁbroscan® at the moment of
PK determination or histological diagnosis patients were classiﬁed in
2 groups:
• NC, no cirrhosis (10 pts); LS< 12 kPa or Knodell ﬁbrosis score (Kfs)
1−3;
• C, cirrhosis (8 pts); LS12 kPa or Kfs 4.
ATV plasma levels were determined by High Performance Liquid
Chromatography.
Samples for the 24 hour PK curve were collected at t = 0–1.5–3.5–8 h
at the steady state. C trough (Ct) was determined before the daily dose.
PK analysis of plasma ATV concentration–time data were conducted
using non-compartmental methods with WinNonlinProfessional soft-
ware, version 4.1. The area under the concentration–time curve during a
dosing interval (AUC0−24) was calculated using the log linear trapezoidal
method. Results are expressed as median and interquartiles.
Parametric and non parametric tests have been used for comparison
of continuous variables between groups when appropriate and linear
regression analysis to test correlation between variables (p< 0.05 was
considered as signiﬁcant).
Results: All but one pts had HIV-RNA <50 copies/mL and 14/18 pts
were on TDF+3TC/FTC. Median (range) LS was 6 (5−9) kPa for NC
and 19 (13−21.5) for C pts (p = 0.0005). Median (range) ATV Ct level
was 390 (180−475) ng/mL in C and 525 (170−620) ng/mL in NC pts
(p =NS). Median ATV AUC was 32,833 (22,480–39,707) ng·h/mL in C
and 25,156 (16,929–50,194) ng·h/mL in NC (p =NS); no statistically
signiﬁcant correlation was found between AUC and LS (p = 0.12).
The analysis restricted to the pts taking ATV/r showed no statistically
signiﬁcant difference of Ct or AUC between groups, but a signiﬁcant
inverse correlation was found between AUC and LS (p = 0.03) and a
trend toward a signiﬁcant correlation was found between Ct and LS
(p = 0.06).
Conclusions: The slight reduction in Ct observed in cirrhotic patients
with mild disease could be related to the reduction and/or diversion of
the liver blood ﬂow related to initial portal hypertension associated to
increased liver stiffness and would probably become signiﬁcant in case
of severe cirrhosis; this could also explain the inverse correlation found
between AUC/Ct and LS.
R2298 Oral side effects of antiretroviral therapy in HIV-infected
patients
M. Nechifor, I. Gradinaru, V. Luca (Iasi, RO)
Objective: To assess the incidence of oral side and adverse effects of
some associations of antiretroviral chemotherapic drugs associations in
HIV-infected patients (both children and adults).
Method: The study was performed on 72 children (age between 3
and 18), and 64 adults HIV-infected of both ganders, hospitalised in
the Infectious Diseases Hospital “Sf. Parascheva” Iaºi between 2000
and 2005. All the included patients had CD4 lower than 400/mm3 and
before hospitalisation had not received any other antiretroviral therapy.
The study included only patients that were clinically surveyed over
90 days. Patients (both children and adults) received the following
chemotherapeutic protocols: Zidovudine + Indinavir + Lamivudine (23
children and 18 adults); Efavirenz + Indinavir + Zalcitabine (29 children
and 24 adults). Oral cavity was daily examined.
Results: Main side effects noticed were: erosions on gingival mucosa
and inferior lip (6.2% of adults and 5.5% of children); ulceration of
jugal mucosa (8.3% of adults and 3.1% of children), oral mucosa
hyperpigmentation (3.1% of adults and 4.1% of children), xerostomia
(11% of adults and 10% of children), necrotic stomatitis (2.7% of
adults and 3.1% of children). In some patients there were more than
one side effect. The presence of saburral tongue and oral candidosis
was considered as disease complication (though it might be induced
also by antiretroviral therapy). The incidence of oral side effects was
about 27−28% in children and about 22−23% in adults. There were
not observed in this study major difference regarding oral side effects
between children and adults. Oral side effects observed did not impose
discontinuation of antiretroviral therapy.
Conclusions: Oral side effects of antiretroviral therapy represent a
certain fact which should be considered in the clinical practice.
R2299 The knowledge level of high school students in Antakya
city, Turkey about AIDS
Y. Onlen, N. Savas, C. Ozer, L. Savas, F. Incecik, A. Kanatli (Antakya,
Adana, TR)
Aim: The aim of the current study was to investigate the knowledge
levels of junior High school students, sources of their knowledge, the
socio-economical facts acting on their kowledge on AIDS
Methods: This is a cross sectional, descriptive study including a total
of 2838 students (1368 females and 1470 males) from 16 high schools
in 4 different types (State, Anatolian, Trade and Private high schools).
A questionaire composed of 5 different sections was used to analyse
the knowledge level seperately; how AIDS is an ilness, how AIDS can
spread, risk factors for AIDS, ways of protection of AIDS, and the
source of their knowledge on AIDS in sections from 1 to 5 respectively.
In the ﬁrst 4 sections the right answers were graded with 2 score, wrong
answers with 0 and with 1 when the student does not have an idea.
The maximum score for the ﬁrst 4 sections of the questionnaire were
12, 38, 14, 14 respectively. In the 5th section the probable sources of
knowledge such as school, friends, family news papers, books and, TV
were questioned.
Results: The mean score received from the questionnaire were
49.50±6.50 (minimum:27, maximum:69). The mean score for the
females was 49.69±6.46, it was 49.32±6.66 for the males (p> 0.05).
The mean score for ﬁrst 4 section were 8.2±2.15, 24.7±4.16, 9.70±2.30,
6.90±1.79, respectively. No statistically signiﬁcant difference was
observed between the 15−16, 17−18 and 19−20 age groups on
knowledge about risk factors for AIDS (p> 0.05), while there were
meaningful differences, how AIDS is an ilness, how AIDS can spread,
ways of protection of AIDS (p< 0.05). Trade school students received
the lowest score from the questionnaire concerning in the total of the
questionnaire, how AIDS is an ilness, how AIDS can spread, risk factors
for AIDS, ways of protection of AIDS. While the highest score about
risk factors were received by Anatolian high school students, the highest
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score how AIDS is an ilness, how AIDS can spread, ways of protection
of AIDS were received by private high school students.
Conclusion: High school students in this region do not have enough
knowledge about AIDS. They need education especially on ways of
protection and contamination.
Hepatitis
R2300 Frequency of haematogenic contagious infections to blood
donors in a general hospital of thoracic diseases in Athens,
Greece, 2001–2005
D.K. Kalikatzaros, M.S. Stagas, N.T. Tsagarakis, N.K. Kendroy,
I.K. Kamatsos, E.A. Anastasakoy, S.M. Mayrea, E.H. Hristaki (Athens,
GR)
Objectives: The purpose of our study is to see the frequency of
haematogenic contagious infections of hepatitis B, hepatitis C, Human
Immunodeﬁciency Virus (HIV) and HTLV among blood donors of our
hospital during the period 1/1/2001 and 1/12/2005.
Materials: Positive results of laboratory examination of 18658 blood
donors for hepatitis B, hepatitis C, HIV and HTLV was recorded. The
recording was made by sorting the results per year. All blood donors
came to our hospital to donate blood during that period of time and
were Greeks and non-native.
Methods: The detection of HBsAg, anti-HCV, and HIV was made
with the microsomic immunoenzymic assay method MEIA-AxSYM of
ABBOTT and the detection of HTLV antibodies was made with the
photometric method MUREX of ABBOTT.
In the case of positive HCV conﬁrmation was made with the RIBA
method at the Hygienist School of Athens, while positive HIV samples
were reexamined with Western Blot.
Results: From the total of the blood donors tested we had the results
shown in the table. Regarding the HIV after re-examining with the
Western Blot method only one sample was found positive. Of all blood
donors, positive for an infection 76.9% were Greeks and 23.1% were
foreigners. 0.005% was positive for HIV (after re-examination), 0.34%
for hepatitisB, 0.2% for hepatitis C and 0.15% for HTLV.
Blood donors Positive HIV HbsAg HCV HTLV
2001 14 (0.37%) 4 3 2 5
2002 49 (1.3%) 2 24 11 12
2003 31 (0.87%) 1 10 9 11
2004 24 (0.63%) 3 13 8 0
2005 27 (0.72%) 4 14 9 0
Conclusions: The frequency of those infectious diseases among the
blood donors is at a low and satisfactory level. Nevertheless we must
be very strict and thorough in choosing blood donors regardless of their
nationality.
R2301 Genotype of hepatitis C virus in Libya
M. Dow, A. Alamari, A. Elahwel, A. Abdulla, S. Albagar,
A. Ranganathan (Sirte, LY)
Objective: Information about the incidence of genotypes in hepatitis C
virus (HCV) infected patients in Libya is limited. Aim of the study to
investigate the incidence of hepatitis C virus (HCV) genotypes in Sirte,
Libya.
Method: Sera were obtained from 78 (48 males and 30 females)
Libyan patients who were anti-HCV positive by ELISA (Enzyme-Linked
Immunosorbent Assay). The studied patients ranged in age from 20 to 80
years old. HCV RNA was genotyped by PCR (Cobas Amplicor Roche,
Switzerland).
Results: In this study, half of the 78 patients (54%) were infected with
genotype 4. Genotype 1 was the second most dominant genotype with a
prevalence of 11.5%. Genotypes 2 and 3−6 were found in 6.4 and 7.6%
of the patients, respectively.
Conclusion: in this study, most of the Libyan isolates were genotype 4.
The higher presence of genotype 4 in the Libya may indicate a larger
immigration from neighbouring country (Egypt) and Central African
countries, where genotype 4 is predominant. Few of the Libyan isolates
were closely related to the European ones where the majority of patients
are infected with genotype 1, 2 or 3.
R2302 Hepatitis C virus genotypes distribution in infected patients
A. Suarez, M. Alvarez, C. Sanchez, J. Picazo (Madrid, ES)
Objectives: Hepatitis C Virus (HCV) is a frequent cause of chronic liver
disease, and clinical features of HCV infection as well as responsiveness
to treatment appear to vary with different genotypes, so the aim of this
study was to evaluate the genotype distribution and identify its frequency
when a Human Immunodeﬁciency Virus HIV infection is associated.
Methods: A total of 2176 patients infected by HCV were tested for
genotype, 503 of them were co-infected with HIV.
HCV genotyping was carried out in all patients using a reverse
transcription-nested polymerase chain reaction (PCR) technique, and
a reverse hybridisation system of the ampliﬁed product (Inno-Lipa.
Innogenetics) The protocol was performed and interpreted according
with the recommendations of the manufacturer.
Clinical diagnoses were conﬁrmed by histopatological analysis.
Results: The patients had a mean age of 53.4±10.6 years (range 25−82)
and 65% were males, (co-infected patients: mean age of 36.3±6.1 years,
and 84% males). HCV type 1 was detected in 1612 patients, in particular
1127 cases showed subtype 1b, type 2 in 42 cases, type 3 in 311 cases,
type 4 in 176, type 5 in 8 cases, only one patient with type 6 and eight
patients were infected with more than one genotype. Among the 503
HIV-co-infected patients (23.1%), the distribution of HCV genotypes
was as follows: type 1 in 292 (19.3% of genotype 1b), 25.3% genotype
3, 14.9% genotype 4, 0.2% genotype 2 and none genotype 5 or 6. Five
patients had mixed genotypes.
All patients suffering from hepatocellular carcinoma were infected by
genotype 1b and 73% of the alcoholic cirrhosis patients. Genotype 1b
was higher in non-co-infected patients (61.6% versus 19.3%), while
genotypes 1a, 3 and 4 were more frequently in HIV-co-infected patients
(all differences were statistically signiﬁcant p< 0.001). However there
were not signiﬁcant differences between genders or among risk factors in
the distribution of HCV genotypes among the HIV co-infected patients.
Conclusion: A high prevalence of HIV and HCV infection has been
found in our results.
A strong association between genotype 1b and the development of a
severe liver disease were detected.
The genotypes vary distribution depends on the co-infection with HIV,
and that knowledge would be useful to the prognosis and treatment of
the HCV infection.
R2303 Detection of total anti-hepatitis A antibodies by the
Immulite® systems compared to Abbott HAVAB® EIA
P. Sen, F. Bronstein, C. Cervantes, D. Sustarsic (Los Angeles, US)
Objective: Hepatitis A virus (HAV) infection is diagnosed by the
detection of antibodies to HAV in serum or plasma. This study compares
the performance of IMMULITE® 2000 and IMMULITE® 2500 to
ABBOTT HAVAB® EIA in detecting total anti-HAV (IgM and IgG).
Methods: IMMULITE® 2000 and IMMULITE® 2500 total anti-
HAV assays are solid phase sequential competitive chemiluminescent
immunometric assay. In the ﬁrst cycle, the patient sample is incubated
with HAV antigen reagent and bead coated with polyclonal anti-HAV
antibody for 30 minutes. After a spin-wash step, alkaline phosphatase-
labeled polyclonal anti-HAV antibody reagent is added to the patient
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sample and incubated for an additional 30 minutes. After another spin-
wash step, a chemiluminescent substrate is added, and the signal is
generated in proportion to the bound enzyme.
Results: Approximately 257 samples were assayed on IMMULITE®
2000 and IMMULITE® 2500. On IMMULITE® 2000, 170 of the
257 were reactive for total anti-HAV antibodies, which correlated to
ABBOTT HAVAB® EIA results; 70 were non-reactive on both methods.
Of 15 discordant samples, 7 were resolved by ABBOTT AxSYM.
Overall agreement, relative sensitivity and speciﬁcity after resolution
were 96.1%, 100% and 89.7%, respectively. On IMMULITE® 2500, 170
of the 257 were reactive for total anti-HAV antibodies, which agreed with
ABBOTT HAVAB® EIA results; 65 were non-reactive on both methods.
Of 22 discordant samples, 7 were resolved by ABBOTT AxSYM.
Overall agreement, relative sensitivity and speciﬁcity after resolution
were 94.2%, 100% and 85.5%, respectively. Precision studies were also
performed on 3 lots of IMMULITE® 2000 and 1 lot of IMMULITE®
2500 to assess lot-to-lot consistency. Nine samples, including controls,
ranging from non-reactive to reactive were assayed for a 20-day
period following the CLSI [NCCLS] document EP5-A, Evaluation of
Precision Performance of Quantitative Measurement Methods; Approved
Guidelines. Overall total precision ranged from 6.3% to 14.7% on
IMMULITE® 2000 and 4.1% to 5.7% on IMMULITE® 2500.
Conclusion: Results of this study show that the IMMULITE® systems
of total anti-HAV assays are comparable to ABBOTT HAVAB®
EIA/AxSYM assay for the serological detection of total antibodies to
hepatitis A virus.
R2304 Detection of anti-hepatitis A IgM antibodies by the
Immulite® systems compared to Abbott HAVAB-M® EIA
P. Sen, F. Bronstein, C. Cervantes, D. Sustarsic (Los Angeles, US)
Objectives: The presence of anti-HAV IgM in serum or plasma indicates
an acute or early convalescent stage of infection to Hepatitis A virus
(HAV). This study compares the performance of IMMULITE® 2000
and IMMULITE® 2500 to ABBOTT HAVAB®-M EIA in detecting IgM
antibodies to HAV.
Methods: IMMULITE® 2000 and IMMULITE® 2500 anti-HAV IgM
assays are solid phase 2-site sequential chemiluminescent immunometric
assay. In the ﬁrst cycle, the pre-diluted patient sample is incubated with
protein buffer and bead coated with monoclonal murine anti-human IgM
antibody for 30 minutes. After a spin-wash step, HAV antigen reagent
and alkaline phosphatase-labeled polyclonal anti-human IgM antibody
reagent is added to the patient sample and incubated for another 30
minutes. After another spin-wash step, a chemiluminescent substrate is
added, and the signal is generated in proportion to the bound enzyme.
Results: Approximately 257 samples were assayed on both
IMMULITE® 2000 and IMMULITE® 2500. On IMMULITE® 2000,
37 of the 257 were reactive for anti-HAV IgM antibodies, which agreed
with ABBOTT HAVAB®-M EIA results; 207 were non-reactive on
both systems. Of 13 discordant samples, 8 were resolved by ABBOTT
AxSYM. Overall agreement, relative sensitivity and speciﬁcity after
resolution were 98.1%, 97.3% and 98.6%, respectively. On IMMULITE®
2500, 36 of the 257 were reactive for anti-HAV IgM antibodies, which
correlated to ABBOTT HAVAB®-M EIA results; 208 were non-reactive
on both systems. Of 13 discordant samples, 8 were resolved by ABBOTT
AxSYM system. Overall agreement, relative sensitivity and speciﬁcity
after resolution were 98.8%, 97.3% and 99.1%, respectively. Precision
studies were also performed on 3 lots of IMMULITE® 2000 and 1
lot of IMMULITE® 2500 to assess lot-to-lot consistency. Ten samples,
including controls, ranging from non-reactive to reactive were assayed
for a 20-day period following the CLSI [NCCLS] document EP5-A,
Evaluation of Precision Performance of Quantitative Measurement
Methods; Approved Guidelines. The overall total precision ranged from
7.8% to 14.7% on IMMULITE® 2000 and from 5.6% to 9.5% on
IMMULITE® 2500.
Conclusion: Results of this study show that the IMMULITE® systems
of anti-HAV IgM assays are comparable to ABBOTT HAVAB®-M
EIA/AxSYM assay for the serological detection of IgM antibodies to
hepatitis A virus.
R2305 Phylogenetic, clinical and virological features of hepatitis B
virus among Iranian HBsAg carriers
G. Bahramali, M. Sadeghi-Zadeh, S. Amini-Bavil-Olyaee, S. Alavian,
A. Behzad-Behbahani, B. Rabbani, E. Sabouri, F. Barkhordari,
R. Bagheri, F. Mahboudi (Tehran, Shiraz, IR)
Objective: Hepatitis B virus (HBV) infection is one of the major
epidemiological problems around the world. Our previous reports
indicated that genotype D of HBV was dominant one in Iranian HBV
carriers. Herein, we have investigated a large number of cases in different
stages of the disease to show phylogenetic, virological and clinical
features of HBV in Iranian infected patients.
Methods: One hundred and twenty HBsAg carriers were selected from
patients attending the hepatitis clinic centres. Liver function, clinical and
serological status, viral load and HBV genome variability were analysed
for each patient. The patients were categorised into four groups;18.8%
inactive carrier patients, 45.4% chronic hepatitis B infected cases,
25.4% patients with cirrhosis and 10.9% with hepatocellular carcinoma
(HCC).HBV genotype (HBsAg), BCP/Core and YMDD motif sequences
were successfully ampliﬁed for Sixty two samples and sequenced in both
direction.
Results: Phylogenetic analysis revealed genotype D and sub-
genotype D1 with a high bootstrap value. Subtypes ayw2 and ayw3
were detected in 98% and 2% of samples, respectively. All patients with
HCC and 64.5% of total patients were shown to be HBeAg-negative.
The highest ALT rate was detected in patients with cirrhosis and HCC.
There was no signiﬁcant correlation between HBeAg negativity and ALT
value in the studied cases. The prevalence of the precore mutation was
78% (70% in chronic infection patients, 20% in HCC patients and 10%
in cirrhosis patients). The BCP double mutation was detected in 48%
of the patients as well. Twenty-ﬁve percent of the patients who had
lamivudine therapy showed mutation in the YMDD motif (50% among
HCC patients, 33% in hepatitis B chronic carriers and 16.6% in cirrhotic
subjects). No HBsAg escape mutant was detected in studied cases.
Conclusion: This work conﬁrmed the earlier studies that the genotype D
of HBV was the predominant one in Iranian patients. The rate of
precore and BCP mutation was high among the studied cases and closely
associated with HCC. The FLLA mutation was also found in patients
who suffered from HCC. Nevertheless, no association was observed
between ALT and HBeAg status. Analysis of these mutants may prove
useful for clinical evaluation and choice of therapy.
R2306 Epidemiological and clinical features of a hepatitis A
outbreak among adults in Albania
A. Harxhi, K. Pano, D. Kraja, S. Bino, E. Kakarriqi, D. Ulqinaku
(Tirana, AL)
Objectives: To present the epidemiological and clinical features of acute
hepatitis A outbreak among adults in a inner city in Albania.
Methods: During July and August 2006 an outbreak of acute hepatitis A
occurred in the city of Tirana, Albania. Overall there were 420 cases of
acute hepatitis A reported to Public Health Authorities in the city of
Tirana. More than 65% of reported cases were above 15 years of age.
126 adult cases hospitalised and diagnosed with acute viral hepatitis A
based on WHO case deﬁnition were included in the study.
Results: Around 90% of hospitalised cases (113) were between 15
to 25 years of age. There was an equal number of male and female
cases. All the cases were inner city inhabitants, living in two to three
close neighbourhoods. These young people belonged to families with
a high socio0economic level. Epidemiological investigation revealed
only drinking water as a common-source of the outbreak. Regarding
clinical features, main prodromal symptoms included fatigue, malaise,
anorexia, nausea and vomiting. Fever was present in 28% of the cases
while arthralgias in 32% of the cases. Splenomegali was present in 42%
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of patients. Jaundice was not present in 6 cases (5%). Mean serum
bilirubin level was 6mg/dl, ranging from 0.3 to 19mg/dl. Peak AST and
ALT levels were 2500 and 3500 UI respectively. No fulminant form of
acute hepatitis was observed. The serological diagnosis was based on
the detection of IgM anti HAV in 49 cases (39%).
Conclusion: The pattern of this common-source water-associated
outbreak indicates that Albania is still considered a country of
moderate/intermediate endemicity of HAV infection.
R2307 Signiﬁcant reduce in hepatitis B prevalence among blood
donors admitted to an Ahwaz blood transfusion service due
to educational and vaccination programmes
M. Jalali Far, J. Torabi Zadeh Maatoghi, S.M. Sajadi, M. Paridar,
A. Ghasem Zadeh, A. Nasimian (Ahwaz, Tehran, IR)
Although blood transfusions save the life of many patients, they carry
a risk of blood-borne diseases such as viral hepatitis. Hepatitis B is
one of the major diseases of mankind and is a serious global public
health problem. Of the 2 billion people who have been infected with the
hepatitis B virus (HBV), more than 350 million have chronic (lifelong)
infections. These chronically infected persons are at high risk of death
from cirrhosis of the liver and liver cancer, diseases that kill about
one million persons each year. Because of the great number of blood
dependent patients such as thalassaemia and other haemoglobinopathies
patients, determination of HBV prevalence helps us to recognize the risk
factors and increase the blood safety.
In this cross-sectional descriptive survey, we studied 39,032 blood donors
admitted to Ahwaz blood transfusion service and related blood centre
between 17 Apr 2005 and 19 Feb 2006 by using non-random simple
sampling. 36,252 (92.9%) male and 2,780 (7.1%) female; 8,817 (22.6%)
single and 30,215 (77.4%) married; 2,351 (6%) was illiterate and has
the lowest rate and blood donors with diploma and below the diploma
consisted the majority of blood donors: 28,948 (74.2%). Age was 17−65
years, mean: 33.03, the largest age group was 15,792 (40.5%) donors
under 29 years old and the smallest age group was donors over 49 years
with 4.9%]. For all of them we did HBs-Ag based on Enzyme immuno
assay (Dade Behring kit).
We found 0.8% (324/39,022) of blood donors were HBs-Ag reactive.
We found signiﬁcant difference between HBV infection and job, marital
status, age group, educational level and blood group, but gender was not
signiﬁcant. The HBV prevalence was higher in blood donors who were
over 49 years groups, farmer, illiterate and married.
Our study showed a signiﬁcant reduction in hepatitis B infection among
blood donors in comparison with previous studies in this region and other
regions in Iran. This is because of the wide spreading educational and
vaccination programmes and the rigid rules in donor selection in Ahwaz.
Further educational programmes should focus especially on married and
illiterate blood donors. HBc-Ab screening for detection all previous and
window period infection are recommended.
R2308 Prevalence of hepatitis C virus genotypes in chronic
infected patients of haemodialysis department
M. Kozachenko, A. Kachanka, B. Samoliuk, I. Karpov (Minsk, BY)
Objectives: At hemodialysis centres patients are well known to be
infected with virus hepatitis not only because of haemotransfusion
but also because of asepsis rules violation while haemodialysis. This
category of patients faces a greater risk of being infected with years.
Hepatitis C virus (HCV) genotypes have been associated with different
treatment response.
The aim of this study was to determine the prevalence of HCV genotypes,
serum HBV-DNA and HCV-RNA levels and severity of liver disease in
chronic infected patients.
Methods: 126 patients, who were diagnosed with chronic kidney
deﬁciency and assigned to programmed haemodialysis, were examined
with the help of ELISA-method. If parenteral hepatitis markers were
deﬁned, molecular-biological methods were employed in order to
continue the examination of the patients, in particular a real time mode
PCR method was adhered to.
Results: 89 patients (70.6%) got positive results for HBV- and HCV-
infection. On grouping aetiologic indicators we registered the following:
HBV-infection – 42 patients (47.2%), HCV-infection – 27 patients
(30.3%), mixed infection HBV+HCV – 20 patients (22.5%). PCR DNA
was positive in 47 cases, PCR RNA was positive in 33 cases. After the
classiﬁcation of genes of the patients infected with HCV-infection 13
patients were registered to have 1b genotype, 6 patients 3a, 4 patients 2a,
1 patient 1a, and 1 patient 1b/3a.
Conclusion: Thus, hemodialysis department patients take a high risk
of being infected with various kinds of parenteral virus hepatitis. In
order to prevent the infection it is necessary not only to observe
the rules of aseptic procedures and hemodialysis very carefully but
also to conduct a preliminary vaccination of the patients who need a
programmed hemodialysis against hepatitis B. Further working out and
development of monitoring and speciﬁc treatment protocol seems to be
very promising.
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R2309 Bladder carcinogenesis via viral infection
H. Badawi, H. Ahmed, A. Ismail, N. El-Khaﬁf, A. Helmy, A. Badawy,
S. Mansy, M. Saber (Imbaba, EG)
Objectives: To investigate the role of human papillomaviruses (HPV16,
18), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and herpes
simplex virus (HSV-2) in the etiopathogenesis of cancer bladder, using
polymerase chain reaction (PCR) and Electron Microscopic Studies
(EMS). It is also a trial to highlight the possible correlation of such
infections with the apoptosis of buffy coat cells and serologic responses
using Enzyme Linked Immunosorbent Assay (ELISA).
Methods: This study was conducted on 80 patients, Urosurgery
Department, Theodor Bilharz Research Institute (TBRI), who were
identiﬁed as three groups, cancer bladder (group I, 20), cystitis (group II,
20), cancer bladder with cystitis (group III, 20), and a fourth group
of 20 normal healthy subjects as controls. They were all subjected
to the following: Detection of viral genomic sequences by PCR
and EMS on bladder tissue biopsies, buffy coat cells, serum and
urine samples, serological detection by ELISA of HPV IgG using
Baculovirus recombinant HPV virus-like particles and IgG & IgM of
EBV, HSV-2 and CMV and detection of CMV antigen (pp65) in PMNL
by monoclonal antibody.
Results: Among all Patients 56.6% were virally infected with different
viruses under the study. HPV16 was detected in 53% cases, HPV18
in 24%, CMV in 48%, EBV in 41% and HSV-2 in 48%. Infection
with multiple viruses (74%) was signiﬁcantly associated with either
cancer or cystitis than single infection (26%) (P< 0.01). EMS of the
examined cases showed remarkable apoptotic changes in lymphocytes
and neutrophils of 75% of either cystitis or cancer cases and were
absolutely associated with virally infected cases. IgG antibodies to
HPV16 VLPs were detected in 66.7% and 11.4% of HPV16 DNA
positive and negative patients respectively and in none of healthy
controls.
Conclusion: Our study conﬁrms signiﬁcant association of mixed viral
infection with bladder cancer in Egyptian patients which suggests
the interesting hypothesis of a viral synergistic action in bladder
carcinogenesis. The sensitivity and accuracy of PCR could be increased
by adding EMS. PCR on serum or urine samples proved to be non-
sensitive. ELISA for detection of anti-HPV16 VLPs could be used in
conjunction with HPV DNA detection techniques for accurate clinical
diagnosis and epidemiological studies. Detailed investigations on the
different apoptotic pathways in general and on the viral manipulations
of these pathways are necessary so as to open up new strategies for
therapy.
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Mycobacterial infections
R2310 Determination of the cut-off value of pleural ﬂuid CA-125
in patients with pleural effusion, to identify the underlying
cause (TB or malignancy)
S. Shokouhi, M. Samanabadi, L. Gachkar (Tehran, IR)
Background: Primary and secondary infections and malignancies are
inﬂammatory causes of ﬂuid accumulation in pleural space. TB is one
of infective causes of pleural effusion and is similar to malignancies
because of its subacute and chronic process, although their management
is extremely different.
CA-125 is a glycoprotein tumour marker with molecular weight of 200
kD, which is found on the surface of ovarian and some normal and
inﬂammatory cells. In both malignancy and tuberculosis, this tumour
marker increases in serum and consequently it increases in pleural ﬂuid
of these cases.
Objective: to evaluate and compare CA-125 tumour marker in pleural
effusion resulted from malignancies and tuberculosis.
Study design: 27 patients affected by tuberculosis (18 men & 9 women),
with the mean (±SD) age of 37/3 13/9 and 23 patients affected by
malignant tumour (16 men & 7 women) with the mean (SD) age of 57/9
17/7 were evaluated during 2004–2005; In malignant cases, diagnosis
was done through pathologic inspection of biopsy samples and cytology
of pleural ﬂuid. For recognition of tuberculosis, culture & smear of
sputum or gastric lavage, biopsy of pleura and pleural ﬂuid PCR methods
were used. Pleural ﬂuid sample were gathered and by CLIA method, the
amount of their CA-125 were measured. The cut-off value of CA-125
was obtained from a ROC curve.
Results: The mean (±SD) level of CA-125 in pleural ﬂuid was
159.1±214, and 2149.2±4513.6 U/mL in tuberculosis and malignancies,
respectively; which showed a statistically signiﬁcant difference between
these two groups (p< 0.01).
Conclusion: we may use CA-125 marker level in pleural effusion as
a diagnostic index for differentiation of TB and malignancy induced
pleural effusions.
R2311 Prevalence of tuberculin reactivity among healthcare
workers from an Iranian hospital
M. Zangeneh, S. Soleimany Amiry, M. Jamshidi Makani, S. Davar
Siadat, S. Haghighi, M. Yarjanli (Tehran, Bandar-Abas, IR)
Objective: According to WHO, the prevalence of tuberculosis (TB)
is increasing worldwide and healthcare workers are at special risk for
tuberculosis. The prevalence of infection is directly proportional to the
duration of employment in the hospital. Lifetime risk of developing
active tuberculosis is about 10%. Tuberculin test (PPD) is a reliable
method for monitoring the exposure of HCWs to TB. According to
CDC reports HCWs need to have pre-employment health screening, a
two-step PPD test and at least annually. The two-step PPD test conform
a negative result. The prevalence of tuberculosis infection in HCWs is
unknown in Iran. In this study we wanted to determine the prevalence
of tuberculin reactivity among HCWs in our hospital.
Method: To evaluate the frequency of tuberculosis infection in our
hospital, we performed a prevalence study of tuberculin reactivity among
170asymptomatic HCWs in the hospital. Trained nurses inoculated
puriﬁed protein derivative (PPD) using the mantoux technique in tow
step. All HCWs tested completed a questionnaire about demographic
data, previous TB infection, previous contact with active tuberculosis
patients, BCG vaccine scar, and immunosuppressive conditions.
Results: 150 (86/5%) returned for test reading including 82 female,
68 male with mean age of 32/3 years, 69 nurses, 37 service workers,
5 ofﬁce workers, 2 lab workers, 24 operation room workers, 1 physician,
12 secretaries. Overall, in ﬁrst step 41 (27/3%) of 150 HCWs was PPD
positive, in second step from 50 HCWs 15 (10%) were PPD positive. The
rate of PPD reactivity among person with a history of BCG vaccination
was the same (P = 0/309). The rate of reactivity was related to hospital
setting (P = 0/045). Induration among reactors was 93 (62%) 0−5mm, 32
(21/3%) 6−10mm, 9 (6%) 11−14mm, 15 (10%) >15mm.. In this study
PPD reactivity was same as general population.
Conclutions: The low prevalence of tuberculin reactivity in this study
may reﬂect low rate of mycobacterium tuberculosis infection & disease
in the community. In addition, in this hospital most of HCWs are young
with low history of work in the hospital.
Infection in the immunocompromised host &
transplant recipients
R2312 Nocardiosis as an unexpected complication of end-stage,
untreated HIV disease
R. Manfredi (Bologna, IT)
Introduction: AIDS presenters are increasing worldwide, due to HIV
infection lasting undiagnosed-neglected for many years.
Case report: A 43-year-old drug-alcohol abuser was recently diagnosed
with HBV-alcohol-related liver cirrhosis, and an advanced, untreated
HIV infection with a CD4+ count of 14 cells/mL, and an initial AIDS-
dementia complex. Hospitalised owing to >15% weight loss, fever,
cough with blood emission, and multiple pulmonary inﬁltrates, when
undergoing a HRCT a consolidated 4−5 diameter lesion involving
the apical-dorsal left upper lung lobe was accompanied by multiple
subpleuric lesion, with excavations at right lower lobe. Either tubercular,
bacterial, other opportunistic infections, or a malignancy, were suspected.
While waiting for microscopy, cytology, and culture examinations of
respiratory secretions-BAL, based on blood cultures which yelded a
multi-sensitive S. epidermidis strain, a broad-spectrum therapy including
cefazolin, and later cefriaxone and ﬂuconazole was attempted. After the
microscopic-culture isolation of Nocardia asteroides (testing susceptible
in vitro to co-amoxiclav, chloraphenicol, cotrimoxazole and gentamycin),
treatment was adjusted to include cotrimoxazole, and a triple HAART
was conducted for 12 days, until an overwhelming anaemia-leukopenia
needed RBC transfusion and G-CSF administration, followed by a
modiﬁed antimicrobial therapy (imipenen-amikacin), in the suspect of
cotrimoxazole intolerance. A slowly progressive clinical ameliorement
occurred, as conﬁrmed by repeated X-ray-HRCT controls, associated
with a partial immune recovery obtained thanks to HAART.
Discussion: In patients with recently diagnosed HIV disease and a
deep immunodeﬁciency, the differential diagnosis of multiple pulmonary
inﬁltrates with tendency to excavation includes tuberculosis-atypical
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mycobacteriosis, but also bacterial infection and malignancies. In our
case, the diagnostic difﬁculties were complicated by the emerging
of cotrimoxazole intolerance which prompted to a severe anaemia-
leukopenia, so that a second-line therapy for nocardiosis was performed
favourably. Notwithstanding Nocardia spp. infects immunosuppressed
hosts, however nocardiosis remains very infrequent in advanced HIV
disease, when only sparse pulmonary, cerebral and skin localisations
were anecdotally reported. Our case underlines that opportunism may
go beyond the most usual disorders, and its treatment may be conducted
effectively with second-choice agents.
R2313 Alert pathogens in blood of haematological patients from
2004 through 2005
H. Marchel, M. Wro´blewska, R. Kamola, A. Majewska, M. Luczak
(Warsaw, PL)
Methods: Analysis comprised the following alert pathogens: MRSA,
VRE, ESBL-positive and carbapenem-resistant Gram negative rods.
Only non-repetitive strains were included in the study. Blood cultures
were tested using a BacT/Alert system (bioMe´rieux). Identiﬁcation
of the isolates was done with API or VITEK tests (bioMe´rieux).
Antimicrobial susceptibility testing was assessed with a disk-diffusion
technique (according to the NCCLS recommendations) or VITEK system
(bioMe´rieux), as well as E-tests (AB Biodisk). ESBL production was
evaluated using a double-disk technique, according to Jarlier. Resistance
to vancomycin was detected on BHI agar plates with vancomycin
6mg/mL (Emapol).
Results: In the analysed period there were 6863 patients hospitalised in
2004 and 7331 in 2005. In total, 6099 culture bottles were examined
in 2004, yielding 647 (10.61%) positive and 5452 (89.39%) negative
results. In 2005, 6350 bottles were cultured, with 638 (10.05%) positive
and 5712 (89.95%) negative results. In 2004, 17 strains of S. aureus
were cultured (including 4 MR), while in 2005 – 12 strains of S. aureus
(including 2 MR). In 2004, a number of strains of Enterococcus spp.
amounted to 15 (including 1 VRE), while in 2005 – 20 (including 4
VRE). In 2004 there were 2/7 ESBL-positive K. pneumoniae strains
isolated, while in 2005 it increased to 10/28. In the analysed period
no ESBL production was detected in cultured E. coli strains. In 2004
among carbapenem-resistant strains predominated non-fermenting rods
(8 strains of S. maltophilia, 4/8 strains of P. aeruginosa, and 1/7 strains
of K. pneumoniae). In 2005, all carbapenem-resistant strains represented
non-fermenters (7 strains of S. maltophilia, 7/15 strains of P. aeruginosa,
and 5/10 strains of A. baumannii).
Conclusion:
1. In the analysed period there was a decrease in the number of isolated
S. aureus strains and an increase in isolation of Enterococcus spp.,
enteric rods of the Enterobacteriaceae family and non-fermenting
rods.
2. A decrease in percentage of MRSA strains was recorded, with
simultaneous increase in frequency of isolation of VRE and
carbapenem-resistant Gram-negative rods.
3. Frequency of ESBL-positive phenotype among the Enterobacteriaceae
family isolates was variable, with highest rates detected in K. pneu-
moniae strains.
4. In this study emergence of carbapenem resistance among enteric rods
of the Enterobacteriaceae family was recorded.
R2314 Disseminated infection with Fusarium solani in an infant
with congenital acute lymphoblastic leukaemia
A. Charissiadou, A. Stathi, A. Velegraki, K. Chryssaki, M. Moschovi,
A. Sergounioti, K. Samantas, A. Pangalis (Athens, GR)
Fusarium species are emerging pathogens, with signiﬁcant morbidity
and mortality, in patients with haematologic malignancies. They invade
through blood, vessel walls, cause tissue infection and necrosis and
disseminate widely.
Case report: A 2-month-old female infant was admitted to the hospital
with severe anaemia (Hgb: 5g/dL), high WBC and low platelets,
(counts 546,000 and 60,000/mm3 respectively), hepatosplenomegaly,
biochemical picture of liver obstruction and abnormal high level of
serum uric acid. Bone marrow aspiration revealed a 99% inﬁltration
with blasts and she was diagnosed as having Acute Lymphoblastic
Leukaemia, pre-b (immunophenotype CD34:85%, DR:98%, CD19:98%,
CD10:0%, CD20:1%) with central nervous system involvement. She was
immediately started induction chemotherapy (New York II protocol).
During the neutropenia phase she developed FUO, received Ceftazidime,
Amikacin, Vancomycin, Amphotericin B, Fluconazole, Imipenem,
entered the ICU and ﬁnally she recovered from this infection. She
remained neutropenic and two months after her admission, while on
chemotherapy and antibiotic prophylaxis, she developed a second febrile
episode, accompanied with signs of low respiratory system infection.
Meanwhile, diffuse skin lesions appeared, presented as macules with
necrotic centre and an ecthyema gangrenosum-like appearance. Rhinitis,
stomatitis, high level of CRP and PCT (up to 260mg/L and 2 ng/mL
respectively) were also present. Skin biopsy and cultures from blood,
Broncho Alveolar Lavage and skin lesions, revealed a rapid growing
fungus with branched hyaline hyphae which was identiﬁed as Fusarium
solani, with conventional and molecular methods. F. solani was also
found directly in samples from blood, CSF and BAL by multiplex
PCR. Galactomannan antigen was detected in serum by ELISA method.
The initial antifungal treatment with Amphotericin B and Fluconazole
changed. Fluconazole was stopped and Voriconazole, the only antifungal
agent in wich the fungus was sensitive (MIC: 0.5mg/mL, measured by
Broth Microdilution method) was added. F. solani was never recovered
from clinical samples. Remission of the ALL was never achieved
although she was administered a second course of chemotherapy. She
died four months after her initial admission to the hospital, from her
disease and the complications of the treatment.
Conclusion: Fusarium an opportunistic fungal agent was recovered from
the blood, skin lesions and BAL from an infant with congenital ALL.
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R2315 Comparison of macrolides, quinolones, and
amoxicillin/clavulanic acid for the treatment of patients
with acute bacterial exacerbations of chronic bronchitis:
a meta-analysis of randomised controlled trials
M. Falagas, I. Siempos, I. Korbila, K. Manta, G. Dimopoulos (Athens,
GR)
Objective: We evaluated the comparative effectiveness and safety of
macrolides, quinolones, and amoxicillin/clavulanic acid (A/C) for the
treatment of patients with acute bacterial exacerbation of chronic
bronchitis (ABECB) by performing a meta-analysis of randomised
controlled trials (RCTs).
Methods: PubMed, Current Contents, and the Cochrane Central Register
of Controlled Trials were searched to identify relevant RCTs.
Results: 20 RCTs (21 comparisons) that studied 7,730 patients and
compared macrolides with quinolones (8 RCTs), A/C with quinolones
(4 RCTs), or A/C with macrolides (9 RCTs) were included in our
meta-analysis. There was no difference regarding treatment success in
intention to treat (ITT) and clinically evaluable (CE) patients between
macrolides and quinolones [ITT: odds ratio (OR) = 1.01, 95% conﬁdence
intervals (CI) 0.81–1.27; CE: OR= 0.94, 95%CI 0.73–1.21], A/C and
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quinolones (CE: OR= 0.86, 95%CI 0.60–1.24), or A/C and macrolides
(ITT: OR= 0.99, 95%CI 0.49–2.04; CE: OR= 1.44, 95%CI 0.71–2.94).
The treatment success in microbiologically evaluable patients was lower
for macrolides compared with quinolones (OR= 0.46, 95%CI 0.32–
0.66), but it was similar between A/C and quinolones (OR= 0.83,
95%CI 0.49–1.40), and A/C and macrolides (OR= 1.31, 95%CI 0.57–
2.98). There was no difference regarding mortality between macrolides
and quinolones. Less quinolone-recipients experienced a recurrence
of ABECB after resolution of the initial episode compared with
macrolide-recipients during the 26-week period after therapy (data from
2 RCTs). Adverse effects in general were similar between macrolides
and quinolones (OR= 1.12, 95%CI 0.96–1.16); however, administration
of A/C was associated with more adverse effects (mainly diarrhoea)
than quinolones (OR= 1.37, 95%CI 1.04–1.79) or macrolides (OR= 1.72,
95%CI 1.22–2.42).
Conclusion: Overall, macrolides, quinolones, and A/C may be
considered equivalent for the treatment of patients with ABECB in terms
of short-term effectiveness. However, quinolones are associated with
better microbiological success and fewer recurrence of ABECB than
macrolides, while A/C with more adverse effects than both comparators.
Antimicrobial clinical trials
R2316 Comparison of cefuroxime and amoxicillin/clavulanate in the
treatment of acute sinusitis in a sample of Iranian population
A. Rastegar lari, F. Alinejad, M. Rahmani, H. Mohamadi, H. Mostafavi,
G. Farzandy, R. Alaghehbandan (Tehran, IR; St. John’s, CA)
Objectives: Acute sinusitis is a common upper respiratory tract infection
worldwide, which can be severely complicated if inappropriate treatment
is applied. The aim of this study was to assess and compare efﬁcacy of
cefuroxime and amoxicillin/clavulanate in the treatment of acute sinusitis
in an Iranian sample population.
Methods: A randomised clinical trial study, comparing the efﬁ-
cacy of two oral antibiotics, cefuroxime (Exiroxime®) and amoxi-
cillin/clavulanate in the treatment of acute sinusitis, was conducted in
2005. A total of 99 patients were enrolled in the study. The clinical
diagnosis of acute sinusitis was based on association of suborbital pain,
purulent rhinorrea and purulent discharge on the middle nasal meatus.
All patients were also radiographically examined and their diagnoses
were conﬁrmed. Patients were randomly assigned to either receive 10
days of treatment with cefuroxime 250mg twice daily (n = 57) or receive
amoxicillin/clavulanate 500/125mg three times daily (n = 42). Patients’
responses to treatment were assessed during and at the end of the
treatment.
Results: A satisfactory clinical outcome (cure or improvement of
symptoms) was found in 86% (49/57) and 71.4% (30/42) of the clinically
evaluable patients treated with cefuroxime or amoxicillin/clavulanate,
respectively (p> 0.05).
Conclusion: Findings of this study suggest that cefuroxime (twice daily)
is more effective than amoxicillin/clavulanate (three times a day) in the
treatment of patients with acute sinusitis. A larger study is needed to
elaborate on the ﬁndings of this study.
R2317 Doxycycline and streptomycin versus doxycycline alone in
the treatment of human brucellosis
E. Martı´nez Alfaro, P. Geijo, F. Marcos, F. Mateos, J. Blanch, I. Ta´rraga,
C. Rosa, J. Solera (Albacete, Cuenca, Talavera de la Reina, ES)
Background: Tetracyclines are at the present time the antibiotics of
choice in human brucellosis. Brucellae is exquisitely susceptible to
tetracyclines with MICs (minimum inhibitory concentration) <1mg/L.
Prolongued treatment reduces the rate of relapse.
Objective: We conducted a pilot study comparing treatment with
doxycicline 45 days plus streptomycin 14 days versus doxycycline alone
60 days.
Material and Methods: 20 patients were included, all of them >18 years
old. Diagnostic criteria were: (1) Isolation of Brucella species in blood
cultures, or (2) the ﬁnding of a titer >1/160 of standard tube agglutination
antibodies. Patients with spondylitis, endocarditis or neurobrucellosis
were excluded.
Results: 10 patients were included in the doxycycline-streptomycin
group and 10 int the doxycycline alone group. 90% of the patients were
male and the mean age was 37 ± 11. 8 patients (44%) had positive blood
cultures. Focal forms were arthritis (4 patients), orchitis (3 patients),
sacroiliitis (1) and hepatitis (1). The 10 patients in the doxycycline-
streptomycin group cured without sequelae. 4 (40%) patients in the
doxycycline alone group had relapses of the disease.
Conclusions: The high percentage of relapses in the treatment with
doxycycline alone does not allow to indicate this treatment for human
brucellosis.
Paediatric infections
R2318 Pyomyositis in children
G. Manoudis, G. Mitsionis, V. Kontogeorgakos, N. Kordalis, I. Sionti,
T. Xenakis (Ioannina, GR)
Introduction: Pyomyositis is an acute pyogenic infection of the skeletal
muscle. Pyomyositis is common in the tropics but rarely reported in
temperate climates.
High fever and painful swelling of the affected limb are the commonest
symptoms. Leucocytosis is present with elevated erythrocytes sedimen-
tation rate (ESR) and C-reactive protein (CRP). The most common
causative organisms are Staphylococcus aureus and Streptococcus
pyogenes. Magnetic Resonance Imaging (MRI) is the image modality
of choice.
Purpose: Diagnosis, clinical course and treatment outcome of children
with pyomyositis.
Material and Methods: Between 2002 and 2004 5 children, 2 boys
and 3 girls were diagnosed and treated for pyomyositis. The mean age
of patients was 7.2 years, ranging from 3 to 14 years. The locations of
involvement were gluteus muscles in 3 cases, quadriceps in one case thus
in one case there was bifocal involvement of gastrocnemius and biceps
muscle. The causative organisms, cultured from blood, were St. aureus
in 3 cases, Str. pyogenes in one case though in one patient no organism
could be identiﬁed. 4 children had fever (>38.5ºC), elevated ESR and
CRP (ESR: 73–110, CRP: 142–410) and raised WBC count (14580–
19900). One patient had normal temperature and increased ESR (<55).
A history of prior trauma at lower limb was obtained in all
patients. MRI plays a signiﬁcant role in the early recognition and
diagnosis of pyomyositis, identifying muscle inﬂammation and detecting
bone involvement. Intravenous antibiotics were administered and were
followed by oral agents for an additional period of time. The duration of
therapy ranged from 6 to 8 weeks. No surgical intervention was needed.
MRI was used in order to evaluate response to the therapy.
Conclusion: Although pyomyositis is a rare disease, it should be
considered in the differential diagnosis of acute onset of musculoskeletal
pain in children. Early diagnosis and antibiotic treatment are important
as abscess formation, which require surgical drainage, sepsis and other
major systemic complications can be avoided.
R2319 Invasive infections due to Haemophilus inﬂuenzae in
paediatrics
N. Rivas, G. Yerino, A. Gaiano, A. Medina, A. Mo´naco, M. Va´zquez,
A. Procopio, E.L. Lo´pez (Buenos Aires, AR)
The invasive infections by Haemophilus inﬂuenzae (Hi) b has decreased
after vaccination. From January 1998 to December 2005 we carried out
our study at Hospital de Nin˜os.
Objective: to describe the characteristics of Hi infections in our
population. Data were collected from clinical ﬁles. Positive cultures
for Haemophilus inﬂuenzae from sterile places were included. Invasive
infections were 78 in 77 patients. Hi type b 20 (26%) and Hi not b
58 (74%). Age:18m (medium) range 8d-216m. Males 53/78 (69%).
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Variables Haemophilus inﬂuenzae
not B, n = 58 B, n = 20
Complete vaccination 56 (96.5%) 2 (10%)
Seasonal period
Atumn–winter 37 (63.7%) 14 (70%)
Spring–summer 21 (36.2%) 6 (30%)
Predisposing disease 52 (89.6%) 6 (30%) p:<0.001
Chronic pneumopathy 21 (36.2%) 4 (20%)
Immune deﬁciency 12 (20.6%) –
Malnutrition 8 (13.7%) 1 (5%)
Nephropathies 6 (10.3%) –
Cardiopathies 5 (8.6%) 1 (5)
Clinical forms
Pneumonia without effusion 33 (56.8%) 10 (50%)
Pneumonia with effusion 6 (10.3%) 2 (10%)
Peritonitus 5 (8.6%) –
Meningitis 4 (6.8%) 5 (25%) p = 0.043
Bacteraemic without focus 4 (6.8%) –
Cellulitis 3 (5.1%) 1 (5%)
Septic arthritis 1 (1.7%) 2 (10%)
Pioventriculitis 1 (1.7%) –
Endophthalmitis 1 (1.7%) –
R to ampicillina 11 (19%) 12 (60%) p = 0.001
Sepsis 9 (11.5%) 1 (5%) p = 0.43
Hospitalisation 14 days 38 (48%) 10 (12.8%) p = 0.16
Mortality 4 (6.8%) –
Conclusion: The infection by Hi type b was observed mainly in children
without completed immunisation. Hi b were signiﬁcantly more resistant
to ampicilin than Hi not b. Predisposal conditions, complication and
mortality were more prevalent in Hi not b infections.
R2320 Features of clinical course of measles in outbreak
M. Javakhadze, K.H. Baquzanashvili (Tbilisi, GE)
Objectives: Description of the peculiarities of the clinical course of
measles during the measles outbreak at the beginning of the XXI century.
Methods: Open type observational-descriptive study.
Results: In 2004, at the beginning of the XXI century, measles outbreak
was reported in Georgia. 392 patients with the measles diagnosis were
hospitalised during one year whereas there were total 6847 cases of
measles registered in Georgia. The cases of the disease were registered
during the whole year and reached its peak in the months of May
and June. It was adults (aged 15−30) who got mainly infected, and
the most vulnerable age group turned out t be the citizens of 20−29.
The hospitalised patients with the measles diagnosis had the following
disease symptoms: prolonged prodromal period with severe course of
disease and with complications. The main reason for hospitalisation of
the patients was the severe course of the disease and complications. Most
(50%) of the patients had bronchopneumonia, 2% of the patients had
bronchopneumonia with encephalitis and 1% had meningoencephalitis.
3% of the patients had gingivitis and 6% had ulcerous damage of oral
cavity. There was one fatal case due to measles of the patient infected
with tuberculosis registered.
Conclusion: The reason for the measles epidemics in Georgia was the
violation of anti-measles vaccination and absence of re-vaccination (the
vaccination schedule did not envisage any re-vaccination up to 2000).
The severe course of the disease, according to statistically conﬁdent
factor analysis, was simultaneously inﬂuenced by the following factors:
age, vaccination status, duration of prodromal period, duration of
temperature, duration and intensity of rush.
R2321 Herpes simplex encephalitis
S. Raﬁee Tabatabaei, A. Karimi, M. Hadipour Jahromy (Tehran, IR)
Objective: To evaluate clinical presentation, radiological and cere-
brospinal ﬂuid ﬁndings and outcome of children with Herpes Simplex
encephalitis (HSE).
Methods: The chart of all the patients (n = 18), who were admitted to the
Moﬁd Children Hospital from 2001–2005, were retrospectively reviewed.
All of them were included in this study.
The variables were identiﬁed (including demographic data, signs and
symptoms at presentation and laboratory investigations such as analysis
including, PCR and neuroimaging). Diagnosis of HSE was classiﬁed into
deﬁnite, probable and possible.
Results: Clinical ﬁndings included fever, loss of consciousness, seizure,
confusion, focal neurologic signs, vomiting, headache and behavioral
changes. CSF, analysed in all patients, was abnormal in ﬁfteen patients.
From eleven persons underwent CT, nine patients had abnormal changes
and from 8 patients who had MRI, 4 of them had hyper intensity in
temporal lobe of their brain. Deﬁnite HSE was diagnosed in seven;
Probable HSE in ten, and one patient had Possible HSE.
Conclusion: HSE remains a serious illness with high mortality and
morbidity despite appropriate antiviral therapy. Adequate antiviral
therapy should be started as soon as possible. CSF examination,
Computerised tomography and magnetic resonance imaging may provide
some clues of HSE, but negative ﬁndings should not deter or delay
treatment in suspicious cases.
R2322 Chryseobacterium meningosepticum septicaemia in a N.I.C.U.
M. Simou, T. Lazaraki, G. Liosis, I. Zorou, G. Saroglou, H. Kada
(Athens, GR)
Chryseobacterium meningosepticum is a Gram negative rod widely
distributed in nature. It is highly pathogenic for newborn infants usually
causing nosocomial infections, with high mortality rate and serious
neurological sequelae in surviving patients.
C. meningosepticum is waterborn, ubiquitously found in the hospital
enviroment and has been associated with infection via contaminated
water. This organism is usually resistant to antibiotics commonly used
for empirical treatment.
In January 2006, a two day old fullterm neonate was transferred from
the postnatal ward to Neonatal Intention Care Unit of our Hospital with
early onset neonatal sepsis.
Blood culture performed in Bact/Alert 3D-60 system (boiMe´rieux) was
positive. The microorganism grew on blood agar and chocolate agar but
not on MacConkey agar. The identiﬁcation was performed in VITEK
automated system (bioMe´rieux). Chryseobacterium meningosepticum
was identiﬁed. The strain was sensitive only to Ciproﬂoxacine,
Trimethoprim/Sulfa and Vancomycin and resistant to all other classes
of antibiotics.
Surface areas, sinks and taps in the nursery were sampled and cultured
with no detection of C. meningosepticum.
Despite proper antibiotic administration the neonate expired within 48
hours.
Two weeks later the same strain of C. meningosepticum was isolated
from a sample from a sink tap.
Control of infection in the N.I.C.U. requires an understanding of the
reservoirs and modes of transmission of nosocomial microorganisms.
Samples for bacteriological examination should be taken periodically
to determine the degree of contamination in the environment and
equipment.
The possible role of hospital staff, new borne babies and their mothers
in the transmission of Chryseobacterium meningosepticum should be
considered together with the measures taken to reduce environmental
contamination.
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R2323 Serological investigation of bacterial and viral pathogens
in children
I. Varzakakos, K. Papavasileiou, T. Panagea, G. Oikonomopoulos,
H. Papavasileiou, A. Makri, A. Voyatzi (Athens, GR)
Purpose: The aim of this study was to investigate the incidence of
community acquired lower respiratory tract ilness (LRTi), caused by
M. pneumoniae, C. pneumoniae, Inﬂuenza A and B in hospitalised
children, seasonal distribution and association with age and sex.
Material and Methods: A total of 150 patients from 2 months
to14 years old with symptoms and signs compatible with CAP were
enrolled during a 2 year period (2004–2006). Thorax radiography
and paired sera were obtained from each patient and the course of
illness was monitored uniformly. Speciﬁc IgG and IgM antibodies for
C. pneumoniae, M. pneumoniae, inﬂuenza A and B were determined
by indirect immunoﬂuorescence (Vircell, Spain) and Immunocard based
IgM EIA (Meridian France) for the detection of antimycoplasma IgM
antibodies. Diagnosis was established by the presence of speciﬁc IgM
antibodies or by detection of fourfold increase of IgG antibody titers.
Results: Speciﬁc IgG and IgM positive antibodies titer was found for
Mycoplasma pneumoniae in 28 patients (18.6%), C. pneumoniae in 3
(2%), inﬂuenza A in 9 (6%) and inﬂuenza B in 12 cases (8%). In one
case coexistence of M. pneumoniae and C. pneumoniae was observed
(0.7%) and in 2 cases coinfection of M. pneumoniae and inﬂuenza B
was demonstrated (1.4%). No signiﬁcant difference between sexes was
found. The average age for M. pneumoniae infections was 7−12 years
and for C. pneumoniae was 2−5 years. Signiﬁcantly higher frequency
of M. pneumoniae infections was recorded during the two last winter
months and the springtime while C. pneumoniae infection mostly occurs
in autumn.
Conclusion: The results show the high incidence of M. pneumoniae
in the aetiology of lower respiratory tract infections and the relatively
low frequency of C. pneumoniae infections in Greek hospitalised
children, especially in children older than 7 years. The knowledge of
the prevalence of bacterial or viral respiratory pathogens or coexistence
of them helps to choose the appropriate antibiotic treatment in children
with CAP. Special antibiotic treatment with macrolides is advisable to
be induced for better treatment of C. pneumoniae infection.
R2324 Risk factors in the development of latent forms of
intrauterine infections in neonates with perinatal pathologies
N. Gorovenko, Z. Rossokha, S. Podolskaya (Kiev, UA)
Objectives: The prevalence of intrauterine infections in neonates is
mainly studied in case of evident clinical presentations. But latent forms
of these infections are also dangerous because of reducing the resistance
of neonates. There is a risk of intrauterine infections manifest forms in
neonates with severe perinatal pathologies. The purpose of the research
was studied the prevalence of intrauterine infections latent forms in
neonates and past histories analysis.
Methods: The prevalence of causative agents of intrauterine infections
was investigated in neonates with severe perinatal pathologies and
in neonates of the comparative group (clinical healthy neonates).
Also was analysed retrospectively risk factors. The neonate’s blood
analysis with the purpose of detecting DNA of Toxoplasma gondii,
Chlamydia trachomatis, Mycoplasma hominis, Herpes virus I/II types,
Cytomegalovirus was tested by means of polymerase chain reaction
(PCR). Differences in these groups were assessed by the Pearson chi-
square analyses.
Results: There were detected latent forms of intrauterine infections in
74 of 117 (63.24%) neonates with perinatal pathologies as compared to
the comparative group the neonates where the frequency of latent forms
accounted for 9 of 70 neonates (12.85%). When analysing perinatal risk
factors it has been detected a signiﬁcantly increase (16.68, P< 0.001)
in the rate of complications in obstetric and gynecologic past history
of infected patient’s mothers (56.75%; 42 of 74 mothers) as compared
to uninfected patient’s mothers (16.27%; 7 of 43 mothers). Thus, the
presence of such complications in the past history in the patient’s mothers
is a risk factor for the development causing intrauterine infections latent
forms.
Conclusion: The neonates with perinatal pathologies whose mothers had
complications in the past history are to be studied with the purpose of
detecting latent forms and preventing clinical presentations.
R2325 A child with endocarditis due to Enterobacter cloacae
responded to long-term antibiotic treatment without
cardiac surgery
R.R. Klont, J.G. Noordzij, P. Bot, T. Schu¨lin-Casonato, A. Warris
(Nijmegen, NL)
Background: Infective native valve endocarditis due to Gram-negative
bacilli is rare. Enterobacter endocarditis occurs primarily in patients with
foreign bodies, mechanical and prosthetic valves, intravenous drug abuse
and cardiac surgery.
Case report: A seven-year-old boy with insulin dependent diabetes
mellitus presented with fever. One year earlier the central venous
catheter (CVC) which was required for the administration of insulin, was
replaced because of a catheter related infection. His medical history was
otherwise uneventful. Blood cultures taken at admission were positive for
E. cloacae. Treatment was started with trimethoprim-sulphamethoxazole
(SXT; 30/6mg/kg/d) intravenously. Ciproﬂoxacin (CIP; 16mg/kg/d) and
cefotaxime (100mg/kg/d) were added after 24 h when repeated blood
cultures were again positive for E. cloacae and the patient began to
deteriorate. The next day the CVC was removed without improvement of
the patient’s condition. Culture of the tip of the CVC was negative. Due
to persistent positive blood cultures antibiotic treatment was switched to
CIP and tobramycin (7mg/kg/d) on day 6. The patient developed a septic
shock and was transferred to the intensive care. On day 11, antibiotic
treatment was changed to meropenem (MEM; 60mg/kg/d). New blood
cultures were positive for E. cloacae although susceptible in vitro for
SXT, CIP, MEM, and ceftriaxone with a minimal inhibitory concentration
(MIC) of 0.5mg/L, 0.125mg/L, 1mg/L, and 1mg/L respectively.
Gentamicin (7mg/kg/d) was added 4 days later because of persistent
positive blood cultures and high fever. Ultrasound of the abdomen
and left subclavian vein, cerebral CT scan, and PET scan showed no
abnormalities. CT scan of the abdomen showed an enlarged spleen and
lymphadenopathy but no abscess. Transoesophageal echocardiography
revealed an abnormal structure in the right atrium (not detected by
earlier transthoracic echocardiography), consistent with endocarditis. The
dosage of MEM was increased (120mg/kg/d) and the patient became
afebrile 5 days later. The last positive blood culture was obtained 7
days after initiation of this antibiotic regimen and 27 days after his ﬁrst
presentation.
Conclusion: E. cloacae endocarditis is a rare complication of catheter
usage. The optimal treatment of E. cloacae endocarditis is not known.
Our patient recovered from this serious infection by antibiotic therapy
and is currently doing well being on antibiotics without the need for
cardiac surgery.
R2326 Brodies abscess: a diagnostic dilemma
A. Pillai, S. Thomas, N. Walker (Glasgow, Manchester, UK)
Introduction: Brodie’s abscess is a subacute osteomyelitis which
presents a diagnostic difﬁculty, as characteristic signs and symptoms of
the acute form of the disease are absent. It has an insidious onset, mild
symptoms and lacks a systemic reaction. Unlike other abscesses, markers
of infection are rarely raised making diagnosis difﬁcult. In children and
young adults Brodie’s abscess can mimic various benign and malignant
conditions including Ewing’s and osteogenic sarcoma.
We report a case of Brodie’s Abscess in a 16 year old where aspiration
to rule out infection was delayed due to possible pitfalls of seeding an
undiagnosed neoplasm. Urgent and appropriate imaging was necessary.
We highlight a diagnostic dilemma for the microbiologist where input
comes only upon deﬁnitive tissue diagnosis following which aggressive
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treatment with prolonged antimicrobial therapy and close microbiology
support is needed.
Case report: A previously healthy 16 year old presented to the
orthopaedic clinic with a 4 week history of upper left leg pain. There
was associated night pain but no weight loss, systemic symptoms,
history of trauma or raised infection markers. On examination there was
localised tenderness to the upper third of the tibia. Initial plain X-Ray
demonstrated a lytic abnormality suggestive of chronic infective process,
but a neoplasm couldn’t be ruled out. An urgent CT demonstrated a
single lesion of the tibia with bony destruction and either free ﬂuid or
solid tissue with sclerotic margins. It was unclear whether an area of
bone within the lower margin represented a sequestrum or bony nidus.
At this point exclusion of malignancy was essential prior to aspiration
of the lesion.
The patient was referred to an orthopaedic oncologist and an MRI was
arranged. The MRI report was consistent with infection. The patient
was taken to theatre for urgent derooﬁng, curatage and cavity washout.
50ml of thick purulent material was evacuated from the cavity under
pressure which grew S. aureus sensitive to Flucloxacillin. Bone histology
conﬁrmed sclerotic, inﬂamed bone consistent with Brodie’s abscess.
Discussion: In children, differentiation of Brodie’s abscess from
possible neoplasm requires clinical suspicion and careful radiological
imaging. Once diagnosed, immediate input and ongoing discussion
with microbiology is essential. Effective treatment requires prolonged,
monitored antimicrobial therapy. A multidisciplinary team approach is
essential.
R2327 Urinary tract infection in asymptomatic jaundiced newborns
Z. Mosayebi, A. Movahhedian (Kashan, IR)
Objectives: The incidence of neonatal urinary tract infection (UTI)
varies from 0.1% to 1% of all infants. Previous studies have noted
that jaundice may be one of the ﬁrst signs of bacterial infection
in infants. The aim of this study was to evaluate the incidence of
UTI in asymptomatic jaundiced newborns admitted for evaluation and
treatment of indirect hyperbilirubinaemia in Beheshti Hospital (Kashan-
Iran) during 15 months period.
Methods: We prospectively investigated 377 asymptomatic jaundiced
newborns during the study period.A bilirubin work up as well as
urinanalysis and urine culture by bag were performed for all patients.
If the urine culture was positive, a suprapubic aspiration were done.
Newborns with positive urine culture by suprapubic aspiration results
were accepted as having UTI.
Results: Of 377 newborns with indirect hyperbilirubinaemia UTI was
diagnosed in 13 cases (3.4%). Isolated organisms included Escherichia
coli (70%), Klebsiella pneumoniae (23%) and Staphylococcus epider-
midis (7%). UTI was more common in male and term newborns.
The mean serum bilirubin level of neonates with UTI was 19.4mg/dl
(SD= 3.2). Eight newborns with UTI had bilirubin level greater
than 20mg/dl.
Patient with the onset of jaundice after 7 days of age had a higher
incidence of UTI.
Conclusion: UTI can be associated with neonatal indirect hyperbiliru-
binaemia. We recommend that urine culture be included as part of the
evaluation in asymptomatic jaundiced newborns.
R2328 Isolation of group B Streptococcus from blood cultures of
newborns at a large Brazilian hospital
G. Duboc-almeida, M. Buratinni, R. Teberges, F. Rossi (Sao Paulo, BR)
Background: Group B Streptococcus (GBS) remains an important cause
of serious neonatal infection. The majority of infections in newborns
occur within the ﬁrst week of life (early-onset disease). Approximately,
10−30% of pregnant are asymptomatic GBS carriers representing a risk
to newborns. In 2002, the CDC published new guidelines for prevention
of GBS perinatal disease which advocates universal screening of all
pregnant women between 35−37 weeks of gestation. Despite that, no
ofﬁcial programme was available in our hospital until recently.
Objective: To analyse the occurrence of GBS in blood cultures collected
from patients from 2000 to 2005 at Hospital das Clı´nicas, a 2000 bed
tertiary hospital, particularly in newborns.
Methods: Blood cultures were processed in a Bactec 9240 and GBS
were identiﬁed according to conventional methods and using a latex
agglutination test.
Results: During the study period, 93 patients with positive blood culture
for GBS were identiﬁed. Of these, 27 (29%) were children, 22 were
newborns. The median age of the newborns at index blood culture was
2.5 ± 8.7 days. 6 patients were male. In 72% of the cases, the episode
was classiﬁed as early-onset sepsis.
Conclusions: These data demonstrated the occurrence of GBS as a cause
of neonatal sepsis in our hospital. The high percentage of early onset
sepsis emphasizes the need to implement the CDC recommendations for
the prevention of perinatal group B streptococcal disease.
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R2329 Prevenar use in children older than ﬁve years
G. Kuli-Lito, G. Sulcebe, Z. Ylli, E. Kallfa (Tirana, AL)
Prevenar (PCV7) is used successfully in infants and children up to 24
months. After its wide use and inclusion in immunisation schedule, a
substantial decrease in incidence of bacteraemia is noticed during last
ﬁve years in countries where the vaccine is routinely applied.
Objectives: To demonstrate the seroconversion rate after the use of
Prevenar in children older than 5 years. To evaluate the clinical beneﬁts
and vaccine safety in this age group.
Material and Methods: We vaccinated with Prevenar 35 children
aged 5−11 years who meet the criteria of high or moderate risk of
invasive pneumococcal infection. Antibody titers were determined by
the method of ELISA at the day 0 and 4−6 weeks after vaccination.
20 unvaccinated children, with no signiﬁcant difference in age and
gender, were considered as control group. Paired pneumococcal antibody
titers were obtained from them at the same time interval. Solicited local
and systemic reactions were recorded in subjects up to 2 weeks after
vaccine administration. The follow up period was one year.
Results: A satisfying seroconversion is registered in children 4−6 weeks
after vaccination. The geometric mean of pneumococcal antibody values
at day 0 and 4−6 weeks after, were respectively 46.78 (R: 11.8–260)
and 150.16 (R: 36.4–451). The difference between two values resulted
statistically signiﬁcant (p< 0.002). The same calculations were done
for pneumococcal antibodies values even for the patients of control
group. The mean geometric values at ﬁrst and second measurement
were respectively 20.67 (R: 14.6–168) and 29.81 (R: 16.8–183), p> 0.05.
The patients had a clinical improvement after vaccine application. No
important respiratory tract diseases or invasive infections were seen
during the follow up period. No vaccine related serious adverse events
were reported for vaccine group. The overall rate of systemic reactions
(high fever) was 2.86%.
Conclusions: PCV7 is immunogenic even when administrated to
children older than 5 years old. No important side effects are reported
after vaccine use.
R2330 A serological survey of measles among a group of adults
receiving measles, rubella booster mass vaccination in Iran,
2003. A preliminary report
A. Emami Naeini, M. Rostami (Isfahan, IR)
Objective: Measles immunisation in Iran is an expanded programme.
Since 1973 to December 2003, all infants received live attenuated
measles vaccine (A.I.K strain, Razi institute, Iran) at 9th and 15th
months of life. Before 2003, we had confronted outbreaks of measles in
previously vaccinated adults from all over the country. Epidemiological
serologic studies revealed a low (40.7%) positive antibody titer in some
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vaccinated individuals, implying that the majority of vaccinated subjects
were susceptible to measles. In December 2003 Ministry of health of Iran
performed one of the biggest vaccination campaign against measles and
rubella for all 5 –25 year old persons. Around one-half of the Iranian
population received the measles (Edmonston strain) and Rubella (RA
27/3 strain) vaccines at the same time. The aim of this preliminary
study is to ﬁnd out seroprevalence of measles antibody titer in a group
of subjects who received the infancy and booster dose of MR vaccine.
Methods:We conducted this cross-sectional survey on subjects referring
to a university clinic for marriage consultation. The subjects100 (50 male
and 50 female) aged 19to28. All had received their routine vaccines
against measles during their infancy, had no physician diagnosed measles
and revaccinated in December 2003. We considered Immune Status Ratio
(ISR) of 0.90 as negative, 0.91–1.09 as intermediate, 1.10 as positive.
The IgG was measured by using ELISA method. Data were analysed by
Chi-Square test, and one –way analysis of variance using SSPS software
version12.
Results: ninety-six (96%), three (3%) and one (1%) of the subjects
had positive, negative and intermediate antibody titers, respectively. The
mean serum titer in female was 1.92IU/mL and in male 1.95.
Conclusion: In our study 96 (96%) of subjects (49 male, 47 female)
had positive antibody titer, meaning that there has been a good vaccine
induced protection for the majority of vaccinated subjects and it shows
our mass vaccination dramatically increased the number of seropositive
persons and there is a signiﬁcant differences between pre and post
vaccination (P< 0.0001). No statistically signiﬁcant correlation was
found between antibody titer and age (P = 0.06). The correlation between
antibody titer and sex also did not turn to be statistically signiﬁcant
(P = 0.05). After 2003 our measles vaccination schedule changed to
MMR (Measles, Mumps, Rubella) vaccine at 15 months of age and
a second booster dose at 4−6 years old children.
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Objective: The response of the international community to a disaster
pivots on the need for cooperation among different countries, organisa-
tions and professional ﬁgures. Epidemics are a likely consequence of the
poor hygienic conditions in IDP (internally displaced people) settlements
in particular during late and post emergency phases.
Our objective is to construct a website with a double aim. On one hand
to provide updated news, manuals and links for humanitarian operators
on the ﬁeld, promoting information sharing to achieve common quality
standards for assistance worldwide. On the other hand, through the use
of a forum, to provide a space of discussion and alert from the ﬁeld in
matters related to novel outbreaks and evolving humanitarian crisis.
Methods: Professional ﬁgures such as psychologists and international
law and geo-policy experts have worked together with hygienists and
infectious disease physicians with the aim of providing a comprehensive
and colloquial approach to the issues raised in epidemics and
humanitarian crisis in particular in developing countries. The effort has
produced a website with a phpnews data insertion, a multiple page forum
and several speciﬁc thematic areas.
Results: The website, www.choleracafe.com, is a pilot programme
approved of by the University of Rome “La Sapienza” department
of Infectious and Tropical Diseases. It is composed of sections
dedicated to: Infectious diseases, vaccination and prophylaxis, minimum
standards, epidemiological surveillance, psychological support, legal
issues and human rights, aero transport of highly contagious diseases
and provides useful links regarding country information and international
organisations. Moreover a manual called “Basic International emergency
setting ﬁeld manual” has been compiled by the working group and
is freely downloadable from the website. This instrument acts as a
digest of the current standards in topics such as disaster management,
psychological support, water and sanitation, reporting, evaluation, media
and communication.
Conclusions: E-learning has developed in recent years to become a
major source of information that is easily accessible, speciﬁc and
universally accepted. Cholera Cafe’ is a website, forum and news
resource for Professionals involved in International Health Promotion in
the ﬁeld of Communicable disease prevention, surveillance and treatment
that has moved beyond organisation-speciﬁc websites.
